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"and I needed you tonight, but you've gone to heaven 
and if you could see me now, would you remember 
how you use to hold me close 
how you always felt like home 
and I know I feel alone 
              but there's an angel looking out for me tonight" 
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Abstract 
The aim of this work was to study the anti-diabetic potential of different berry-producing 
plants. Their mineral and phytochemical composition was studied by inductively coupled plasma 
- mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem 
mass spectrometry analysis, respectively. A static model to simulate gastrointestinal digestion 
was employed to analyse the stability of phenolic compounds from targeted species. The 
mechanism of hypoglycaemic activity was evaluated in terms of in vitro inhibitory action on key 
digestive enzymes linked to type-2 diabetes (α-,β-glucosidases and α-amylase) and obesity 
(pancreatic lipase). Additionally, the inhibitory effect towards human aldose reductase and 
protein glycation, associated with long-term diabetic complications, was determined. The 
antioxidant activity of methanolic extracts was investigated using four different free radicals 
(ABTS•+, DPPH•, NO• and O2•-). Finally, the cytotoxicity of analysed species was assessed in 
Caco-2 cells by the resazurin reduction fluorescence method. 
Berry species proved to be good sources of essential minerals, some of which, are known 
to possess hypoglycaemic effects. Analysed extracts showed diverse phytochemical profiles, 
anthocyanins, hydroxycinnamic acids, flavonols, flavan-3-ols and ellagitannins being the 
dominant compounds. Extracts showed a stronger inhibition towards glucosidases and were 
moderate inhibitors of α-amylase and pancreatic lipase. Potent inhibitory effects were observed 
in aldose reductase assay and towards formation of advanced glycation end-products. 
Additionally, good antioxidant activities were observed. Preliminary cytotoxicity measurements 
revealed that plant extracts can be considered safe for human consumption. The phenolic content 
and biological activities were substantially affected by the simulated in vitro digestion. Still, 
positive health effects were verified for digested samples. 
The generated data about these berry-producing plants and their potential effect on the 
management/control of type-2 diabetes and prevention of associated complications may be useful 
in designing future dietary/nutraceutical strategies aimed at alleviating hyperglycaemia. 
 
 
Keywords: Type-2 Diabetes; Berry-producing plants; Phenolic Compounds; Enzyme inhibition; 
Anti-glycation; Antioxidant activities.  
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Resumo 
O objectivo deste trabalho foi estudar o potencial antidiabético de diferentes plantas 
produtoras de bagas. A composição mineral e fitoquímica foi estudada recorrendo, 
respectivmente, a plasma indutivamente acoplado a espectrometria de massa e cromatografia 
líquida de alta eficiência com espectrometria de massa. Um modelo estático para simular a 
digestão gastrointestinal foi utilizado para analisar a estabilidade dos compostos fenólicos das 
espécies alvo. A actividade hipoglicémica foi avaliada in vitro em enzimas digestivas ligadas à 
diabetes tipo-2 (α, β-glucosidases e α-amilase) e à obesidade (lípase pancreática). O efeito 
inibitório sob a actividade da aldose reductase e a glicação de proteínas, associadas a 
complicações diabéticas, foi também determinado. A actividade antioxidante dos extratos foi 
investigada usando quatro radicais livres diferentes (ABTS•+, DPPH•, NO• e O2•-). Finalmente, a 
citotoxicidade das espécies analisadas foi avaliada em células Caco-2 pelo método da redução da 
resasurina.  
As bagas mostraram ser boas fontes de minerais essenciais, alguns com atribuídas 
capacidades hipoglicémicas. Os extratos analisados apresentaram perfis fitoquímicos diversos, 
sendo as antocianinas, os ácidos hidroxicinâmicos, os flavonóis, os flavan-3-oís, e os elagitaninos 
os compostos dominantes. Os extratos demostraram fortes inibições para as glucosidases e foram 
inibidores moderados da α-amilase e da lipase pancreática. Foram observados potentes efeitos 
inibitórios no ensaio da aldose reductase e na glicação de proteínas. Adicionalmente, observaram-
se boas actividades antioxidantes. A avaliação preliminar da citotoxicidade dos extractos, revelou 
que são seguros para o consumo humano. O conteúdo fenólico e as atividades biológicas foram 
substancialmente afectados pela simulação in vitro do processo de digestão. Contudo, foram 
verificados efeitos positivos para a saúde nas amostras sujeitas à digestão.  
Os dados gerados sobre as plantas produtoras de bagas analisadas relativamente ao 
potencial controlo da diabetes tipo-2 e prevenção de complicações associadas podem ser úteis no 
desenvolvimento de futuras estratégias dietéticas/nutracêuticas destinadas a aliviar a 
hiperglicemia. 
 
Palavras-chave: Diabetes tipo-2; Plantas produtoras de bagas; Compostos fenólicos; Inibição 
enzimática; Anti-glicação; Actividade antioxidante.  
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Preamble 
The present work was developed in the Laboratory of Natural Products and Organic 
Chemistry (NatLab) of the Madeira Chemistry Centre (CQM), University of Madeira (Portugal). 
This study arises from the need to investigate the potential effects of edible and non-
edible plants on the control/management of type-2 diabetes and obesity, as an alternative to 
current pharmaceutical drugs. The phytochemical profiles, ability to inhibit key digestive 
enzymes and protein glycation, and antioxidant activities were studied. The initial work plan of 
this Ph.D. project consisted of a list of more than 30 plants. Considering the results of an initial 
screening (yeast α-glucosidase and α-amylase assays), the plant list was shortened and we decided 
to focus the investigation on berry-producing plants regarding their higher inhibitory activities 
towards key carbohydrate-hydrolysing enzymes. 
For a better understanding, the dissertation is organized in six parts. In Chapter I – 
Introduction, a general contextualization on the scientific topics addressed in the dissertation is 
given. Afterwards, Chapter II – Materials and Methods provides an explanation of the procedures 
and analytical assays conducted in this study. Chapter III – Results and discussion is organized in 
five sub-chapters: (A) addresses the phytochemical profiles (mineral and phenolic composition) 
of berry-producing plants under study; (B) concerns the ability of analysed extracts to inhibit the 
activity of key digestive enzymes linked to type-2 diabetes and obesity; (C) the inhibitory capacity 
of human aldose reductase activity and bovine-serum albumin glycation by fructose and ribose 
were assessed; (D) the antioxidant activity of plant extracts was determined against four free 
radicals by colorimetric assays; (E) a preliminary evaluation of the cytotoxic effects of selected 
extracts was assessed in Caco-2 cells. Chapter IV – Conclusions and Future Perspective is devoted 
to the final considerations of this project. Finally, the dissertation is completed with the references 
used, as well as complementary data. 
The central part of this dissertation is formed by four already published scientific papers 
(I to IV - List of publications). The remaining data are being prepared to submit for publication 
in international, peer-reviewed journals in the near future. Throughout this study, other articles 
were published referring to the plant species not included in this dissertation, which are listed in 
the Curriculum Vitae of the author. 
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1. Diabetes 
Diabetes mellitus (DM) is becoming one of the most common chronic metabolic disorders 
worldwide (Figure 1) that results from disturbances in glucose homeostasis [1–6]. The global 
prevalence of DM in 2017 was 425 million among adults and it is estimated to affect almost 630 
million people by 2045 (Figure 1), becoming the 7th leading cause of death in developed countries 
[7,8]. In Portugal, the estimated prevalence of DM in 2015 was 13.3%, that is, more than 1 million 
Portuguese in the 20-79 age group had DM [9]. Due to its high incidence and the vast range of 
associated health complications, this disease presents a  significant burden in health care systems 
[2,5,8–10].  
 
Figure 1 – Prevalence of Diabetes mellitus (DM) worldwide and per region in 2017 and 2045 (20 – 79 age 
group) (adapted from [8]). 
DM is associated with deficiency or abnormalities in insulin secretion, or 
insensitivity/resistance to the metabolic action of this hormone in its target tissues, which results 
in raised blood sugar levels (hyperglycaemia) [3,11–13]. Lack of insulin leads to an improper 
balance of glucose homeostasis and disturbances of lipid and protein metabolism [1,3,14,15]. 
Failure of control of glucose homeostasis results in the metabolic syndrome, which comprises 
hyperglycaemia, glucose intolerance, chronic inflammation, dyslipidaemia and hypertension. 
This combination of pathological conditions leads to changes in the structure and function of 
major organs and tissues, especially the eyes, kidneys, nerves, heart and blood vessels. Overall, 
this condition diminished the patient quality of life and can lead to life-threatening complications 
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(neuropathy, nephropathy, retinopathy, artherosclerosis, macro- an microvascular damage, etc) 
and ultimately pre-mature death [3,4,14–16]. 
DM is commonly categorized into two main groups: type 1 diabetes (T1DM) (insulin-
dependent DM) and type 2 diabetes (T2DM) (non-insulin dependent DM) [1–4,16]. The first case 
is characterized by insufficient or no endogenous insulin production and it accounts for 5 - 10% 
of the total cases, showing a higher incidence in children and adolescents. T1DM arises by 
autoimmune processes or infections, where pancreatic β-cells are destroyed and fail to produce 
insulin [1–3,5]. Hence, treatment of T1DM involves the administration of exogeneous insulin [2–
4]. In the second category, the produced insulin by pancreatic β-cells is ineffective and insulin-
dependent tissues (muscle, adipose tissue, liver, etc) show variable degrees of resistance to the 
insulin action [1–3,5,15]. T2DM is the predominant form (approximately 90 - 95% of all cases) 
and is generally related with older age, calorie overload, overweight, obesity, sedentary lifestyle 
and genetic factors [1–3,10,17].  
T2DM is considered a “sneaky condition” since its harmful long-term complications 
develop slowly over many years before it is diagnosed [2]. “Pre-diabetes” is an intermediate stage 
for individuals with higher blood glucose or glycated hemoglobin A1C (HbA1C) levels than 
normal, but not high enough to meet the diagnostic criteria for T2DM [2,8,10]. Pre-diabetes is a 
warning status to the predisposition of developing T2DM and increases the risk of developing 
retinopathy, nephropathy, neuropathy, cardiovascular diseases and stroke [2,5,8,10]. Unlike 
T1DM, this condition can be controlled and even reverted with the right lifestyle alterations, 
including regular physical activity and weight loss and dietary intervention, by increasing 
consumption of fruits and vegetables, whole grains and nuts in appropriate amounts [1–4,16,18]. 
It has been suggested that 90% of T2DM cases could be potentially prevented [1]. This reversible 
particularity has made it a popular target of research, in order to find new ways to prevent/control 
or even avoid the onset of T2DM [2].  
1.1. Carbohydrate Metabolism and Glucose homeostasis 
At normal physiological state, glucose homeostasis is maintained by the peptide 
hormones insulin and glucagon, which tightly control blood glucose levels after ingestion of 
carbohydrate-rich meals [2,3,5].  
1.1.1. Carbohydrate Digestion and Absorption 
In humans, complex dietary carbohydrates (starch, sucrose, maltose, lactose, etc) are 
broken down into smaller molecules (glucose, fructose, etc) in the gastrointestinal (GI) tract 
before absorption [2,19,20]. α-Amylase (AMY) and α-glucosidase (AGLU) are the key enzymes 
in the digestion of dietary carbohydrates [2,16,19,20].  
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1.1.1.1. α-Amylase 
AMY (α-1,4-glucan 4-glucanohydrolase; EC 3.2.1.1) (aprox. 55 kDa) performs the first 
step in the digestion of dietary polysaccharides, hydrolysing the α-1,4-glycosidic linkages of 
starch, glycogen, amylose and amylopectin [2,3,16,19].  Digestion of carbohydrates begins in the 
mouth. However, the action of salivary AMY is limited by the short time that food remains in this 
stage (about 5 % of carbohydrate digestion). Digestion by salivary AMY continues after the food 
reach the stomach, as long as 30 minutes. Then, its activity is stopped due to the high-acidic 
environment of the stomach. At the small intestinal, pancreatic AMY catalyses the hydrolysis of 
the remaining starch (about 70% of overall digestion) [19,20]. Maltose, isomaltose, maltotriose, 
and α-dextrins are the major products of AMY digestion and AGLU enzymes substrates [2–
4,16,18,20].  
1.1.1.1.  Glucosidases 
Glucosidase enzymes (including isoforms lactase, maltase, and sucrase) (260 kDa) are 
located in the brush border membrane of small intestine cells (enterocytes) [18–20]. Glucosidases 
complete the hydrolysis of oligosaccharides to monomer units [2,4,16,20]. Sucrose is hydrolysed 
by sucrase (sucrose alpha-glucosidase; EC 3.2.1.48) into glucose and fructose, while isomaltose 
is converted into glucose units by sucrase-isomaltase (oligo-1,6-glucosidase; EC 3.2.1.10). 
Maltose is hydrolysed by maltase (or maltase-glucoamylase; EC 3.2.1.20) [2,19,20]. All these 
enzymes present AGLU activity, which is the hydrolysis of (1->4)-α-glucosidic bonds 
[2,16,19,20]. β-Glucosidases (BGLUs) are brush border enzymes that hydrolyses (1->4)-β-
glucosidic linkages, such as those found in lactose. Lactase (β-galactosidase, EC 3.2.1.108) is 
responsible for the hydrolysis of lactose resulting in galactose and glucose units [19]. 
Among all the enzymes involved in the carbohydrate digestion process, AGLU enzymes 
seem the most important due to the rate-limiting step in sugar hydrolysis [14,20].  
Glucose, the main product of carbohydrate digestion, is highly hydrophilic and its intra-
cellular transportation must be aided by specific glucose transporters (GLUTs) [3,5,19]. Glucose 
is actively taken up in the intestinal lumen against its concentration gradient (active transport) by 
the sodium-dependent glucose transporter-1 (SGLUT-1) located in the brush border of the 
enterocytes [2,3,5,16,19]. Then, glucose is passively released (facilitated diffusion) into the blood 
circulation via the glucose transporter-2 (GLUT-2), present in the basal and lateral membranes of 
enterocytes [2,3,5,19].  
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1.1.2. Glucose Homeostasis 
When glucose enters the pancreas via GLUT-2, it is metabolized for energy production 
(glycolysis and Krebs cycle) which signals β-cells to produce and secrete insulin and suppress 
glucagon production by α-cells (Figure 2) [2,3,16,19]. Then, insulin controls the rise of blood 
glucose by promoting the uptake of glucose in peripheral tissues (muscle, liver and adipocytes) 
through translocation of GLUT-4 to the plasma membrane, enhancing glucose utilization/storage 
in the muscle and liver (glycolysis/glycogenesis) and inhibiting lipolysis and promoting 
lipogenesis in adipocytes (Figure 2)  [2,3,5,16,19].  
 
Figure 2 – Maintenance of glucose homeostasis by insulin and glucagon regulatory action (adapted 
from[8]). 
Under fasting or between meals, blood glucose concentrations decrease to under a 
particular level (< 4 mM) and pancreatic α-cells secrete glucagon (Figure 2) [2,3]. This 
counterregulatory hormone acts initially on the liver, activating catabolic pathways 
(glycogenolysis and gluconeogenesis) to raise blood glucose to normal levels (Figure 2) [3,16]. 
Any metabolic dysregulation, associated with absolute or relative deficiency in insulin secretion 
or action, contributes to the development of hyperglycaemia due to depletion of glycogen storage 
and increased gluconeogenesis [1–3,16]. Uncontrolled or poorly managed hyperglycaemia leads, 
ultimately, to the onset of DM [3]. 
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1.2. Pathogenesis of Type-2 Diabetes 
Over the past few decades, lifestyles changes characterized by excessive calorie intake 
(sugars and saturated-fats rich foods) and sedentary life have promoted overweight and obesity 
[1,5,18,21]. Obesity is a debilitating condition characterized by excess body fat accumulation, 
and is a key contributing risk factor for cardiovascular disease and T2DM [1,5,21–23]. 
Obesity-linked T2DM is associated with dyslipidemia, low-grade inflammation due to 
increased release and action of proinflammatory cytokines from adipose tissue (interleukin (IL)-
6), nuclear factor-kappa B (NF-kB) and tumor necrosis factor-alpha (TNF-α) and activation of 
inflammatory signaling pathways, which impede insulin action in peripheral tissues [1,16,17,23].  
Insulin resistance usually precedes and predicts the onset of T2DM (pre-diabetes) and is 
characterized by the reduction of glucose uptake in peripheral tissues (Figure 3) [2,3]. As a 
mechanism of compensation, there is an increased secretion of insulin by the pancreas 
(hyperinsulinemia) through which normal glucose tolerance is preserved [4–6]. Overtime, insulin-
dependent cells become desensitized to insulin and β-cells fail to produce more insulin due to 
exhaustion (dysfunction), resulting in chronic hyperglycaemia [3] (Figure 3). In addition, 
activation of hepatic glucose production (glycogenolysis and gluconeogenesis) contributes to 
fasting hyperglycaemia. In this scenario, the muscle glucose uptake is reduced and glycogenolysis 
and muscle proteolysis are also enhanced. Similarly, there is activation of lipolysis in adipose 
tissue with elevation of fatty acids (FAs) and glycerol in the bloodstream (Figure 3). 
Hyperglycaemia is a pre-requisite for the development of T2DM and is mainly caused by 
insulin resistance and impaired insulin secretion due to β-cell dysfunction [2,3,5,13,15]. Chronic 
exposure to glucose (glucotoxicity), free fatty acids (FFAs) (lipotoxicity) as well as increased 
secretory need for insulin, due to insulin resistance, lead to the diminution of pancreatic β-cell 
mass and further continues the progression of diabetes and its complications (retinopathy, 
nephropathy, neuropathy, cardiovascular disease, etc) (Figure 3) [2,3,16]. 
1.3. Oxidative stress and Type-2 Diabetes 
Under normal homeostatic conditions, reactive oxygen and nitrogen species (ROS and 
RNS, respectively) like superoxide anion (O2•-), hydrogen peroxide (H2O2), hydroxyl radical              
(OH•-), nitric oxide (NO•) and peroxynitrite (ONOO-) are involved in important physiological 
processes, including defence against infections, regulation of certain biological processes 
(vascular tone and blood pressure) and key cellular functions (gene expression, cellular growth, 
differentiation, mitochondrial function and apoptosis) [2,12,24–28]. They are highly unstable and 
reactive oxidized molecules due to one or more unpaired electrons [2]. During the normal aerobic 
metabolism, ROS are mainly generated by the mitochondrial respiratory chain and inflammation 
processes [12]. Additionally, exogeneous sources like ultra-violet (UV) and gamma radiation 
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exposure, xenobiotic agents (toxins, pesticids, herbicids), polluents, drugs and diet can induce 
ROS [4,17]. 
 
Figure 3 – Overall pathophysiology of T2DM development, with hyperglycaemia and oxidative stress as 
the key central mechanisms responsible for the development and progression of diabetic complications. 
At normal conditions, the human organism naturally defends itself from ROS/RNS with 
endogenous antioxidants, including superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidase (GPx), glutathione reductase (GRx) and hemeoxygenase (HO)[4,12,15,17,26]. Non-
enzymatic antioxidants include gluthatione, bilirubinuric acid, coenzyme Q, melanin and lipoic 
acid [12,17,26]. Additionally, diet can provide exogeneous antioxidants like vitamins (A, C, E), 
phenolic compounds (PCs), carotenoids, tocopherols and minerals [2,12,26].  
Antioxidants are effective to neutralize the toxic effects of ROS/RNS [2,26,27]. However, 
the imbalance between these reactive species and the antioxidant defences, due to an 
overproduction or reduction in the removal of free radicals from cells, may cause structural 
deterioration and instability of macromolecules (proteins, membrane lipids, nucleic acids) 
resulting in cellular oxidative damage and eventually apoptosis [2–4,17,24,26]. This condition is 
referred to as “oxidative stress” (OS) and is considered a deleterious factor in the occurrence of 
several chronic pathologies (cardiovascular, neurodegenerative, cancer, etc) including pre-
diabetes and onset of late complications [2,3,12,15,17,24,27].  
It seems that hyperglycaemia alone is not exclusively responsible for the later diabetic 
complications since usually hyperglycaemia is not detected until severe complications become 
clinically evident [2,4]. In fact, a loop between hyperglycaemia and OS plays a pivotal role in the 
initiation, promotion, and progression of T2DM (Figure 3) [2–4,12,13,15]. Hyperglycaemia 
triggers glucose autoxidation, increased  flux through polyol and hexosamine pathways, 
activation of protein kinase C (PKC) and increased formation of advanced glycation end-products 
(AGEs) [1,3,12–14,17]. All these detrimental pathways increases the generation of ROS which 
further enhances OS, contributing to various diabetic complications (Figure 3) [3,4,12,13].  
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The major cellular OS comes from overactivation of xanthine oxidase and NADPH 
oxidases enzymes, but mainly from mitochondrial respiration (electron transport chain complex). 
Hyperglycaemia condition leads to an overproduction of mitochondrial O2•-, which is the key 
event for the activation of other detrimental pathways involved in oxidative stress-related diabetic 
complications [12,13,17]. Additionally, the combination of excessive O2•-  and NO leads to the 
formation of ONOO-, a powerful oxidant responsible for lipid peroxidation [2,12,17,27]. When 
occurring, lipid peroxidation exert cellular damages associated with pathophysiology of 
inflammation, atherosclerosis, etc [12,17,29]. OS activates intracellular stress-signaling pathways 
(via NF-kB) and contribute to the expression of transforming growth factor-β (TGF-β), insulin-
like growth factor (IGF) and TNF-α, which are involved in insulin resistance [2,5,13,15,17]  
Due to the low antioxidant enzymes levels (CAT, GPx, SOD) and  large swings in protein 
flux through its secretory pathways, pancreatic β-cells are exquisitely sensitive to ROS/RNS 
[2,14,17]. Hyperglycemia-induced OS is an important factor in  pancreatic β-cells dysfunction 
and destruction in T2DM [3,5,12,15,17]. Therefore, OS is associated with the decrease in insulin 
secretion and its action on target tissues, accelerating disease progression from insulin resistance, 
impaired glucose tolerance and ultimately T2DM.  
1.4. Treatment of Type -2 Diabetes 
1.4.1. Conventional therapy 
At early stage (pre-diabetes), the slight hyperglycaemia can be controlled through 
lifestyle modification (diet restriction and physical activity) [2–4,17]. Generally, prescription of 
anti-diabetic drugs are needed for patients who fail the preliminary therapy [2,3]. The main 
pharmacological intervention includes a wide variety of oral anti-diabetic agents (AMY and 
AGLU inhibitors, biguanides, thiazolidinediones, sulfonylureas, etc) with the aim of improving 
glycemic control and prevention of diabetes complications (Table 1). Their main therapeutic 
mechanisms include inhibition of glucose digestion, reduction of hepatic glucose production, 
enhancement of pancreatic insulin secretion and peripheral glucose uptake [1–4,13,15,17]. 
Glucagon-like peptide-1 (GLP-1) receptor agonists, GLUTs-2 and dipeptidyl peptidase-4 (DPP-
4, EC 3.4.14.5) inhibitors are more recent therapies [2,4,11,14,17,30]. 
Due to the multifactorial pathogenicity of T2DM, the available therapeutics are used 
mostly in combination to restore normal glucose levels in blood [4,14]. However, none of these 
approaches can be termed as an ideal one, due to some undesirable side effects (Table 1), high 
costs, and often response decrease after prolonged use. To overcome the adverse effects, there is 
a demand to research for novel targets and safer and more effective hypoglycemic agents [2–
4,14]. In such context, plants have long been considered a target for source of new anti-diabetic 
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agents based on their traditional use, less side effects and economic viability [11,13,31]. In fact, 
current medicines today were based on natural products properties [2,4]. 
1.4.1.1. Inhibition of digestive enzymes 
In diabetic patients, the rapid digestion and absorption of carbohydrates is not desirable. 
Post-prandial hyperglycemia plays an important role in the incidence of T2DM and related 
complications [2,3]. Therefore, controlling post-prandial hyperglycaemia, by slowing down 
glucose metabolism via inhibition of the activities of AGLU enzymes, is a key strategy to manage 
this disease [1,4,14,15,18].  
The use of synthetic drugs that inhibit digestive enzymes (AGLU, AMY and PL) has been 
proposed as a treatment for T2DM and obesity [3,14,19,20]. Acarbose (Glucobay®, 
Precose®, Prandase®) (Figure 4), isolated from Steptomyces spp., is the most prescribed drug 
for inhibition of AMY and AGLU [2,20]. Other employed medication include miglitol (Glyset®) 
(Figure 5) and voglibose (Glasen®) (Table 1). These drugs delay the digestion of complex 
carbohydrates, thus decreasing the post-prandial hyperglycaemia. However, these medications 
produce undesirable GI disturbances (Table 1) [2,20].  
In humans, 50-70% of dietary lipids are mainly hydrolysed by pancreactic lipase (PL) 
(E.C. 3.1.1.3; triacylglycerol acyl hydrolase) (50 kDa) in the small intestine, yielding glycerol and 
FAs as main products [18,20,21]. Inhibition of PL activity is a therapeutic approach used to reduce 
calorie intake, promote weight loss and combat obesity in diabetic patients [18,22,23]. Orlistat 
(Xenical®, Alli®) (Figure 4), a synthetic derivative of a lipostatin produced by Streptomyces 
toxytricini, was the first effective PL inhibitor approved as anti-obesity drug [20,21,32]. However, 
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Table 1 - Main oral anti-diabetic drugs, their mechanisms of action and side effects. 
Categories Target Mechanism Example Main Side Effects 
AMY and AGLU 
inhibitors 
Small intestine Reduce carbohydrate digestion and absorption Acarbose, Miglitol,  
Voglibose 
Diarrhea, nausea, abdominal 
bloating, flatulence 
Biguanides Liver, muscle  
and adipocytes 
Reduce hepatic glucose production (gluconeogenesis) 
and promotes peripheral glucose uptake (reduce 
insulin resistance via AMPK1 activation) 
Metmorfin, Phenformin Diarrhea, nausea, abdominal 
pain, lactic acidosis 






vomiting, nausea, pancreatitis, 
hypersensitivity, skin reactions 
Sulfonylureas 
 





Hypoglycaemia, weight gain, 





Reduce hepatic glucose production (gluconeogenesis) 
and promotes peripheral glucose uptake (reduce 




increased risk of heart failure, 
weight gain, anemia 
1AMPK (5' adenosine monophosphate-activated protein kinase, EC 2.7.11.31) has a key role in glucose and lipid homeostasis control [1,2,15,23]. Activation of this 
pathway in adipose tissue and skeletal muscle increases GLUT4 expression and membrane translocation, which provides a greater uptake and utilization of glucose 
through insulin-independent mechanisms; and simultaneously inhibits hepatic gluconeogenesis, which results in lower glucose blood circulation [1,2,5,15,16,23]. 
2DPP-4 is a serine exopeptidase responsible for the degradation of incretins (GLP-1 and glucose-dependent insulinotopic peptide, GIP) which maintain glucose 
balance by stimulation of insulin secretion. Inhibition of DPP-4 will prologue the half-life of incretins (~ 2 min) and, consequently, inhibit glucagon secretion and 
elevate insulin levels in human body [2,4,14,17,30]. 3PPAR-γ (peroxisome proliferator-activated receptor gamma) is a major regulator of fatty acid storage and 
glucose metabolism in adipocytes. Activation of PPAR-γ lowers blood glucose levels, by improving the insulin action and glucose uptake, without increasing 
pancreatic insulin secretion [1,3,4,14]. 
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1.4.2. Medicinal Plants and Phytotherapy 
Since ancient times, edible and non-edible plants are used in traditional medicine throughout 
the world to treat T2DM and related complications [2,4,11,13,14]. Currently, approximately 800 plant 
species and their active extracts are still relevant for their anti-diabetic properties [11,14]. Plants are 
rich in unique secondary metabolites such as phenolic compounds (PCs), alkaloids, terpenoids, 
polysaccharides, phytosterols, etc, that have been regognized for their beneficial health effects 
[4,13,14]. Flavonoids, terpenoids and phenolic acids constitute the most studied and effective 
compounds for attenuation of diabetic complications [2,13]. As a result, plant extracts have drawn 
the attention of the scientific community due to their efficiency and fewer toxic and side effects 
[11,13]. Additionally, in developing countries where conventional drugs pose an economic burden 
for rural population, plants offer a cheaper and, in the case of T2DM, effective alternative [3,11,13].  
There are some natural isolated compounds that possess higher therapeutic potential than 
synthetic drugs [11]. For example, 1-deoxynojirimycin (1-DNJ) or moranoline (Figure 5), isolated 
from mulberry (Morus spp.), is a more effective AGLU inhibitor than acarbose [14,33]. Miglitol 
(Glyset™) (Figure 5) is a synthetic N-hydroxyethyl derivative of 1-DNJ used in the treatment of 
T2DM (Table 1). In this view, natural products are potential sources of new anti-diabetic drugs either 
by providing lead molecules or as natural herbal products (infusions, teas, tinctures, poultices, 
powders, etc) [2,3,22].  
Detailed revision about plant extracts and bioactive compounds with reported in vitro and in 
vivo anti-diabetic properties is documented in several works [4,11,13,14]. 
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2. Phenolic Compounds and Type-2 Diabetes 
Plant-derived products (i.e. fruit, vegetables, herbs, medicinal plants) are considered valuable 
sources of health-promoting phytochemicals [1,3,13,15,16,22]. In fact, a long-term consumption of 
fruit and vegetables has been associated with a low risk of development of T2DM, obesity, cancers, 
cardiovascular and neurodegenerative diseases [1,5,16,18,26,34,35]. Within secondary metabolites, 
PCs stand out due to their several biological activities and positive health effects (antioxidant, anti-
inflammatory, anti-viral, antibacterial, anti-atherosclerotic, anti-proliferative, etc)[1,2,15,36,37]. 
Hence, PCs constitute a dietary resource for prevention of OS-induced diseases, such as T2DM [2,18].  
2.1. Phenolic Compounds 
PCs are a heterogeneous class of low to high molecular weight secondary metabolites that 
result from shikimate, acetate and mevalonate pathways [2,16,37,38]. These are synthesized during 
normal plant development (growth, reproduction) but are mostly involved in response to abiotic and 
biotic stress conditions like sun UV radiation, infection by pathogens (bacteria, fungi), attack by 
herbivores and wounding [1–3,20,39]. Additionally, this class of compounds is responsible for the 
organoleptic properties (flavour, bitterness, astringency, pigmentation) of plants [2,3,5,37,38,40]. 
PCs are practically ubiquitous in medicinal and edible plants, being the main group of secondary 
metabolites in human diet [2,15,37,40]. 
PCs are characterized by having at least one aromatic ring with one or more hydroxyl groups 
attached (Figure 6)[2,20,36,38,40,41]. They can be found in the free form (aglycones) but are 
generally conjugated to sugars (hexosides, pentosides, glucuronides), organic acids (citric, malic, 
quinic, shikimic acids) or acylated with other PCs [1,2]. This contributes to their complexity and the 
large number of identified individual molecules (> 8000) [1,16,37,38].  
These compounds are mainly divided into two main groups, non-flavonoids and flavonoids, 
based on their chemical structure (Figure 6). The simplest PCs are phenolic acids, which are 
subdivided into two classes: hydroxybenzoic acids (HBAs) and hydroxycinnamic acids (HCAs). 
Flavonoids are more complex molecules and there are six main sub-groups: flavonols, flavones, 
isoflavones, flavanones, flavan-3-ols and anthocyanidins (Figure 6) [1–3,15,16,20,36–38,40]. 
Aurones, chalcones, flavan-3,4-diols, coumarins, lignans, and stilbenes (e.g. resveratrol) comprises 
other classes of non-flavonoids [1,3,15,16,20,37,41]. In this work, the focus will be on phenolic acids 
and flavonoids since they are the most relevant dietary groups of phenolics. 
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2.1.1. Phenolic acids (non-flavonoids) 
Phenolic acids are composed by a single phenolic ring and classified as HBAs (C6-C1) and 
HCAs (C6-C3) (Figure 6) [2,15,20,40]. The most common HBAs are p-hydroxybenzoic, 
protocatechuic, gallic, vanilic and syringic acids, present in berries (cranberries, raspberries) and nuts 
[2,15,37]. Gallic acid can be converted to ellagic acid, which is the basic structure of hydrolysable 
tannins. These molecules consist of a polyol central core (e.g. D-glucose, flavonoid) and the hydroxyl 
groups are partially or totally esterified with gallic acid (gallotannins) or ellagic acid (ellagitannins) 
[1,2]. Hydrolysable tannins are common in pomegranate, strawberries, blackberries and raspberries 
[2,35].  
The most common HCAs are p-coumaric, ferulic, sinapic and caffeic acids, the latter most 
often esterified with quinic acid as in caffeoylquinic acids (CQAs) (Figure 6). HCAs are significative 
in berries, apples, cereals, coffee and green-leafy vegetables [2,15,37,40].  
2.1.2. Flavonoids 
Flavonoids are the largest and most studied group of  dietary PCs (> 4000 molecules) 
[2,15,37,38,40]. Their basic structure (C6-C3-C6) contains two phenolic rings (A- and B-rings), 
which are linked by a three-carbon chain that forms an oxygenated heterocycle (C-ring). Based on 
the substitution patterns of C-ring (oxygenation, alkylation, glycosylation, acylation, etc), flavonoids 
can be divided into six main sub-classes: flavonols, flavones, flavanones, isoflavones, flavan-3-ols 
and anthocyanidins (Figure 6) [1,5,15,20,38,40]. Flavonoids are usually associated to sugar moieties 
(glycosides) or other compounds, with the conjugation occurring at the 3- and 7-positions [2,37]. 
2.1.2.1. Flavonols 
Flavonols are structurally characterized by a 3-hydroxy pyran-4-one group on the position 3- 
of the C-ring and a 2,3-double bound (Figure 6). They are the most abundant flavonoids, especially 
in fruits, vegetables (onions, spinach, broccoli) and tea. Quercetin, kaempferol and myricetin are 
representative of this class (Figure 6) [2,15,37,38].  
2.1.2.2. Flavones 
Flavones are structurally similar to flavonols, but they lack 3-hydroxygroup on the C-ring 
(Figure 6). They are not so common in human diet, but are present in grains, herbs, peppers, parsley 
and celery. Apigenin and luteolin are the most abundant dietary flavones [2,15,37]. 
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2.1.2.3. Isoflavones 
Isoflavones possess the B-ring attached to the C-3, rather than in the position 2 (as in 
flavones) (Figure 6). The most significant amounts of isoflavones are found in soybean and its by-
products (milk, miso, tofu), green beans, lentils, chickpeas and peanuts. Genistein, glycitein and 
daidzein are the three main isoflavones aglycones [2,15,37]. 
2.1.2.4.  Flavan-3-ols 
Flavan-3-ols are characterized by the absence of the pyran-4-one structure and the C-2,3-
double bond (Figure 6). These flavonoids vary from the simple monomer form (catechin and (-)-
epicatechin) to oligomers and polymers (proanthocyanidins, PACs) (Figure 6). The structure of 
PACs, also known as condensed tannins, is dependent on the kind of monomer (catechin, (epi)-
catechin) and the type of connection between units (Figure 6) [1,2,37]. Tea, red wine, beans, apricots, 
apples, cherries, chocolate, and cinnamon are among the richest sources of flavan-3-ols [1,2].  
2.1.2.5. Flavanones 
Flavanones are characterized by a saturated 2,3- bond in the C-ring (Figure 6). These 
compounds are mainly found in citrus fruits (lemons, oranges, grapefruits), mint and tomatoes. The 
most common dietary flavanones are eriodictyol, hesperitin, and naringenin [2,15,38].  
2.1.2.6. Anthocyanidins 
Anthocyanidins are the most important pigments in plant foods. They are widely distributed 
in red fruits (berries, plums, cherries, grapes) and certain dark coloured vegetables (cabbage, beans, 
onions)[2,5,15,36–38,42]. Their colour can range from blue, purple and red, depending on the pH and 
their structural composition. This property is related to the presence of a flavylium ion on the C-ring 
[36,42,43]. The most important dietary anthocyanidins are cyanidin, delphinidin, malvidin, 
pelargonidin, peonidin, and petunidin (Figure 6)  [2,15,42,43]. When aglycones are conjugated to a 
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2.2. Digestion, Absorption and Metabolism of Phenolic Compounds 
To exert their beneficial properties, PCs must be first delivered to and absorbed in the GI tract 
and transported in the bloodstream to reach tissues and organs [40,44,45]. During digestion, PCs 
undergo several transformations due to physical, chemical and biochemical conditions, thereby, 
affecting their bioavailability1 [40,46–49]. Hence, determination of PCs content directly from 
foodstuff is not enough for the prediction of potential in vivo effects. Metabolites formed from PCs 
may be different from their original compounds as a result of an intensive metabolism during 
digestion [40,41]. This is why data from animal studies or human interventions are not as promising 
as those from in vitro studies [3,16,27,35,47]. 
Digestion starts in the mouth, where mastication and saliva action enable the release of food 
constituents [44,45,50,51]. Decreasing the particle size enlarges the contact area available for the 
attack by digestive enzymes, thus increasing the overall digestion efficiency. Once in the stomach, 
the mixing and acidic conditions have low impact on PCs [41,44,48,49,52–55]. In the small intestine, 
PCs undergo substantial modifications (hydrolysis, oxidation, epimerization and/or degradation) 
since they are highly unstable in alkaline environments [40,41,44,47,49,56]. Food matrix and co-
consumed foods, basic structure, molecular size, polymerization, glycosylation, and solubility of PCs 
greatly determine their absorption in the lumen [1,2,16,41,44,50]. Dosage, prior diet, gender and 
differences in the gut microbial populations are also important factors [1,35,45]. While aglycones and 
some simple phenolic acids can be directly absorbed in the small intestine, large and polymerised 
PCs are not readily uptaken [2,40,41]. Gallic acid and isoflavones are best absorbed and in decreasing 
order so are flavones, catechins, quercetin glycosides and flavanones. The weakest absorption was 
reported for PACs, (epi)catechin-gallate (ECG) and ANTCs [1,40,41]. Therefore, the most abundant 
PCs in human diet are not necessarily those with the highest bioavailability [2,40,41]. 
Phase I of PCs metabolism is the cleavage and release of the aglycone moiety for absorption, 
which takes place on the surface of enterocytes by the action of endogenous cytosolic BGLU (EC 
3.2.1.21) and lactase-phlorizin hydrolase (EC 3.2.1.108; 3.2.1.62) [1,2,15,35,40,41,45]. However, 
only a small amount of PCs (5 - 10%) is absorbed in the small intestine [1,16]. The majority of the 
ingested PCs reach the colon, where they undergo intensive microbiota metabolism prior to 
                                                     
1In nutrition, bioavailability of a nutritional or non-nutritional compound includes its gastrointestinal digestion 
(GID), absorption, metabolism, tissue distribution and bioactivity. Bioaccessibility and bioactivity are the most 
important factors determining the bioavailability of a substance. Bioacessibility refers to the quantity or fraction 
of a compound that is released from food matrix, during gastrointestinal digestion (GID), and becomes 
potentially available for further uptake and absorption. Bioactivity is the specific physiological effect 
(antioxidant, anti-inflammatory, etc) upon exposure to a compound [41,47]. 
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absorption [1,2,15,16,35,40,45]. Colonical bacterial enzymes catalyse deglycosylations, 
dehydroxylations, and fermentation that leads to aromatic ring-fission products (phenolic acids, 
catechols, among others metabolites) [1,2,35,40,45,52]. 
After absorption, uptaken molecules undergo intensive phase II transformations, which 
accounts for the absence or low concentrations of aglycones in blood [1,2,40,41,45]. These processes 
occur mainly in the liver and involve methylation, glucuronidation and sulfuronidation of aglycones, 
resulting in conjugated forms [1,2,15,16,40,47]. Metabolites are, then, transferred to the bloodstream 
and delivered to peripheral tissues where may exert their beneficial effects [16,40,44,45]. Phase II 
metabolism is responsible for increasing the hydrophilicity of PCs, which facilitates their excretion 
through the urine and bile (feces) [1,45]. 
 The low absorption of PCs, extensive metabolism in the gut and rapid elimination from the 
body are greatly responsible for their low bioavailability after consumption [1,2,15,40,45,47]. 
2.2.1. In Vitro Models for Simulation of Phenolic Compounds Digestion 
Methods for determining bioavailability and/or bioaccessibility of food components involve 
in vitro or animal/human (in vivo) models [44,46,57]. The latter provide the most accurate results and 
have been used for a great variety of compounds and foodstuffs  [46,58]. However, these are lengthy, 
costly, and due to ethical restrictions and severe protocols, their use is limited [44,46]. As a result, 
much effort has been directed to the development of in vitro procedures that enable the prediction of 
PCs stability during digestion [41,47,57].  
In vitro digestive models are a useful alternative by simulating the putative behaviour of food 
components in the GI tract since they are simple, rapid, less expensive and not subject to restrictions 
[44,46,57,58]. Despite their limitation regarding the significance of generated data [41,44,46,47,57], 
similar trends for digestion of PCs are obtained by in vitro and in vivo models [59]. 
GI models try to reproduce the physiological conditions in the mouth, stomach, small 
intestine, and occasionally large intestinal fermentation [46,47,57]. The digestion process is simulated 
under controlled conditions (temperature, pH, digestion time, salt concentrations, bile acids, etc) 
using commercial digestive enzymes (e.g. AMY, pepsin, pancreatin, PL, etc) while the final 
absorption process is commonly assessed using Caco-2 cell cultures or colonic fermentation 
[41,44,51,52]. In general, in vitro models can be divided in two categories: static models, where the 
products of digestion remain largely immobile and do not mimic physical processes such as shear, 
mixing, hydration, and so on; dynamic models try to include physical and mechanical processes 
(mechanical forces, continuous changes in pH,  secretion flow rates) and temporal changes to mimic 
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in vivo conditions [44,47,57]. However, these latter models are much more labor- and cost-intensive 
than the static ones [47], which are the most widely used for screening PCs bioaccessibility [41]. 
2.3. Phenolic Compounds as Potential Anti-diabetic Agents 
Intake of PCs-rich foods and/or supplementation (nutraceuticals and functional foods) has 
been suggested as prophylactic therapy against T2DM and latter complications [2,5,15,16,18]. 
Additionally, due to their safety and fewer secondary effects, PCs can be used synergistically with 
pharmaceuticals and reduce their dose or intake [2,3,15,60,61]. Therefore, PCs have become popular 
emerging sources of natural anti-diabetic drugs discovery and development [1–3,15].  
The glycaemic control is putatively achieved by dietary PCs due to the integration of multiple 
and complementary mechanisms to improve glucose homeostasis (Figure 7): modulation of glucose 
digestion and absorption, regulation of the carbohydrate homeostasis, protection and restoration of β-
cells integrity, stimulation of insulin release and improvement of glucose peripheral uptake through 
regulation of insulin dependent and independent signalling pathways. Additionally, PCs can also 
inhibit aldose reductase (AR) activity, prevent the formation AGEs and alleviate OS and 
inflammatory status, associated with the development of long-term diabetic complications [1–
3,5,6,15,16].  
Dietary human interventions are scarce, therefore, most of scientific evidence arises from in 
vitro or animal studies [3,5,16]. The most common in vitro models include inhibition of standard 
enzymes (AMY, AGLU, PL, etc) commercially available using specific probes as substrates 
(reducing sugars or synthetic molecules) accompanied by spectrophotometric measurements 
[18,19,22]. In addition to enzymatic assays, cellular models (Caco-2, HepG2, etc) are often used to 
evaluate glucose uptake or the effect of OS-induced toxicity [5,11,19,23,62,63]. Animal models 
provide more accurate results and use rats and mice with diet or chemical induced-diabetes 
[11,13,14]. In the latter case, pancreatic β-cells are destroyed by allozan (ALX) or streptotozin (STZ) 
treatment resulting in insulin deficiency, thereby resembling the T2DM in humans [14]. Overall, most 
epidemiological and intervention studies showed that dietary PCs were associated with a lower risk 
of T2DM, but these have not been as successful as in vitro and animal studies have pointed out [16]. 
Further investigation and new approaches are needed to clarify the inconsistent results and confirm 
the beneficial effects of dietary PCs [1,3,6,16].  
In the following sub-sections, the main mechanisms involved in the potential anti-diabetic 
properties of PCs are summarised.  
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Figure 7 – Potential health benefits of phenolic compounds on management/control of hyperglycaemia in 
T2DM (adapted from [16]). 
2.3.1. Inhibition of Carbohydrate Digestion, Absorption and Metabolism 
Due to their importance in carbohydrate metabolism, AMY and AGLU enzymes are the first 
therapeutic target for T2DM [15,20]. Inhibition of their hydrolysing activity by PCs is considered an 
effective therapeutic tool to reduce post-prandial hyperglycaemia since it can limit the digestion of 
carbohydrates and, therefore, reduce their absorption (Figure 7)[1–3,5,18]. Phenolic acids (CQAs, 
rosmarinic acid), flavonoids (quercetin, luteolin, catechins and ANTCs) and tannins have been 
reported as effective carbohydrate-digestive enzymes inhibitors [1–3,15,16,18,21,61,64,65].  
When insulin resistance occurs, T2DM progresses, and the risk for developing hypertension, 
obesity and cardiovascular diseases increases greatly [1,2]. CQAs, ANTCs and tannins are also 
capable to modulate lipid metabolism by inhibition of PL activity [15,18,20,21,23]. This could 
potentially help to prevent diabetes-induced obesity and cardiovascular pathogenesis by promoting 
weight loss and improving dyslipidemia [15,18].  
Inhibition of GLUTs is another target for glycaemia control since it prevents glucose 
absorption, thereby avoiding the increase in post-prandial glucose (Figure 7) [2,3,15,16]. Phloridzin, 
flavan-3-ols (ECG and gallo(epi)catechin-O-gallate, EGCG), flavonols (quercetin, myricetin, 
isorhamnetin) naringenin and phenolic acids (CQAs, caffeic acid, ferulic acid) can limit glucose 
absorption via interaction with SGLUT-1 and GLUT-2 [2,3,15,16].  
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Another therapeutic mechanism is the suppress of hepatic glucose production by inhibition 
of glycogenolysis and gluconeogenesis routes (Figure 7) [2,3,5,15,16]. Diosmin, narigenin, 
isoflavones (genistein and daidzein), ferulic acid, hesperidin, EGCG, and 5-O-CQA presented 
positive inhibitory effects towards enzymes involved in these pathways (pyruvate carboxylase (EC 
6.4.1.1), phosphoenolpyruvate carboxykinase (EC 4.1.1.32), fructose-1,6-bisphosphatase (EC 
3.1.3.11), and glucose-6-phosphatase (EC 3.1.3.9)) and simultaneously enhanced hepatic glucose 
uptake and glucogenesis  [1–3,15,16]. 
2.3.2. Protection of Pancreatic β-Cells Integrity and Enhancement of Insulin Secretion  
Hyperglycaemia, hyperlipidaemia, increased ROS production and inflammation exert 
deleterious effects on β-cells function, ultimately leading to their failure and/or destruction [1,3,16]. 
PCs contribute to the protection of β-cells by alleviating glucolipotoxicity, ROS/RNS action and cells 
apoptosis and increasing the defence capacity of β-cells (Figure 7)[1–3,5,15]. Simultaneously, PCs 
promote β-cell proliferation and stimulates insulin production and secretion [1,3,5]. Resveratrol, 
flavones (diosmin, apigenin, luteolin), flavonols (quercetin, rutin) and flavan-3-ols ((epi)-catechin 
and ECGC) effectively prevent β-cells dysfunction and failure and, at the same time, they promote 
insulin secretion [3,15].  
2.3.3. Improvement of Insulin Activity and enhancement of Glucose Uptake 
PCs contribute to the increase of insulin sensitivity and enhancement of peripheral glucose 
tissue uptake through modulation of both insulin sensitive and non-insulin sensitive signalling 
pathways (Figure 7)[2,3,5,15,16].  
These phytochemicals can influence insulin action by activating PPAR-γ, which improves 
the sensitivity of membrane insulin receptors (IRs). Consequently, insulin binding to target receptors 
increases the expression of GLUT-4, the main glucose membrane transporter in adipocytes and 
skeletal and cardiac muscles. This facilitates glucose uptake into these tissues and consequent 
clearance from the blood through insulin-dependent mechanisms (Figure 7) [1–3,42]. Alternatively, 
when insulin is low/absent, PCs can also promote glucose uptake via activation of AMPK signalling 
pathway accompanied by translocation of GLUT-4 to plasma membrane (Figure 7)[3,5,16,23]. 
Therefore, increase of GLUT-4 expression is considered an attractive target for developing new 
treatments for T2DM, but also for obesity and metabolic syndrome [2,3,15,16,23]. The improvement 
of glucose uptake through GLUT-4 by HCAs (CQAs, ferulic acid), flavan-3-ols (PACs, EGCG), 
quercetin, isoflavones and resveratrol is comparable to the performance of biguanides and 
thiazolodinediones, main oral hypoglycemic drugs (Table 1)[1–3,5,15,16].  
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In addition, quercetin, kaempferitin and catechin showed the ability to mimic the action of 
insulin by interfering with IRs and consequently stimulate glucose uptake [3].  
2.3.4. Inhibition of Human Aldose Reductase (HAR) Activity 
Human aldose reductase (EC: 1.1.1.21, HAR) is the first enzyme in the polyol pathway. 
Under normal physiological conditions, its substrate affinity to glucose is very low and primarily 
reduces toxic aldehydes and carbonyls (Figure 8) [3,12,66]. But, in hyperglycaemia conditions, this 
enzyme reduces the excessive glucose to sorbitol, which is further metabolized to fructose by sorbitol 
dehydrogenase (EC: 1.1.1.14, SDG) (Figure 8) [4,12,17,67]. Overactivity of HAR is an important 
factor in the pathogenesis of retinopathy, neuropathy, nephropathy and cataract [3,12,66–68]. It is 
also associated with increased OS due to enhancement of ROS production and depletion of cellular 
NADPH that leads to low GSH levels (Figure 8) [4,12,17,67]. 
 Currently, inhibition of HAR activity by PCs has gained importance in T2DM treatment 
(Figure 7)[3,6,67,68]. HBAs (gallic, vanillic, syringic, and protocatechuic acids), CQAs, ferulic acid, 
flavonols (quercetin, quercitrin and myrciarin IV), EGCG and ellagic acid have been reported as 
effective HAR inhibitors [3,67,69].  
 
Figure 8 – The polyol pathway flux. In hyperglycaemia conditions, glucose is sequentially reduced to sorbitol 
and fructose by the combined action of human aldose reductase (HAR) and sorbitol dehydrogenase (SDG) 
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2.3.5. Inhibition of Advanced Glycation End-Products (AGEs) Formation 
The elevated blood glucose levels cause also the generation of AGEs through non-enzymatic 
Maillard or “browning” reaction [3,12,66]. These adducts are originated via binding of carbonyl 
groups (ketones or aldehydes) of reducing sugars (glucose, fructose, ribose) to free amino groups of 
proteins. Figure 9 summarises the non-enzymetic reactions that leads to AGEs generation. The first 
product of the glycation reaction is the fast and highly reversible Schiff base intermediates, which are 
further converted to more stable Amadori products. These molecules undergo a series of reactions 
(dehydration, oxidation, rearrangement) resulting in carbonyl compounds such as glyoxal (GO), 
methylglyoxal (MGO), 3-deoxyglucosone (3-DG). These compounds are highly reactive and act as 
reaction propagators, finally leading to the generation of AGES (Figure 9) [17,70–72]. These 
molecules are classified into three groups: fluorescent crosslinking AGEs (crossline and pentosidine); 
non-fluorescent cross- linking AGEs (imidazolium dilysine crosslinks) and non-fluorescent non-
crosslinking AGEs (N3-carboxyethyllysine (CEL) and N3-carboxymethyl-lysine (CML) [70,72,73].  
 
Figure 9 – Non-enzymatic protein glycation pathways leading to formation of advanced glycation end-products 
(AGEs) adducts. GO: glyoxal; 3-DG: 3-deoxyglucosone; MGO: methylglyoxal (adapted from [66,70,72]). 
AGEs accumulation lead to structural and functional changes in cellular and tissues 
components, such as proteins (collagen, elastin and albumin), DNA and lipids. Hence, AGEs have 
been implicated in the pathogenesis of angiopathy, neuropathy, nephropathy and retinopathy (Figure 
8) [66,70,72,74]. Additionally, binding of AGEs to specific AGEs receptors (RAGEs) may further 
increase the production of ROS and subsequent activates the expression of NF-kB and pro-
inflammatory mediators (TNF-α, VEGF) [4,12,17].  
Reducing sugar Protein (lysine)
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Therefore, inhibition of AGEs formation by PCs may be a basis for a unique therapeutic 
approach for delaying and/or alleviating some diabetic complications (Figure 7)[3,15]. CQAs, 
ANTCs, catechin and PACs exert potent inhibitory effects on AGEs generation [3,70,74–77].  
2.3.6. Alleviation of Oxidative Stress 
Hyperglycaemia and increased production of ROS are crucial contributors for increased OS 
[1,3,15,17]. OS has been implicated in the development of T2DM, since it is responsible for insulin 
resistance and tissue damage that leads to several pathophysiological conditions [2–4,12,13]. 
Dietary PCs, due to their potent antioxidant effects, are effective in neutralizing or trapping 
ROS/RNS and inhibiting lipid peroxidation (Figure 7)[1,2,15,16]. PCs restore the chemical balance 
in these reactive molecules due to their ability to provide the electrons that they are lacking [2,26,27]. 
PCs also attenuate the production of pro-inflammatory cytokines (such as C-reactive protein, 
IL-6, and TNF-α) contributing to alleviate low-grade inflammatory processes associated with T2DM 
(Figure 7)[1,15,16,37]. Furthermore, PCs can enhance the cellular defence capacity through 
stimulation of synthesis or regeneration of antioxidant enzymes (SOD, CAT, GPx and 
GRx)[1,2,15,37]. Therefore, PCs can potentially prevent oxidative damage and related diabetic 
complications (Figure 7)[2,3,15].  
Flavan-3-ols, resveratrol, quercetin and ANTCs showed promising results and might play a 
role in the treatment of T2DM [1,3,15,16,42]. 
2.3.7. Other anti-diabetic mechanisms 
Insulin secretion by β-cells is mainly regulated by glucose, but intestinal incretins (GIP and 
GLP-1) play also a role in stimulation of glucose-dependent insulin secretion [2,17]. Moreover, 
incretins inhibit glucagon secretion, attenuate gastric emptying, and decrease appetite/weight gain 
[2,4,17]. CQAs, PACs, ANTCs and resveratrol are able to stimulate incretins secretion, resulting in 
the elevation of insulin levels [2,15]. However, incretins are rapidly inactivated by DPP-4 enzyme 
[2,4,14,17]. In order to extend the effects of incretins, DPP-4 inhibition has become one of the newest 
targets for the development of anti-diabetic drugs [4,14,17] (Table 4). Resveratrol, ANTCs, flavones 
(luteolin, apigenin, flavone), kaempferol, flavanones (hesperidin, naringenin), and genistein showed 
potent DPP-4 inhibitory effects [30]. 
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3. Berries 
Fruits, vegetables, legumes, cereal grains, spices and some beverages (tea, coffee, red wine) 
are major sources of PCs in the human diet [2,16,78]. Increasing evidence suggests favourable effects 
between fruit consumption and prevention/management of various diseases and disorders, including 
T2DM [1,2,5,18,35,39]. Hence, a dietary intervention could play an important role in 
preventing/managing T2DM or at least slowing down the rate of development of diabetes 
complications [2,5,18].  
In addition to basic nutrition (vitamins, sugars, minerals), fibers and low energy density, fruits 
also contain a wide variety of non-essential compounds, such as PCs, carotenoids, etc [5,34,35]. 
Among fruits, berries (or berry fruits) stand out due to their unique and appreciable phenolic content 
(Figure 10) and significant health benefits (antioxidant, anti-inflammatory, anti-proliferative, anti-
diabetic, etc)[5,16,34,35,39]. In this sense, there has been a growing trend in the popularity of berries 
consumption or as ingredients in dietary supplements and nutraceuticals, being recently recognized 
as “superfoods” [34,39]. Consumers are highly attracted to berries mainly because of their brightly 
and sharp colours (red-blue-purple), delicate taste and unique flavour [5,35,39]. Berries could be 
cultivated or collected from the wild and are commonly consumed fresh and in processed forms 
(beverages, jams, jellies, smoothies, yogurts, etc) [34,35].  
Recently, leaves from berry-producing plants (BPPs) have also gained attention due to their 
traditional medicinal use against several diseases (colds, inflammation, diabetes, and ocular 
dysfunction) [34]. The phenolic composition of leaves is higher and richer than of berries, suggesting 
their use as alternative sources of PCs for the development of food supplements, nutraceuticals, or 
functional foods [34,79–81]. 
3.1. Phenolic Compounds in Berries 
Berries represent a quite diverse group of the so-called “soft fruits” that include blackberries, 
blueberries, strawberries, currants, gooseberries, raspberries, etc, belonging to several botanical 
families (Table S 1 - Supplementary Material) [5,34,35].  
Botanically, berries are known as simple (e.g. blueberry, cranberry) or composite (e.g. 
strawberry, mulberry, raspberry, blackberry, wax-myrtle) small fleshy fruits produced from single or 
multiple fused ovaries, respectively [5,35].  
The total amounts of PCs can vary largely between different species and cultivars (Figure 
10). Edaphoclimatic and growing conditions, degree of ripening and post-harvest treatments and 
processing operations also impact the phenolic profiles [5,35,39]. The phenolic composition of berries 
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is associated with their organoleptic properties but it also influences greatly their potential health 
benefits [5,18,34,35]. 
The red-to-blue-purple coloration of berries is due to the significant amounts of ANTCs in 
epidermal tissues (skin), making them the richest dietary source of ANTCs [5,34]. Cyanidin, 
delphinidin, malvidin, pelargonidin, peonidin, and petunidin are the most common anthocyanidins in 
berries (Figure 6) [5,34,35]. 
 
 
Figure 10 – The phenolic composition of some berries (adapted from [34,82]). EU: European, USA: American; 
LB: Low-bush; HB: High-bush. HBAs: Hydroxybenzoic acids; HCAs: Hydroxycinnamic acids; ANTCs: 
Anthocyanins; PACs: Proanthocyanidins. For nomenclature of berries species please check (Table S 1 – 
Supplementary Material). 
Strawberries are composed mainly of pelargonidin conjugates, while deep purple-black 
berries (e.g. blueberries, blackberries, elderberries, chokeberries, lingonberries) possess high amounts 
of delphinidin and cyanidin derivatives [34,35,83]. Sugars (glucose, rhamnose, arabinose, rutinose, 
sambubiose, etc) or other organic compounds (acetic, malonic, malic and phenolic acids) are the main 
residues associated with berry anthocyanidins [35].  
Besides ANTCs, berries contain also other flavonoids, phenolic acids, and tannins (Figure 
10) [5,34,35,39]. Ferulic, caffeic and p-coumaric acids and CQAs are the most common HCAs in 
berries, being very abundant in Vaccinium spp. (Figure 10) [34,35,63,84,85]. O-and C-glycosides of 
flavonols (quercetin, kaempferol and myricetin) are present in high amounts in blackcurrants, 
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(raspberry, cloudberry and blackberry) present the most diverse phenolic composition, being 
particularly rich in ellagitannins (Figure 10)  [34,35,87,88]. This class of compounds is also found in 
strawberries [34,35]. Chokeberries are rich sources of HBAs and condensed tannins (Figure 10). 
PACs are significant in high- and low-bush blueberries and cranberries (Figure 10) [34,35]. 
3.2. Anti-diabetic Potential of Berries 
The anti-diabetic activity of the berries has been demonstrated by in vitro studies, animal and 
human models, largely attributed to their phenolic composition [5,16,18,21,23,63,64,77,89,90]. PCs 
from berries exert their favourable effects by regulating glucose digestion and absorption, enhancing 
insulin production and reducing apoptosis and promoting proliferation of pancreatic β-cells via 
reduction of OS and inflammation and by enhancing peripheral tissue glucose uptake [5,15,16,34]. 
Other targets include inhibition of AR activity and AGEs generation (Table 2). Hence, berries 
consumption may offer a non-toxic, dietary approach to manage hyperglycaemia linked to T2DM 
[5,18,21]. Even though berries present a fair content of total sugars (7-10 g/100 g), these are mainly 
free glucose and fructose with very little contents of sucrose compared to other fresh fruits of similar 
total sugars, which make them valuable for diabetic patients. Additionally, the high fiber content of 
berries is important since pectin is a intestinal regulator [39]. 
Information regarding animal models or human intervention studies displaying the anti-
diabetic effect of berries is summarised in recent reviews [5,16]. 
Table 2 -  Summary of in vitro studies showing the potential anti-diabetic effect of different berries. For berries 
nomenclature please check Table S1 (Supplementary Material). 
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(berries and leaves) 
Inhibition of AMY activity Malvidin-3-O-glucoside, 
quercetin 
[95,96] 
Black chokeberries Inhibition of AGLU, AMY 





Raspberries Inhibition of AGLU activity Ellagic acid, cyanidin-
diglucoside, 
pelargonidin-3-O-
rutinoside and catechin 
[98] 
Bayberries (leaves) Inhibition of PL activity; 
improvement of glucose 
uptake by HepG2 cells 







strawberry and raspberry. 
Inhibition of PL activity Ellagitannins and 
proanthocyanidins 
[64] 
High-bush blueberry and 
blackberry 
Inhibition of DPP-4 Cyanidin-3-glucoside, 
cyanidin and malvidin 
[30] 
Bayberries Prevention of pancreatic β-
cells H2O2-induced apoptosis, 
increased cellular viability, 
and decreased mitochondrial 





(berries, leaves, roots) 
Enhancement of 
deoxyglucose uptake in 
C2C12 muscle cells and 3T3-
L1 adipocytes; protection of 
PC12 cells against 
glucotoxicity: stimulation of 
insulin secretion and 
proliferation of pancreatic β-
cells 
- [63] 
Bayberries Enhancement of glucose 








Indian gooseberry  Inhibition of AR activity Gallo- and ellagitannins 








Cranberry Inhibition of AGEs formation Proanthocyanidins [76] 
Low-bush blueberry 
(leaves and stems) 
Inhibition of AGEs formation Caffeoylquinic acids and 
proanthocyanidins 
[75] 
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3.3. Berries from Madeira Archipelago 
The vascular flora of Madeira archipelago (Portugal) (Figure 11), includes some endemic 
BPPs, such as M. faya, R. grandifolius, S. lanceolata and V. padifolium [101]. The study of these wild 
berries is relevant since it can provide information about new medicinal applications that would result 
in higher concern about its cultivation and/or collection. This would possibly increase their market 
penetration and consumers awareness/interest with some economic benefit.  
 
Figure 11 - Location of Madeira and Azores archipleagos in the North Atlantic Ocean. 
3.3.1. Elaeagnus umbellata  
E. umbellata Thunb (Elaeagnaceae), commonly known as autumn olive or Japanese 
silverberry (Figure 12), is a introduced (non-native) species that grows well in Madeira Island. This 
species is indigenous to Eastern Asia and is characterized as a deciduous shrub or small tree, typically 
up to 3.5 m tall. It grows small, round edible berries, which ripen to red, dotted with silver or brown 
color [102–104]. Berries are included in the diet of most Asian countries, but are also used to produce 
beverages, sauces, jams, or other products, like powders or extracts for food industry [104].  
E. umbellata extracts have putative health benefits against hepatitis, fracture, injury and 
diarrhea [104]. Several phytochemicals have been reported in this species, namely PCs (catechins, 
PACs), L-ascorbic acid, α- and γ-tocopherol and appreciable amounts of carotenoids (in particular 
lycopene) [104,105].  
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            Figure 12 – Elaeagnus umbellata (Autumn olive). 
3.3.2. Myrica faya 
M. faya Aiton (Myricaceae) or wax-myrtle (locally called “amorinhos”) is native to 
Macaronesia region [101] (Figure 13). The plant is an evergreen shrub or small tree, usually about 8 
m tall. Its fruits are small edible berries, red to purple in color when ripe [101]. They can be directly 
consumed but, due to their astringency which limits their palatability, they are mainly used to produce 
jams, liquors and to add colour to homemade wine. Formerly, wax was extracted from the berries for 
candles production and also for skin care products [106].  
A previous study developed by our work group [106] reported ANTCs (in particular cyanidin-
3-O-glucoside, C3G) and flavonoids (flavonols and flavan-3-ols) as the main compounds of wax-
myrtle berries and leaves, respectively. To our best knowledge, no medicinal properties have been 
yet documented for this species. 
 
            Figure 13 –  Myrica faya (wax-myrtle, fire tree) 
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3.3.3. Rubus grandifolius 
R. grandifolius Lowe (Rosaceae) or wild blackberries is an endemic plant to Madeira 
Archipelago (Portugal), which inhabits in moist and shady areas (Figure 14)[101,107]. Its berries, 
known as “amoras”, are physically similar to other blackberries, and become black when rippen. 
These are consumed fresh or processed as jam, juice or liquor [107]. The leaves, shoots and fruits are 
described in the folk medicine as astringent for children and also as remedy for diabetes, depurative, 
diuretic and to relieve sore throat as herbal teas or alcoholic infusions [108]. 
Previously [107], our research group has identified ANTCs, flavonoids and HCAs in berries 






           Figure 14 – Rubus grandifolius (wild blackberries). 
3.3.4. Sambucus lanceolata 
S. lanceolata R. Br. in Buch (Adoxaceae) (Madeira elderberry) or “sabugueiro” is a small 
tree or shrub, up to 7 m tall, endemic to Madeira Island (Portugal) (Figure 15). Berries are small 
yellowish round edible fruits that get dark-purple when ripe in the late Summer [101]. Infusion made 
of berries have been used in folk medicine to relieve colds, diarrhea and menstrual pains. 
Additionally, flowers are used as diuretic and emollient, while leaves are applied in poultices on 
bruises, wounds and sores [108]. To our best knowledge, no phytochemical studies on this species 
have been conducted so far. 
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Figure 15 - Sambucus lanceolata (Madeira elderberry) 
3.3.5. Vaccinium cylindraceum 
V. cylindraceum J.E. Sm (Ericaceae), locally known as “uveira” or “uva-da-serra” (Azores 
blueberry)(Figure 16) is a deciduous shrub endemic to the Azores archipelago (Portugal) (Figure 
11). This species is not found in Madeira Island but it was included in this study for comparison 
purposes. It grows as a semi-evergreen shrub or small tree, up to 5 m tall, in some rural areas (above 
300 m of altitude) in all the Azores Islands (except Graciosa) [109,110]. In the late summer, these 
plants produce ovoid-shape berries of blue-black colour, when ripe, which are consumed fresh or 
used to make candy and jams [110]. 
Previously [109], twenty-four ANTCs were identified in V. cylindraceum berries, mainly 
glycosides of malvidin, delphinidin, cyanidin, petunidin and peonin. 
 
Figure 16 – Vaccinium cylindraceum (Azores blueberry) (photo reproduced from [111]). 
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3.3.6. Vaccinium padifolium 
V. padifolium Sm (Ericaceae) is endemic to Madeira Island (Portugal), where is commonly 
called “uveira” or “uva-da-serra” (Madeira blueberry) (Figure 17) [101,112,113]. This small tree can 
grow up to 3 m tall and is physically similar to the previous described species. It grows only at high 
altitudes (above 1300 m) and its edible berries are used for jams, liquors and as food preserves 
[101,112,113]. Additionally, they are used in local ethnopharmacology for cough, colds, bronchitis 
and dysentery, and exported for commercial production of ophthalmic specialities [108]. 
Previously [112,113], twenty-five ANTCs were identified in V. padifolium, glycosides of 
malvidin, delphinidin and petunidin being the main compounds of berries. 
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4. Extraction and Characterization of Phenolic Compounds 
Accumulative data showed that PCs, due to their biological and pharmacological properties, 
may offer prophylactic or complementary treatments for various aspects of T2DM as dietary agents 
or nutraceuticals and functional foods [3,15].  
To benefit from their health-promoting properties, PCs must be first extracted from plant 
matrices to obtain a phenolic-rich concentrate (extract) for nutraceutical/pharmaceutical applications 
[29,36,37]. The main goal is to obtain the maximum extraction yield, and, therefore, more benefits to 
human health [36]. Further steps in PCs analysis include their separation, characterization, 
quantification and determination of their physiological properties (antioxidant, anti-inflammatory, 
anti-proliferative, etc) [36,37,78]. 
4.1.  Sample preparation 
Before extraction of PCs, plant samples should be collected, reserved and properly prepared 
[78]. To avoid degradation of PCs, samples are often preserved at low temperatures and/or dried (air, 
oven, lyophilization) before extraction [78]. Dried samples are then milled or ground to obtain a 
smaller particle sizes, while liquid samples are treated by filtration, centrifugation and pre-
concentration/purification [38,78]  .  
4.2.  Extraction  
The next step to separate PCs from other substances in the matrix is their extraction, which 
usually involves using solvents (organic or inorganic), supercritical fluids, microwave procedures, 
ultrasonics, among others [36–38,78]. Several parameters like extraction time, temperature, solvent-
to-sample ratio, particle size, the number of repetitions, pH and solvent type are known to influence 
the extraction yield [38,78]. Ethanol, methanol, propanol, ethyl acetate, acetone and their combination 
with different proportions of water are the most common solvents for PCs extraction [36,37,43,78]. 
Most extractions are carried out under acidic conditions because PCs are generally more stable in low 
pH. Usually weak organic acids (acetic, formic, citric, etc) are used at low concentrations to avoid 
hydrolysis of glycosides [36,43,78]. In general, increasing time and temperature promote higher 
extraction efficiencies; however, PCs can undergo degradation, hydrolyzation or oxidation reactions 
[38,78].  
Conventional solvent extraction is the most widespread technique which applies a solvent to 
release/separate a desired component (the solute) from solid (solid-liquid) or liquid matrix (liquid-
liquid) [36–38]. Maceration and solvent extraction are frequently used to extracts PCs from a solid 
matrix [36,78]. These extraction techniques are based in the same mass transfer phenomena, but heat 
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and/or stirring are applied in the latter case to faster the process [36,37]. These methods are simple, 
require relatively cheap apparatus and result in satisfactory  extraction rates [36,78]. However, some 
disadvantages include the need to use a great amount of resources (energy and solvents) and long 
extraction periods [36,37,78]. 
New alternative methods have emerged as “environmentally friendly”, namely ultrasound-
assisted extraction (UAE), microwave-assisted extraction (MAE), and pressure assisted extractions 
[36–38,78]. These are faster, relatively simple to perform and most importantly reduce energy and 
solvent requirements in comparison with conventional techniques [36,38,78]. 
UAE is a simple, fast, efficient and inexpensive alternative to conventional solvent extraction 
[36–38,78]. It is a non-thermal technique in which ultrasound waves (≥ 20 kHz) causes cell wall 
disruption and release of cell contents, thereby facilitating the mass transfer from the matrix to the 
solvent [36,78,114].  
MAE has been commonly used in the extraction of PCs due to low amounts of solvent, faster 
extraction times and increased extraction yields compared to traditional methods [36–38,78]. In this 
technique, cells are damaged by microwaves (non-ionizing radiation), which result in sample heating, 
and enhance the release of  intracellular content to the solvent [36,78]. 
Extraction with supercritical fluids (SCF) has become increasingly popular. SCF extraction 
use solvents in their supercritical states (high temperature and pressure), which enables  high mass 
transfer rates [36,37]. As a result, the extraction is more efficient, fast and selective. Also, SCF 
extraction requires small amounts of sample and solvent and no additional clean-up step [36–38,78]. 
CO2 is the most common solvent due to its stability, low toxicity and price and non-flammability 
[38,78]. However, CO2 is a non-polar molecule, and small amounts of polar solvents (modifiers) have 
to be added to enhance the extraction of PCs [36–38,78]. The main disadvantage of this technique is 
the high price of equipment [38,78]. 
4.3.  Isolation, fractionation and purification 
Extraction techniques are not selective and imply the co-extraction of non-phenolic 
compounds (sugars, organic acids and proteins), which sometimes requires subsequent purification 
processes [38,43]. Isolation and purification of PCs from crude sample extracts can be achieved by 
column chromatography, high-speed counter-current chromatography (HSCCC), solid-phase 
extraction (SPE), ultrafiltration, among others. In these techniques, PCs are separated into several 
fractions according to their physical properties (weight, solubility and polarity) using partitionable 
solvents and different resins (Sephadex LH-20, EXA-31, XAD 4, XAD16, EXA-90, etc)  
[37,38,78,115]. However, these methods are time-consuming, labor intensive and expensive, thereby, 
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used only when strictly necessary to study isolated compounds or partial concentration prior to 
chromatographic analysis [37,78]. 
4.4. Determination of Phenolic Compounds 
There are several developed techniques for the quantification of PCs, present in crude extracts 
or isolated from plant matrices: spectrophotometry, chromatography, capillary electrophoresis, 
nuclear magnetic resonance (NMR), among others [36–38,78]. In the following sub-sections, the 
focus will be on spectrophotometric and chromatographic methods since are the most used and 
applied in this work for identification and quantification of PCs from crude extracts. 
4.4.1. Spectrophotometric methods 
Colorimetric methods, such as total phenolic content (TPC), total flavonoids content (TFC) 
and total anthocyanin content (TAC) are simple, low-cost, reproductible and fast spectrophotometric 
assays routinely used for qualitative and quantitative estimation of PCs in plant-based extracts 
[29,36,38,78]. However, these methods are not specific, being affected also by vitamin C, sugars, and 
aromatic proteins, which leads to overestimation of PCs amounts [29,36,78]. Additionally, these 
assays do not separate or quantify PCs individually[38,47,78].  
TPC involves the reduction of Folin-Ciocalteu reagent (FCR) by PCs, under alkaline 
conditions [29,36,78]. FCR is composed by complexes of phosphomolibdic/phosphotungstic acid, 
which form blue coloured complexes around 760 nm [29,36,78]. Usually, gallic acid is used as a 
reference standard [29,36].  
TFC measurements by the AlCl3 method are based on the complexation of flavonoids with 
Al(III) in the range of 410 – 423 nm [38,78].  
4.4.2. Chromatographic methods 
In order to separate and accurately quantify individual PCs, these compounds must be 
separated first [78]. Chromatographic techniques for analysis of PCs include thin-layer 
chromatography (TLC), gas chromatography (GC) and high-performance liquid chromatography 
(HPLC), high speed counter current chromatography (HSCCC) and supercritical fluid 
chromatography (SFC) [37,38,78]. 
Due to its precision, reproducibility and versatility, HPLC is the dominating analytical tool 
for separation and quantification of PCs [37,38,78]. Generally, reverse-phase C18 columns are 
preferred along with a binary mobile phase system containing acidified water (acetic, formic and 
phosphoric acid) and polar organic solvent (methanol or acetonitrile), possibly acidified, in order to 
Chapter I - Introduction 
 
 
Vítor Spínola   2018                                                                                                               37 
avoid the ionization of PCs during analysis [37,43,78]. A gradient elution system is more frequent 
than isocratic mode [78]. Ultraviolet-visible (UV–vis), photo-diode array (PDA), fluorimetric and 
electrochemical detectors are normally coupled to HPLC. However, these tools are not enough for 
the complete identification of the composition of plant extracts [26,37,38,78]. The use of mass 
spectrometry (MS) detectors coupled to HPLC (HPLC-MS) have become very popular as it is a 
powerful analytical tool and very effective for structural characterization and identification of 
different PCs [26,38,78]. These equipments separate ionized atoms or molecules according to their 
difference in mass to charge ratio (m/z)[37]. The main ionization sources reported in the analysis of 
PCs are electrospray ionization (ESI), chemical ionization (CI), atmospheric pressure chemical 
ionization (APCI), matrix-assisted laser desorption/ionization (MALDI) and fast atom bombardment 
ionization (FAB) [37,38,78]. Nowadays, HPLC-MS is the best analytical technique to identify PCs 
in plant extracts due to its high selectivity, sensitivity, robustness and specificity [37,38,78]. 
Configurations that allow for multiple fragmentation, such as ion trap detectors, are particularly useful 
since fragments provide precious information for the identification of multiple isomers, so common 
among PCs. 
4.5. Antioxidant Activity (AOA) Evaluation of Phenolic Compounds 
Antioxidant molecules are a heterogeneous category of molecules, that include PCs, 
carotenoids, vitamins C and E, minerals, etc [35,37]. These  compounds interact with free radicals 
and reduce, control or prevent cellular oxidative processes and inflammation before vital molecules 
are damaged [2,27,37].  
PCs are the most abundant dietary antioxidants and are especially important due to their 
aromatic rings and the highly conjugated system with multiple hydroxyl groups, which allows them 
to act as reducing agents or hydrogen donors [2,38]. The arrangement and number of hydroxyl groups 
determine greatly the antioxidant potency of PCs [2,35]. These compounds alleviate OS through 
varied mechanisms (Figure 18): (A) inhibition of pro-oxidative enzymes and modulation of redox 
cell signalling and gene expression, chelating metal ions, (B) enhancing antioxidant and detoxifying 
enzymes expression and (C) neutralization/reduction of ROS/RNS formation [1,2,15,27,29,37]. 
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Figure 18 – Different mechanisms of action of phenolic compounds: (A) inhibition of oxidant enzymes (NOS: 
nitric oxide synthase; NOx: NADPH oxidase; COX: cyclooxygenase; MPO: myeloperoxidase), that translate 
in a decrease in ROS/RNS production; (B) interaction with cellular signalling pathways that translate in cellular 
antioxidant response; (C) direct scavenging of ROS/RNS (adapted from [12,27]). 
In this context, it has been suggested that an intake of a phenolic-rich diet may be of great 
value in the prevention of the on-set and/or progression of OS-associate diseases (including T2DM), 
particularly due to their antioxidant activity (AOA) [2,5,16,18,27,37]. Therefore, a lot of interest is 
focused on the determination of AOA of isolated PCs or plant extracts [27]. Different in vitro 
methodologies, based on different strategies, have been developed for this aim [26,27,29,36]. 
Considering the complexity of the involved mechanisms/variables, it is recommended to conduct 
several tests to evaluate and compare the AOA of natural products [26,27,35].  
4.5.1. In Vitro Assays to Determine Antioxidant Activity  
The most widely in vitro assays used for evaluation of AOA are: ABTS•+ (2,2-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) scavenging activity, DPPH• (1,1-diphenyl-2-picrylhydrazyl) 
scavenging activity, FRAP (ferric ion reducing/antioxidant power) and ORAC (oxygen radical 
absorbance capacity) [2,27,36,37]. These methods involve the reactions of PCs with free radicals and 
the complex formed is UV-Vis spectrophotometrically detected at a certain wavelength in the case of 
colour complex (ABTS•+, DPPH• and FRAP) or fluorescence decay (ORAC assay). Results from 
radical scavenging assays can be expressed in different units, Trolox equivalents (TE), inhibition % 
or IC50 value [27,29,36,37]. In vitro assays are simple, quick, low-cost, high-throughput and very 
useful for screening of antioxidant activities [27,29]. However, they have been designed for the use 
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[26,27,29]. Hence, other methodologies have been proposed, aiming to evaluate scavenging activity 
toward ROS/RNS formed in vivo like O2•-, OH-, ONOO-, ClO- (hypochlorite) and NO [26,27]. 
Since it is difficult to conduct studies involving animals or humans, cell-based models emerge 
as very attractive, cheaper and intermediate alternative to assess in vitro AOAs 
[23,27,29,35,116,117]. These assays are biologically more relevant than “test tubes” since they take 
into consideration some aspects of the bioavailability of PCs within the cells (absorption, distribution, 
and metabolism) [26,27,29,35]. Therefore, they provide a more comprehensive understanding of 
AOA at cellular level [26,27,29]. Different cell types have been used for these biological assays: 
erythrocytes, liver cancer line HepG2, Caco-2 intestinal cancer cells, human gastric adenocarcinoma 
cells AGS, vascular endothelial cells EA.hy926, human macrophages RAW264.7, human lung 
fibroblasts (WI38, IMR-90), etc [27,29]. One of the main drawbacks of these assays is related to the 
dosage of PCs which may be too high to achieve physiologically upon intake [5,16,26,35].  
Still, in vitro tests are limited and the obtained data cannot be extrapolated to in vivo 
performance [26,27,29,35]. The in vivo antioxidant status is mainly dependent of 
absorption/adsorption, bioavailability, stability, and metabolism of the dietary PCs in the body 
[26,27,35]. Nevertheless, chemical methods are very helpful and should be considered for initial 
screening before clinical studies, since they provide important ranking information about the capacity 
of PCs to neutralize ROS/RNS, under comparable test conditions with minimum environmental 
interference [27,29].  
The following sub-sections explain in detail the in vitro assays used in this work for 
evaluation of AOA of plant extracts. 
4.5.1.1. ABTS radical (ABTS•+) scavenging assay 
ABTS•+ scavenging assay is as a simple and convenient in vitro method widely applied for 
total antioxidant capacity assessment [27,29,36]. ABTS•+ is generated from ABTS by strong 
oxidizing agents (potassium persulfate, manganese dioxide or peroxyl radicals) [27,29,118]. In the 
presence of antioxidants, the blue green ABTS•+ solution (pH 7.4) is discoloured and the scavenging 
efficiency is measured by the decrease in absorption of the chromophore at 734 nm [27,29,118,119]. 
4.5.1.2. DPPH• radical scavenging assay 
DPPH• radical scavenging assay is among the most frequently used in vitro methods [27,29]. 
DPPH• is a stable, commercially available free radical with a deep purple colour. It is a simple and 
fast test based on the neutralization of DPPH• radical by antioxidants through electron donation 
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[27,29,36]. This reduction is measured spectrophotometrically (around 517 nm) by discoloration of 
the DPPH• solution, which acts as an indicator of the antioxidant efficacy [27,29,119].  
4.5.1.3. Nitric Oxide (NO•) Radical Scavenging assay 
NO is produced in biological systems by specific nitric oxide synthases [12,17]. NO• can be 
generated in vitro from sodium nitroprusside. This compound decomposes in aqueous solutions (pH 
7.2 - 7.4) to yield NO•. Under aerobic conditions, the principal end-product of NO• autooxidation is 
nitrite (NO-2) [26]. After addition of the Griess reagent, the absorbance of the chromophore formed 
during the diazotization of NO-2 with sulfanilamide and subsequent coupling with naphthyl-
ethylenediamine is measured spectrophotometrically around 560 nm [26,28]. The Griess reaction is 
also used in enzymes or cells models to measure NO-2 as an indicator of OS condition [25,26]. 
4.5.1.4. Superoxide Anion (O2•-) Radical Scavenging assay 
The mitochondrial production of superoxide anion (O2•−) is a major cause of cellular OS 
[12,13,17,26]. O•2− is mainly generated in vitro by the hypoxanthine−xanthine oxidase system and, in 
minor extent, by the phenazine methosulfate-β-nicotinamide adenine dinucleotide (PMS-NADH) 
model (non-enzymatic) [26,27,120]. The inhibition of O2•− production by PCs is followed with the 
use of probes such as ferricytochrome-c or nitroblue tetrazolium (NBT) [26,27]. The reduction of the 
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1. Materials 
1.1. Plant Material 
Six different berry-producing plants (BPPs) were studied in this work: four endemic species 
from Madeira Island (M. faya, R. grandifolius, S. lanceolata and V. padifolium), one endemic to Azores 
archipelago (V. cylindraceum) and one non-native species (E. umbellata). These plants are presented 
in Table 3 and their origin/collection areas are marked in Figure 19 and Figure 20. Identification of 
plant material was carried out by Dr. Francisco Carvalho and Dr. José Augusto Carvalho from Madeira 
Botanical Garden (Funchal, Madeira). Voucher specimens have been stored at Madeira Botanical 
Garden Herbarium.  
E. umbellata (1) samples were collected at “A Quintinha das Ervas Aromáticas” (Funchal, 
Madeira Island) in two consecutive years (October 2013 and 2014) (Table 3). This species is the only 
one that is not native to Macaronesia region and did not grown in the wild. 
M. faya was collected in the wild at seven different locations (2 - 8) in Madeira Island during 
July – September 2014 (Table 3). An additional sample was collected in Terceira Island (9) (Azores 
archipelago), shipped in styrofoam boxes over dry ice and delivered to Centro de Química da Madeira 
(CQM), within 3 days.  
Plant material of R. grandifolius was collected in the wild at two different location in Madeira 
Island: (10) Pico do Arieiro (Funchal) and (11) Santo António da Serra (Machico) in September 2014 
(Table 3). 
S. lanceolata (12) was collected in the wild at Pico das Pedras (Santana, Madeira Island) in 
October 2014 (Table 3). 
Two Vaccinium species endemic to Macaronesia region were studied in this work (Table 3). 
V. cylindraceum was collected in the wild at Flores Island (13) (Azores archipelago) by Cândida Dias. 
Plant material was send by air transportation to Madeira Island, the day after collection, in styrofoam 
boxes over dry ice and delivered to CQM, within 3 days (Table 3). Vaccinium padifolium was collected 
in the wild at Pico do Arieiro (14) (Funchal, Madeira Island) in two consecutive years (September 2013 
and 2014) (Table 3). 
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Figure 19 - Collection area of analyzed berry-plant species from Madeira Island. A green-pine symbol marks 







Figure 20 - Collection area of M. faya (9) and V. cylindraceum (13) from Azores archipelago. A green-pine 
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Table 3 – Information of berry-producing plants under study (origin, collection date, voucher numbers). 
Plant Species/Family Common name Collection area  Collection date Voucher number 
E. umbellata1 
(Elaeagnaceae) 
Autumn olive (1) Funchal  










(2) Machico  






  (3) Faial  
(32° 46' 53.23"N, 16° 51' 47.34"W) 
Madeira 
Archipelago 
July 2014 MADJ13239 
  (4) Arco de São Jorge 
(32° 49' 19.10"N, 16° 57' 2.21"W) 
Madeira 
Archipelago 
July 2014 MADJ13237 
  (5) Boaventura 
(32° 49' 8.33"N, 16° 58' 33.28"W) 
Madeira 
Archipelago 
July 2014 MADJ13235 
  (6) Seixal 
(32° 48' 10.45"N, 17° 6' 51.23"W) 
Madeira 
Archipelago 
July 2014 MADJ13236 
  (7) Ribeira da Janela 
(32° 50' 26.02"N, 17° 10' 4.19"W) 
Madeira 
Archipelago 
July 2014 MADJ13238 
  (8) Porto Moniz 
(32° 51' 17.15"N, 17° 10' 33.27"W) 
Madeira 
Archipelago 
August 2014 MADJ13280 
  (9) Terceira Island 
(38º 43' 0'N, 27º 4' 0'W) 
Azores 
Archipelago 
September 2014 MADJ 14337 
R. grandifolius2 
(Rosaceae) 
Wild blackberry (10) Pico do Arieiro, Funchal 
(32° 42' 50.72"N, 16° 55' 55.07"W) 
Madeira 
Archipelago 
September 2014 MADJ08618 
 (11) Santo da Serra, Machico 
(32° 43' 13.72"N, 16° 51' 2.43"W) 
Madeira 
Archipelago 
September 2014 MADJ05179 
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S. lanceolata2 
(Adoxaceae) 
Madeira elderberry (12) Pico das Pedras, Santana 
(32° 46' 54.96"N, 16° 54' 21.85"W) 
Madeira 
Archipelago 
October 2014 MADJ13284 
V. cylindraceum3 
(Ericaceae) 
Azores blueberry (13) Flores Island 
(39º 26' 26"N, 31º 13' 9'' W) 
Azores 
Archipelago 
August 2014 MADJ13281 
V. padifolium2 
(Ericaceae) 
Madeira blueberry (14) Pico do Arieiro, Funchal  






           1introduced in Madeira Island; 2endemic to Madeira archipelago; 2endemic to Azores archipelago. 
 
Collected plant material of each species was separated into leaves and fruits (fully ripe), destemmed, washed and frozen at -80 ºC in sealed 
plastic bags. In the case of V. padifolium, leaves were divided in two groups: young leaves (red colored tips) and mature leaves (fully green). This 
was not verified for the other berry-producing plants, being considered only leaves (fully green) and berries. Then, samples were freeze-dried (Christ 
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1.2. Chemicals and reference compounds 
Standard compounds and specific reagents used in the experimental procedures are listed in 
Table S 2 (Supplementary Material). 
2. Methods 
In Figure 21 is summarised the procedures and assays carried out in the present work. 
 
Figure 21 – Overview of the work carried out in this thesis. TSS: Total soluble solids. ICP-MS: inductively 
coupled plasma-mass spectrometry. HPLC-DAD-ESI-/MSn: High performance liquid chromatography with 
diode-array and electrospray ionization mass spectrometric detection; HPLC-DAD: High performance liquid 
chromatography with diode-array detector. TPC: Total phenolic content; TFC: Total flavonoids content. 
2.1. Total soluble solids (TSS) determination 
 The total soluble solids (TSS) content, measured in Brix degree (°Brix), was determined 
for fresh berries. The fresh fruit was placed in a blender (Kenwood Excel) and reduced to pulp. After 
centrifugation (4000 rpm, 20 min) (Sigma 3K30), the supernatant was analyzed on a refractometer 
(ATAGO RX-1000; Tokyo, Japan). A calibration curve of sucrose (1 - 200 g L-1) was prepared and 




4 mL saliva juice
Shake 150 rpm, 37 ºC, 5 min
Stomach phase
10 mL gastric juice
Shake 150 rpm, 37 ºC, 2 hours
Small intestine phase
10 mL duodenal juice + 4 mL bile juice
Shake 150 rpm, 37 ºC, 2 hours
HPLC-DAD-ESI-/MSn screening




Digestive enzymes inhibitory 
assays




Aldose reductase inhibitory assay









































Chapter II – Materials and Methods 
 
48  Vítor Spínola (2018) 
2.2. Moisture content determination 
For determination of moisture content, fresh plant material (berries and leaves) was weighted 
before and after freeze-drying (-52 ºC, 0.72 atm) (Christ Alpha 1-2 LD plus). The percentage (%) of 
moisture was calculated based on the following equation: 
𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (%) = [1 − (
𝑚𝑝𝑟𝑒
𝑚𝑝𝑜𝑠𝑡
)]  × 100   (Equation 1) 
where mpre and mpost were the mass of fresh plant material pre- and post-freeze drying. 
2.3. Determination of mineral content by inductively coupled plasma-mass spectrometry 
(ICP-MS)2 
This part of the work has been already published [121], and so it will only be briefly 
explained in the following sub-sections. 
2.3.1. Sample preparation and microwave digestion 
Samples of freeze-dried berries were shipped to University of Jáen (Spain). Briefly, 0.25 g of 
sample, 6 mL HNO3 and 1 mL H2O2 were added to 50 mL PFA vessels. After 30 min, they were 
placed in an ultra-high throughput microwave digestion system (MARSXpress, CEM; Gilson, 
Madrid, Spain) and the temperature was increased to 200 ºC in 15 min, and maintained at 200 ºC for 
15 min. The power of the microwave oven was set at 1000 W. After cooling at room temperature, all 
the digestion solutions were quantitatively transferred into plastic containers and diluted to 60 mL 
with ultra-pure (UP) water. 
2.3.2. ICP-MS analysis 
For determination of mineral content of berries, a quadrupole Agilent 7500a (Agilent 
Technologies, CA, USA) ICP-MS equipped with a Babington nebuliser, a Peltier-cooled quartz spray 
chamber and a standard torch (2.5 mm i.d.) was used. The operation conditions and validation 
parameters are summarised in (Table S 3 - Supplementary Material)3. The mineral content was 
expressed as micrograms of mineral per gram of fresh weight (µg g-1 FW) of berries. 
                                                     
2This experimental part was performed by Doctor Eulogio J. Llorent-Martínez, Department of Physical and 
Analytical Chemistry, University of Jaén, Campus Las Lagunillas S/N, E-23071 Jaén, Spain. 
3For more details please check reference [121]. 
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2.4. Preparation of methanolic extracts 
Extraction of phenolic compounds (PCs) followed a previous protocol [106]: 1 g of 
lyophilized material was extracted with 25 mL of methanol (in a 100 mL Erlenmeyer wrapped in foil) 
in an ultra-sonic bath (Bandelin Sonorex, Germany) at 35 kHz and 200 W for 60 min (22 ± 2 ºC). For 
berries, an extraction solution composed of MeOH/H2O (acidulated with 7% acetic acid) (80:20, v/v) 
was used. After sonication, solutions were filtered through Whatman No.1 filter papers, concentrated 
to dryness under reduced pressure in a rotary evaporator (Buchi Rotavapor R-114; USA) at 40 ºC 
(under reduced light). Duplicate extractions were made for each sample and the resulting dry extracts 
(DE) were stored in 5 mL capped flasks at 4 ºC until further analysis (Figure 21).  
In the case of leaves, an extra step was used for removal of chlorophylls. After the first 
filtration step, a small amount of activated charcoal was added to the liquid extract and, after mixing 
for a few seconds, the solution was filtered. Then, it was concentrated to dryness and stored as 
aforementioned.  
2.5. In vitro simulation of gastrointestinal digestion 
A static model that simulated, sequentially, mouth, stomach and small intestine digestion was 
employed [122], with slight adjustments [123]. Lyophilized berries and leaves (approximately 2 g) 
were added, separately, to 50 mL Falcon tubes. The digestion started with the addition of 4 mL of 
salivary juice and incubation at 37 ºC in a water bath (Heidolph MR Hei-Standard) with agitation 
(150 rpm), protected from light. Then, 10 mL of gastric juice was added to the mixture and further 
incubated for an additional 2 h. After this period, 10 mL of duodenal and 4 mL of bile juices are 
added and the solution was mixed for 2 hours. At the end of the simulation digestion process, solutions 
were centrifuged and supernatants were frozen at -20 ºC, lyophilized, submitted to extraction (section 
2.4), and stored until analysis (Figure 21). All experiments were performed in duplicate for each 
sample. The detailed composition of digestive juices (salivary, gastric, intestine and bile) is given in 
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Table 4 - Composition of simulated gastrointestinal juices (adapted from [122]). 
Stock solutions Saliva Gastric Duodenal Bile 
Distilled water 500 mL 500 mL 500 mL 500 mL 
NaCl 58.50 mg 2.75 g 7.03 g 5.27 g 
KCl 74.50 mg 0.82 g 0.57 g 0.38 g 
NaHCO3 1.06g - 3.39 g 5.79g 
CaCl.2H2O - 0.40 g - - 
NaH2PO4 - 0.266 g - - 
KH2PO4 - - 80.30 mg - 
NH4Cl - 0.306 g - - 
MgCl2 - - 50.40 mg - 
Urea 0.20 g 0.09 g 0.10 g 0.26 g 
Concentrated HCl  - 6.50 mL 0.15 mL 0.15mL 
Adjuncts 0.50 g mucin 2.50 g pepsin 9.02 g pancreatin 12.01 g bile salts 
 1.06g α-amylase 3.00 g mucin 1.50 g lipase - 
pH 6.8 ± 0.2 1.30 ± 0.02 8.1 ± 0.2 8.2 ± 0.2 
 
2.6. HPLC-DAD-ESI/MSn analysis of methanolic extracts 
2.6.1. Sample preparation 
Extract solutions with concentration of 5 mg mL-1 were prepared by dissolving each dry 
extract (DE) in the initial HPLC mobile phase (UP H2O:ACN; 80:20, v/v). These extract solutions 
were filtered through 0.45 µM PTFE micropore membranes prior to use. 
2.6.2. Liquid chromatography-mass spectrometry analysis 
The HPLC-DAD-ESI/MSn analysis was performed on a Dionex ultimate 3000 series 
instrument (Thermo Scientific Inc., California, USA) equipped with a binary pump, an autosampler, 
a column compartment, a diode-array detector hyphenated to an ion trap mass detector (Bruker 
Esquire model 6000; Bremen, Germany) equipped with an ESI source. Separation of PCs was 
achieved using the chromatographic conditions summarised in Table 5. Each extract solution was 
injected and analyzed in triplicate. 
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Table 5 – Operation conditions of HPLC-DAD-ESI/MSn analysis. This method was previously optimized for 
the analysis of phenolic compounds [107]. 
HPLC conditions 
Column Phenomenex Gemini C18 column (5 µm, 250 x 3.0 mm i.d.) 
Mobile phase flow 0.4 mL min-1 
Injection volume 5 µL 
Column temperature 30 ºC 
Mobile phase A: acidified ultra-pure (UP) water (with 0.1% formic acid, v/v) 
B: Acetonitrile 
Gradient elution 20% B (0 min), 25% B (10 min), 25% A (20 min), 50% B (40 min), 
100% B (42 – 47 min), 20% B (49 – 55 min) 
Detection DAD (210 – 520 nm) 
MSn (ESI-, ESI+) 
2.6.2.1.  Mass spectrometry analysis 
For this analysis, a coupled Bruker Esquire model 6000 (Bremen, Germany) ion trap MS 
equipped with an ESI source was used. Mass spectrometry analysis was performed in negative 
(phenolic acids and non-anthocyanins flavonoids) and positive (anthocyanins, ANTCs) modes and 
scan range was set at m/z 100–1000 with a speed of 13,000 Da s-1. The ESI conditions were as follows: 
drying and nebulizer gas (N2) flow rate and pressure, 10 mL min−1 and 50 psi; capillary temperature, 
325 ºC; capillary voltage, 4.5 keV; collision gas (He) pressure and energy, 1 × 10−5 mbar and 40 eV. 
Data acquisition was made in auto MSn mode, with an isolation width of 4.0 m/z, and a fragmentation 
amplitude of 1.0 V (MSn up to MS4). Esquire control and Data Analysis softwares (Bremen, 
Germany) were used for the data acquisition and processing, respectively. 
2.6.3. HPLC-DAD quantification of phenolic compouds in the methanolic extracts 
Quantitative determination of phenolic compounds was carried out via HPLC–DAD analysis. 
For this, one PC was selected as the standard for each group/family of PCs, based on the structural 
similarities, and used to determinate relative individual concentrations [84]. Caffeic and 
protocatechuic acids were selected as the external standards for quantification of hydroxycinnamic 
acids (HCAs) and hydroxybenzoic acids (HBAs), respectively. ANTCs standard was cyanidin-3-O-
glucoside (C3G). Quercetin dihydrate, (+)-catechin hydrate, apigenin, ellagic acid and hesperidin 
were the standards used for the flavonols, flavan-3-ols, flavones, ellagitannins and flavanones, 
respectively. Myricitrin (MCT) was used for the relative quantification of myricetin derivatives. 
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Stock standard solutions (1000 mg L-1) were freshly prepared in methanol and stored at -20 
ºC until use. Six different concentration levels (5 - 100 mg L-1) were prepared by dilution with the 
initial eluent gradient (UP H2O:ACN; 80:20, v/v) and analysed under previous conditions (section 
2.6.2), to obtain the respective calibration curve, plotting HPLC chromatogram peak area versus 
concentrations of the standard solutions. A linear regression equation was calculated by the least 
squares method. The selected detection wavelengths were 520 nm for ANTCs, 320 nm for HCAs and 
280 nm for the other PCs. HPLC–MS data analyses were used to corroborate peak assignment. The 
calculations of the relative individual phenolic contents were carried out by direct extrapolation from 
the calibration curve of selected reference standard. Total individual phenolic content (TIPC) was 
defined as the sum of the relative amount of the compounds in the methanolic extracts and expressed 
as milligrams per gram of dry extract (mg g-1 DE). 
2.7. Total phenolic and flavonoid contents 
2.7.1. Total phenolic content (TPC) 
TPC was measured by the Folin-Ciocalteu method [124] with some adjustments [125]. 
Extracts were dissolved in methanol to yield a concentration (w/v) of 5 mg mL-1. Each extract solution 
(50 µL) was mixed with 1.25 mL Folin-Ciocalteu reagent (FCR) (diluted 1:10 fold with distilled 
water) and 1 mL of sodium carbonate (7.5%) solution. The mixture was incubated for 30 minutes at 
room temperature (protected from light) and absorbance was measured at 765 nm (Perkin Elmer UV–
vis Lambda 2, Germany). TPC was expressed as miligrams of gallic acid equivalents per gram of dry 
extract (mg GAE g-1 DE), based on the gallic acid calibration curve (50 - 600 mg L-1). 
2.7.2. Total flavonoid content (TFC) 
TFC was determined by the aluminium chloride method [126] with some modifications [125]. 
In a 5-mL flask, 0.5 mL of extract solution (5 mg mL-1 in methanol), 1.5 mL of methanol, 2.8 mL of 
distilled water, 0.1 mL of potassium acetate solution (1 M) and 0.1 mL of aluminium chloride (10% 
in methanol) solution were added and mixed. After incubation for 30 min at room temperature 
(protected from light) the absorbance was read at 415 nm (Perkin Elmer UV–vis Lambda 2, 
Germany). Results were expressed as miligrams of rutin equivalent per gram of dry extract (mg RUE 
g-1 DE), based on the rutin calibration curve (10 – 200 mg L-1). 
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2.8. In vitro enzyme inhibitory assays 
2.8.1. Yeast α-glucosidase inhibitory assay 
The inhibition of yeast α-glucosidase (AGLU) activity was determined by measuring the 
amount of p-nitrophenyl, hydrolyzed by the enzyme from p-nitrophenyl-α-D-glucopyranoside (α-
pNPG). This assay performed using a previous methodology [18] with some adaptions [125]. In a 96-
well plate, 50 μL of extract solution (sequential dilutions) was combined with 50 μL of enzyme 
solution (0.1 mg mL-1) and 50 μL of α-pNPG solution (5 mM). All solutions were prepared in 0.1 M 
phosphate buffer (pH 6.9). The mixture was incubated at 37 °C for 20 minutes in the dark. Finally, 
100 μL of sodium carbonate  aqueous solution (0.1 M) was added and the absorbance was read at 405 
nm (Victor3 1420 multilable plate counter, Perkin-Elmer). Acarbose and 1-deoxynojirimycin (1-DNJ) 
were used as positive controls. Serial dilutions of these reference compounds were prepared in the 
above buffer and the same procedure for samples was used. AGLU control (C) was representative of 
the 100% enzyme activity and, in this case, extract was replaced by buffer. Appropriate sample blanks 
(SB) were also included, for each sample, for correcting the background absorbance. For this, buffer 
was used instead of the substrate. Blank to control (CB) consisted of the buffer (instead of extract and 
substrate), enzyme and sodium carbonate solution (added after incubation). Inhibition (%) of AGLU 




×  100   (Equation 2) 
where AC, ACB, AS, ASB were the absorbance of control, blank control, sample and blank sample, 
respectively. The inhibitory activity was expressed as the IC50 value (mg mL-1 DE) determined from 
the least-squares regression line of the logarithmic concentrations plotted against percentage 
inhibition. This value corresponds to the concentration of extract able to reduce the enzyme activity 
by 50% with reference to the control.  
2.8.2. Rat α-glucosidase inhibitory assay 
For this assay, 0.5 g of intestinal acetone powder from rat was dissolved in 10 mL of 
phosphate buffer (0.1 M, pH 6.9) and sonicated for 10 min. After centrifugation (4000 rpm, 10 min, 
4 °C)(Sigma 3K30), the resulting supernatant was diluted 5 times with above buffer and was used as 
the enzyme solution. It was prepared freshly for each experiment. The measurement of rat AGLU 
inhibition was performed as described in the previous section (section 2.8.1). Acarbose and 1-DNJ 
were used as positive controls. Serial dilutions of these reference compounds were prepared in the 
above buffer and the same procedure for samples was used. 
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2.8.3. Almonds β-glucosidase inhibitory assay 
The inhibition of β-glucosidase (BGLU) was carried out as above (section 2.8.1) using β-
pNPG as substrate. For this case, conduritol B epoxide (CBE) and 1-DNJ were used as positive 
controls. Serial dilutions of these reference compounds were prepared in phosphate buffer (0.1 M, pH 
6.9) and the same procedure for samples was used. 
2.8.4. Pancreatic α-amylase (AMY) inhibitory assay 
The AMY inhibitory effect of the methanolic extracts was assayed by measuring the amount 
of hydrolysed starch by the enzyme, using iodine/iodate solution. The assay was performed as 
described before [18], with slight modifications [125]. Briefly, 20 µL of extract solution (serial 
dilutions) and 40 μL of starch solution (2 g L-1) were mixed with 20 μL of AMY solution (0.1 mg 
mL-1). All solutions were prepared in 0.1 M phosphate buffer (pH 6.9). After incubation, at 37 °C for 
20 min, the reaction was stopped by the addition of 80 μL of HCl (0.4 M) followed by 100 μL of I2 
solution (5 mM in 5 mM KI) and the absorbance was read at 620 nm (Victor3 1420 multilabel plate 
counter, Perkin-Elmer). Acarbose was used as positive control. Sequential dilutions were prepared in 
the above buffer and the same procedure for samples was used. The inhibitory activity was expressed 
as the IC50 value (mg mL-1 DE) and determined as described previously (section 2.8.1).  
2.8.5. Pancreatic lipase (PL) inhibitory assay 
The inhibition of PL activity was determined by measuring the release of p-nitro-phenol, from 
p-nitrophenyl butyrate (p-NPB), by the enzyme. This assay was based on a previous procedure [22], 
with some modifications [125]. In resume, 40 µL of extract solution (serial dilutions) was mixed with 
20 µL of p-NPB solution (10 mM) and 40 µL of the enzyme solution (2.5 mg mL-1). Extracts and 
enzyme solution were prepared in phosphate buffer (0.1 M, pH 8). The enzyme substrate was 
dissolved in ethanol. After 20 minutes of incubation (37 °C) absorbance was read at 405 nm (Victor3 
1420 multilabel plate counter, Perkin-Elmer). A stock solution of orlistat (positive control) was 
prepared in DMSO (10 mg mL-1) and further diluted with buffer. The experiment was conducted as 
described above. The inhibitory activity was expressed as the IC50 value (mg mL-1 DE) and 
determined as described previously (section 2.8.1).  
2.8.6. Human aldose reductase (HAR) inhibitory assay 
The inhibition of HAR activity was assayed spectrophotometrically by measuring the 
decrease in the absorption of NADPH due to its oxidation, adapted from a previous publication [127]. 
In a 96 well-plate (UV-transparent), 25 µL of extract solution (serial dilutions) were mixed with 25 
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µL of DL-glyceraldehyde (10 mM) and 25 µL of enzyme solution (1 mg mL-1). All solutions were 
prepared in 0.1 M phosphate buffer containing 0.2 mM ammonium sulfate and 5 mM β-
mercaptoethanol (pH 6.2). The reaction was initiated with the addition of 50 µL NADPH solution 
(0.5 mM) and incubation at 37 ºC for 20 minutes. The enzyme activity was measured at 340 nm 
(Victor3 1420 multilabel plate counter, Perkin-Elmer) over 0 and 20 min of reaction. Quercetin was 
used as positive control. A stock solution was prepared in ethanol (10 mg mL-1) and further diluted 
with above buffer. The absorbance of the sample mixture (S) was measured against control (C), 
representative of 100% enzyme activity (contained all components except for the extract). The 
inhibition (%) of aldose reductase activity was calculated by the following equation: 
𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 (%) =
(𝐴𝐶 20𝑚𝑖𝑛−𝐴𝐶 0𝑚𝑖𝑛)−(𝐴𝑆 20𝑚𝑖𝑛−𝐴𝑆 0𝑚𝑖𝑛)
(𝐴𝐶 20𝑚𝑖𝑛−𝐴𝐶 0𝑚𝑖𝑛)
×  100   (Equation 3) 
where AC, AS, were the absorbance of control and the sample at 0 and 20 min of reaction. The 
inhibitory activity was expressed as the IC50 value (mg mL-1 DE) determined from the least-squares 
regression line of the logarithmic concentrations plotted against percentage inhibition. This value 
corresponds to the concentration of extract able to reduce the enzyme activity by 50% with reference 
to the control.  
2.9. In vitro evaluation of anti-glycation potential of methanolic extracts 
2.9.1. Bovine-serum albumin (BSA) glycation inhibition assay 
Inhibition of BSA glycation was measured fluorimetrically in 96 black well-plates, with slight 
modifications from a published protocol [73]. Each well contained 20 µL of sample extracts (serial 
dilutions), 50 µL of BSA solution (10 mg mL-1), 80 µL of phosphate buffer (0.1 M containing NaN3, 
3 mM; pH 7.4) and 50 µL of fructose or ribose solution (0.5 M). All solutions were prepared in the 
above buffer. Plates were incubated for 24 hours at 37 °C (in the dark) and then analyzed at an 
excitation wavelength of 355 nm and emission wavelength of 460 nm (Victor3 1420 multilabel plate 
counter, Perkin-Elmer). Aminoguanidine (AMG) and quercetin were used as positive controls. A 
stock solution of quercetin was prepared in ethanol (10 mg mL-1) and further diluted with buffer. A 
control (C), i.e., 100% AGEs formation, consisted of wells with buffer (instead of sample), BSA and 
sugar. To subtract intrinsic fluorescence resulting from incubation with BSA, a blank (SB) was made 
for each sample (replacing the sugar by buffer). A blank control (BC), with no AGE formation, 
consisted of wells with only BSA and buffer. The percentage (%) of inhibition of AGEs formation 
was calculated according to the following equation: 
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×  100            (Equation 4) 
where FC, FCB, FS, FSB were the fluorescence of control, blank control, sample and blank sample, 
respectively. The inhibitory activity was expressed as the IC50 value (mg mL-1 DE) determined from 
the least-squares regression line of the logarithmic concentrations plotted against percentage 
inhibition. This value corresponds to the concentration of extract able to reduce fluorescence by 50% 
with reference to the control.  
2.10.  In vitro Antioxidant Assays 
2.10.1.  ABTS radical cation (ABTS•+) scavenging assay 
The antioxidant activity (AOA) of extracts was evaluated by the method of decolorization of 
ABTS•+ solution. First, 50 mL of ABTS aqueous solution (2 mM) was reacted with 200 µL of 
potassium persulfate solution (70 mM) [118]. This mixture was kept in the dark for at least 16 hours 
at room temperature and was stable in this form during two days [118]. 
Before usage, the ABTS•+ solution was diluted with phosphate buffered saline (PBS) solution 
(10 mM) to an initial absorbance of 0.700 ± 0.021 at 734 nm. This solution was freshly prepared for 
each analysis. For the evaluation of the radical scavenging activity, 40 µL of extract solution (5 mg 
mL-1 in MeOH) was added to 1.96 mL of ABTS•+ solution. PBS was used as a blank. The decrease of 
absorbance at 734 nm (Perkin Elmer UV–vis Lambda 2, Germany) was measured during 6 minutes 
[125]. Results were expressed based on the Trolox calibration curve (0.5 - 0.7 mM in ethanol) as 
millimole of Trolox equivalents per gram of dry extract (mmol TE g-1 DE).  
2.10.2.  DPPH• radical scavenging activity 
The measurement of decolorization of the DPPH• radical solution followed a previous 
reported methodology [119] with some adaptations [125]. For each determination, 100 µL of extract 
solution (5 mg mL-1 in MeOH) was added to 3.5 mL of DPPH• solution (0.06 mM in MeOH). 
Absorbance was measured at 516 nm (Perkin Elmer UV–vis Lambda 2, Germany), after 30 min of 
reaction in the dark (room temperature). Methanol was used as blank control. The radical scavenging 
activities were expressed as mmol TE g-1 DE, based on the Trolox calibration curve (0.2 – 1.2 mM). 
2.10.3.  Nitric oxide (NO•) radical scavenging activity 
The anti-radical activity was determined spectrophotometrically, with slight modifications 
[125] from a previous publication [28]. In a 96-well plate, 50 µL of sodium nitroprusside solution (20 
mM) was mixed with 50 µL of extract solution (5 mg mL−1) for 60 min, at room temperature, under 
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light. All solutions were prepared in 0.1 M phosphate buffer (pH 7.4). After incubation, 50 µL of 
Griess reagent (1% sulfanilamide and 0.1% N-(1-naphthyl)ethylene-diamine dihydrochloride 
(NEDA) in 2% phosphoric acid), was added to each well. For the blank measurements, Griess reagent 
was replaced by 2% phosphoric acid solution. After 10 minutes, the absorbance was read at 550 nm 
(Victor3 1420 multilabel plate counter, Perkin-Elmer) and the results were expressed as mmol TE g-1 
DE, based on the Trolox calibration curve (4 - 40 mM in EtOH). 
2.10.4.  Superoxide Anion (O2•-) radical scavenging activity 
Superoxide anion radicals (O2•-) were generated by the NADH/PMS system according to a 
described procedure [120]. In a 96 well-plate, 25 µL of extract solution (5 mg mL−1) was mixed with 
200 µL of a solution composed of EDTA (0.1 mM), nitroblue tetrazolium chloride (62 µM) and 
NADH (98 µM). The reaction was initiated by the addition of 25 µL of phenazine methosulfate 
(PMS) (33 µM, containing 0.1 mM EDTA) to each well. All solutions were prepared in 0.1 M 
phosphate buffer (pH 7.4). After 5 minutes, the absorbance was measured at 550 nm (Victor3 1420 
multilabel plate counter, Perkin-Elmer). For the individual blanks, buffer was used instead of PMS 
solution. The AOA was expressed as mmol TE g-1 DE, based on the Trolox calibration curve (4 – 40 
mM in EtOH).  
2.11.  Cytotoxicity evaluation of the methanolic extracts  
2.11.1. Cell Culture 
Human Caco-2 cells were supplied by the European Collection of Authenticated Cell 
Cultures (ECACC; UK). Caco-2 cells were cultured in minimum essential medium (MEM) 
supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (v/v) antibiotic mixture (10,000 units/mL 
of penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of amphotericin B), 1% (v/v) non-
essential aminoacids (NEAA) and 1% (v/v) L-glutamine (200 mM) in petri dishes. The cells were 
grown at 37 ºC in an incubator with 5% CO2. Growth medium was changed 3 times per week. 
2.11.2. Cell viability (resazurin reduction assay) 
The cytotoxic effect of plant extracts was evaluated in Caco-2 cells, as a model of intestinal 
epithelial cells, by the resazurin reduction assay [128]. Caco-2 cells were seeded on 96-well flat-
bottom plates at a concentration of 5 x 104 cells/well. Each well contained 100 µl of growth medium. 
Following a 24 h incubation (37 ºC, 5% CO2), the growth medium was removed. Then, different 
concentrations of extract solutions (dissolved in PBS) were added to 200 µL of growth medium. The 
cells were incubated at 37 ºC and 5% CO2 for 24 h. After this period, the growth medium was removed 
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and 150 µL of 10% v/v resazurin (0.1 mg mL-1) in cell culture was added to each well. After 3 hours 
of incubation at 37 ºC and 5% CO2, resorufin's fluorescence was measured (λex = 530nm, λem = 
590nm; Victor3 1420 multilabel plate counter, Perkin-Elmer). All tests were performed in duplicate 
(n = 8). The percentage (%) of cell viability was determined as follows: 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
𝐹𝐶−𝐹𝑆
𝐹𝐶
×  100  (Equation 5) 
where FC and FS were the fluorescence of control (untreated cells) and samples respectively. 
Cytotoxicity was expressed as the IC50 value (mg mL-1 DE) determined from the least-squares 
regression line of the logarithmic concentrations plotted against percentage inhibition. This value 
corresponds to the concentration of extract able to reduce the fluorescence of treated cells by 50% 
with reference to the control (cells treated only with culture medium). 
2.12. Statistical Analysis 
All experiments were run at least in triplicate for each sample and results are given as the 
means ± standard deviations. Data was analysed using one-way analysis of variance (ANOVA) 
followed by Tukey’s post hoc test using SPSS for Windows, IBM SPSS Statistics 20 (SPSS, Inc., 
USA).  A value of p < 0.05 was considered statistically significant. Pearson correlation coefficients 


































Chapter III – Results and Discussion 
A. Phytochemical Composition 
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The initial work plan of this Ph.D. project consisted of a list of more than 30 plants species. 
As it will be explained in the next sections, the main goal was to evaluate the potential of targeted 
plants extracts/components as modulators of glucose and lipids metabolism, anti-glycatives and 
antioxidant agents. Considering the results of an initial screening (yeast α-glucosidase (AGLU) and 
α-amylase (AMY) assays (Table S 4 – Supplementary Material), we decided to focus this 
investigation on berry-producing plants (BPPs) in regard to their higher inhibitory activities towards 
key carbohydrate-hydrolysing enzymes. Nevertheless, the remaining plant species were studied in 
parallell and, some of the obtained data, has been already published in scientific literature.  
Hence, the anti-diabetic potential of six BPPs were evaluated in this study: four endemic from 
Madeira archipelago (M. faya, R. grandifolius, S. lanceolata and V. padifolium), one non-native 
species (E. umbellata) and one endemism from Azores archipelago (V. padifolium). Additionally, a 
sample of M. faya was collected at Ilha Terceira (Azores) to establish a comparison of the phenolic 
profiles and bioactivities. 
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1. Physico-chemical analysis 
In the present work, the total soluble solids (TSS) and moisture contents of selected BPPs were 
determined. 
1.1. Total soluble solids (TSS) determination 
The TSS content was determined for each berry species. The values ranged between 4.4 and 
16.9 (Table 6), corresponding to S. lanceolata and E. umbellata, respectively. 
Table 6- Content of total soluble solids (TSS) and total sugars of berries under study.  
Berry species  º Brix Sucrose eq. (g L-1) Total sugars (g 100 g-1 FW) 
  2013 2014 2013 2014 2013 2014 
E. umbellata  16.9 16.5 179.68 175.39 5.74 5.60 
M. faya MX - 15.5 158.24 164.67 6.60 7.39 
 FL - 16.2 - 172.18 - 7.68 
 ASJ - 15.2 - 161.46 - 7.21 
 BV - 16.3 - 173.25 - 7.70 
 SX - 16.0 - 170.03 - 7.47 
 RJ - 16.2 - 172.18 - 7.23 
 PM - 15.7 - 166.82 - 6.27 
 TC - 13.4 - 142.17 - 7.14 
R. grandifolius FX - 8.3 - 87.50 - 5.10 
 MX - 10.3 - 108.94 - 5.72 
S. lanceolata  - 4.4 - 45.70 - 2.15 
V. cylindraceum  - 11.4 - 120.73 - 4.16 
V. padifolium  11.7 12.1 123.94 128.23 4.57 5.13 
MX: Machico; FL: Faial; ASJ: Arco de São Jorge; BV: Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: 
Porto Moniz; TC: Ilha Terceira. 
E. umbellata berries presented a higher TSS content as compared to previous works (14.5º 
Brix)[129]. Values of M. faya berries varied between 13.4 and 16.3 ºBrix; slightly higher than that 
found in different cultivars of M. rubra (8.74 – 11.67 ºBrix)[82].                                                                                                               
Berries of R. grandifolius collected in Funchal (FX) showed a higher TSS content than Machico (MX) 
counterpart. These values are slightly lower than those reported for other Rubus species (10.2 – 12.0 
º Brix) [88]. Previous analysis on Sambucus nigra and S. canadenses [130] showed superior values 
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(11.2 – 15.4 º Brix). According to literature [131–134], TSS content of Vaccinium spp. berries range 
between 6.0 and 15.5 ºBrix, which agrees with the obtained values in this analysis (Table 6). 
1.2. Moisture content 
The moisture content (%) of berries and leaves of analyzed berry-producing plants (BPPs) 
was determined after freeze-drying and the percentages are shown in Table 7. 
Table 7- Moisture content (%) of berry-producing plants under study. 
Plant species  Berries Leaves 
2013 2014 2013 2014 
E. umbellata  31.95 35.42 16.99 17.84 
M. faya MX - 45.48 - 31.42 
 FL - 46.37 - 24.08 
 ASJ - 45.29 - 29.91 
 BV - 45.05 - 22.93 
 SX - 44.51 - 27.48 
 RJ - 41.98 - 26.32 
 PM - 37.59 - 27.74 
 TC - 36.12 - 20.34 
R. grandifolius FX - 58.31 - 48.33 
 MX - 52.50 - 47.41 
S. lanceolata  - 47.06 - 25.17 
V. cylindraceum  - 27.82 - 21.68 
V. padifolium  28.79 40.0 10.79* 10.35* 
    14.04** 13.76** 
*Young Leaves; **Mature Leaves. MX: Machico; FL: Faial; ASJ: Arco de São Jorge; BV:       
Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Ilha Terceira. 
Berries possessed a higher moisture content (27.82 – 58.31%) than leaves (10.35 – 48.33%). 
The highest values were observed for R. grandifolius samples, while berries of V. cylindraceum and 
young leaves (YLs) of V. padifolium showed the lowest contents (Table 7).  
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2. Determination of berries mineral content by inductively coupled plasma-mass 
spectrometry (ICP-MS)4 
Berries represent a good source of both macro- and micronutrients (K, Ca, Mg, Fe, Cu,  
among others) [5,35,39]. Many elements are required in small amounts to maintain human health due 
to their nutritious value, as they play important roles in various important physiological and 
biochemical processes in the human system. These elements must be regularly provided through the 
diet [39,103]. In contrast, toxic metals can turn a potential foodstuff unfit for human consumption. It 
has also been proposed that the anti-diabetic activity of some plant-based products is the result of 
elevated levels of metals such as Mg, Mn, Ca, Cr and Zn, which are known to regulate blood sugar 
levels [135–137].  
The inorganic content os targeted berries has not been previously described in scientific 
literature (except for E. umbellata). For an easier discussion, only the average concentrations 
(including different years and different locations) will be used (Table 8). The range of mineral 
concentrations (min – max value) for each species are shown in Supplementary Material (Table S 5 
- Table S 9). When detected, the levels of different toxic elements (Ag, As, Cd, Hg, Pb, Sb, Sn, and 
Tl) were very low, so none of these berries would represent a risk to human health from this point of 
view.  
The recommended dietary allowance (RDA) values for minerals provided by the Commission 
of the European Communities [138] have been used to calculate the amount of minerals ingested 
through the consumption of each of the analyzed berries. For this case, calculations were made 
considering a daily consumption of 30 g of fresh berries, which is a normal amount for similar 







                                                     
4 This part of the work has already been published [121]. 
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Table 8 - Average mineral content of analysed berries (µg g-1 of FW) determined by inductively coupled 
plasma-mass spectrometry (ICP-MS). Data represent the mean ± standard deviation (n = 3). Reprinted (adapted) 
with permission from [121]. 
 E. umbellata M. faya R. grandifolius S. lanceolata V. cylindraceum V. padifolium 
Al  30 ± 30a 80 ± 50a 100 ± 100a 4.7 ± 0.5a 37 ± 3a 25 ± 5a 
Ba  1.1 ± 0.1a 0.5 ± 0.3a 5 ± 1c 3.3 ± 0.3b 5.6 ± 0.5c 3.1 ± 0.1b 
Ca  1000 ± 100a 900 ± 100a 1700 ± 400c 1200 ± 100ab 1400 ± 100c 860 ± 80ab 
Cd N.D. N.D. N.D. N.D. N.D. Detected 
Co  0.03 ± 0.01a 0.2 ± 0.1b 0.05 ± 0.01a 0.016 ± 0.01a 0.008 ± 0.01a 0.08 ± 0.03a 
Cr  Detected 0.6 ± 0.5a 0.6 ± 0.4a 0.12 ± 0.01a 0.08 ± 0.01a Detected 
Cu  6.0 ± 0.9c 1.6 ± 0.5a 5 ± 1bc 3.5 ± 0.3ab 3.7 ± 0.3b 4 ± 1bc 
Fe 32 ± 5a 110 ± 50b 120 ± 90b 28 ± 5a 19 ± 1a 17 ± 3a 
K  7900 ± 300c 4400 ± 500ab 5000 ± 700b 15100 ± 400d 4700 ± 300ab 3500 ± 400a 
Mg  420 ± 10a 550 ± 100a 1500 ± 200b 1590 ± 50b 420 ± 20a 530 ± 10a 
Mn  11 ± 1a 9 ± 3a 30 ± 10b 12 ± 1a 131 ± 5c 44 ± 5b 
Mo 0.7 ± 0.1b 0.11 ± 0.05a 0.12 ± 0.01a Detected N.D. N.D. 
Na  70 ± 6a 2000 ± 400c 70 ± 10a 65 ± 3a 560 ± 30b 60 ± 5a 
Ni  1.4 ± 0.2b 1.6 ± 0.6b 1.1 ± 0.3ab 0.42 ± 0.05a 0.36 ± 0.03a 1.1 ± 0.1ab 
P  800 ± 100b 330 ± 50a 800 ± 200b 2010 ± 70c 760 ± 30b 560 ± 40ab 
Pb  N.D. Detected N.D. N.D. N.D. N.D. 
Sb N.D. Detected N.D. N.D. N.D. N.D. 
Ti  1.7 ± 0.3a 20 ± 10a 20 ± 20a 0.69 ± 0.05a 0.44 ± 0.03a 0.5 ± 0.2a 
V  Detected 0.3 ± 0.2a 0.4 ± 0.3a Detected N.D. Detected 
Zn  10 ± 6ab 4.4 ± 0.5ab 9 ± 3b 5.9 ± 0.4b 5.3 ± 0.3b 5.4 ± 0.9a 
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Table 9 – Mineral percentage (%) contribution for RDA of analysed berry species. Data represent the mean ± 
















Ca 800 3.8 3.4 6.5 4.4 5.4 3.2 
Cu 1 18 4.8 15 10.5 11.1 12 
Fe 14 6.9 23.6 25.7 6 4.1 3.6 
K 2000 11.8 6.6 7.5 22.6 7.1 5.2 
Mg 375 3.4 4.4 12 12.7 3.4 4.2 
Mn 2 16.5 13.5 45 18 193 66 
Mo 0.05 42 6.6 7.2 --- --- --- 
P 700 3.4 1.4 3.4 8.6 3.3 2.4 
Zn 10 3 1.3 2.7 1.8 1.6 1.6 
 
2.1.  Elaeagnus umbellata 
In general, the average levels of the most important nutritional elements varied between 7900 
µg g-1 of K and 0.03 µg g-1 of Co. Concentrations decreased in the following order: K > Ca > P > Mg 
> Na > Fe > Mn > Cu > Ni > Mo > Co (Table 8). V was detected, although in amounts too low to be 
quantified. Some elements concentration was affected by the year of collection (p < 0.05), namely K, 
Mn, Mo, P and Zn (Table S 6). The latter decreased approximately 3-fold from 2013 to 2014. The 
contribution to the RDA (Table 9) was lower than 10 % for Ca, Fe, Mg, P, and Zn. However, 
contributions between 10-20 % were observed expected for Cu, K, and Mn, and higher than 40% for 
Mo.  
Previous analysis on this species [102,103] have also reported K, P, Mg and Ca as the main 
minerals, but at lower concentrations that those here observed. Different cultivars and edaphoclimatic 
conditions might be the reason for the observed variations but accuracy of analytical method is a more 
reasonable explanation, since those authors used atomic absorption for quantification. 
2.2.  Myrica faya 
For this species, the levels of nutritional elements decreased in the following order: K (4400 
µg g-1) > Na > Ca > Mg > P > Fe > Mn > Zn > Cu > Ni > V > Co > Mo (0.11 µg g-1) (Table 8). 
Significant variations (p < 0.05) were found among berries collected in different locations (except for 
Ba and Cu levels) (Table S 7). Different soil compositions and climatic conditions might justify these 
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differences. Except for Mn (13%) and Fe (24%), all elements showed a contribution to the RDA lower 
than 10% (Table 9).  
Similarly, K, Ca and Mg have been reported as dominant elements in M. rubra (bayberry) 
[139]. Levels of K in M.  faya were superior than in M. rubra [139], but the remaining elements 
presented lower or similar concentrations.  
2.3.  Rubus grandifolius 
In this case, the contents of nutritional elements decreased in the following order: K (5000 
µg g-1) > Ca > Mg > P > Fe > Na > Mn > Zn > Cu > Ni > V > Mo > Co (0.05 µg g-1) (Table 8). 
Variations were found for Ba, Ca, K, Mg, Mn, P and Zn contents in samples collected in different 
locations (p < 0.05). Except for Ba and Mo, berries collected in Machico (MX) (600 m high) presented 
higher concentrations than Funchal (FX) counterparts (collected at 1000 m high) (Table S 8). This is 
probably due to the different soil characteristics. The contribution of R. grandifolius minerals to the 
RDA is significant for Cu (15%), Fe (26%), Mg (12%) and Mn (45%) (Table 9).  
The concentration of minerals found in the present study, were higher than those reported for 
other Rubus species (blackberry and raspberry) [39,134]. 
2.4. Sambucus lanceolata 
The levels of the nutritional elements in this case decreased in the following order: K (15100 
µg g-1) > P > Mg > Ca > Na > Fe > Mn > Zn > Cu > Ni > Co (0.016 µg g-1) (Table 8). In terms of 
contribution to the mineral RDA, P, Cu, K, Mg and Mn present percentages close or higher than 10 
% (Table 9).  
Inferior mineral levels were documented in S. nigra [39].  
2.5.  Vaccinium cylindraceum 
For this species, the quantified levels of the inorganic elements decreased in the following 
order: K (4700 µg g-1) > Ca > P > Na > Mg > Mn > Fe > Zn > Cu > Ni > Co (0.008 µg g-1) (Table 
8). Except for Cu (11%) and Mn (> 190 %)5, the contribution to the RDA of most elements were 
below 10 % (Table 9).  
                                                     
5The highest level of intake at which unwanted side effects are mot expected has been established at 11 mg/day 
for adults (including pregnant and breast feeding women). So consumption of V. cylindraceum is not toxic for 
humans. 
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2.6.  Vaccinium padifolium 
Similar to previous species, K, Ca and P were the major components of V. padifolium. In this 
case, the concentrations of the nutritional elements decreased in the following order: K (3500 µg g-1) 
> Ca > P > Mg > Na > Mn > Fe > Zn > Cu > Ni > Co (0.08 µg g-1) (Table 8). Significant differences 
(p < 0.05) were observed for the contents of Al, Ca, K, Mg, Mn and P in berries collected in 
consecutive years (Table S 9). Additionally, variations were observed between species: V. 
cylindraceum showed higher contents of minerals (except for C, Cu, Mg and Ni) (Table 8). Genetic 
factors (species, cultivar) and edaphoclimatic conditions (soil conditions, climate, etc) are known to 
affect chemical composition of berries [35]. The contribution to the RDA of minerals was lower than 
10 % for all elements (Table 9). Exceptions were observed for Cu (12 %) and Mn (66 %), which 
makes this species less interesting in terms of their mineral content than the previous ones. The levels 
of all minerals in analysed Vaccinium spp. berries were higher than some reports in V. corymbosum 
berries [39,134]. 
2.7. General discussion 
In general, the highest levels of Ca and Fe were observed in R. grandifolius. Berries of E. 
umbellata presented the highest levels of Cu and Zn. S. lanceolata exhibited the highest content in K, 
Mg and P. V. cylindraceum berries showed the highest levels of Mn, much higher than in the other 
berries. For comparison basis, the levels of all the minerals were higher than some reports in 
strawberries and cherries [134], cranberries and blackcurrants [39]. 
In conclusion, the mineral composition was diverse among the different species. The analysed 
berries presented low concentrations of Co, Ni, Mo and Cu, but proved to be good sources of K, Ca, 
P, Na and Mg. Moreover, only very low contents of toxic elements were detected, if at all, ensuring 
the absence of risk for human health. In this sense, R. grandifolius and S. lanceolata stand out due to 
their highest contribution of dietary essential elements (Ca, Cu, Fe, K, Mg, Mn, P and Zn). 
Consumption of E. umbellata, R. grandifolius, and S. lanceolata may potentially contribute to a 
dietary control/management of hyperglycaemia in diabetic patients due to their appreciable Ca, Mg 
and Zn amounts. The high Mn content in V. cylindraceum could also be beneficial for glucose 
homeostasis. It has been suggested that minerals like Ca, Cr, Mg, Mn, and Zn are involved in insulin 
synthesis and secretion, increase insulin sensivity and glucose tolerance, scavenge free radicals and 
reduce lipid oxidation [34,135–137]. Hence, dietary supplementation of minerals with anti-diabetic 
effects, through berries intake, seems an interesting approach to prevent T2DM symptoms. 
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3. Extraction of Phenolic Compounds (PCs) 
Prior to the phenolic characterization, the influence of different experimental variables on the 
extraction procedure (solvent type, concentration, and duration of extraction) was investigated to 
increase the extraction efficiency of PCs. Initially, the extraction process was optimized for leaves of 
M. faya, with acetone and methanol tested as solvents6. The concentration of extractor in water (70 - 
100%, v/v) was also evaluated. The efficiency of the different extraction conditions was determined 
by means of TPC assay (section 2.7.1) (expressed as mg GAE 100 g-1 FW).  
Considering obtained data (Figure 22 A-B), pure methanol exhibited the highest phenolics 
amounts and was used to further evaluate the influence of extraction time (15, 30 and 60 min). Results 
indicated that increasing the extraction duration had a positive effect on the extraction efficiency 
(Figure 22 C), therefore, an extraction time of 60 min with 100% methanol was considered as 
optimum conditions.  
Figure 22 - Extraction efficiency of different extraction conditions determined by TPC (mg/100 g DW) in 
Myrica faya leaves: (A) effect of solvent (methanol versus acetone); (B) effect of methanol concentration (v/v); 
(C) effect of extraction time. Data represent the mean ± standard deviation (n = 3). Reprinted (adapted) with 
permission from [106]. 
 
For berries, a solution composed of 80:20 MeOH/water (containing 7% acetic acid) was 
chosen instead. According to literature, anthocyanins (ANTCs) extraction is more efficient when 
using acidified aqueous mixtures of polar solvents, like methanol. This enhances extraction due to 
rupture of cellular membranes and simultaneously dissolve and stabilize ANTCs [36,37,43]. This 
same extraction procedure was further applied to berries and leaves of other BPPs (non-digested and 
digested) to maintain the homogeneity of the extraction process and facilitate comparison between 
all samples. The extraction percentage yields are shown in Table 10. 
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In general, extraction yields of berries were higher than those of leaves (Table 10). This could 
be due to the higher content of other non-phenolic components (sugars, organic acids, fibers, among 
others) that are co-extracted by polar solvents [37,43]. 
Table 10 – Extraction yield (%) of berry-producing plants (BPPs) under study (pre- and post in vitro 
gastrointestinal digestion). 
Plant species  Extraction Yield (%) 
Year/ Collection area Berries Leaves 
 Non-Digested Digested Non-Digested Digested 
E. umbellata 2013 6.93 - 11.69 - 
 2014 14.94 32.06 13.87 26.91 
M. faya MX 58.13 - 23.05 - 
 FL  53.13 - 24.10 - 
 ASJ  57.88 - 29.08 - 
 BV  54.63 33.06 19.02 22.00 
 SX  46.21 - 21.94 - 
 RJ  53.59 - 22.30 - 
 PM  51.25 - 23.64 - 
 TC  42.35 - 18.07 - 
S. lanceolata  16.34 37.70 14.63 10.74 
R. grandifolius FX 53.89 37.41 30.05 20.54 
 MX 41.75 - 29.17 - 
V. cylindraceum  52.54 40.19 35.08 18.35 
V. padifolium 2013 50.49 - 30.57* - 
33.72** - 
 2014 49.34 45.53 31.47* 20.50* 
  26.47** 26.38** 
*Young Leaves; **Mature Leaves. MX: Machico; FL: Faial; ASJ: Arco de São Jorge; BV:             
Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Ilha Terceira 
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4. HPLC-DAD-ESI/MSn analysis of methanolic extracts 
Berries contain a high amount of a diverse range of phythochemicals, most of which are PCs 
(anthocyanins (ANTCs), flavonols, flavan-3-ols, proanthocyanidins (PACs), ellagitannins and 
phenolic acids)[5,34–36,39].  
The aim of this part of the work was to characterize the phytochemical composition, in 
particular PCs, of methanolic extracts by HPLC-DAD-ESI/MSn. Identification of phytochemicals 
was achieved based on MSn spectrum data, authentic standards (when available) and literature7. After 
identification of phytochemicals by HPLC-ESI-/MSn, the main PCs of analysed methanolic extracts 
were quantified by HPLC-DAD. For this analysis, a corresponding standard was used for calibration 
of each phenolic group to calculate relative individual concentrations (Table 11). It was not possible 
to quantify all identified compounds because some were present in trace amounts and did not permit 
a proper integration of peaks.  
Table 11 – Regression curves and linearity of selected standards used for quantification purposes. 
Standard Equation R2 Phenolic group 
m b   
Caffeic acid 0.437 0.383 0.997 Hydroxycinnamic acids 
Protocatechuic acid 0.172 -0.678 0.998 Hydroxybenzoic acids 
5-O-Caffeoylquinic acid 0.537 1.878 0.999 Caffeoylquinic acids 
Cyanidin 3-O-glucoside 0.080 0.168 0.998 Anthocyanins 
Quercetin hydrate 0.127 0.173 0.990 Flavonols 
(+)-Catechin hydrate 0.063 0.201 0.996 Flavan-3-ols 
Apigenin 0.433 -1.276 0.993 Flavones 
Hesperidin 0.076 -0.295 0.997 Flavanones 
Ellagic acid 0.145 0.059 0.995 Ellagic acid derivatives 
Myricitrin 0.133 0.144 0.999 Myricetin derivatives 
 
A great number of different PCs were identified and the structures of the most relevant are 
presented in Figure 6 and Figure 23. 
The quantification data is presented in the following sections, and discussion will be presented 
for each plant individually. 
                                                     
7For detailed information about the identification/characterization of phytochemicals in analysed methanolic 
extracts please check the Supplementary Material. 
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4.1. Elaeagnus umbellata 
The methanolic extracts of E. umbellata (berries and leaves) collected in two consecutive 
years were analysed. The distribution of phytochemicals in the different morphological parts are 
shown in Figure 24 (only the most abundant compounds are numbered for the sake of clarity). A 
total of 85 phytochemicals were identified, including flavonoids, ellagitannins, phenolic acids, 
organic acids, saccharides and terpenoids (Supplementary Material - Table S 10). 
 
 
Figure 24 – Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of E. umbellata 
(collected in 2014) methanolic extracts (berries and leaves). For peak identification check Table S 10 
(Supplementary Material). 
4.1.1. Pre-in vitro gastrointestinal digestion 
In the present analysis, 38 main PCs were quantified in E. umbellata extracts and values 
ranged between 3.87 - 5.56 and 37.94 - 42.35 mg g-1 DE for berries and leaves, respectively (Table 
12). Quantitative variations (p < 0.05) were found between berries and leaves collected in different 
years. Samples from 2014 contained, in general, higher phenolic contents (except for flavan-3-ols) 
(Table 12). Inter-annual discrepancies could be related to different climacteric conditions (solar 
radiation, rainfall and temperature) observed during 2013 and 2014. These factors could have a 
substantial impact on plants phenolic composition [35].  
The compositional percentages of E. umbellata extracts (pre- and post in vitro digestion) are 
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Figure 25  - Phenolic composition of E. umbellata extracts (pre- and post-in vitro digestion). In the case of 
undigested extracts the values represent the means from data of samples collected in two consecutive years. For 
more detailed data check Table S 10. HBAs: hydroxybenzoic acids; HCAs hydroxycinnamic acids; FLAVOs: 
flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELGTs: ellagitannis. 
Kaempferol-O-rutinoside (87) was the most abundant compound (18.06 – 37.18%) in berries; 
other compounds such as kaempferol-O-hexoside (73) (6.11 - 10.20%), dihydrokaempferol-O-
hexoside (37) (8.67%), quercetin-O-pentoside (49) (8.38%) and kaempferol-O-rutinoside (89) 
(6.65%) were also relevant (Table 12). In the case of leaves, bis-HHDP-O-hexoside (17) (26.68 – 
31.81%), galloyl-HHDP-O-hexoside (22) (12.77 – 15.49%) pendunculagin I (15) (10.25%) and 
quercetin-O-pentosyl(hexoside) (51) (10.25 – 12.53%) were the main phenolics. 
Little is known about the phenolic composition of E. umbellata. In a previous work [104], 
catechin polymers were main compounds of berries aqueous/acetone extracts. However, these 
compounds were not found in the present analysis. From another study [105], gallic acid and 
kaempferol were quantified in leaves (0.95 and 0.81 mg g-1 DE, respectively). These discrepancies 
could be related to edaphoclimatic conditions and/or differences in the extraction methodology 
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Table 12 – Quantification (mg g-1 DE) of main phenolic compounds present in E. umbellata extracts (berries 
and leaves) collected in two consecutive years. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries  Leaves  
Hydroxycinnamic acids 2013 2014 2013 2014 
28 Sinapic acid-O-(pentosyl)hexoside  0.04 ± 0.01b 0.10 ± 0.01a 0.73 ± 0.03c 1.42 ± 0.04d 
35 Sinapic acid-O-hexoside   0.15 ± 002a 0.18 ± 0.01a 
41 Sinapic acid derivative   0.20 ± 0.01a 0.31 ± 0.01b 
78 Caffeic acid derivative   0.04 ± 0.01  
85 Disinapoyl-O-hexoside   0.19 ± 0.01a 0.21 ± 0.02a 
Total 0.04 ± 0.01b 0.10 ± 0.01a 1.32 ± 0.08c 2.12 ± 0.10d 
Hydroxybenzoic acids     
68 Trigalloylglucose derivative   0.16 ± 0.01  
Total   0.16 ± 0.01  
Flavonols     
14 Q-O-(pentosyl)dihexoside   0.73 ± 0.03b 0.67 ± 0.03a 
26 K-O-dihexoside-O-rhamnoside  0.05 ± 0.01   
33 I-O-glucuronide derivative 0.13 ± 0.01a 0.17 ± 0.01b   
37 Dihydro-K-O-hexoside 0.34 ± 0.01b 0.21 ± 0.01a   
38 I-O-(pentosyl)hexoside-O-rhamnoside 0.19 ± 0.01a 0.17 ± 0.01a   
43 Q-O-dihexoside   0.42 ± 0.01c 0.59 ± 0.02d 
48 Q-O-(pentosyl)hexoside 0.22 ± 0.01a 0.20 ± 0.01a   
49 Q-O-pentoside 0.04 ± 0.01a 0.47 ± 0.01b   
51 Q-O-pentosyl(hexoside)   4.13 ± 0.06a 5.06 ± 0.29b 
54 I-O-dihexoside   0.40 ± 0.02a 0.39 ± 0.02a 
60 I-O-(pentosyl)hexoside 0.19 ± 0.01b 0.14 ± 0.01a   
61 Q-O-hexoside 0.09 ± 0.01a 0.13 ± 0.01b   
65 I-O-pentosyl(hexoside)   2.69 ± 0.11a 3.94 ± 0.17b 
73 K-O-hexoside 0.40 ± 0.03b 0.34 ± 0.01a 0.53 ± 0.02c 0.51 ± 0.01c 
74 I-O-hexoside    0.90 ± 0.03a 1.71 ± 0.08b 
80 K-O-(coumaroyl)dihexoside  0.07 ± 0.01   
84 I-O-dihexoside derivative   0.19 ± 0.01a 0.94 ± 0.02b 
87 K-O-(coumaroyl)hexoside 0.70 ± 0.03a 2.07 ± 0.01c 0.90 ± 0.15b 2.02 ± 0.05c 
89 K-O-(coumaroyl)hexoside 0.23 ± 0.01a 0.37 ± 0.01b 0.35 ± 0.02b 0.62 ± 0.01c 
Total 2.51 ± 0.13a 4.38 ± 0.12b 11.26 ± 0.79c 16.44 ± 0.78d 
Flavones     
88 Diosmetin-C-dihexoside 0.08 ± 0.01a 0.09 ± 0.01a   
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90 Diosmetin-O-dihexoside 0.13 ± 0.01a 0.11 ± 0.01a   
91 Diosmetin-C-dihexoside 0.25 ± 0.01a 0.24 ± 0.01a   
Total  0.46 ± 0.03a 0.43 ± 0.02a   
Flavan-3-ols      
16 Gallo(epi)catechin 0.23 ± 0.01b 0.15 ± 0.01a 0.91 ± 0.04d 0.85 ± 0.03c 
Total  0.23 ± 0.01b 0.15 ± 0.01a 0.91 ± 0.04d 0.85 ± 0.03c 
Ellagic acid derivatives/Ellagitannins     
13 Pedunculagin I   2.15 ± 0.04b 1.21 ± 0.03a 
15 Pedunculagin I   4.07 ± 0.11b 3.28 ± 0.14a 
17 Pedunculagin I   12.64 ± 0.45b 10.77 ± 0.23a 
21 Galloyl-HHDP-O-hexoside 0.14 ± 0.01a 0.16 ± 0.01a   
22 Galloyl-HHDP-O-hexoside   5.07 ± 0.27a 6.25 ± 0.40b 
24 Casuarinin 0.16 ± 0.01a 0.35 ± 0.01b   
40 Ellagic acid-O-hexoside   0.14 ± 0.01a 0.28 ± 0.02b 
42 Ellagic acid-O-(acetyl)pentoside   2.01 ± 0.09b 1.15 ± 0.05a 
Total 0.30 ± 0.02a 0.50 ± 0.03b 26.09 ± 1.37d  22.93 ± 1.75c 
TIPC 3.87 ± 0.28a 5.56 ± 0.39b 37.94 ± 1.63c 42.34 ± 2.95c 
HHDP: Hexahydroxydiphenoyl; K: Kaempferol; I: Isorhamnetin; Q: Quercetin. TIPC: total individual phenolic 
content. Bold values represent the sum of each type of components. Means in the same line not sharing the 
same letter are significantly different at p < 0.05 probability level. 
 
 
4.1.2. Post in vitro gastrointestinal digestion 
For this analysis, samples collected in 2014 were selected in detriment of those collected in 
previous year due to the higher TIPC (total individual phenolic content). After simulated digestion, 
qualitative and quantitative differences were found in E. umbellata in relation to native values (p < 
0.05) (Figure 25 and Table 13). Berries components were most unstable than in leaves (a reduction 
of 71.05% and 62.24% of TIPC, respectively). Hydroxycinnamic acids (HCAs) and ellagitannins 
were not quantifiable in digested berries extracts (Figure 25 and Table 13). Flavonols and flavones 
suffered a degradation of 67.28% and 59.30%, respectively. Flavones and flavan-3-ols were not 
quantified after digestion of leaves (Figure 25 and Table 13). HCAs content showed the highest loss 
(90.20%), followed by ellagitannins (62.59%) and flavonols (43.63%). 
Regarding individual phenolic compounds, kaempferol-O-rutinoside (87) (60.76%) and 
quercetin-O-pentoside (49) (11.58%) remained the major component in berries (Table 13). A 
reduction of 52.70% and 60.00% was verified, respectively. In leaves, pedunculagin I (17) (25.52%) 
quercetin-O-pentosyl(hexoside) (51) (17.33%) and galloyl-HHDP-O-hexoside (22) (14.93%) were 
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still dominant (Table 13). These compounds showed a decrease of 62.51%, 43.10% and 61.68%, 
respectively, upon digestion. 
Unfortunately, information regarding the stability of PCs in the gastrointestinal (GI) tract 
occurring in E. umbellata is lacking in the literature. However, this issue has been extensively studied 
for other berries species and losses of TIPC have also been reported (23.7- 
80.50%)[24,49,54,59,117,140,141]. 
 
Table 13 - Quantification of main polyphenolic compounds present in E. umbellata (mg g-1 DE) before and 
after in vitro gastrointestinal digestion. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries  Leaves  
Hydroxycinnamic acids Non-digested Digested Non-digested Digested 
28 Sinapic acid-O-(pentosyl)hexoside 0.10 ± 0.01a  1.42 ± 0.04b  
35 Sinapic acid-O-hexoside   0.18 ± 0.02b 0.08 ± 0.01a 
41 Sinapic acid derivative   0.31 ± 0.01b 0.11 ± 0.01a 
78 Caffeic acid derivative     
85 Disinapoyl-O-hexoside   0.21 ± 0.02  
Total  0.10 ± 0.01a  2.13 ± 0.07c 0.20 ± 0.01b 
Flavonols     
14 Q-O-(pentosyl)dihexoside   0.67 ± 0.03b 0.22 ± 0.08a 
26 K-O-dihexoside-O-rhamnoside 0.06 ± 0.01    
33 I-O-glucuronide derivative 0.17 ± 0.01    
37 Dihydro-K-O-hexoside 0.21 ± 0.01    
38 I-O-(pentosyl)hexoside-O-rhamnoside 0.17 ± 0.01    
43 Q-O-dihexoside   0.59 ± 0.02b 0.20 ± 0.01a 
48 Q-O-(pentosyl)hexoside 0.19 ± 0.01    
49 Q-O-pentoside 0.47 ± 0.01b 0.19 ± 0.05a   
51 Q-O-pentosyl(hexoside)   5.05 ± 0.25b 2.37 ± 0.05a 
54 I-O-dihexoside   0.39 ± 0.01b 0.12 ± 0.01a 
60 I-O-(pentosyl)hexoside 0.14 ± 0.01    
61 Q-O-hexoside 0.13 ± 0.01    
65 I-O-pentosyl(hexoside)   3.94 ± 0.14b 1.27 ± 0.03a 
73 K-O-hexoside 0.34 ± 0.01c 0.13 ± 0.02a 0.51 ± 0.02d 0.22 ± 0.01b 
74 I-O-hexoside    1.71 ± 0.05b 0.73 ± 0.03a 
79 I-O-dihexoside-O-glucuronide     
80 K-O-(coumaroyl)dihexoside 0.07 ± 0.01    
84 I-O-dihexoside derivative   0.94 ± 0.01b 0.22 ± 0.01a 
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87 K-O-rutinoside 2.07 ± 0.13c 0.98 ± 0.03a 2.02 ± 0.05c 1.17 ± 0.31b 
89 K-O-rutinoside 0.37 ± 0.05c 0.14 ± 0.01a 0.62 ± 0.02d 0.21 ± 0.02b 
Total 4.38 ± 0.12b 1.43 ± 0.08a 16.45 ± 0.55d 6.74 ± 0.43c 
Flavones     
88 Diosmetin-C-dihexoside 0.09 ± 0.01    
90 Diosmetin-O-dihexoside 0.1 ± 0.01b 0.06 ± 0.01a    
91 Diosmetin-C-dihexoside 0.24 ± 0.01b 0.11 ± 0.01a   
Total 0.43 ± 0.03b 0.18 ± 0.02a   
Flavan-3-ols     
16 Gallo(epi)catechin 0.15 ± 0.01a  0.85 ± 0.03b  
Total 0.15 ± 0.01a  0.85 ± 0.03b  
Ellagic acid derivatives/ Ellagitannins     
13 Pedunculagin I   1.21 ± 0.03  
15 Pedunculagin I   3.28 ± 0.09b 1.54 ± 0.13a 
17 Pedunculagin I   10.77 ± 0.13b 4.03 ± 0.32a 
21 Galloyl-HHDP-O-hexoside 0.16 ± 0.01    
22 Galloyl-HHDP-O-hexoside   6.25 ± 0.04b 2.39 ± 0.09a 
24 Casuarinin 0.35 ± 0.01    
40 Ellagic acid-O-hexoside   0.28 ± 0.01  
42 Ellagic acid-O-(acetyl)pentoside   1.15 ± 0.01b 0.61 ± 0.03a 
Total 0.50 ± 0.03a  22.93 ± 0.30c 8.58 ± 0.33b 
TIPC 5.56 ± 0.19b 1.61 ± 0.09a 42.35 ± 0.95d 15.52 ± 0.84c 
HHDP: Hexahydroxydiphenoyl; K: Kaempferol; I: Isorhamnetin; Q: Quercetin. TIPC: total individual phenolic 
content. Bold values represent the sum of each type of components. Means in the same line not sharing the 
same letter are significantly different at p < 0.05 probability level.
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4.2. Myrica faya 
4.2.1. Identification of phythochemicals 
More than 160 phytochemicals were identified in M. faya extracts (berries and leaves) from 
different origins. ANTCs, other flavonoids, phenolic acids, organic acids, terpenoids, lignans and 
oxylipins were detected; similar to previous established profiles for M. faya [106] and M. rubra 
[82,142,143]. Figure 26 and Figure 27 show representative BPCs obtained during the analysis of M. 
faya extracts. Identification of phytochemicals is presented in Supplementary Material (Table S 11 
and Table S 12).  
 
Figure 26 – Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of M. faya 
methanolic extracts (berries and leaves). For peak identification check Table S 11 (Supplementary Material). 
 
Figure 27 - Representative base peak chromatogram (BPC) of the HPLC-ESI+/MSn analysis of M. faya 
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4.2.2. Pre-in vitro gastrointestinal digestion 
In this analysis, 66 main PCs were quantified in M. faya samples by HPLC-DAD (Table 14 
and Table 15). TIPC ranged between 83.48 – 102.35 and 34.52 – 43.63 mg g-1 DE for leaves and 
berries, respectively (Table 14 and Table 15). Significant variations (p < 0.05) were observed in the 
phenolic composition of M. faya from different origins. These are possibly due to climacteric and soil 
conditions. Samples collected in the northeast part of the Island (Seixal (SX), Ribeira da Janela (RJ) 
and Porto Moniz (PM)) are subjected to different climacteric conditions than those in the 
west/northwest (Machico (MX), Faial (FL), Arco de São Jorge (ASJ) and Boaventura (BV)). 
Additionally, samples from a different archipelago (Terceira Island (TC), Azores archipelago) have 
grown under completely different environmental conditions, that are known to impact qualitative and 
quantitative measurements [35].  
The compositional percentages of M. faya extracts (pre- and post in vitro digestion) are 
represented in Figure 28. 
 
Figure 28 - Phenolic composition of M. faya extracts (pre- and post-in vitro digestion). In the case of undigested 
extracts, the values represent the means from data of samples collected in different locations. For more detailed 
data check Table 14 and Table 15. ANTCs: anthocyanins; HBAs: hydroxybenzoic acids; HCAs 
hydroxycinnamic acids; FLAVOs: flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELGTs: ellagitannis. 
Cyanidin-3-O-glucoside (C3G) (16) was the absolute predominant phenolic in berries (67.20 
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general, BV berries showed the highest phenolic amounts, while RJ and MX presented the lowest (p 
< 0.05) (Table 14). Myricitrin (MCT) (112) was the main compound in leaves (13.19 – 24.36%) 
(Table 15), as previous reported for Myrica spp. [106,117,142]. Digalloyl(epi)gallocatehcin dimer 
(71) (6.00 – 15.73%), casuarin (53) (4.58 – 9.70%) EGCG (81) (4.02 – 8.29%), and pedunculagin I 
(31) (2.26 – 6.32%) were also relevant. Overall, leaves from BV showed the highest phenolic contents 
and RJ the lowest (p < 0.05) (Table 15). Differences in phenolic contents were more notorious in 
leaves, in particular, for those collected in a different Island/archipelago: digalloyl(epi)gallocatehcin 
dimer (71) (15.73%), MCT (112) (13.19%) and EGCG-EGCG (46) (10.18%) were major in TC leaves 
(Table 15). 
Previously analysis  on M. faya [106] and M. rubra [65,82,142,143] showed similar phenolic 
compositions. However, different units make it difficult to establish a comparison with present data 
(Table 14 and Table 15).  
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Table 14 - Quantification (mg g-1 DE) of main phenolic compounds present in M. faya extracts (berries) collected in eight different locations. Data represent the 
mean ± standard deviation (n = 3). 
Nº Assigned identification MX FL ASJ BV SX RJ PM TC 
Anthocyanins         
5 Delphinidin-O-hexoside 0.26 ± 0.01c 0.10 ± 0.02a 0.24 ± 0.01b 0.31 ± 0.01d 0.31 ± 0.01d 0.24 ± 0.01b 0.35 ± 0.01e 0.31 ± 0.01d 
11 Delphinidin-O-hexoside 2.02 ± 0.02d 1.87 ± 0.05c 2.10 ± 0.01e 2.34 ± 0.01f 1.37 ± 0.04a 1.67 ± 0.01b 1.40 ± 0.06a 1.60 ± 0.07d 
16 Cyanidin-3-O-glucoside 24.47 ± 0.05b 26.54 ± 0.46b 33.19 ± 0.25f 32.01 ± 0.18e 28.53 ± 0.10d   23.73 ± 0.30a 27.33 ± 0.61b 27.20 ± 0.05cd 
48 Cyanidin-O-pentoside   0.17 ± 0.01      
50 Cyanidin-O-hexoside 0.28 ± 0.01c  0.23 ± 0.01b 0.15 ± 0.01a   0.34 ± 0.01d  
69 Cyanidin-O-(acetyl)hexoside 0.21 ± 0.01a  0.20 ± 0.01a 0.30 ± 0.01b   0.33 ± 0.01c 0.21 ± 0.08a 
Total 27.24 ± 0.10b 28.51 ± 0.54b 36.13 ± 0.27f 35.11 ± 0.21e 30.21 ± 0.07c 25.64 ± 0.32a 29.75 ± 0.69b 29.32 ± 0.13d 
Hydroxycinnamic acids         
10 Caffeoylisocitrate  0.41 ± 0.01d  0.12 ± 0.01a  0.20 ± 0.01b 0.33 ± 0.01c  
56 Coumaric acid-O-hexoside 0.01 ± 0.01a 0.02 ± 0.01b    0.01 ± 0.01a   
63 5-O-CQA    0.29 ± 0.01b 0.21 ± 0.01a    
76 Dihydro-Co-O-hexoside        0.08 ± 0.01 
164 B-p-tri-CoDOA 0.39 ± 0.01a 0.69 ± 0.02d 0.51 ± 0.01b 0.54 ± 0.01c 0.38 ± 0.02a 0.48 ± 0.01b 0.53 ± 0.01c 0.79 ± 0.01e 
Total 0.40 ± 0.01a 1.12 ± 0.03f 0.51 ± 0.01b 0.95 ± 0.02 0.59 ± 0.02c 0.69 ± 0.01d 0.86 ± 0.02e 0.87 ± 0.01e 
Hydroxybenzoic acids         
4 Galloyl-O-hexoside 0.25 ± 0.01d 0.21 ± 0.01c 0.19 ± 0.01 0.16 ± 0.01a 0.21 ± 0.01c 0.22 ± 0.01c 0.18 ± 0.01ab 0.14 ± 0.01a 
12 Galloyl-O-hexoside 1.11 ± 0.03b 1.03 ± 0.01a 1.31 ± 0.02c 1.45 ± 0.03d 1.53 ± 0.04e 1.30 ± 0.01c 1.00 ± 0.01a 1.08 ± 0.01f 
15 Galloylquinic acid   0.20 ± 0.01      
27 Digalloyl-O-hexoside 0.39 ± 0.01d 0.27 ± 0.08bc 0.20 ± 0.01b 0.20 ± 0.01b 0.27 ± 0.01c 0.21 ± 0.01b 0.10 ± 0.01a 0.69 ± 0.01e 
88 Trigalloyl glucose  0.24 ± 0.01b  0.06 ± 0.01a     
161 Methyl gallate derivative        0.05 ± 0.01 
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Total 1.75 ± 0.05b 1.75 ± 0.03e 1.90 ± 0.03e 1.87 ± 0.04d 2.01 ± 0.05ef 1.73 ± 0.02c 1.28 ± 0.01a 1.96 ± 0.07g 
Flavonols         
83 Dihydro-K-O-hexoside        0.29 ± 0.01 
91 M-O-hexoside 0.22 ± 0.01c 0.16 ± 0.01b 0.26 ± 0.01de 0.25 ± 0.01d 0.29 ± 0.01f 0.24 ± 0.01cd 0.12 ± 0.01a 0.25 ± 0.01d 
92 M-O-(galloyl)hexoside 0.14 ± 0.01cd 0.21 ± 0.01e 0.14 ± 0.01cd 0.09 ± 0.01a 0.10 ± 0.01b 0.12 ± 0.01bc 0.09 ± 0.01a 0.12 ± 0.01bc 
108 M-O-pentoside  0.49 ± 0.01c     0.11 ± 0.01a 0.18 ±0.01b 
112 Myricitrin 1.36 ± 0.02c 1.09 ± 0.02a 1.13 ± 0.03a 1.20 ± 0.02b 1.53 ± 0.02d 1.37 ± 0.03c 1.38 ± 0.05c 1.23 ± 0.02b 
121 Q-O-hexoside 0.07 ± 0.01a  0.18 ± 0.01c 0.12 ± 0.01b 0.45 ± 0.01e 0.17 ± 0.01c 0.07 ± 0.01a 0.28 ± 0.01d 
122 Q-O-(galloyl)hexoside 0.27 ± 0.01d  0.10 ± 0.01a 0.10 ± 0.01a 0.17 ± 0.02b 0.15 ± 0.01b 0.19 ± 0.01c 0.18 ± 0.01c 
127 Q-O-(galloyl)hexoside 0.20 ± 0.01b  0.22 ± 0.01bc 0.15 ± 0.01a    0.21 ± 0.01b 
131 K-O-hexoside 0.15 ± 0.01a 0.26 ± 0.01c 0.25 ± 0.02c 0.32 ± 0.01d 0.27 ± 0.01c 0.19 ± 0.01b 0.14 ± 0.01a 0.14 ± 0.01a 
136 K-O-hexoside 0.60 ± 0.01c   0.20 ± 0.01a 0.19 ± 0.01a  0.27 ± 0.01b  
137 Q-O-deoxyhexoside    0.24 ± 0.01a   0.25 ± 0.01ab 0.27 ± 0.01b 
139 K-O-(galloyl)hexoside 0.35 ± 0.01b 0.47 ± 0.03c 0.43 ± 0.01c  0.27 ± 0.01a 0.82 ± 0.01d  0.84 ± 0.01d 
140 Dimethyl-M-O-pentoside       0.25 ± 0.01  
145 M-O-(galloyl)deoxyhexoside 0.42 ± 0.01e 0.38 ± 0.01c 0.35 ± 0.01cd  0.30 ± 0.02b 0.38 ± 0.01d  0.19 ± 0.01a 
151 Q-O-(galloyl)deoxyhexoside 0.40 ± 0.01c  0.21 ± 0.01a 0.27 ± 0.01b   0.60 ± 0.01e 0.46 ± 0.01d 
153 Q-O-(galloyl)deoxyhexoside  0.38 ± 0.02b 0.28 ± 0.01a   1.13 ± 0.01d 0.40 ± 0.01b 1.09 ± 0.01c 
160 Quercetin        0.31 ± 0.01 
Total 4.34 ± 0.08e 3.44 ± 0.15b 3.61 ± 0.08c 2.93 ± 0.05a 3.57 ± 0.07bc 4.57 ± 0.13e 3.98 ± 0.08d 6.26 ± 0.20f 
Flavan-3-ols         
43 Gallo(epi)catechin 0.20 ± 0.01ab 0.76 ± 0.03e 0.12 ± 0.01a 0.11 ± 0.01a  0.12 ± 0.07a 0.23 ± 0.01c 0.34 ± 0.01d 
45 Gallocatechin dimer   0.16 ± 0.01a 0.26 ± 0.01b     
71 Digalloyl(epi)gallocatechin 
dimer 
 0.50 ± 0.01c 0.38 ± 0.01b 0.32 ± 0.01a  0.37 ± 0.01b 0.58 ± 0.01d  
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79 Catechin 0.16 ± 0.01a     0.25 ± 0.01b   
81 Gallo(epi)catechin-O-gallate 0.04 ± 0.01a 0.12 ± 0.01c  0.05 ± 0.01ab  0.06 ± 0.01b 0.05 ± 0.01ab  
87 Digallocatechin derivative  0.45 ± 0.01c   0.14 ± 0.01a   0.28 ± 0.01b 
99 Gallo(epi)catechin-O-gallate 0.46 ± 0.01b   0.25 ± 0.01a    
Total 0.40 ± 0.01a 2.29 ± 0.07e 0.66 ± 0.02b 0.74 ± 0.02c 0.39 ± 0.01a 0.80 ± 0.09cd 0.86 ± 0.02d 0.62 ± 0.01b 
Flavones         
86 Tricin-O-hexoside derivative 0.25 ± 0.01c      0.11 ± 0.01a 0.21 ± 0.01b 
Total 0.25 ± 0.01c      0.11 ± 0.01a 0.21 ± 0.01b 
Elagic acid derivatives/ Ellagitannins         
31 Pedunculagin I 0.11 ± 0.01a  0.39 ± 0.01d 0.46 ± 0.01e 0.24 ± 0.01c 0.24 ± 0.01c 0.18 ± 0.01b  
39 Pedunculagin I 0.13 ± 0.01a 0. 19 ± 0.01  0.17 ± 0.01b 0.37 ± 0.01d 0.42 ± 0.02e 0.23 ± 0.01c 0.47 ± 0.01f 
53 Casuarinin 0.26 ± 0.01d   0.14 ± 0.01a 0.20 ± 0.01b 0.21 ± 0.01b 0.23 ± 0.01bc  
65 Casuarinin 0.18 ± 0.01bc 0.44 ± 0.01e  0.16 ± 0.01b   0.06 ± 0.01a 0.23 ± 0.01d 
67 Casuarinin like ellagitannin   0.26 ± 0.01d 0.21 ± 0.01b  0.16 ± 0.01a  0.22 ± 0.01bc 
80 HHDP-O-hexoside 0.05 ± 0.01a 0.14 ± 0.01c   0.25 ± 0.01d 0.06 ± 0.01ab   
89 Ellagitannin 0.10 ± 0.01a      0.12 ± 0.01ab  
93 Ellagic acid-O-pentoside   0.17 ± 0.01a  0.29 ± 0.01c  0.22 ± 0.02b 0.32 ± 0.02cd 
Total 0.83 ± 0.02b 0.77 ± 0.01a 0.82 ± 0.01b 1.14 ± 0.02d 1.35 ± 0.03f 1.09 ± 0.04c 1.04 ± 0.03c 1.24 ± 0.02e 
TIPC 35.20 ± 0.66a 37.88 ± 0.77b 42.74 ± 0.90d  43.63 ± 0.78d 38.12 ± 0.92bc 34.52 ± 0.57a 37.88 ± 0.85b 40.48 ± 0.25c 
 
MX: Machico; FL: Faial; ASJ: Arco de São Jorge; BV: Boaventura; SX: Seixal; PM: Porto Moniz; TC: Terceira; B: benzoyl; HHDP: Hexahydroxydiphenoyl; 
CoDOA: coumaroyl-2,7-anhydro-3- deoxy-2-octulopyranosonic acid; K: Kaempferol; M: Myricetin; Q: Quercetin. TIPC: total individual phenolic content. Bold 
values represent the sum of each type of components. Means in the same line not sharing the same letter are significantly different at p < 0.05 probability level.
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Table 15 – Quantification (mg g-1 DE) of main phenolic compounds present in M. faya extracts (leaves) collected in eight different locations. Data represent the 
mean ± standard deviation (n = 3). 
Nº Assigned identification MX FL ASJ BV SX RJ PM TC 
Hydroxycinnamic acids         
56 Co-O-hexoside        0.21 ± 0.01 
164 B-p-tri-CoDOA 0.07± 0.01cd 0.03 ± 0.01a 0.05 ± 0.01bc 0.04 ± 0.01ab  0.08 ± 0.01de 0.04 ± 0.01ab 0.03 ± 0.01a 
Total 0.07± 0.01cd 0.03 ± 0.01a 0.05 ± 0.01bc 0.04 ± 0.01ab  0.08 ± 0.01de 0.04 ± 0.01ab 0.24 ± 0.01f 
Hydroxybenzoic acids         
12 Galloyl-O-hexoside 3.13 ± 0.06e 3.25 ± 0.10ef 3.58 ± 0.04gh 2.12 ± 0.03ab 2.76 ± 0.01c 1.99 ± 0.08a 2.97 ± 0.05d 3.45 ± 0.29g 
15 Galloylquinic acid 2.08 ± 0.09d 2.65 ± 0.06f 2.39 ± 0.05e 1.42 ± 0.01a 1.61 ± 0.01b 2.02 ± 0.04d 1.76 ± 0.07c 3.19 ± 0.02g 
18 Gallic acid 1.67 ± 0.03d   0.79 ± 0.02b 0.83 ± 0.01bc 0.94 ± 0.18c 0.56 ± 0.02a  
88 Trigalloyl-O-hexoside 0.22 ± 0.01c 0.23 ± 0.01c 0.25 ± 0.01cd 0.16 ± 0.01b 0.18 ± 0.01b 0.12 ± 0.01a 0.10 ± 0.01a 0.49 ± 0.03e 
106 Tetragalloyl-O-hexoside   0.47 ± 0.02b    0.12 ± 0.01a 1.13 ± 0.03c 
Total 7.10 ± 0.29e 6.13 ± 0.35d 6.69 ± 0.25d 4.49 ± 0.09a 5.38 ± 0.04bc 5.07 ± 0.36b 5.51 ± 0.23c 8.36 ± 0.50f 
Flavonols         
91 M-O-hexoside 3.11 ± 0.09d 2.43 ± 0.18c 3.58 ± 0.16e 5.39 ± 0.17f 3.10 ± 0.01d 1.75 ± 0.06b 1.17 ± 0.01a 1.22 ± 0.04a 
92 M-O-(galloyl)hexoside 3.70 ± 0.04d 2.84 ± 0.06b 7.23 ± 0.32g 9.77 ± 0.15h 6.09 ± 0.08f 3.38 ± 0.03c 2.32 ± 0.08a 4.19 ± 0.03e 
104 Rutin 0.64 ± 0.02d 0.57 ± 0.01c  0.23 ± 0.01a 0.34 ± 0.01b 0.78 ± 0.02e 0.65 ± 0.01d  
108 M-O-pentoside       0.57 ± 0.01b 0.14 ± 0.01a 
112 Myricetin 15.91 ± 0.03b 21.57 ± 0.53f 19.59 ± 0.09e 18.47 ± 0.38d 23.55 ± 0.11g 17.59 ± 0.09c 21.66 ± 0.28f 13.27 ± 0.31a 
121 Q-O-hexoside 0.20 ± 0.01b 0.28 ± 0.01c 0.12 ± 0.01a 0.33 ± 0.01d 0.19 ± 0.01b 0.27 ± 0.01c 0.35 ± 0.01d 0.70 ± 0.01e 
122 Q-O-(galloyl)hexoside 2.00 ± 0.06cd 1.97 ± 0.07c 2.88 ± 0.05f 2.66 ±0.03e 3.75 ± 0.01g 1.83 ± 0.07c 1.52 ± 0.03b 0.57 ± 0.02a 
131 K-O-hexoside 0.68 ± 0.03c 0.62 ± 0.01b 0.86 ± 0.02f 0.77 ± 0.03e 0.71 ± 0.02cd 0.77 ± 0.01e 0.60 ± 0.02b 0.44 ± 0.01a 
137 Q-O-deoxyhexoside 0.60 ± 0.03ab 0.79 ± 0.03c 1.15 ± 0.01e 1.42 ± 0.03f 0.56 ± 0.01a 0.91 ± 0.03d 0.88 ± 0.03d 0.57 ± 0.02a 
139 K-O-(galloyl)hexoside 0.37 ± 0.02a 0.51 ± 0.01c 0.83 ± 0.01e 0.43 ± 0.01b 0.55 ± 0.01c 0.33 ± 0.01a 0.55 ± 0.01c 0.63 ± 0.01d 
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140 Dimethyl-M-O-pentoside 0.32 ± 0.01c   0.19 ± 0.01a   0.25 ± 0.01b  
145 M-O-(galloyl)hexoside 0.20 ± 0.01a  0.24 ± 0.01b 0.18 ± 0.01a  0.42 ± 0.02d 0.34 ± 0.01c  
148 K-O-rhamnoside 0.76 ± 0.01b 0.58 ± 0.01a 0.90 ± 0.03c 1.24 ± 0.04e 0.60 ± 0.01a 0.76 ± 0.03b 1.11 ± 0.04d 1.17 ± 0.02d 
150 M-O-(galloyl)deoxyhexoside 3.00 ± 0.08d 2.89 ± 0.13c 2.32 ± 0.07b 1.17 ± 0.02a 3.73 ± 0.04f 2.92 ± 0.03cd 2.26 ± 0.06b 3.24 ± 0.11e 
151 Q-O-(galloyl)deoxyhexoside 1.16 ± 0.03a 1.27 ± 0.46ab 1.84 ± 0.02d 3.61 ± 0.12e  1.06 ± 0.10a 1.40 ± 0.02c  
152 Q-O-(acetyl)rhamnoside   0.23 ± 0.01b 0.17 ± 0.01a    0.36 ± 0.01c 
153 Q-O-(galloyl)deoxyhexoside 0.13 ± 0.01a 0.16 ± 0.01ab 0.22 ± 0.01c  0.33 ± 0.01d 0.25 ± 0.01c 0.14 ± 0.01a 0.13 ± 0.01a 
160 Quercetin        0.16 ± 0.01 
Total 32.78 ± 0.5b 36.48 ± 1.53c 41.99 ± 0.86d 46.04 ± 1.13e 43.50 ± 0.36d 33.02 ± 0.52b 35.77 ± 0.64c 26.79 ± 0.63a 
Flavan-3-ols         
32 Gallocatechin 0.26 ± 0.01b 0.26 ± 0.03b 0.42 ± 0.02e  0.36 ± 0.02d 0.20 ± 0.01a 0.61 ± 0.01f 0.31 ± 0.02c 
43 Gallocatechin 2.38 ± 0.01b 3.30 ± 0.06c  1.28 ± 0.05a     
46 Gallo(epi)catechin- 
Gallo(epi)catechin-O-gallate 
2.52 ± 0.01a 3.63 ± 0.03b 6.44 ± 0.04e 5.84 ± 0.03d 5.68 ± 0.10d 4.69 ± 0.03c 4.92 ± 0.12c 10.24 ± 0.28f 
71 Digalloyl(epi)gallocatechin 
dimer 
2.68 ± 0.39e 2.28 ± 0.28d 0.55 ± 0.02a   3.33 ± 0.09b 7.54 ± 0.26c  
75 Digalloyl(epi)gallocatechin 
dimer 
6.93 ± 0.19d 5.51 ± 0.17a 6.00 ± 0.13c 10.63 ± 0.40g 7.60 ± 0.07e 8.29 ± 0.08f 6.16 ± 0.18b 15.82 ± 0.22h 
81 Gallo(epi)catechin-O-gallate 7.25 ± 0.07f 6.74 ± 0.19de 6.54 ± 0.12d 7.20 ± 0.06f 6.06 ± 0.01c 6.36 ± 0.22d 3.89 ± 0.10a 4.41 ± 0.12b 
87 Digallo(epi)catechin 
derivative 
2.03 ± 0.05c 2.96 ± 0.12e 2.04 ± 0.09c 0.70 ± 0.02a 2.77 ± 0.02d 1.48 ± 0.11b 2.99 ± 0.11e  
99 Gallo(epi)catechin-O-gallate 2.16 ± 0.02c 1.82 ± 0.01a  3.43 ± 0.07d 1.71 ± 0.07a 2.00 ± 0.06b 1.93 ± 0.03b  
Total 26.21 ± 0.67c 26.50 ± 0.70c 21.99 ± 0.61a 28.08 ± 0.59d 24.18 ± 0.52b 26.35 ± 0.39c 28.04 ± 0.96d 30.78 ± 0.50e 
Flavones         
86 Tricin-O-hexoside derivative  1.06 ± 0.01c  0.87 ± 0.01b    0.64 ± 0.01a 
94 Tricin-O-hexoside derivative 0.41 ± 0.01a    0.43 ± 0.01a    
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Total 0.41 ± 0.01a 1.06 ± 0.01d  0.87 ± 0.01c 0.43 ± 0.01a   0.64 ± 0.01b 
Ellagic acid deriatives/Ellagitannins         
8 HHDP-O-hexoside  0.27 ± 0.01a 0.46 ± 0.02c 0.23 ± 0.01a    0.33 ± 0.01b 
19 Pedunculagin I derivative        0.31 ± 0.01 
22 Pedunculagin I     3.61 ± 0.13b  2.24 ± 0.22a  
31 Pedunculagin I 3.62 ± 0.01d 4.09 ± 0.18e 3.36 ± 0.07c 3.07 ± 0.10b 2.24 ± 0.01a 3.00 ± 0.01b 4.34 ± 0.16e 6.44 ± 0.27f 
37 Casuarinin        1.07 ± 0.04 
38 HHDP-O-hexoside   0.30 ± 0.01a 0.47 ± 0.01b   0.49 ± 0.01b  
39 Pedunculagin I 3.23 ± 0.13b 2.73 ± 0.16a 4.45 ± 0.01e 3.78 ± 0.18c 3.45 ± 0.11b 4.12 ± 0.18e 3.96 ± 0.09cd 5.94 ± 0.28f 
49 Ellagic acid derivative 2.89 ± 0.01c 3.74 ± 0.13d 2.63 ± 0.02ab 2.61 ± 0.14e 3.91 ± 0.11d 2.58 ± 0.05a 4.52 ± 0.11e 2.50 ± 0.01a 
53 Casuarinin 1.44 ± 0.02d 1.14 ± 0.05b 2.00 ± 0.01e 2.93 ± 0.01g 2.19 ± 0.08f 0.94 ± 0.04a 2.80 ± 0.06g 1.34 ± 0.04c 
62 Casuarinin 6.35 ± 0.05d 6.56 ± 0.09e 5.04 ± 0.23b 5.74 ± 0.20c 4.94 ± 0.04b 3.82 ± 0.25a 5.54 ± 0.33bc 9.76 ± 0.27f 
65 Casuarinin 0.99 ± 0.01c 1.37 ± 0.04d   0.50 ± 0.01a 1.64 ± 0.06e  0.72 ± 0.01b 
73 Pedunculagin II        0.31 ± 0.01 
80 HHDP-O-hexoside 0.95 ± 0.02c 0.66 ± 0.03a 0.84 ± 0.03b 1.16 ± 0.03d 1.18 ± 0.06d 0.83 ± 0.03b 0.90 ± 0.01c 2.59 ± 0.05e 
89 Ellagitannin 1.44 ± 0.01d 1.11 ± 0.05a 2.46 ± 0.01f 2.84 ± 0.12g 1.19 ± 0.05b 2.03 ± 0.02e 1.31 ± 0.04c 1.17 ± 0.06g 
93 Ellagic acid-O-pentoside   0.89 ± 0.01a    1.15 ± 0.01b 1.31 ± 0.07c 
Total 20.91 ± 0.27b 21.67 ± 0.86bc 22.43 ± 0.28c 22.83 ± 1.05c 23.21 ± 0.59c 18.96 ± 0.64a 27.25 ± 0.79d 33.79 ± 1.12e 
TIPC 87.48 ± 1.26b 91.87 ± 1.46c 93.15 ± 2.16c 102.35 ± 2.00e 96.70 ± 1.25d 83.45 ± 1.91a 96.61 ± 2.08d 100.60 ± 1.49e 
MX: Machico; FL: Faial; ASJ: Arco de São Jorge; BV: Boaventura; SX: Seixal; PM: Porto Moniz; TC: Terceira; B: benzoyl; HHDP: Hexahydroxydiphenoyl; 
CoDOA: coumaroyl-2,7-anhydro-3- deoxy-2-octulopyranosonic acid; K: Kaempferol; M: Myricetin; Q: Quercetin. TIPC: total individual phenolic content.  Bold 
values represent the sum of each type of components. Means in the same line not sharing the same letter are significantly different at p < 0.05 probability level. 
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4.2.3. Post in vitro gastrointestinal digestion 
In this case, BV samples were submitted to in vitro digestion due to the higher phenolic 
amounts and available plant material. Differences on the composition of M. faya extracts was 
observed after in vitro digestion (p < 0.05) (Figure 28 and Table 16). TIPC of digested berries and 
leaves decreased 70.20% and 56.64%, respectively (Table 16).  
HCAs and ANTCs were the most affected classes in berries (-71.27% and -69.71%, 
respectively); flavan-3-ols, ellagitannins and flavonols contents also decreased: -69.41%, -61.90% 
and -53.85%, respectively (Table 16). HCAs were not quantified in digested leaves (Figure 28 and 
Table 16). Flavones were the most affected class (59.88%), while HBAs the least (-31.09%). 
Flavonols (-59.47%), ellagitannins (63.62%) and flavonols (57.14%) showed different degradation 
rates.  
C3G (16) remained the main compound in berries (77.83%) (Table 16), although in minor 
amounts (-68.74%). MCT (112) (18.97%), digalloyl(epi)gallocatechin dimer (71) (10.63%) and 
EGCG (81) (6.20%) were still relevant in leaves. A reduction of 54.55%, 55.72% and 61.89% was 
verified, respectively, in their contents.  
Previously [117], MCT and quercetin-O-deoxyhexoside contents of M. rubra leaves were 
significantly decreased upon in vitro digestion (80.32% and 56.09%, respectively).  
Table 16 - Quantification of main phenolic compounds present in M. faya (mg g-1 DE) before and after in vitro 
gastrointestinal digestion. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries  Leaves  
Anthocyanins Non-Digested Digested Non-Digested Digested 
5 Delphinidin-O-hexoside 0.31 ± 0.01     
11 Delphinidin-O-hexoside 2.34 ± 0.01a 0.63 ± 0.02a   
16 Cyanidin-3-O-glucoside 32.01 ± 0.18b 10.01 ± 0.16a   
50 Cyanidin-O-hexoside 0.15 ± 0.01    
69 Cyanidin-O-(acetyl)hexoside 0.30 ± 0.01    
Total 35.11 ± 0.65b 10.64 ± 0.21a   
Hydroxycinnamic acids     
10 Caffeoylisocitrate 0.12 ± 0.01    
63 5-O-CQA 0.29 ± 0.02    
164 B-p-tri-CoDOA 0.54 ± 0.01d 0.27 ± 0.01c 0.04 ± 0.01b 0.01 ± 0.01a 
Total 0.95 ± 0.04d 0.27 ± 0.01a 0.04 ± 0.01b 0.01 ± 0.01a 
Hydroxybenzoic acids     
4 Galloyl-O-hexoside 0.16 ± 0.01    
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12 Galloyl-O-hexoside 1.45 ± 0.51ab  2.12 ± 0.37b 1.05 ± 0.05a 
15 Galloylquinic acid   1.42 ± 0.21b 0.61 ± 0.02a 
18 Gallic acid   0.79 ± 0.03a 1.43 ± 0.06b 
27 Digalloyl-O-hexoside 0.20 ± 0.01    
88 Trigalloyl glucose 0.06 ± 0.01a  0.16 ± 0.01b  
Total 1.87 ± 0.62a  4.49 ± 0.19c 3.09 ± 0.18b 
Flavonols     
91 M-O-hexoside 0.25 ± 0.01b 0.11 ± 0.01a 5.39 ± 0.17d 2.43 ± 0.03c 
92 M-O-(galloyl)hexoside 0.09 ± 0.01b 0.06 ± 0.01a 9.77 ± 0.35d 3.80 ± 0.21c 
104 Rutin   0.23 ± 0.01b 0.09 ± 0.01a 
112 Myricitrin 1.20 ± 0.01b 0.51 ± 0.01a 18.48 ± 0.79d 8.40 ± 0.17c 
121 Q-O-hexoside 0.12 ± 0.01b 0.06 ± 0.01a 0.33 ± 0.01c 0.12 ± 0.02b 
122 Q-O-(galloyl)hexoside 0.10 ± 0.01b 0.05 ± 0.01a 2.66 ± 0.33d 1.03 ± 0.06c 
131 K-O-hexoside 0.32 ± 0.01c 0.14 ± 0.01a 0.77 ± 0.04d 0.24 ± 0.02b 
136 K-O-hexoside 0.20 ± 0.01b 0.10 ± 0.01a 1.42 ± 0.47d 0.62 ± 0.03c 
137 Q-O-deoxyhexoside 0.24 ± 0.01b 0.11 ± 0.01a 0.43 ± 0.02c 0.19 ± 0.01a 
140 Dimethyl-M-O-pentoside   0.19 ± 0.01  
145 M-O-(galloyl)deoxyhexoside   0.18 ± 0.01b 0.06 ± 0.01a 
148 K-O-rhamnoside   1.24 ± 0.08b 0.43 ± 0.01a 
150 M-O-(galloyl)deoxyhexoside   1.17 ± 0.04b 0.33 ± 0.01a 
151 Q-O-(galloyl)deoxyhexoside 0.27 ± 0.01b 0.15 ± 0.01a 3.61 ± 0.27d 1.37 ± 0.10c 
152 Q-O-(acetyl)rhamnoside   0.17 ± 0.03b 0.03 ± 0.01a 
160 Quercetin    0.60 ± 0.01 
Total 2.93 ± 0.09b 1.29 ± 0.02a 46.04 ± 3.74d 17.97 ± 1.31c 
Flavan-3-ols     
43 Gallo(epi)catechin 0.11 ± 0.01a  1.28 ± 0.1c 0.47 ± 0.03b 
45 Gallocatechin dimer 0.26 ± 0.01b 0.10 ± 0.01a   
46 Gallo(epi)catechin- 
Gallo(epi)catechin-O-gallate 
  5.84 ± 0.24b 2.16 ± 0.50a 
71 Digalloyl(epi)gallocatechin dimer 0.32 ± 0.01b 0.11 ± 0.01a   
75 Digalloyl(epi)gallocatechin dimer   9.63 ± 0.68b 4.71 ± 0.33a 
81 Gallo(epi)catechin-O-gallate 0.05 ± 0.01b 0.02 ± 0.01a 7.20 ± 0.25d 2.74 ± 0.16c 
87 Digallo(epi)catechin derivative   0.70 ± 0.02b 0.35 ± 0.02a 
99 Gallo(epi)catechin-O-gallate   3.43 ± 0.17b 1.35 ± 0.27a 
Total 0.74 ± 0.04b 0.23 ± 0.02a 28.08 ± 1.95d 11.45 ± 0.61c 
Flavones     
86 Tricin-O-hexoside derivative   0.87 ± 0.04b 0.35 ± 0.02a 
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Total   0.87 ± 0.04b 0.35 ± 0.02a 
Ellagic acid derivativesEllagitannins     
8 HHDP-O-hexoside   0.23 ± 0.01  
31 Pedunculagin I 0.46 ± 0.01b 0.19 ± 0.01a 3.07 ± 0.15d  1.18 ± 0.09c 
38 HHDP-O-hexoside   0.47 ± 0.20  
39 Pedunculagin I 0.17 ± 0.01b 0.04 ± 0.02a 3.78 ± 0.28d 1.41 ± 0.08c 
49 Ellagic acid derivative   2.61 ± 0.32b 0.97 ± 0.13a 
53 Casuarinin 0.14 ± 0.01b 0.03 ± 0.01a 2.93 ± 0.11d 0.93 ± 0.04c 
62 Casuarinin   5.74 ± 0.43b 1.96 ± 0.10a 
65 Casuarinin 0.16 ± 0.01b 0.10 ± 0.01a   
67 Casuarinin like ellagitannin 0.21 ± 0.01b 0.05 ± 0.01a   
75 Digalloyl(epi)gallocatechin dimer      
80 HHDP-O-hexoside   1.16 ± 0.08b 0.40 ± 0.04a 
81 Gallo(epi)catechin-O-gallate     
89 Ellagitannin   2.84 ± 0.17b 1.02 ± 0.17a 
93 Ellagic acid-O-pentoside  0.03 ± 0.01   
Total 1.14 ± 0.05b 0.43 0.02a 22.83 ± 1.46d 7.86 ± 0.75c 
TIPC 43.63 ± 0.92a 12.86 ± 0.84a 102.35 ± 2.00b 42.83 ± 2.71a 
B: benzoyl; HHDP: Hexahydroxydiphenoyl; CoDOA: coumaroyl-2,7-anhydro-3- deoxy-2-octulopyranosonic 
acid; K: Kaempferol; M: Myricetin; Q: Quercetin. TIPC: total individual phenolic content. Bold values 
represent the sum of each type of components. Means in the same line not sharing the same letter are 
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4.3. Rubus grandifolius 
The phytochemical profile of R. grandifolius from two locations of Madeira Island (Funchal 
and Machico) was composed by 122 compounds, including ANTCs, other flavonoids, phenolic acids, 
terpenoids, coumarins and organic acids (Supplementary Material - Table S 13 and Table S 14).  
The BPCs of the methanolic extracts are shown in Figure 29 - Figure 31 (only the most 
abundant compounds are numbered for the sake of clarity). 
 
Figure 29 – Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of R. grandifolius 
methanolic extracts (berries) collected in two different locations. For peak identification check Table S 13 
(Supplementary Material). 
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Figure 30 - Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of R. grandifolius 





Figure 31 - Representative base peak chromatogram (BPC) of the HPLC-ESI+/MSn analysis of R. grandifolius 
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4.3.1. Pre-in vitro gastrointestinal digestion 
Fifty main PCs were quantified in R. grandifolius samples (Table 17). The phenolic 
composition of analysed extracts ranged from 92.96 – 97.47 and 118.01 – 137.41 mg g-1 DE, for 
berries and leaves, respectively (Table 17). Significant variations (p < 0.05) were observed from 
samples collected in different locations. In general, FX samples showed the highest amounts of PCs. 
Exceptions were observed for HCAs and flavan-3-ols contents in berries and leaves, respectively.  
The compositional percentages of R. grandifolius extracts (pre- and post in vitro digestion) 
are represented in Figure 32. 
 
 
Figure 32 - Phenolic composition of R. grandifolius extracts (pre- and post-in vitro digestion). In the case of 
undigested extracts, the values represent the means from data of samples collected in different locations. For 
more detailed data check Table 17 and Table 18. ANTCs: anthocyanins; HBAs: hydroxybenzoic acids; HCAs 
hydroxycinnamic acids; FLAVOs: flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELGTs: ellagitannis. 
C3G (12) was major compound in R. grandifolius (41 – 45%) (Table 17), which is also 
reported for other Rubus berries [88,114,144]. Ellagic acid-O-glucuronide (11.65 – 15.39%) (48) and 
casuarinin (20.97 – 22.30%) (53) were also present in high amounts (Table 17). Similar TIPC, 
ellagitannins, flavonoids and HCAs were documented in wild blackberries [114]. Casuarinin (53) was 
the main PC in leaves (33 – 43%) (Table 17), which is corroborative with literature data [34,87,88]. 
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identified, previously, in R. grandifolius [107]. These discrepancies could be due differences in the 
period of collection and drying techniques. Quercetin-O-glucuronide (81) (9.56%), catechin (39) 
(8.91%), 3-O-CQA (18) (6.21 - 7.24%), caffeic acid derivative (49) (6.57%) and ellagic acid-O-
hexoside (74) (5.7%) were also major compounds (Table 17).  
Flavan-3-ols contents seemed significantly (p < 0.05) affected by the collection area: catechin 
(39) content in MX leaves were almost 8-fold higher. An explanation for the observed variations in 
the phenolic composition might be due to geographical differences of collection areas. Samples 
collected in Funchal grown at approximately 1400 m high (while Machico at about 500). 
Environmental factors like ligh/solar radiation, temperature, rainfall, among others, affect the 
phenolic composition [35]. At higher altitudes, plants are more subject to stress conditions that may 
induce intense higher synthesis of PCs as response to abiotic stress. It is known that the amounts of 
PCs in Rubus species is influenced by the collection area [31,87,88]. 
ANTCs, ellagitannins, flavonols and HCAs contents of berries (Table 17) were within those 
determined for other Rubus spp. [114]. Berries of R. glaucus and R. adenotrichus showed inferior 
TIPC (18.61 and 41.71 mg g-1 DE, respectively) than R. grandifolius [88]. TIPC of leaves was found 
within the range of other wild blackberries (83.02 – 334.24 mg g-1 DE)[87]. However, ellagitannins 
and flavonoids contents found in the present work were lower (51.59 – 255.01 and 8.68 – 61.27 mg 
g-1 DE, respectively), while HCAs amounts was in the upper limit (8.62 - 43.14 mg g-1 DE).   
Table 17 - Quantification (mg g-1 DE) of main phenolic compounds present in R. grandifolius extracts (leaves 
and berries) collected in two different locations. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries Leaves 
Anthocyanins FX MX FX MX 
2 Cyanidin-O-hexoside 5.19 ± 0.14b 3.46 ± 0.05a   
12 Cyanidin-3-O-glucoside 39.49 ± 0.44a 40.94 ± 1.20a   
13 Cyanidin-O-pentoside 2.86 ± 0.03b 1.67 ± 0.06a   
30 Cyanidin-O-(pentosyl)glucoside 4.76 ± 0.08b 3.74 ± 0.13a   
Total 52.31 ± 0.72b 48.81 ± 0.89a   
Hydroxycinnamic acids     
18 3-O-CQA  0.54 ± 0.02a 9.96 ± 0.24c 6.75 ± 0.32b 
19 Caffeic acid-O-hexoside   5.84 ± 0.13b 3.09 ± 0.11a 
22 Caffeic acid-O-hexoside   6.41 ± 0.21b 2.59 ± 0.08a 
24 Caffeic acid derivative   1.85 ± 0.05b 1.27 ± 0.02a 
27 Salvianolic acid   1.55 ± 0.03a 1.72 ± 0.03b 
29 5-O-CQA dimer 0.69 ± 0.02c 0.35 ± 0.01a 1.20 ± 0.02d 0.58 ± 0.02b 
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34 Ferulic acid-O-hexoside 0.04 ± 0.01    
40 Ferulic acid derivative   7.29 ± 0.12b 3.97 ± 0.14a 
44 Caffeic acid-O-hexoside derivative   0.84 ± 0.02a 1.09 ± 0.02b 
49 Caffeic acid derivative   6.42 ± 0.14a 7.14 ± 0.12b 
54 Caffeic acid derivative   0.24 ± 0.01  
56 Caffeic acid-O-(galloyl)hexoside   1.99 ± 0.03b 0.08 ± 0.01a 
65 Caffeic acid derivative   1.18 ± 0.03  
77 Caffeic acid derivative   0.25 ± 0.01b 0.13 ± 0.01a 
93 Umbelliferone   0.46 ± 0.01b 0.38 ± 0.02a 
96 Caffeic acid-O-dihexoside   4.76 ± 0.07b 1.56 ± 0.06a 
98 Umbelliferone   0.72 ± 0.01b 0.35 ± 0.01a 
104 Caffeic acid-O-(Co)hexoside   0.20 ± 0.01  
109 Umbelliferone   0.18 ± 0.01  
121 Coumaric acid    0.08 ± 0.01 
Total 0.72 ± 0.02a 0.89 ± 0.02b 51.69 ± 1.15d 30.79 ± 0.95c 
Flavonols     
55 Q-O-(pentosyl)hexoside 0.65 ± 0.02b 0.58 ± 0.01a   
62 I-O-glucuronide 0.47 ± 0.01a 0.48 ± 0.01a   
64 Rutin 0.44 ± 0.01a 0.65 ± 0.01b  2.14 ± 0.02c 
71 Q-O-hexoside 1.11 ± 0.02a 2.02 ± 0.04b 3.70 ± 0.09d 2.14 ± 0.02c 
81 Q-O-glucuronide 1.74 ± 0.02b 1.08 ± 0.02a 13.13 ± 0.05d 10.22 ± 0.20c 
82 3-Hydroxy-3-MG-Q-O-hexoside 1.21 ± 0.02b 1.00 ± 0.02a   
85 Q-O-pentoside 1.37 ± 0.02b 0.60 ± 0.01a 4.82 ± 0.08b 2.84 ± 0.04a 
90 Q-O-(acetyl)hexoside 0.32 ± 0.01a 0.30 ± 0.01a 2.08 ± 0.06b 1.99 ± 0.06b 
91 K-O-hexoside   1.75 ± 0.04a 1.80 ± 0.02a 
92 I derivative 0.31 ± 0.01a 0.38 ± 0.01a   
114 K-O-(coumaroyl)hexoside 0.34 ± 0.01a 0.48 ± 0.02b 2.07 ± 0.04d 0.71 ± 0.03c 
115 Quercetin 0.27 ± 0.01    
Total 8.23 ± 0.16b 7.81 ± 0.14a 27.54 ± 0.49d 21.98 ± 0.39c 
Flavan-3-ols     
32 Procyanidin dimer (B type)    1.23 ± 0.02 
39 Catechin   2.67 ± 0.07a 9.68 ± 0.15b 
Total   2.67 ± 0.07a 10.91 ± 0.17b 
Flavones     
99 Apigenin-O-glucuronide   0.39 ± 0.01a 0.35 ± 0.01a 
Total   0.39 ± 0.01a 0.35 ± 0.01a 
Ellagic acid derivatives/ Ellagitannins     
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9 HHDP-O-hexoside    1.83 ± 0.04 
15 Pedunculagin I   0.38 ± 0.01a 0.36 ± 0.01a 
21 Pedunculagin I  1.99 ± 0.06c 0.51 ± 0.01a 1.01 ± 0.03b 
37 Trigalloyl-O-hexoside   1.42 ± 0.04  
42 Ellagic acid-O-glucuronide 1.02 ± 0.02    
48 Ellagic acid-O-glucuronide 11.35 ± 0.18a 14.31 ± 0.31b   
53 Casuarinin 21.74 ± 0.72b 19.49 ± 0.34a 44.83 ± 0.77c 47.00 ± 0.67d 
58 Ellagic acid-O-pentoside 0.44 ± 0.01a 0.40 ± 0.02a 0.73 ± 0.03b  
61 Ellagic acid derivative    0.27 ± 0.01 
73 Ellagic acid-O-hexoside 0.20 ± 0.01a 0.25 ± 0.01a 7.86 ± 0.16c 1.01 ± 0.04b 
113 Ellagic acid derivative 1.47 ± 0.02    
Total 36.21 ± 0.95a 36.45 ± 0.73a 59.93 ± 1.10c 53.98 ± 0.80b 
TIPC 97.47 ± 1.85b 92.96 ± 1.94a 137.41 ± 2.22d 118.01 ± 1.89c 
FX: Funchal; MX: Machico. HHDP: Hexahydroxydiphenoyl; MG: methlyglutaroyl; K: Kaempferol; I: 
Isorhamnetin; Q: Quercetin; Co: coumaroyl. TIPC: total individual phenolic content. Bold values represent the 
sum of each type of components. Means in the same line not sharing the same letter are significantly different 
at p < 0.05 probability level. 
 
4.3.2. Post in vitro gastrointestinal digestion 
In this case, FX samples were selected for the in vitro digestion. The phenolic profile of R. 
grandifolius was affected by simulated digestion (Figure 28), with a reduction (p < 0.05) on TIPC of 
71.88% and 59.17% for berries and leaves, respectively (Table 18).  
In berries, flavonols (-86.18%), HCAs (-80.07%), ellagitannins (-72.94%) and ANTCs (-
68.80%) were substantially affected. Lower degradation rates (54.18 – 63.22%) were observed in 
leaves for flavan-3-ols, HCAS, flavanones, ellagitannins and flavonols contents. Main compounds of 
berries, C3G (12) (60.75%), casuarinin (53) (19.68%) and ellagic acid-O-glucuronide (48) (11.02%), 
showed lower amounts after simulated digestion (Table 18); a reduction of 62.32%, 71.88% and 
69.83% was noted, respectively. Casuarinin (53) and quercetin-O-glucuronide (81), major phenolic 
in leaves (34.19% and 11.02% of TIPC), suffered losses of 62.62% and 49.07%, respectively.  
Previous studies [56,141,145–147] reported the effect of in vitro digestion on Rubus spp., but 
this is the first study on R. grandifolius. ANTCs were the most affected class (- 90%) in blackberries 
[56,141]. Ellagitannins (60 - 70%) and quercetin derivatives contents (20 – 60%) were also 
significantly reduced [56]. Lower degradation rates were verified for ANTCs in other study (4.7 – 
68.30%)[147].  
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Table 18 - Quantification of main phenolic compounds (mg g-1 DE) present in R. grandifolius (Funchal, FX) 
before and after in vitro gastrointestinal digestion. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries   Leaves  
Anthocyanins Non-Digested Digested Non-Digested Digested 
2 Cyanidin-O-hexoside 5.19 ± 0.14b 1.44 ± 0.10a   
12 Cyanidin-3-O-glucoside 39.49 ± 1.78b 14.87 ± 0.69a   
13 Cyanidin-O-pentoside 2.86 ± 0.03    
30 Cyanidin-O-dioxaloylglucoside 4.76 ± 0.08    
Total 52.31 ± 0.72b 16.32 ± 1.79a    
Hydroxycinnamic acids     
18 3-O-CQA   9.96 ± 0.24b 4.02 ± 0.03a  
19 Caffeic acid-O-hexoside   5.84 ± 0.13b 2.51 ± 0.12a 
22 Caffeic acid-O-hexoside   6.41 ± 0.21b 3.03 ± 0.06a 
24 Caffeic acid derivative   1.85 ± 0.05b 0.55 ± 0.01a 
27 Salvianolic acid   1.55 ± 0.03b 0.47 ± 0.01a 
29 5-O-CQA dimer 0.69 ± 0.02c 0.14 ± 0.01a 1.2 ± 0.02d 0.31 ± 0.01b 
34 Ferulic acid-O-hexoside 0.04 ± 0.01    
40 Ferulic acid-O-hexoside   7.29 ± 0.12b 2.38 ± 0.10a 
44 Caffeic acid-O-hexoside derivative   0.84 ± 0.02b 0.23 ± 0.02a 
49 Caffeic acid derivative   6.42 ± 0.14b 2.60 ± 0.15a 
54 Caffeic acid derivative   0.24 ± 0.01b 0.10 ± 0.01a 
56 Caffeic acid-O-(galloyl)hexoside   1.99 ± 0.03b 0.76 ± 0.02a 
65 Caffeic acid derivative   1.18 ± 0.03b 0.04 ± 0.01a 
77 Caffeic acid derivative   0.25 ± 0.01  
93 Umbelliferone   0.46 ± 0.01  
96 Caffeic acid-O-dihexoside   4.76 ± 0.07b 1.96 ± 0.09a 
98 Umbelliferone   0.72 ± 0.01b 0.27 ± 0.02a 
104 Caffeic acid-O-(Co)hexoside   0.20 ± 0.01  
109 Umbelliferone   0.18 ± 0.01b 0.08 ± 0.01a 
121 Coumaric acid     
Total 0.72 ± 0.02a 0.14 ± 0.01b 51.69 ± 1.15d 19.32 ± 0.93a 
Flavonols     
55 Q-O-(pentosyl)hexoside 0.65 ± 0.02    
62 I-O-glucuronide 0.47 ± 0.01b 0.14 ± 0.01a   
64 Rutin 0.44 ± 0.01b 0.16 ± 0.01a   
71 Q-O-hexoside 1.11 ± 0.02b 0.30 ± 0.01a 3.7 ± 0.09d 1.49 ± 0.03c 
81 Q-O-glucuronide 1.74 ± 0.02a  13.13 ± 0.50c 6.69 ± 0.35b 
82 3-Hydroxy-3-MG-Q-O-hexoside 1.21 ± 0.02b 0.16 ± 0.03a   
85 Q-O-pentoside 1.37 ± 0.02b 0.19 ± 0.01a 4.82 ± 0.08d 1.93 ± 0.07c 
90 Q-O-(acetyl)hexoside 0.32 ± 0.01a 0.98 ± 0.01c 2.08 ± 0.06d 0.84 ± 0.02b 
91 K-O-hexoside   1.75 ± 0.04b 0.65 ± 0.03a 
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92 I derivative 0.31 ± 0.01    
114 K-O-(coumaroyl)hexoside 0.34 ± 0.01b 0.08 ± 0.01a 2.07 ± 0.04d 1.03 ± 0.03c 
115 Quercetin 0.27 ± 0.01    
Total 8.23 ± 0.37b 1.14 ± 0.05a 27.54 ± 0.49d 12.62 ± 0.54c 
Flavan-3-ols     
39 Catechin   2.67 ± 0.07b 0.98 ± 0.03a 
Total     2.67 ± 0.07b 0.98 ± 0.03a 
Flavones     
99 Apigenin-O-glucuronide   0.73 ± 0.04b 0.29 ± 0.01a 
Total     0.73 ± 0.04b 0.29 ± 0.01a 
Ellagic acid derivatives/ Ellagitannins     
9 HHDP-O-hexoside     
15 Pedunculagin I   0.38 ± 0.01  
21 Pedunculagin I   0.51 ± 0.01b 0.18 ± 0.05a 
37 Trigalloyl-O-hexoside   1.42 ± 0.04b 0.53 ± 0.01a 
42 Ellagic acid-O-glucuronide 1.02 ± 0.02    
48 Ellagic acid-O-glucuronide 11.35 ± 0.18b 3.42 ± 0.15a   
53 Casuarinin 21.74 ± 0.72c 6.11 ± 0.43a 44.83 ± 0.77d 16.76 ± 0.87b 
58 Ellagic acid-O-pentoside 0.44 ± 0.01c 0.14 ± 0.02a 0.73 ± 0.03d 0.31 ± 0.01b 
61 Ellagic acid derivative     
70 Ellagic acid  0.12 ± 0.03a  2.35 ± 0.09b 
74 Ellagic acid-O-hexoside 0.20 ± 0.01a  7.86 ± 0.16c 2.75 ± 0.12b 
113 Ellagic acid derivative 1.47 ± 0.02    
Total 36.22 ± 0.96c 9.80 ± 0.47a 59.93 ± 1.11d 22.89 ± 1.11b 
TIPC 97.47 ± 1.85c 27.40 ± 1.54a 137.41 ± 3.75d 56.10 ± 2.83b 
HHDP: Hexahydroxydiphenoyl; MG: methlyglutaroyl; K: Kaempferol; I: Isorhamnetin; Q: Quercetin; Co: 
coumaroyl. TIPC: total individual phenolic content. Bold values represent the sum of each type of components. 
Means in the same line not sharing the same letter are significantly different at p < 0.05 probability level. 
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4.4. Sambucus lanceolata8 
Seventy-seven phytochemicals were identified in S. lanceolata namely ANTCs, other 
flavonoids, phenolic acids, oligosaccharides, organic acids, terpenoids, lignans and fatty acids 
(Figure 33 and Figure 34). The characterization of the compounds is reported in Supplementary 
Material (Table S 15 and Table S 16).  
 
Figure 33 - Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of S. lanceolata 
methanolic extracts (berries and leaves). For peak assignment check Table S 15 (Supplementary Material). 
 
Figure 34 - Representative base peak chromatogram (BPC) of the HPLC-ESI+/MSn analysis of S. lanceolata 
(berries) methanolic extracts. For peak identification check Table S 16 (Supplementary Material). 
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4.4.1. Pre-in vitro gastrointestinal digestion 
Thirty-one PCs were quantified in S. lanceolata extracts (Table 19). In this case, berries 
showed a higher phenolic composition than leaves (p < 0.05) (Table 19). The same trend was 
observed for S. nigra [148]. However, leaves displayed superior contents of HCAs and flavonols (p 
< 0.05). The compositional percentages of S. lanceolata extracts (pre- and post in vitro digestion) are 
represented in Figure 35. 
 
Figure 35 - Phenolic composition of S. lanceolata extracts (pre- and post-in vitro digestion). For more detailed 
data check Table 19. ANTCs: anthocyanins; HBAs: hydroxybenzoic acids; HCAs hydroxycinnamic acids; 
FLAVOs: flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELGTs: ellagitannis. 
 Cyanidin-O-sambubioside (8) was dominant in berries (73.95%) (Table 19), as reported 
previously for other Sambucus species [24,148,149]. By contrast, C3G was dominant in other works 
[150,151]. Comparable C3G (0.4 – 0.7 mg g-1 DE) but lower ANTCs total amounts (8.8 – 13.4 mg g-
1 DE) were documented in S. nigra [150,151]. 3-O-Caffeoylquinic acid (3-O-CQA) (28) (44.71%), 
rutin (52) (17.06%), and quercetin-O-(rhamnosyl)rutinoside (41) (14.67%) were representative in 
leaves (Table 19). TIPC of S. lanceolata berries was within the range found on S. nigra (0.7 – 27.4 
mg g-1 DE) [148,150].  
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Table 19 - Quantification (mg g-1 DE) of main phenolic compounds of S. lanceolata extracts (berries and leaves) 
before and after in vitro gastrointestinal digestion. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries  Leaves  
Anthocyanins Non-digested Digested Non-digested Digested 
6 Cyandin-O-sambubioside 3.16 ± 0.04    
8 Cyandin-O-sambubioside 20.13 ± 0.11b 3.10 ± 0.02a   
12 Cyanidin-O-hexoside 0.85 ± 0.03    
Total 24.13 ± 0.13b 3.10 ± 0.02a   
Hydroxycinnamic acids     
4 Caffeoylisocitrate 0.15 ± 0.01b 0.06 ± 0.01a   
10 Hydroxytyrosol-O-hexoside 0.53 ± 0.02b  1.03 ± 0.01c 0.02 ± 0.01a 
21 Caffeic acid-O-hexoside   0.31 ± 0.01  
28 3-O-CQA 0.68 ± 0.03a 0.77 ±0.01b 11.58 ± 0.17d 5.22 ± 0.07c 
36 CQA derivative   0.08 ± 0.01  
37 5-O-CQA 0.06 ± 0.01a 0.14 ± 0.01b 0.50 ± 0.01c 0.15 ± 0.01b 
42 5-O-Feruloylquinic acid   0.06 ±0.01  
66 Coumaric acid derivative   0.28 ± 0.01b 0.23 ± 0.01a 
68 Caffeic acid derivative   0.14 ± 0.01  
69 Coumaric acid derivative   0.20 ± 0.01b 0.14 ± 0.01a 
70 Coumaric acid derivative   0.23 ± 0.01b 0.12 ± 0.01a 
75 Coumaric acid derivative   0.16 ± 0.01b 0.08 ± 0.01a 
78 Coumaric acid derivative   0.16 ± 0.01b 0.09 ± 0.01a 
79 Ferulic acid derivative   0.06 ± 0.01b 0.02 ± 0.01a 
Total 1.51 ± 0.05b 0.98 ± 0.01a 14.78 ± 0.11d 6.66 ± 0.07c 
Flavonols     
41 Q-O-(rhamnosyl)rutinoside 0.10 ± 0.01a  3.80 ± 0.04c 2.12 ± 0.11b 
43 M derivative   0.46 ± 0.01b 0.25 ± 0.01a 
46 Q-O-(pentosyl)hexoside 0.11 ± 0.01b 0.07 ± 0.01a 0.74 ± 0.01d 0.41 ± 0.01c 
48 Q-O-(pentosyl)hexoside 0.13 ± 0.01    
52 Rutin 0.29 ± 0.01b 0.19 ± 0.01a 4.42 ± 0.01c 1.90 ± 0.01b 
56 Q-O-hexoside 0.21 ± 0.01b 0.12 ± 0.01a   
60 I-O-rutinoside 0.08 ± 0.01b 0.01 ± 0.01a   
61 K-O-rutinoside   1.52 ± 0.03b 0.36 ± 0.01a 
74 I-O-pentoside derivative   0.18 ± 0.01  
83 Quercetin 0.12 ± 0.01    
Total 0.89 ± 0.01b 0.39 ± 0.01a 11.12 ± 0.08d 4.87 ± 0.01c 
Flavones     
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20 Luteolin derivative 0.09 ± 0.01    
38 Tricin-O-hexoside 0.06 ± 0.01    
Total 0.15 ± 0.03    
Ellagic acid derivatives     
26 Ellagic acid-O-(pentosyl)hexoside  
derivative 
0.16 ± 0.01 
   
81 Ellagic acid derivative 0.39 ± 0.01    
Total 0.55 ± 0.01    
TIPC 27.22 ± 0.20d 4.97 ± 0.02a 25.90 ± 0.19c 11.53 ± 0.07b 
K: Kaempferol; I: Isorhamnetin; Q: Quercetin. TIPC: total individual phenolic content. Bold values represent 
the sum of each type of components. Means in the same line not sharing the same letter are significantly different 
at p < 0.05 probability level. 
 
 
4.4.2. Post in vitro gastrointestinal digestion 
Significant changes (p < 0.05) in the amounts of phenolic compounds of S. lanceolata were 
observed following in vitro digestion (Figure 35 and Table 19). Berries were more affected than 
leaves, with 81.8% and 61.5% reduction of TIPC, respectively, upon simulated digestion. 
The most significant reduction mainly concerned the ANTCs content in berries (-87.15%). 
Only cyanidin-O-sambuboside (8) was detected in the digested extract (Table 19) and its amount was 
reduced by 84.60%. Loss of HCAs (35.10%) and flavonols (56.18%) contents were also observed in 
berries, although, in lower extent. Ellagitannins and flavones were not quantified upon the digestion 
process (Figure 35 and Table 19). An exception was observed for 3-O-CQA (28) which increased 
by 13% (p < 0.05), with reference to native amounts (Table 19). Similarly, Zhou and co-workers 
[152] reported an increase by 214% of 3-O-CQA after simulated digestion of S. nigra. These might 
be due to this compound being bound to proteins or fibre in the original matrix and, because of 
enzymatic action, it was released from these structures. In leaves, a similar reduction of HCAs an 
flavonols contents was observed (≈ 55%). 3-O-CQA (28) (45.27%), quercetin-O-
(rhamnosyl)hexoside (41) (18.37%) and rutin (52) (16.48%) remained main compounds (Table 19), 
despite the observed reductions of 54.92%, 44.21% and 57.01%, respectively. 
In vitro GID of S. nigra has been documented in the literature [24,152], however, none was 
conducted in S. lanceolata so far. Similar degradation rates were noted for ANTCs and TIPC of S. 
nigra (88.4% and 80.5%, respectively) [24].  
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4.6. Vaccinium cylindraceum9 
Eighty-four phytochemicals were characterized in V. cylindraceum extracts (Figure 36 and 
Figure 37), including ANTCs, other flavonoids, phenolic acids, oligosaccharides, organic acids, 
terpenoids and coumarins (Supplementary Material - Table S 17 and Table S 18). This species was 
collected at Ilha das Flores (Azores archipelago) and it was selected for this study to establish a 
comparison with Madeira Island counterpart. A previous study [109] have focused only on the 
ANTCs composition of berries, hence, the complete phenolic profile of this species (berries and 
leaves) is here reported for the first time.  
 
Figure 36 – Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of V. cylindraceum 
methanolic extracts (berries and leaves). For peak identification check Table S 17 (Supplementary Material). 
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Figure 37 – Representative base peak chromatogram (BPC) of the HPLC-ESI+/MSn analysis of V. cylindraceum 
methanolic extracts (berries). For peak assignment check Table S 18. 
4.6.1. Pre-in vitro gastrointestinal digestion 
In this species, the contents of 44 PCs were determined by HPLC-DAD (Table 20). TIPC 
ranged between 84.13 to 103.37 mg g-1 DE for berries and leaves, respectively (Table 20). Similarly, 
leaves of other Vaccinium species possessed higher phenolic amounts than berries [79,80,84,132]. 
The compositional percentages of V. cylindraceum (pre- and post in vitro digestion) are shown in 
Figure 38. 
 
Figure 38 - Phenolic composition of V. cylindraceum extracts (pre- and post-in vitro digestion). For more 
detailed data check Table 20. ANTCs: anthocyanins; HBAs: hydroxybenzoic acids; HCAs hydroxycinnamic 
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 Delphinidin, petunidin and malvidin glycosides (11, 14 and 30) were dominant ANTCs in 
berries (31.80%, 18.09% and 12.54%, respectively) (Table 20). In a previous study [109], malvidin 
glycosides showed superior amounts (31 – 46%) than delphinidin conjugates (20 – 30%) in V. 
cylindraceum. This slight variation could be related to different years of collection and sample 
preparation methodologies. 5-O-CQA (41) (36.85 %), kaempferol-O-hexoside (81) (11.27%), B-type 
PAC dimer (45) (10.94 %), quercetin-O-hexoside (70) (8.76 %) and catechin (48) (7.87 %) were 
relevant in leaves (Table 20). Alike phenolic compositions were reported for other Vaccinium species 
[63,79,84,85,132]. As oppose to previous works [63,79,84,86,132], flavan-3-ols were the most 
abundant flavonoids in analysed berries (Table 20). 
 Higher and lower TIPC were documented in literature (4.59 – 42.19 and 68.84 – 185.18 mg 
g-1 DE) for berries and leaves, respectively, of other Vaccinium species [63,80,131]. 5-O-CQA was 
also relevant in berries and leaves of Vaccinium spp. (0.72 – 12.96 and 104.00 mg g-1 DE, 
respectively) [63]. The highest TIPC found in literature were determined in V. macrocarpon extracts 
(91.10 – 137.44 and 215.49 – 388.94 mg g-1 DE in berries and leaves, respectively) [79]. 
Table 20 - Quantification (mg g-1 DE) of main phenolic compounds of V. cylindraceum extracts (berries and 
leaves) before and after in vitro gastrointestinal digestion. Data represent the mean ± standard deviation (n =3). 
Nº Assigned identification Berries  Leaves  
Anthocyanins Non-digested Digested Non-digested Digested 
3 Delphinidin-O-(pentosyl)hexoside 0.82 ± 0.03    
5 Delphinidin-O-hexoside 7.88 ± 0.03b 2.42 ± 0.15a   
11 Delphinidin-O-hexoside 26.81 ± 0.96b 13.41 ± 0.35a   
14 Petunidin-O-hexoside 15.25 ± 0.11b 4.38 ± 0.21a   
21 Delphinidin-O-rhamnoside 2.14 ± 0.09    
24 Peonidin-O-hexoside 2.04 ± 0.04    
30 Malvidin-O- hexoside 10.57 ± 0.07b 4.23 ± 0.19a   
33 Malvidin-O-pentoside 2.13 ± 0.09    
44 Malvidin-O-pentoside 0.63 ± 0.01    
Total 68.17 ± 3.15b 24.44 ± 1.17a   
Hydroxycinnamic acids     
7 Caffeoylisocitrate 0.35 ± 0.01    
35 Caffeic acid-O-hexoside 0.56 ± 0.03c  0.49 ± 0.02b 0.16 ± 0.01a 
41 5-O-Caffeoylquinic acid 5.57 ± 0.05b 2.24 ± 0.17a 33.11 ± 1.30d 16.26 ± 0.98c 
47 Caffeoylquinic acid 0.03 ± 0.01a 0.01 ± 0.01a 1.03 ± 0.04c 0.50 ± 0.02b 
49 Caffeoylshikimic acid 0.26 ± 0.01b 0.11 ± 0.01a   
54 5-p-Coumaroylquinic acid   0.55 ± 0.01b 0.21 ± 0.02a 
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58 5-p-Coumaroylquinic acid   0.78 ± 0.02b 0.35 ± 0.02a 
59 Methyl-(5-caffeoyl)quinate 0.01 ± 0.01a 0.07 ± 0.01b 0.09 ± 0.01c  
64 Coumaroyl iridoid 0.31 ± 0.01b 0.12 ± 0.01a 0.29 ± 0.01b 0.11 ± 0.01a 
67 Coumaroyl iridoid 0.52 ± 0.02b  0.55 ± 0.01b 0.29 ± 0.02a 
75 Coumaric acid derivative   0.11 ± 0.01b 0.06 ± 0.01a 
Total 7.67 ± 0.11b 2.86 ± 0.17a 37.00 ± 1.51d 17.83 ± 1.26c 
Hydroxybenzoic acids     
25 Protocatechuic acid-O-hexoside 0.80 ± 0.02b  0.60 ± 0.02a  
34 Protocatechuic acid derivative   1.15 ± 0.02  
Total 0.80 ± 0.02a  1.74 ± 0.07b  
Flavonols     
61 Myricetin-O-hexoside 0.11 ± 0.01b 0.06 ± 0.01a   
68 Cinchonain Ib   0.24 ± 0.01b 0.12 ± 0.01a 
69 Myricetin-O-(deoxy)hexoside 0.41 ± 0.01b 0.18 ± 0.01a 4.93 ± 0.11d 2.13 ± 0.17c 
70 Quercetin-O-hexoside 0.13 ± 0.01a  9.06 ± 0.30c 5.04 ± 0.27b 
77 Cinchonain Ib   1.38 ± 0.03b 0.55 ± 0.03a 
79 Cinchonain Ib   1.24 ± 0.05b 0.64 ± 0.02a 
81 Kaempferol-O-hexoside   11.65 ± 0.24b 5.14 ± 0.24a 
83 6-Hydroxy-7,4-dimethoxy- 
quercetin-O-hexoside 
0.14 ± 0.01    
84 Isorhamentin-O-hexoside 0.14 ± 0.01    
86 Quercetin-O-(acetyl)hexoside 0.07 ± 0.01  0.16 ± 0.01b 0.09 ± 0.01a 
93 Cinchonain Ib   4.49 ± 0.04b 2.49 ± 0.14a 
97 Kaempferol-O-(acetyl)hexoside   0.21 ± 0.01b 0.10 ± 0.01a 
100 6-Hydroxy-7,4-dimethoxy- 
quercetin-O-hexoside derivative 
  1.47 ± 0.04b 0.76 ± 0.02a 
Total 1.00 ± 0.01b 0.24 ± 0.01a 34.75 ± 1.74d 17.07 ± 1.23c 
Flavan-3-ols     
31 Procyanidin dimer (B type)   3.28 ± 0.08b 0.93 ± 0.02a 
37 Procyanidin dimer (B type)   1.92 ± 0.03b 0.65 ± 0.03a 
45 Procyanidin dimer (B type) 1.22 ± 0.03a  11.31 ± 0.38c 4.19 ± 0.23b 
48 Catechin 0.83 ± 0.04b 0.52 ± 0.01a 8.14 ± 0.21d 5.50 ± 0.17c 
52 Procyanidin trimer (B type) 0.57 ± 0.02b  4.08 ± 0.04c 0.18 ± 0.02a 
Total 2.62 ± 0.07b 0.52 ± 0.01a 28.73 ± 0.91d 11.45 ± 0.92c 
Flavanones     
87 Phlorizin   1.02 ± 0.04b 0.51 ± 0.02a 
Total     1.02 ± 0.04b 0.51 ± 0.02a 
Chapter III.A – Phytochemical Composition 
 
Vítor Spínola   2018                                                                                                                                      
  107 
 
Flavones     
50 Dimethoxy-hydroxytricin-O-hexoside   0.12 ± 0.01  
Total     0.12 ± 0.01  
Ellagic acid derivatives     
16 Tergallagic acid 1.15 ± 0.06    
28 Methyl-ellagic acid-O-pentoside 0.86 ± 0.01    
Total 2.01 ± 0.06      
TIPC 84.13 ± 1.44c 28.06 ± 0.13a 103.37 ± 2.55d 46.36 ± 2.03b 
TIPC: total individual phenolic content. Bold values represent the sum of each type of components. Means in 
the same line not sharing the same letter are significantly different at p < 0.05 probability level. 
 
4.6.2. Post in vitro gastrointestinal digestion 
After simulated digestion, quantitative differences in relation to native values were observed 
(p < 0.05) (Figure 38 and Table 20). Berries were more affected than in leaves, showing a reduction 
of 66.65% and 55.15% of TIPC, respectively.  
Flavan-3-ols (-80.16%), flavonols (-76.00%), ANTCs (-64.15%) and HCAs (-62.69%) were 
the most unstable compounds in berries. Ellagic acid derivatives and HBAs were not determined after 
simulated digestion (Figure 38 and Table 20). In leaves, flavan-3-ols contents were also highly 
affected (-60.15%). HCAs, flavanones and flavonols concentrations suffered similar reductions 
(46.54%, 50.43% and 50.87%, respectively). Flavones and HBAs were not quantifiable in digested 
leaves (Figure 38 and Table 20). 
Regarding main PCs in berries, petunidin-O-hexoside (14) malvidin-O-hexoside (30), 5-O-
CQA (41) and delphinidin-O-hexoside (11) showed the highest decreases (71.27%, 60.00%, 59.70% 
and 50.00%, respectively) (Table 20). The dominant compounds of leaves were also affected: 
kaempferol-O-hexoside (81) (-55.88%), 5-O-CQA (41) (-50.93%), quercetin-O-hexoside (70) (-
44.37%) and catechin (48) (-32.44%).  
Other Vaccinium species have been submitted to GID studies [54,59,140,141,153]. Similarly, 
ANTCs were very unstable to GID, with losses from 35.60% to 96.9% [54,59,140,141,153]. By 
contrast, 5-O-CQA and quercetin-O-arabinoside seemed unaffected by the adverse conditions [54]. 
A reduction of TIPC (-50.59%) was reported for V. vitis-idea, PAC dimer (B type) being the most 
affected compound (-93%) [59]. Higher recoveries were also noted for quercetin glycosides (42 – 
99%), after human digestion. In another study [153], only 3.10% of initial TIPC was recovered after 
simulated GID of blueberries (Vaccinium spp.). 
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4.7. Vaccinium padifolium10 
The phytochemical profiles of different morphological parts of V. padifolium were 
determined by HPLC-ESI-MSn (Figure 39 and Figure 40). A total of 102 phytochemicals were 
identified (Supplementary Material – Table S 19 and Table S 20), such as ANTCs, other flavonoids, 
phenolic acids, oligosaccharides and organic acids. Previous works [112,113] have focused only on 
the ANTCs composition of berries, not the complete phenolic profile of this species (berries and 
leaves). In this case, leaves were separated into young leaves (YLs) and mature leaves (MLs) based 
on the coloration of their twigs. 
 
Figure 39 – Representative base peak chromatogram (BPC) of the HPLC-ESI-/MSn analysis of V. padifolium 
methanolic extracts (berries and leaves). For peak assignment please check Table S 19 (Supplementary 
Material). 
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Figure 40 – Representative base peak chromatogram (BPC) of the HPLC-ESI+/MSn analysis of V. padifolium 
methanolic extracts (berries and leaves). For peak assignment please check Table S 20 (Supplementary 
Material). 
4.7.1. Pre-in vitro gastrointestinal digestion 
Forty-six PCs were quantified by HPLC-DAD in V. padifolium, collected in two consecutive 
years (2013 - 2014). TIPC ranged between 82.09 to 134.42 mg g-1 DE, for berries and leaves, 
respectively (Table 21). The compositional percentages of V. padifolium extracts (pre- and post in 
vitro digestion) are shown in Figure 41. 
Delphinidin-O-hexoside (5 and 16) (14.61 – 15.16% and 32.41 – 32.61%, respectively), 
petunidin-O-hexoside (20) (11.04 – 11.89%), malvidin-O-hexoside (46) (9.84 – 10.46%) and 5-O-
CQA (57) (9.40 – 9.68%) were dominant in berries (Table 21). Differences in the relative abundance 
of ANTCs were observed (malvidin > delphinidin > petunidin) in previous studies [112,113] on this 
species, which could be related to different sample preparation and extraction procedures. Moreover, 
in the present analysis, tri-glycosides of ANTCs were not detected. In general, berries collected in 
2014 showed higher phenolic contents than samples collected in previous year (p < 0.05) (Table 21). 
This difference was highlighted in the case of ANTCs content (p < 0.05). 
 The amounts of remaining phenolic classes were slightly affected between 2013 and 2014. 
These variations could be attributed to different climacteric conditions (rainfall, solar radiation, 
thermal amplitude), that are known to affect the phytochemical composition [35]. 
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Figure 41 - Phenolic composition of V. padifolium extracts (pre- and post-in vitro digestion). In the case of 
undigested extracts, the values represent the means from data of samples collected in different years.For more 
detailed data check Table 21 and Table 22. ANTCs: anthocyanins; HBAs: hydroxybenzoic acids; HCAs 
hydroxycinnamic acids; FLAVOs: flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELGTs: ellagitannis. 
TIPC of leaves extracts are similar, although their individual phenolic composition was 
slightly different (p < 0.05) (Figure 41 and Table 21). Leaves were rich sources of 5-O-CQA (57) 
(47.90 – 67.11%), but quercetin-O-hexoside (93 and 95) (5.40 – 16.46%) and a coumaric acid 
derivative (113) (6.87 – 10.03%) were also relevant. In general, YLs showed superior phenolic 
amounts than mature counterparts. Exception was noted in HCAs content, where 5-O-CQA content 
was 1.3 times-fold higher. Inter-annual variations (p < 0.05) were also observed and, in general, 
samples collected in 2014 had higher concentrations (Table 21). Previous works [84,154] observed 
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years. Environmental conditions, like precipitation and temperature, that influence phenotypic factors 
may have significant impact on phenolic composition. Unfortunately, this climacteric data was not 
available to justify the obtained results (Table 21). Cyanidin glycosides (10 and 23) (6.82 - 7.61%) 
were quantified only in YLs with considerably lower (p < 0.05) concentrations than in fruits (Figure 
41 and Table 21). Usually, ANTCs are present in red fruits, but cyanidin derivatives have also been 
quantified in leaves of other Vaccinium species (22.38 – 28.26 mg g-1 DE) [79,132]. According to 
literature [132], synthesis of ANTCs is activated/stimulated by the higher sun exposure of young 
leaves. Additionally, quercetin glycosides and HCAs play simultaneously a predominant role in 
defense against solar radiation [132].  
 V. padifolium extracts showed similar compositions to other Vaccinium species 
[84][63,79,85,86,132]. By comparison, inferior phenolic contents (p < 0.05) were found in berries 
and leaves of V. cylindraceum (Table 20). Exceptions were verified in flavonols and flavan-3-ols 
amounts (p < 0.05). In the latter group, amounts were 6 to 8-times higher than in V. padifolium (Table 
21). HCAs content was superior in V. padifolium, mostly due to the higher 5-O-CQA amounts (almost 
3 times-fold higher). Moreover, V. padifolium berries, collected in 2013, showed lower ANTCs and 
TIPC than V. cylindraceum (p < 0.05) (Table 20 and Table 21). Genetic factors (species/cultivar) 
and different environmental conditions (since V. padifolium was collected in a different 
island/archipelago) could play an important role in the obtained results [35]. It is known that 
blueberries phenolic content is influenced by genotype and growing locations [154]. Overall, the 
amounts of quantified PCs were within the range reported for other Vaccinium species, as discussed 
previously (section 4.6.1).  
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Table 21 - Quantification (mg g-1 DE) of main phenolic compounds present in V. padifolium extracts (berries and leaves). Data represent the mean ± standard 
deviation (n = 3). 
Nº Assigned identification Berries Young Leaves Mature Leaves 
Anthocyanins 2013 2014 2013 2014 2013 2014 
3 Delphinidin-O-(pentosyl)hexoside 1.58 ± 0.01a 1.88 ± 0.02b     
5 Delphinidin-O-hexoside 12.03 ± 0.19a 13.77 ± 0.20b     
10 Cyanidin-3-O-glucoside   5.83 ± 0.24a 6.65 ± 0.20b   
16 Delphinidin-O-hexoside 26.78 ± 0.05a 29.40 ± 0.22b     
20 Petunidin-O-hexoside 9.76 ± 0.08a 10.02 ± 0.40a     
23 Cyanidin-O-pentoside   3.15 ± 0.06a 3.58 ± 0.16b   
34 Peonidin-O-hexoside 3.11 ± 0.03a 3.62 ± 0.11b     
42 Malvidin-O-hexoside 1.19 ± 0.02a 1.36 ± 0.03b     
45 Malvidin-O-pentoside 0.95 ± 0.02a 1.08 ± 0.04b     
46 Malvidin-O-hexoside 8.08 ± 0.24a 9.49 ± 0.28b     
52 Malvidin-O-hexoside 0.19 ± 0.01b 0.13 ± 0.01a     
Total  63.67 ± 0.54c 70.73 ± 1.01d 8.98 ± 0.32a 10.23 ± 0.47b   
Hydroxycinnamic acids       
17 Caffeoylquinic acid derivative   0.30 ± 0.01ab 0.33 ± 0.01b 0.32 ± 0.01b 0.29 ± 0.01a 
30 3-O-Caffeoylquinic acid dimer   0.59 ± 0.01c 0.65 ± 0.02d 0.19 ± 0.01a 0.22 ± 0.01b 
44 Caffeoylquinic acid derivative   0.33 ± 0.01a 0.39 ± 0.01b 0.35 ± 0.01a 0.38 ± 0.01b 
48 Caffeoylquinic acid derivative   0.57 ± 0.01d 0.48 ± 0.01c 0.39 ± 0.01b 0.27 ± 0.01a 
49 Caffeic acid-O-hexoside 0.37 ± 0.01a 0.40 ± 0.02b 0.58 ± 0.01c 0.60 ± 0.02c 0.65 ± 0.02c 0.70 ± 0.02d 
57 5-O-Caffeoylquinic acid 7.72 ± 0.32a 8.88 ± 0.10b 63.07 ± 2.55c 66.05 ± 0.52c 86.47 ± 0.39d 87.27 ± 1.11d 
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64 Caffeoylquinic acid 0.17 ± 0.01a 0.22 ± 0.01b 2.67 ± 0.04c 2.64 ± 0.05c 1.91 ± 0.10d 2.00 ± 0.08d 
70 5-p-Coumaroylquinic acid 0.24 ± 0.01a 0.28 ± 0.01b 1.48 ± 0.05d 1.62 ± 0.04e 1.36 ± 0.05c 1.58 ± 0.10e 
73 Caffeoylquinic acid derivative   0.30 ± 0.01b 0.33 ± 0.01b 0.30 ± 0.02b 0.24 ± 0.01a 
78 Caffeoylquinic acid derivative   0.73 ± 0.02b 0.77 ± 0.02b 0.24 ± 0.01a 0.25 ± 0.01a 
82 Methyl-(5-caffeoyl)quinate 0.63 ± 0.01b 0.24 ± 0.01a 0.74 ± 0.03c 0.78 ± 0.02c 1.52 ± 0.08e 0.96 ± 0.02d 
83 Coumaroyl iridoid 0.36 ± 0.01a 0.34 ± 0.01a 1.14 ± 0.02c 1.06 ± 0.02c 0.73 ± 0.02b 0.75 ± 0.01b 
84 Coumaric acid derivative   1.36 ± 0.04b 0.86 ± 0.01a 2.01 ± 0.02d 1.62 ± 0.02c 
103 4-B-9-p-Co- 2,7-anhydro-3-DOA 0.24 ± 0.01a 0.23 ± 0.01a 1.66 ± 0.04d 1.05 ± 0.02b 2.37 ± 0.08e 1.44 ± 0.03c 
113 Coumaric acid derivative 0.76 ± 0.01a 0.93 ± 0.02b 9.81 ± 0.22c 13.02 ± 0.24d 12.91 ± 0.02d 13.48 ± 0.06e 
114 Coumaric acid derivative 0.12 ± 0.01a 0.13 ± 0.01a 0.97 ± 0.04b 1.18 ± 0.05c 1.35 ± 0.05d 1.40 ± 0.01d 
124 Coumaric acid derivative   0.24 ± 0.01c 0.04 ± 0.01a 0.11 ± 0.01b 0.08 ± 0.02a 
Total  10.59 ± 0.30a 11.64 ± 0.14b 86.54 ± 2.51c 91.85 ± 0.86d 113.16 ± 0.60e 112.91 ± 1.08e 
Flavonols       
80 Myricetin-O-hexoside 0.23 ± 0.01a 0.29 ± 0.01b     
86 Rutin   0.64 ± 0.02a 0.71 ± 0.04bc 0.78 ± 0.03c 0.81 ± 0.06c 
93 Quercetin-O-hexoside   21.67 ± 0.98c 17.98 ± 0.63b 10.17 ± 0.02a 10.68 ± 0.01a 
94 Myricetin-O-deoxyhexoside 0.50 ± 0.01a 0.58 ± 0.01b     
95 Quercetin-O-hexoside 0.80 ± 0.02a 0.88 ± 0.02b 9.04 ± 0.26f 7.26 ± 0.20e 6.94 ± 0.01d 6.51 ± 0.16c 
101 Quercetin-O-pentoside   0.63 ± 0.02a 0.65 ± 0.02ab 0.60 ± 0.02a 0.63 ± 0.02b 
105 Cinchonain-Ib   0.51 ± 0.05bc 0.54 ± 0.01c 0.42 ± 0.01a 0.46 ± 0.01b 
107 Quercetin-O-(acetyl)hexoside     0.12 ± 0.01a 0.15 ± 0.01b 
117 Kaempferol-O-(acetyl)hexoside   2.63 ± 0.09ab 2.96 ± 0.05c 2.71 ± 0.08b 2.57 ± 0.02a 
120 Cinchonain-Ib   0.98 ± 0.02c 0.65 ± 0.01b 1.35 ± 0.02d 0.60 ± 0.02a 
122 6-Hydroxy-7,4-dimethoxy-Q-O-(acetyl)hexoside 0.36 ± 0.01b 0.20 ± 0.01a     
123 Kaempferol-O-(acetyl)hexoside   0.25 ± 0.01a 0.26 ± 0.01b 0.42 ± 0.15c 0.46 ± 0.02c 
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B:Benzoyl; Co: Coumaroyl, Q: Quercetin. TIPC: total individual phenolic content. Bold values represent the sum of each type of components. Means in the same 









125 6-Hydroxy-7,4-dimethoxyquercetin derivative 0.39 ± 0.01a 0.38 ± 0.01a 
Total  2.77 ± 0.03a 2.90 ± 0.05b 36.74 ± 1.18e 31.39 ± 0.78d 23.85 ± 0.30c 23.14 ± 0.27c 
Flavan-3-ols       
65 Catechin   2.76 ± 0.01c 2.89 ± 0.07d 0.63 ± 0.02a 1.66 ± 0.06b 
68 Procyanidin trimer (B type)   1.53 ± 0.07b 1.99 ± 0.06c 1.21 ± 0.04a 1.99 ± 0.03c 
100 Procyanidin dimer (A type) 0.40 ± 0.01a 0.45 ± 0.01b     
Total  0.40 ± 0.01a 0.45 ± 0.01b 4.29 ± 0.60de 4.88 ± 0.11e 1.84 ± 0.05c 3.65 ± 0.07d 
Ellagic acid derivatives       
35 Methyl-ellagic acid derivative 2.52 ± 0.16a 2.85 ± 0.13b     
40 Methyl-ellagic acid-O-pentoside 0.10 ± 0.01a 0.10 ± 0.02a     
Total  2.62 ± 0.09a 2.95 ± 0.18b     
TIPC  82.10 ± 0.91a 90.72 ± 1.44b 131.66 ± 4.02c 134.42 ± 2.06c 128.85 ± 0.95c 129.70 ± 1.41c 
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4.7.2. Post in vitro gastrointestinal digestion 
For this analysis, samples collected in 2014 were selected in detriment of those collected in 
previous year. After simulated digestion, a decrease (p < 0.05) on the TIPC of V. padifolium was 
verified (Table 22): berries (64.03%) and leaves (54.12 – 56.50%).  
Flavonols (-71.68%), ANTCs (-61.78%) and HCAs (-58.97%) contents were significantly 
affected, after in vitro digestion of berries (Table 22). Ellagic acid conjugates were not quantified in 
digested berries (Figure 41 and Table 22). ANTCs (-83.94%), flavonols (-59.59 – 63.77%) and 
HCAs (-51.95 – 54.73%) were the most affected classes in leaves. 
Regarding major PCs of berries, delphinidin-O-hexoside (16) (35.84%), delphinidin-O-
hexoside (5) (15.86%), petunidin-O-hexoside (20) (13.84%) and 5-O-CQA (57) (10.90%) and 
showed a decrease of 60.22%, 62.40%, 59.93% and 54.91%, respectively, with respect to native 
amounts (Table 22). 5-O-CQA (57), the main compound of leaves (62.61 – 73.57%), also suffered 
losses on its initial content: 47.83% and 50.20% for young and mature leaves, respectively.  
The impact of in vitro GID on Vaccinium species has been discussed previously (section 
4.6.2), and, to our best knowledge this is the first study conducted on V. padifolium. By comparison 
with V. cylindraceum, submitted to equal digestive conditions (section 4.6.2), similar degradation 
rates were verified for phenolic contents of berries (66.65%) and leaves (54.12 – 56.51%). However, 
TIPC was slightly higher for V. padifolium digested extracts (Table 22), which could be due to its 
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Table 22 - Quantification (mg g-1 DE) of main phenolic compounds present in V. padifolium extracts (berries and leaves) before and after in vitro gastrointestinal 
digestion. Data represent the mean ± standard deviation (n = 3). 
Nº Assigned identification Berries Young Leaves Mature Leaves 
Anthocyanins Non-Digested Digested Non-Digested Digested Non-Digested Digested 
3 Delphinidin-O-(pentosyl)hexoside 1.88 ± 0.02b      
5 Delphinidin-O-hexoside 13.77 ± 0.20b 5.18 ± 0.09     
10 Cyanidin-O-glucoside   6.65 ± 0.20b 1.64 ± 0.14    
16 Delphinidin-O-hexoside 29.40 ± 0.22b 11.69 ± 0.17     
20 Petunidin-O-hexoside 10.02 ± 0.40a 4.52 ± 0.11     
23 Cyanidin-O-pentoside   3.58 ± 0.16b    
34 Peonidin-O-hexoside 3.62 ± 0.11b 1.82 ± 0.06     
42 Malvidin-O-hexoside 1.36 ± 0.03b 0.59 ± 0.01     
45 Malvidin-O-pentoside 1.08 ± 0.04b      
46 Malvidin-O-hexoside 9.49 ± 0.28b 3.24 ± 0.03     
52 Malvidin-O-hexoside 0.13 ± 0.01a      
Total  70.73 ± 1.01d 27.04 ± 0.42 10.23 ± 0.47b 1.64 ± 0.14   
Hydroxycinnamic acids       
17 Caffeoylquinic acid derivative   0.33 ± 0.01b 0.14 ± 0.04 0.29 ± 0.01a 0.11 ± 0.02  
30 3-O-Caffeoylquinic acid dimer   0.65 ± 0.02d 0.23 ± 0.03 0.22 ± 0.01b 0.09 ± 0.06 
44 Caffeoylquinic acid derivative   0.39 ± 0.01b 0.09 ± 0.01 0.38 ± 0.01b  
48 Caffeoylquinic acid derivative   0.48 ± 0.01c  0.27 ± 0.01a  
49 Caffeic acid-O-hexoside 0.40 ± 0.02b 0.20 ± 0.01 0.60 ± 0.02c  0.70 ± 0.02d  
57 5-O-Caffeoylquinic acid 8.88 ± 0.10b 3.56 ± 0.03 66.05 ± 0.52c 34.46 ± 1.95 87.27 ± 1.11d 43.46 ± 1.59 
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64 Caffeoylquinic acid 0.22 ± 0.01b 0.09 ± 0.01 2.64 ± 0.05c 1.31 ± 0.05 2.00 ± 0.08d 0.75 ± 0.03 
70 5-p-Coumaroylquinic acid 0.28 ± 0.01b 0.11 ± 0.01 1.62 ± 0.04e 0.77 ± 0.05 1.58 ± 0.10e 0.74 ± 0.02 
73 Caffeoylquinic acid derivative   0.33 ± 0.01b 1.00 ± 0.04 0.24 ± 0.01a  
78 Caffeoylquinic acid derivative   0.77 ± 0.02b 0.38 ± 0.02 0.25 ± 0.01a  
82 Methyl-(5-caffeoyl)quinate 0.24 ± 0.01a 0.06 ± 0.01 0.78 ± 0.02c 0.30 ± 0.01 0.96 ± 0.02d 0.44 ± 0.02 
83 Coumaroyl iridoid 0.34 ± 0.01a 0.09 ± 0.01 1.06 ± 0.02c 0.36 ± 0.02 0.75 ± 0.01b  
84 Coumaric acid derivative   0.86 ± 0.01a 0.41 ± 0.02 1.62 ± 0.02c  
103 4-B-9-p-Co- 2,7-anhydro-3-DOA 0.23 ± 0.01a 0.06 ± 0.01 1.05 ± 0.02b 0.34 ± 0.01 1.44 ± 0.03c 0.63 ± 0.03 
113 Coumaric acid derivative 0.93 ± 0.02b 0.57 ± 0.02 13.02 ± 0.24d 3.92 ± 0.16 13.48 ± 0.06e 4.51 ± 0.09 
114 Coumaric acid derivative 0.13 ± 0.01a 0.05 ± 0.01 1.18 ± 0.05c 0.42 ± 0.01 1.40 ± 0.01d 0.36 ± 0.01 
124 Coumaric acid derivative   0.04 ± 0.01a 0.02 ± 0.01 0.08 ± 0.02a 0.03 ± 0.01 
Total  11.64 ± 0.14b 4.78 ± 0.17 91.85 ± 0.86d 44.14 ± 2.32 112.91 ± 1.08e 51.11 ± 2.88 
Flavonols       
80 Myricetin-O-hexoside 0.29 ± 0.01b 0.08 ± 0.01     
86 Rutin   0.71 ± 0.04bc 0.25 ± 0.02 0.81 ± 0.06c 0.26 ± 0.01 
93 Quercetin-O-hexoside  0.03 ± 0.01 17.98 ± 0.63b 5.40 ± 0.29 10.68 ± 0.01a 3.74 ± 0.20 
94 Myricetin-O-deoxyhexoside 0.58 ± 0.01b 0.20 ± 0.01     
95 Quercetin-O-hexoside 0.88 ± 0.02b 0.33 ± 0.01 7.26 ± 0.20e 2.44 ± 0.12 6.51 ± 0.16c 2.57 ± 0.21 
101 Quercetin-O-pentoside   0.65 ± 0.02ab 0.27 ± 0.02 0.63 ± 0.02b 0.28 ± 0.02 
105 Cinchonain-Ib   0.54 ± 0.01c 0.18 ± 0.01 0.46 ± 0.01b  
107 Quercetin-O-(acetyl)hexoside  0.03 ± 0.01   0.15 ± 0.01b  
117 Kaempferol-O-(acetyl)hexoside   2.96 ± 0.05c 1.02 ± 0.05 2.57 ± 0.02a 1.10 ± 0.06 
120 Cinchonain-Ib   0.65 ± 0.01b 0.25 ± 0.01 0.60 ± 0.02a 0.22 ± 0.01 
122 6-Hydroxy-7,4-dimethoxy-Q-O-(acetyl)hexoside 0.20 ± 0.01a 0.10 ± 0.01  2.30 ± 0.16   
123 Kaempferol-O-(acetyl)hexoside   0.26 ± 0.01b 0.57 ± 0.02 0.46 ± 0.02c 0.23 ± 0.02 
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TIPC: total individual phenolic content. Bold values represent the sum of each type of components. Means not sharing the same letter are significantly different at 






125 6-Hydroxy-7,4-dimethoxyquercetin derivative 0.38 ± 0.01a 0.05 ± 0.01     
Total  2.90 ± 0.05b 0.82 ± 0.03 31.39 ± 0.78d 12.69 ± 0.54 23.14 ± 0.27c 8.38 ± 0.43 
Flavan-3-ols       
65 Catechin  0.20 ± 0.01 2.89 ± 0.07d  1.66 ± 0.06b  
68 Procyanidin trimer (B type)   1.99 ± 0.06c  1.99 ± 0.03c  
100 Procyanidin dimer (A type) 0.45 ± 0.01b      
Total  0.45 ± 0.01b  4.88 ± 0.11e  3.65 ± 0.07d  
Ellagic acid derivatives       
35 Methyl-ellagic acid derivative 2.85 ± 0.13b      
40 Methyl-ellagic acid-O-pentoside 0.10 ± 0.02a      
Total  2.95 ± 0.18b      
TIPC  90.72 ± 1.44b 32.63 ± 1.54 134.42 ± 2.06c 59.62 ± 2.86 129.70 ± 1.41c 59.50 ± 3.98 
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4.1. General discussion 
4.1.1. Pre-in vitro gastrointestinal digestion 
The individual phenolic contents of six BPPs was determined by HPLC-DAD. For a better 
comparison between the phenolic profiles of different species, the results were all included and a brief 
discussion is presented in Figure 42.  
 
Figure 42 - Individual phenolic content (IPC) of analysed berries extracts (mg g-1 DE). Data represent the mean 
± standard deviation (n = 3). EU: E. umbellata; MF: M. faya; RG: R. grandifolius; SL: S. lanceolata: VC: V. 
cylindraceum; VP: V. padifolium. ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: 
hydroxybenzoic acids; FLAVOs: flavonols; FLAVAs: flavan-3-ols; FLAVNs: flavones; ELLGTs: ellagic acid 
derivatives. 
 
TIPC of different berries extracts varied between 3.87 and 97.47 mg g-1 DE, corresponding 
to E. umbellata and R. grandifolius, respectively (Figure 42). Phenolic profiles varied according to 
species. ANTCs were the main compounds in all berries extracts, except for E. umbellata, in which 
they were not detected. In this case, flavonols were main compounds (Figure 42). Based on ANTCs 
type, extracts could be divided in two sub-groups: cyanidin group (M. faya, R. grandifolius and S. 
lanceolata) and delphinidin/malvidin group (Vaccinium spp.). HCAs and ellagitannins were relevant 
in Vaccinium species and R. grandifolius, respectively (Figure 42).  
In the case of leaves, TIPC ranged from 27.94 to 137.41 mg g-1 DE (Figure 43), for S. 
lanceolata and R. grandifolius (FX), respectively. The higher content of TIPC in leaves (except in S. 
lanceolata) could be justified to an increased expression of genes related to a biosynthesis of 
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conditions that affect the accumulation of these compounds in plant tissues [79,132]. Additionnaly, 
the phenolic profiles of leaves were much more complex than berries. 
Differences in phenolic compositions were found among species (Figure 43). ANTCs were 
only present in V. padifolium (YLs). HCAs were relevant in Vaccinium species and in R. grandifolius. 
Flavan-3-ols were representative in V. cylindraceum and M. faya extracts and, in a smaller extent, in 
R. grandifolius (MX). Ellagitannins were present in high amounts in E. umbellata, M. faya and R. 
grandifolius (Figure 43). 
 
Figure 43 - Individual phenolic contents (IPC) of analysed leaves extracts (mg g-1 DE). Data represent the mean 
± standard deviation (n = 3). EU: E. umbellata; MF: M. faya; RG: R. grandifolius; SL: S. lanceolata: VC: V. 
cylindraceum; VP: V. padifolium. ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: 
hydroxybenzoic acids; FLAVO: flavonols; FLAVA: flavan-3-ols; FLAVN: flavones; ELLG: ellagic acid 
derivatives. 
4.1.2. Post in vitro gastrointestinal digestion 
As mentioned, for the simulated digestion studies only samples collected in 2014 were 
selected. After subjected to in vitro digestion, a reduction of phenolic amounts (p < 0.05) was 
observed in all berries (Figure 44). TIPC ranged from 1.61 to 32.63 mg g-1 DE, corresponding to E. 
umbellata and V. padifolium. The decrease of TIPC ranged from 64.0% to 81.74% for V. padifolium 
and S. lanceolata, respectively (Figure 44). The latter species showed also the highest loss in ANTCs 
levels (-87.2%). Still, these compounds remained dominant in all berries (except on E. umbellata 
where flavonols were major). Ellagitannins and HCAs reamained relevant in R. grandifolius and 
Vaccinium berries, respectively. Some families present in native extracts (Figure 44), were not 
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cylindraceum and V. padifolium), flavones (E. umbellata and S. lanceolata), flavan-3-ols (M. faya) 
and ellagitannins (E. umbellata, V. cylindraceum and V. padifolium). 
 
Figure 44 - Individual phenolic contents (mg g-1 DE) of digested berries extracts. ANT: anthocyanins; HCAs: 
hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVO: flavonols; FLAVA: flavan-3-ols; FLAVN: 
flavones; ELLG: ellagic acid derivatives. 
 
A reduction of phenolic concentrations was also observed (p < 0.05) for leaves, although to 
a lesser extent than in berries (Figure 45). TIPC ranged from 11.53 to 59.62 mg g-1 DE, corresponding 
to E. umbellata and V. padifolium. Reduction of TIPC ranged between 54.12% and 63.35% for V. 
padifolium (MLs) and E. umbellata (Figure 45). HCAS remained dominant in S. lanceolata and 
Vaccinium leaves. Flavonols were still major in M. faya and become more relevant in V. cylindraceum 
after in vitro digestion. Ellagitannins continued as main compounds of R. grandifolius. Some phenolic 
groups present in native extracts (Figure 43), were not quantifiable after the digestion simulation, 
namely HCAS (M. faya), HBAs (E. umbellata and V. cylindraceum), flavan-3-ols (E. umbellata and 
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Figure 45 – Individual phenolic contents (mg g-1 DE) of digested leaves extracts. ANT: anthocyanins; HCAs: 
hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVO: flavonols; FLAVA: flavan-3-ols; FLAVN: 
flavones; ELLG: ellagic acid derivatives.  
ANTCs were poorly recovered following the digestion of berries (60.28 – 87.15%). Declines 
from 28.10 to 99.9% of the initial ANTCs content are reported in literature, in different foodstuffs 
submitted to in vitro [24,48,49,53,54,56,58,140,141,145,147] and in vivo [59] digestion.  
Flavan-3-ols were also highly affected by the digestion process (60.62 – 80.16%). The same 
trend was observed in different in chokeberry (- 28%), while pure (+)-catechin was recovered at only 
42% [49]. In another study [55], (–)-epicatechin and B2-PAC from apples were completely degraded. 
Breakdown of oligomeric flavan-3-ols to (epi)catechin and further isomerization to catechin or 
degradation to unknown products is documented [52,55,59]. Moreover, B-type PACs seemed to be 
more affected by intestinal digestion than A-type due to their structural differences (Figure 23) [59].  
5-O-CQA content decreased in analysed Vaccinium species (49.32 – 59.70%), which agrees 
with data on digested apples (41 – 77% reduction) [55]. This decline could be associate with the 
instability of CQAs in mild alkaline environments. By contrast, 5-O-CQA content increased by 24% 
in chokeberry [49], which was justified by regio-isomerization between CQAs under mild alkaline 
conditions. 5-O-CQA concentration remained constant during digestion of V. angustifolium [54]. 
A decrease on flavonols (-26%) was also observed in chokeberry [49], although in lower 
extent than present data (43.63 – 90.23%). On the contrary, quercetin content was improved by 2 and 
more than 4 times-fold in Ribes uva-crispa post in vitro digestion [155], while other PCs remained 
stable.  
Ellagi- and gallotannins were strongly affected by in vitro digestion (50.93 – 72.94%), with 
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digestion than are ANTCs, being hydrolysed to smaller components like ellagic acid [51,52,56]. For 
example, an increase of ellagic acid amounts was verified after in vitro digestion of pomegranate peel 
and strawberry-tree fruits (Arbustus unedo) (+ 113% and + 379%, respectively) [51,52], mainly due 
to the hydrolysis of ellagitannins. 
Contradictory findings on the recovery of PCs after in vitro digestion are mainly due to 
differences in the type of food matrix and its initial state (frozen, freeze-dried, particle size, extract, 
etc). In fact, the stability and bioavailability of PCs during digestion depends mainly on the chemical 
environment (pH, ion strength, temperature, etc) than interaction with digestive enzymes [48,49,155]. 
Thus, stability of PCs from one fruit cannot be readily extended to other foodstuffs [47]. 
Discrepancies between studies could also result from the diversity of model conditions (time of 
digestion, concentration of salts/enzymes, pH, inclusion of various digestion steps, static vs dynamic 
models).  
Before becoming bioavailable to exert their potential beneficial effects, PCs must be released 
from food matrix and hydrolysed/metabolised by intestinal enzymes and/or microflora [40,44,45]. 
During human digestion, dietary PCs are simultaneously exposed to different physical (temperature 
and agitation), chemical (pH) and biochemical (enzymes) conditions, which influences their 
bioavailability [40,46,47,49]. This environment results in several changes in their chemical 
structure/weight (hydrolysis, oxidation, epimerization and/or transformation/degradation) and 
solubility [44,49–51,56,146].  
In the oral step, mastication along with the enzyme activity could facilitate the breakage of 
large molecules, which initially may be insoluble [44,50,51]. However, oral digestion has minimal 
modifications in the concentrations of PCs due to short exposure time and marginal effects of saliva 
[44,52]. Subsequently, the food bolus undergoes GID, where stomach and small intestine digestive 
enzymes, together play a key role in the release of PCs, making them available for absorption [55,57]. 
In general, PCs are very stable in the gastric media [41,47]. In fact, gastric digestion usually increases 
the amounts of PCs since the majority of these compounds appear to be released in the stomach 
[48,49,51,53,54,140,147,153]. However, polymerized flavan-3-ols seem to be highly susceptible to 
stomach conditions and are hydrolyzed into monomers or aglycones before being absorbed 
[41,52,55]. Most of the transformations of ingested PCs occur during the intestinal step, where they 
are exposed to mild alkaline conditions of digestive juices [40,41,47]. This leads to their hydrolysis 
and degradation and/or their conversion/break-down into other unknown or undetected metabolites 
[44,49,56]. Absorption and metabolism of PCs is highly variable and determined primarily by their 
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physicochemical characteristics, namely type of compound, molecular size, basic structure, degree of 
polymerization, acylation or glycosylation and solubility [1,2,16,44,50]. 
Among PCs, ANTCs seem the less efficiently absorbed in the lumen and their content may 
largely disappear after GID [40,47]. During the digestion process ANTCs can be found in different 
chemical forms due to dramatic pH variations [54,141]. In the oral phase, some minimal 
transformations are initiated in ANTCs [43]. When the food reaches the stomach (pH < 2), ANTCs 
are present in the form of stable flavylium cation and quinoidal form. This favorable chemical 
environment is responsible for their high recovery after gastric digestion [48,51–53,153]. However, 
the transition to the intestinal environment result in an intense degradation of ANTCs, due to their 
high unstability at mild-alkaline conditions [48,49,52–54,153]. At pH > 6, ANTCs are transformed 
to colourless carbinol and chalcone pseudobase, as a result of the chromophore desctruction 
[48,54,140,147]. At alkaline environments (pH > 7), ANTCs are further degraded upon C-ring fission 
and metabolized into low molecular weight compounds (protocatechuic acid, catechol, etc) 
[43,52,147]. In general, acylated anthocyanins are more stable than non-acylated forms; 3,5-
diglycosides are more stable than 3-monoglycosides. This behavior is explained because the sugar 
moieties protect the molecule from degradation [43,52,54,140,147]. Also, increased aglycone 
hydroxyl methoxylation enhances stability, whereas anthocyanins with more hydroxylated aglycones 
are less stable [147]. C3G could contribute to the stabilization of other ANTCs due to sacrificial 
protection from oxidation [147]. The present data corroborate this explanation, since berries 
composed mainly by cyanidin derivatives (S. lanceolata, M. faya and R. grandifolius) showed the 
highest ANTCs degradation. Additionally, the superior loss verified in S. lanceolata berries is 
possibly due to the lower native amounts of ANTCs. 
The non-ANTCs compounds are, overall, relatively stable at the intestinal environment 
[48,58,59,147]. The high pH values may induce structural changes in these molecules, namely 
deprotonation of hydroxyl groups and even degradation to other metabolites [47,48,53].  
Additionally, it has become clear that stability/bioavailability of PCs is affected by 
interactions with other food constituents (proteins, lipids, carbohydrates, dietary fibers, minerals) that 
are released in the digestion process [45,47,49]. Some molecules have a very complex, porous 
structure which can trap PCs and, consequently, confer protection from oxidation during their passage 
through the GI tract [50,55]. For example, a higher recovery of ANTCs was observed in red cabbage 
(67.7%) versus the ANTCs-rich extract (13.2%), which suggested that vegetable components (like 
fibers) protected labile ANTCs from degradation under simulated digestion [156]. On the other hand, 
binding to proteins, dietary fibers and polysaccharies can limit their bioavailability by reducing their 
solubility and contact with digestive enzymes [45,47,50]. Food microstructure composition (matrix 
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type), namely variations in concentration within plant tissues, variations in cell wall structure and 
location of glycosides in cells can influence the release of PCs from the food matrix and impact also 
their bioavailability [44,54]. In this sense, the higher recoveries of PCs from leaves (Figure 45) could 
be related to the absence of pectinases and cellulases in the applied digestion model, which limited 
the degradation of PCs in leaves by comparison with berries. Finally, binding of PCs with components 
of the pancreatin/bile juices and digestive enzymes can lead to precipitation (insoluble complexes) 
and also mask compounds and make them undetectable with HPLC analysis [40,48,147].  
In conclusion, the obtained results and previous reports confirm that dietary PCs are highly 
sensitive to in vitro digestion and suggest that, a substantial part of these compounds can be degraded 
and/or transformed into other unknown and/or undetected structural forms and, consequently, 
different bioavailability. In this case, the observed high losses (< 50%) could be partially attributed 
to the incomplete release/lower efficiency of aqueous extraction (i.e. digestion process) compared 
with initial chemical extraction using methanol. The same was verified by other authors [48,53]. Most 
of studies regarding plant-foods analysis usually refers to extraction of PCs in mixtures of aqueous 
and organic solvents. The amount of PCs extracted from the GID may differ quantitatively and 
qualitatively from those extracted by chemical methods; the latter extractor can lead to an 
overestimation of bioavailable PCs [48,53]. 
After examination of HPLC chromatograms from non-digested and digested extracts, the 
presence of new compounds resultant from digestion was not observed. The presence of PCs 
derivatives might be masked by other dominant compounds in analysed extracts and was not detected 
under current analytical conditions. Other possible scenario is the the lack of esterase activity on the 
commercial pancreatin, as reported by other authors [49,116]. In fact, the existence of degradation 
products derived from the catabolism of PCs have been documented only in studies that included 
microbiota fermentation or cell models [51,52,54,59].  
Although the obtained data with in vitro GID simulation cannot be directly extrapolated to 
human conditions, this model was useful to predict the impact of this physiological process on 
bioavailability of PCs from BPPs. However, this model can be further improved to better reproduce 
the digestive process. Further investigations employing dialysis bags or including cellular models 
such as Caco-2, should be performed to study the bioaccessibility of PCs. 
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5. Total phenolic and total flavonoid contents 
In this work, total phenolic and total flavonoids contents were also determined for the 
methanolic extracts (pre- and post in vitro digestion) and results are presented and discussed below. 
5.1. Pre-in vitro gastrointestinal digestion 
Total phenolic content (TPC) of analysed berries extracts ranged between 19.06 and 103.42 
mg GAE g-1 DE (Figure 46), which corresponded to E. umbellata (2013) and R. grandifolius (FX). 
An opposite trend was found in other work [18], where blueberries, bilberries and lingonberries 
showed higher TPC than blackberries. Intra-species variations (p < 0.05) were observed between TPC 
of berries and leaves extracts from different years/collection. respectively.  
 
Figure 46 - Total phenolic content (TPC) of analysed berries extracts (mg GAE g-1 DE) determined by the 
Folin-Ciocalteu method. Data represent the mean ± standard deviation (n = 3). 
TPC of leaves extracts ranged between 90.65 and 346.61 mg GAE g-1 DE (Figure 47), which 
corresponded to S. lanceolata and V. padifolium (YL 2013), respectively. Differences (p < 0.05) were 
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Figure 47 - Total phenolic content (TPC) of analysed leaves extracts (mg GAE g-1 DE) determined by the 
Folin-Ciocalteu method. Data represent the mean ± standard deviation (n = 3). 
Total flavonoids content (TFC) of analysed berries extracts ranged between 6.69 and 14.67 
mg RUE g-1 DE (Figure 48), which corresponded to M. faya (PM) and R. grandifolius (MX), 
respectively. Variations (p < 0.05) were also observed for different years/collection areas in TFC 
measurements  
 
Figure 48 - Total flavonoid content (TFC) of analysed berries extracts (mg RUE g-1 DE) determined by the 
aluminium chloride method. Data represent the mean ± standard deviation (n = 3). 
TFC of leaves extracts ranged between 35.41 and 134.06 mg RUE g-1 DE (Figure 49), which 
corresponded to V. cylindraceum and V. padifolium (YLs 2013), respectively. Variations (p < 0.05) 
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Figure 49 - Total flavonoid content (TFC) of analysed leaves extracts (mg RUE g-1 DE) determined by the 
aluminium chloride method. Data represent the mean ± standard deviation (n = 3). 
Similar TPC but lower TFC values were found in E. umbellata berries (23.3 mg GAE g-1 DE 
and 3.6 mg QE g-1 DE, respectively)[103]. On another study [157], a lower TPC was reported (7.67 
mg GAE g-1 DE). M. rubra had higher TPC (341 – 634 mg GAE g-1 DE) [62] and TFC (182.8 – 920 
mg RUE g-1 DE) [62,117] than analysed M. faya extracts. Berries of R. grandifolius had hihgher TPC 
than other blackberries, cranberries, lingonberries and blueberries (3.27 – 83.13 mg GAE g-1 DE) 
[88,158–160]. Higher TPCs (49.2 – 90.6 mg GAE g-1 DE) were determined for other Sambucus 
species [151,161] compared with S. lanceolata. Inferior TPC [84,159] were described for different 
Vaccinium berries; while other studies [74,162] documented opposite results (100.5 - 630 mg GAE 
g-1 DE). TPC of YLs was comparable to that of other Vaccinium species [81,163,164], but lower TFC 
(63.24 – 114.21 mg catechin equivalent g-1 DE) was observed [163]. Variations in species/cultivar, 
sample preparation, extraction and methodologies could justify the discrepancies between obtained 
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5.2. Post in vitro gastrointestinal digestion 
After in vitro GID, a significant (p < 0.05) reduction was observed for TPC. The decline 
ranged from 30.22% to 64.88%, corresponding to S. lanceolata and E. umbellata, respectively 
(Figure 50). TPC of digested berries ranged from 9.84 to 44.70 mg GAE g-1 DE. 
 
Figure 50 - Total phenolic content (TPC) (mg GAE g-1 DE) of analysed berries extracts (pre- and post in vitro 
digestion) determined by the Folin-Ciocalteu method. Data represent the mean ± standard deviation (n = 3). 
In the case of digested leaves, a similar behaviour was observed. The decrease of TPC ranged 
from 52.90% to 64.40%, corresponding to V. padifolium and E. umbellata, respectively (Figure 51). 
The amounts ranged from 27.92 to 149.78 GAE g-1 DE. 
 
Figure 51 - Total phenolic content (TPC) (mg GAE g-1 DE) of analysed leaves extracts (pre- and post in vitro 
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TFC was also significantly (p < 0.05) affected upon in vitro digestion. The decline of digested 
berries TFC ranged from 28.52% to 54.33%, corresponding to R. grandifolius and M. faya, 
respectively (Figure 52). The aomunts in digested berries ranged between 3.80 and 10.19 RUE g-1 
DE. 
 
Figure 52 - Total flavonoid content (TFC) (mg RUE g-1 DE) of analysed berries extracts (pre- and post in vitro 
digestion) determined by the aluminium chloride method. Data represent the mean ± standard deviation (n = 
3). 
In the case of digested leaves, the decrease of TPC ranged from 26.10% to 73.81%, 
corresponding to V. padifolium (YLs) and S. lanceolata, respectively (Figure 53). The amounts 
ranged from 10.65 to 94.52 RUE g-1 DE. 
 
Figure 53 -  Total flavonoid content (TFC) (mg RUE g-1 DE) of analysed leaves extracts (pre- and post in vitro 
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5.3.  General discussion 
TPC and TFC measurements are generally used by the scientific community and, despite their 
shortcomings, they are useful to compare results with available literature [18]. TPC and TFC are 
based in reduction reactions, so any reductant component of the sample will test positive and 
contribute to an increase on the overall value [29,36,78]. FCR is non-specific to PCs as it can be 
reduced by other compounds such as aromatic aminoacids, organic acids, sugars, thiols derivatives 
and vitamins (specially vitamin C) [18,36,47,55]. Additionally, these colorimetric assays do not yield 
information on the recovery of specific compounds or molecules [38,47,78]. Hence, TIPC, as 
discussed previously (section 4), is a much more accurate method to assess PCs content in natural 
products.  
In the present work, TPC and TFC of methanolic extracts were significantly reduced after 
smiluated digestion. TPC and TFC of M. rubra was decreased by 13.2 – 43-0% [116] and 27.23% 
[117] for berries and leaves, respectively, upon in vitro digestion. Losses of 86% and 88.5% of TPC 
were previously reported V. vitis-idea and R. idaeus, respectively [59,147]. A decrease of 86.07% and 
84.32% was reported for TPC and TFC, respectively, of digested blueberries (Vaccinium spp.) [153]. 
Similarly to present work, blackberries showed a greater TPC loss than blueberries (27% and 67%,  
respectively), upon GID [56,141]. In other study, a reduction of 86% of TPC was verified after 
digestion of chokeberry. [49]. By contrast, an increase of phenolic amounts was observed for 
blackberries (+ 35.1% TPC, + 31.9% TFC) and gooseberries (+ 21% TPC) subjected to in vitro 
digestion [146,155]. The chemical action during the digestive process can contribute to a higher 
extraction of non-PCs from food matrices [48,155]. FCR can potentially react with degradation 
products and macromolecule-bound PCs [55]. Additionally, interactions with matrix components 
(proteins, sugars) and other food components (vitamins) can overestimate TPC and TFC and lead to 
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1. Inhibition of digestive enzymes responsible for the sugar metabolism 
Berries have been widely studied for their potential to inhibit digestive enzymes involved in 
the glucose and lipids metabolism [5,16,18,21]. Retarding or inhibiting the digestion of these nutrients 
has therapeutic implications for controlling post-prandial hyperglycaemia and hyperlipidaemia 
[3,15,18,89,115]. In this view, the main aim of this part of the study was to evaluate the ability of 
berry-producing plants (BPPs) extracts to inhibit key digestive enzymes linked to type-2 diabetes 
melitus (T2DM) and obesity.  
1.1. Glucosidases (GLUs) 
The in vitro inhibitory activity of analysed extracts towards GLUs (α- and β-) was 
investigated using p-nitrophenyl-α-D-glucopyranoside (α-pNPG) and p-Nitrophenyl-β-D-
glucopyranoside (β-pNPG) as substrates, respectively. 
1.1.1. Yeast α-glucosidase 
α-Glucosidases (AGLUs), including sucrase and maltase, are the main enzymes responsible 
for the breakdown of oligosaccharides and disaccharides into monosaccharides during digestion 
[2,4,16,20,91]. AGLU isolated from baker’s yeast (Saccharomyces cerevisae) has been widely used 
for preliminary pharmacological screenings [31,65,85,98,115,162]. The inhibition of yeast AGLU by 
tested extracts was in a wide range with the IC50 values from 0.11 to 4.77 mg mL-1 (Table 23). Leaf 
extracts were the most potent inhibitors for AGLU (p < 0.05). Additionally, inter and intra-species 
differences (p < 0.05) were found in this assay. The order of the most potent inhibitors for berries 
extracts was as follows: R. grandifolius < M. faya < V. padifolium ≈ V. cylindraceum << E. umbellata 
< S. lanceolata. For the leaves, a slight different trend was observed: R. grandifolius < M. faya < V. 
padifolium (young leaves, YLs > mature leaves, MLs) < V. cylindraceum << E. umbellata << S. 
lanceolata.  
In general, analysed extracts were more effective than commercial drug acarbose (Figure 4) 
(except for E. umbellata and S. lanceolata) (Table 23). Other studies also found acarbose to be less 
effective towards yeast AGLU than Vaccinium berries extracts [85,162]. 1-Deoxynojirimycin (1-
DNJ) (Figure 5), a natural competitive GLUs inhibitor extracted from Morus spp. [33], showed 
stronger inhibitory activities (p < 0.05) than berries extracts (Table 23). Of course, it must be taken 
in account that this is a comparison of the activity of pure substances with that of plant extract where 
the amount of active substances is a small percentage of the sample, as shown in Chapter III. 
No studies regarding the inhibition of digestive enzymes by E. umbellata and S. lanceolata 
or alike species were found in literature. M. rubra berries showed lower inhibitory activities towards 
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AGLU (IC50: 2.08 – 3.17 mg mL-1)[65] than most of the analysed extracts. Different Rubus berries 
cultivars strongly inhibited yeast AGLU (IC50 = 0.001–0.034 mg mL-1) [98,162]. Blackberries and 
blueberries studied by Tan and co-workers [115] displayed higher activities (IC50: 0.031 – 0.057 mg 
mL-1) than analysed samples. On another study, blackberry extracts showed lower activities towards 
yeast AGLU (≥ 26 mg mL-1)[31]. Different berry species (strawberries, black currants, blueberries 
and rowanberries) showed also the ability to modulate starch metabolism by inhibition of digestive 
enzymes [5,18,21,90,93,154].  
Table 23 – In vitro inhibitory activities of analysed extracts towards α- and β-glucosidases (expressed as IC50 
value, mg mL-1). Data represent the mean ± standard deviation (n = 3). 
  α-Glucosidase  β-Glucosidase 
Berries  Yeast  Rat   
E. umbellata  3.14 ± 0.09q 6.88 ± 0.33u 18.70 ± 2.34x 
M. faya MX 0.76 ± 0.02lm 4.51 ± 0.13r 12.51 ± 0.20w 
 FL 0.75 ± 0.02l 4.22 ± 0.11p 12.05 ± 0.31uv 
 ASJ 0.69 ± 0.02k 4.35 ± 0.15pq 11.06 ± 0.15t 
 BV 0.72 ± 0.02k 3.78 ± 0.11o 11.45 ± 0.19u 
 SX 0.78 ± 0.01m 4.40 ± 0.11q 12.38 ± 0.30w 
 RJ 0.83 ± 0.02n 4.63 ± 0.10s 12.78 ± 0.20w 
 PM 0.71 ± 0.02k 3.85 ± 0.12o 12.10 ± 0.26v 
 TC 0.73 ± 0.03k 3.91 ± 0.14o 11.76 ± 0.20u 
R. grandifolius FX 0.61 ± 0.02i 3.26 ± 0.17n 8.27 ± 0.15p 
 MX 0.68 ± 0.02k 3.78 ± 0.23o 8.79 ± 0.22q 
S. lanceolata  4.77 ± 0.27r 7.95 ± 0.34v 15.65 ± 0.65 
V. cylindraceum  1.10 ± 0.04o 4.36 ± 0.14pq 9.88 ± 0.27s 
V. padifolium  1.03 ± 0.03o 4.13 ± 0.10o 9.36 ± 0.19r 
Leaves     
E. umbellata  1.98 ± 0.04p 3.76 ± 0.09o 9.38 ± 0.41r 
M. faya MX 0.31 ± 0.02f 1.41 ± 0.05k 6.33 ± 0.10n 
 FL 0.27 ± 0.01e 1.29 ± 0.08j 6.48 ± 0.20n 
 ASJ 0.21 ± 0.01d 1.13 ± 0.05i 5.79 ± 0.21m 
 BV 0.20 ± 0.01cd 1.16 ± 0.06i 5.15 ± 0.17k 
 SX 0.27 ± 0.01e 1.26 ± 0.03j 5.41 ± 0.12l 
 RJ 0.33 ± 0.02f 1.53 ± 0.04l 6.86 ± 0.15o 
 PM 0.25 ± 0.01e 1.35 ± 0.07jk 5.55 ± 0.19lm 
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 TC 0.18 ± 0.01c 1.09 ± 0.06h 4.86 ± 0.10j 
R. grandifolius FX 0.11 ± 0.01a 0.97 ± 0.03g 3.24 ± 0.08g 
 MX 0.15 ± 0.01b 0.89 ± 0.05g 3.87 ± 0.12h 
S. lanceolata  3.73 ± 0.15q 4.97 ± 0.25t 11.28 ± 0.37t 
V. cylindraceum  0.85 ± 0.03m 1.64 ± 0.06m 4.59 ± 0.40ij 
V. padifolium YLs 0.58 ± 0.01h 0.80 ± 0.04f 2.33 ± 0.19e 
 MLs 0.76 ± 0.02kl 0.86 ± 0.02fg 2.60 ± 0.12f 
Acarbose  2.06 ± 0.04p 0.12 ± 0.01b N.I. 
1-Deoxynojirimycin 0.65 ± 0.02i 0.01 ± 0.01a 0.45 ± 0.02b 
Conduritol B epoxide - - 8.94 ± 0.19q 
Cyanidin-3-O-glucoside 0.38 ± 0.02g 0.23 ± 0.01d 0.86 ± 0.03d 
5-O-Caffeoylquinic acid 0.36 ± 0.02g 0.27 ± 0.02c 0.39 ± 0.01c 
Myricitrin  0.63 ± 0.04i 0.39 ± 0.02e 0.35 ± 0.02a 
YLs: Young leaves. MLs: Mature leaves. N.I.: no inhibition. MX: Machico; FL: Faial; ASJ: Arco 
de S. Jorge; BV: Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; 
FX: Funchal. Means in the same column not sharing the same letter are significantly different at p 
< 0.05 probability level. 
1.1.2. Rat intestinal α-glucosidase 
In this study, rat AGLU was also tested to verify and compare any differences in the enzyme 
inhibitory action of berry-plants extracts, since it reasonably matches the human enzyme providing a 
better model to validate results [19]. At a first look, the IC50 values of analysed extracts were higher 
than in the microbial version of the enzyme; ranging from 0.82 to 7.95 mg mL-1 (Table 23). Other 
studies [165–167] also observed a decrease on the efficiency of extracts on mammalian enzyme when 
compared to the microbial equivalent. This suggests that most yeast AGLU inhibitors show a lower 
or no inhibitory effect on the mammalian equivalent. Additionally, a weak correlation (r = 0.612) was 
verified between results of both models. Again, statistical differences were verified among species 
and morphological parts (p < 0.05). 
In this case, R. grandifolius berries showed the highest inhibitory activities (FX > MX) and 
the order of potency was as follows: V. padifolium ≈ V. cylindraceum ≈ M. faya > E. umbellata > S. 
lanceolata. Leaves of V. padifolium (YLs > MLs) were the most active, followed by R. grandifolius 
(MX > FX), M. faya, V. cylindraceum, E. umbellata and S. lanceolata. Positive controls (acarbose 
and 1-DNJ) showed the strongest activities (p < 0.05). Contrary to assayed extracts, these reference 
compounds displayed higher inhibitory activity over mammalian AGLU (about 17 and 65 times 
higher, respectively) than over the yeast counterpart (Table 23). Shai and co-workers [167] reported 
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a similar trend. Overall, obtained data confirm that inhibition of yeast AGLU does not translate into 
comparable inhibition of the mammalian enzyme [19,166,167] 
. The divergent results are mainly due to the structural differences of the catalytic regions 
responsible for molecular recognition in the binding site of the enzymes [167]. AGLU are widely 
distributed in microorganisms, plants and animals and the catalytic region is known to differ greatly 
depending on their origin [168]. By analysis of the amino acid sequences containing the catalytic 
sites, these enzymes are generally classified into two groups: family I and family II. The first family 
consists of bacterial, yeast and insect enzymes and are composed of four catalytic regions, while 
family II (mold, plants and mammalians) have two catalytic sites responsible for the enzyme reaction 
[165]. These differences justify the discrepancies obtained in the present study (Table 23) and support 
the use of mammalian AGLU as a desirable model to search for new natural hypoglycaemic 
compounds. 
Previously [10,89,93,94], different berry species have shown strong inhibitory activities 
towards rat AGLU. Unfortunately, results were expressed in total phenolic content basis which makes 
it difficult to establish a comparison. 
1.1.3. Almond β-glucosidase (BGLU) 
The inhibitory potential of BPPs extracts against BGLU was also evaluated. Although with a 
lower impact, BGLUs (galactosidase, lactase, etc) play also a role in the hydrolysis of dietary 
carbohydrates [19]. In the present study, almond BGLU from almonds was used due to the lack of a 
commercial version of this enzyme from animal origin. The IC50 values of analysed extracts ranged 
from 2.33 to 18.70 mg mL-1 (Table 23). Significant variations (p < 0.05) were observed between 
samples. Berries of R. grandifolius (FX > MX) were the most active sample, followed by V. 
padifolium, V. cylindraceum, M. faya, S. lanceolata and E. umbellata. The order of potency for leaves 
extracts was as follows: V. padifolium (YLs > MLs) > R. grandifolius (FX > MX) > V. cylindraceum 
≈ M. faya > S. lanceolata > E. umbellata.  
Acarbose was ineffective against BGLU activity, as documented previously [33]. Pure 
conduritol B epoxide (CBE)(Figure 54), an effective BGLU inhibitor [33], showed stronger activities 
(p < 0.05) than berries extracts (except for R. grandifolius), while pure 1-DNJ showed the best 
inhibitory activity among tested samples (Table 23). 
Previously [169], Chinese quince (Chaenomeles sinensis) fruit extract showed also moderate 
BGLU inhibition. 
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Figure 54 - Chemical strucutre of Conduritol B epoxide (CBE) (adapted from [33]). 
1.2. Pancreatic α-Amylase (AMY) 
Pancreatic AMY is responsible for the hydrolysis of large polysaccharides (starch, glycogen, 
amylose) into maltose, dextrin and maltotriose in the digestion system [2,3,16,19,61,95,96]. In this 
study, the in vitro inhibitory potential of BPPs extracts against AMY was investigated, using starch 
as substrate. 
The IC50 values of assayed extracts ranged from 0.57 – 7.71 mg mL-1 (Table 24). Intra and 
inter-species variations were observed (p < 0.05). Berries of R. grandifolius (FX > MX) showed the 
highest activity, followed by M. faya > V. padifolium ≈ V. cylindraceum > E. umbellata > S. 
lanceolata. In the case of the leaves a slight different trend was verified: M. faya > R. grandifolius > 
V. cylindraceum > V. padifolium (YLs > MLs) > E. umbellata > S. lanceolata. Although the tested 
plant-extracts appeared to have strong glucosidases inhibitory potential, they showed lower potency 
against AMY. All samples were less effective (p < 0.05)  than pure acarbose (Table 24).  
V. arctostaphylos berries showed comparable IC50 values (1.91 mg mL-1) [95] while leaves 
were more effective towards AMY (0.53 mg mL-1) [96] than targeted Vaccinium species (Table 24). 
Black chokeberry extracts were less effective towards AMY (IC50 = 10.31 mg mL-1) [97] than present 
samples (Table 24). R. fruticosus extracts were potent AMY inhibitors (0.054 mg mL-1) [162]. 
Blackberry extract showed lower activity (1.56 mg mL-1) [115] to R. grandifolius. Higher IC50 values 
for different blackberry extracts (≥ 95 mg mL-1) [31]. On another study [98], raspberry extracts did 
not show any inhibitory activity towards AMY, which could be due to absence of tannins. 





Chapter III.B – Digestive Enzymes Inhibition 
 
 
140  Vítor Spínola (2018) 
 
Table 24 - In vitro inhibitory activities of analysed extracts and reference compounds towards porcine 
pancreatic α-amylase (expressed as IC50 value, mg mL-1). Data represent the mean ± standard deviation (n = 3). 
  Berries Leaves 
E. umbellata   4.01 ± 0.20s 2.18 ± 0.13p 
M. faya MX 1.38 ± 0.04l 0.66 ± 0.02c 
 FL 1.25 ± 0.03k 0.65 ± 0.03c 
 ASJ 1.19 ± 0.02j 0.57 ± 0.02a 
 BV 1.08 ± 0.03i 0.61 ± 0.02ab 
 SX 1.22 ± 0.03jk 0.63 ± 0.02b 
 RJ 1.68 ± 0.02n 0.67 ± 0.03c 
 PM 1.53 ± 0.04m 0.76 ± 0.01e 
 TC 0.99 ± 0.02h 0.58 ± 0.02a 
R. grandifolius  FX 0.94 ± 0.04g 0.83 ± 0.03f 
 MX 0.97 ± 0.02gh 0.72 ± 0.05de 
S. lanceolata  6.01 ± 0.54t 7.71 ± 0.32u 
V. cylindraceum  2.78 ± 0.04r 1.05 ± 0.03h 
V. padifolium   2.63 ± 0.09q 1.75 ± 0.06n* 
   2.03 ± 0.04o** 
Acarbose  0.02 ± 0.01a  
Cyanidin-3-O-glucosidase 0.97 ± 0.03gh  
5-O-Caffeoylquinic acid 1.20 ± 0.04j  
Myricitrin 2.02 ± 0.10o  
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: 
Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. 
Means not sharing the same letter are significantly different at p < 0.05 probability level. 
 
1.3. Pancreatic Lipase (PL) 
PL is the most important enzyme responsible for the digestion of dietary fat, so its inhibition 
can lead to beneficial effects on overweight and obesity [18,64,170]. The inhibitory activity of berry-
plants extracts towards PL was tested using p-nitrophenyl butyrate (p-NPB) as substrate. The IC50 
values of samples varied from 1.49 to 9.68 mg mL-1 (Table 25). Significant differences (p < 0.05) 
were found among the analysed extracts in the inhibitory activities against PL. R. grandifolius berries 
were the most active, followed by M. faya > V. padifolium > V. cylindraceum > S. lanceolata > E. 
umbellata. In the case of leaves extracts the order of potency was as follows: M. faya > V. padifolium 
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≈ R. grandifolius ≈ V. cylindraceum > E. umbellata > S. lanceolata. In this case, the commercial drug 
orlistat (Figure 4) showed the strongest inhibitory activity (p < 0.05) (Table 25).  
On another study, M. rubra leaves extracts were more active towards PL (IC50: 0.25 – 0.73 
mg mL-1)[23]. Black chokeberry extracts were less effective (IC50 = 85.45 mg mL-1) [97] than 
analysed samples (Table 25). Blackberries and blueberries extracts showed potent inhibitory 
activities against PL (IC50: 0.26 and 0.36 mg mL-1, respectively)[115]. On another study [171], 
blackberry extract showed comparable activities (IC50: 1.99 mg mL-1) to M. faya leaves (Table 25). 
Again, raspberry extracts were ineffective towards PL since they have no tannins [98]. The potential 
of other berry species (strawberries, black currants, blueberries, blackberries, raspberries and 
rowanberries) to inhibit PL activity is documented in literature [5,18,21,64].  
Table 25 - In vitro inhibitory activities of analysed extracts and reference compounds towards porcine 
pancreatic lipase (expressed as IC50 value, mg mL-1). Data represent the mean ± standard deviation (n = 3). 
  Berries Leaves 
E. umbellata   9.68 ± 0.51t 5.03 ± 0.22m 
M. faya MX 5.75 ± 0.19op 2.04 ± 0.07f 
 FL 5.30 ± 0.20n 2.24 ± 0.05g 
 ASJ 4.83 ± 0.13l 1.93 ± 0.10ef 
 BV 4.98 ± 0.10l 1.60 ± 0.04d 
 SX 5.78 ± 0.15op 1.68 ± 0.05d 
 RJ 6.15 ± 0.22q 2.34 ± 0.08h 
 PM 5.46 ± 0.20n 1.89 ± 0.06e 
 TC 5.26 ± 0.12mn 1.49 ± 0.04c 
R. grandifolius  FX 4.45 ± 0.13k 2.97 ± 0.09h 
 MX 3.97 ± 0.25j 3.33 ± 0.08i 
S. lanceolata  7.75 ± 0.48s 6.64 ± 0.25r 
V. cylindraceum  6.50 ± 0.34r 4.20 ± 0.27k 
V. padifolium   5.97 ± 0.38pq 2.18 ± 0.09g* 
   3.56 ± 0.25i** 
Orlistat 0.47 ± 0.02b  
Cyanidin-3-O-glucoside 0.30 ± 0.01a  
5-O-Caffeoylquinic acid 0.31 ± 0.01a  
Myricitrin  0.51 ± 0.03b  
*Young leaves; **Mature leaves; MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: 
Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. 
Means not sharing the same letter are significantly different at p < 0.05 probability level. 
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1.4. General Discussion 
Phenolic compounds (PCs) are mainly known for their potential beneficial properties to 
human health, including antioxidant, antiproliferative, anti-inflammatory, anti-diabetic, anti-obesity, 
antibacterial, antiviral activities, among others [1,3,172]. Dietary PCs have also shown relevant anti-
diabetic properties due to effectiveness to suppress post-prandial hyperglycaemia achieved by several 
mechanisms (Figure 7): enhancing of β-cell function, stimulation of insulin secretion, suppression of 
glucose release from the liver and improve glucose uptake in peripheral tissues by modulating 
intracellular signalling [5,6,16,172]. However, their main hypoglycaemic effect is primarily attributed 
to their binding to carbohydrate hydrolysing enzymes, which delays dietary carbohydrate intestinal 
breakdown and absorption. In humans, AMY and GLUs enzymes are responsible for the hydrolysis 
of polysaccharides and oligosaccharides, to produce glucose. [5,20,31,42]. These two enzymes can 
be acting at the same time, whereas the AGLU activity would be the rate-limiting step in starch 
hydrolysis [20]. Therefore, inhibition of the latter enzyme is more attractive within the search of new 
hypoglycaemic agents [14].  
Similarly, the inhibitory activity of PCs towards PL is the main mechanism by which these 
compounds can prevent hyperlipidaemia and obesity [18,20,23,64]. The decreased digestion and 
absorption of dietary fats (triacylglycerols, fats and oils) lead to overall decreased caloric absorption, 
ultimately leading to weight loss [18,23]. In this view, inhibition of digestive enzymes by PCs is an 
effective and established approach to manage hyperglycaemia and hyperlipidaemia [18,21,31,32,90]. 
The use of synthetic drugs (like acarbose, miglitol, voglibose and orlistat) is very common, however, 
there have been reported undesired side effects from their intake (flatulence, diahrea, liver toxicity, 
abdominal pain, among others) [2,18,20,33,90] (Table 1). Therefore, PCs from natural products have 
been extensively evaluated as safe, cost-effective therapeutic agents for diabetes and obesity, 
throughout digestive enzyme activity inhibition [3,5,16,20,21,31,32,172].  
Many studies have associated the increase in the consumption of PC-rich fruit and vegetables 
with the reduction on the risk of certain chronic diseases, including T2DM [18,85,94,171–173]. There 
is some evidence that berries have a favourable potential to inhibit key enzymes linked to T2DM and 
obesity, so their consumption seems highly beneficial aside from their nutritional value 
[5,18,21,31,32,61,65,89,93,154]. Additionally, leaves from BPPs are known to have similar phenolic 
composition to berries, but in higher amounts [34,80,87]. Therefore, leaves resulting from pruning 
and harvesting may be used as an alternative source of bioactive compounds for the development of 
food supplements, functional foods and/or nutraceuticals [34]. 
In the present work, different correlations were observed between total individual phenolic 
content (TIPC) of analysed extracts and inhibition of digestive enzymes: glucosidases (r ≥ -0.636), 
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AMY (r ≥ -0.481) and PL (r ≥ -0.579) (Table 26). These low correlations could be justified by the 
diverse phenolic composition of analysed extracts (Chapter III). The same was verified in other 
studies [18,31,90,98,173].  
Table 26 – Pearson’s correlation coefficients (r) between digestive enzymes inhibitory assays and phenolic 
composition of analysed extracts. TIPC: total individual phenolic content; ANTCs: anthocyanins; HCAs: 
hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: flavonols; FLAVAs: flavan-3ols; FLAVNs: 
flavanones; ELGTs: ellagitannins; Y: yeast; R: rat. 
 TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.636 0.01 -0.076 -0.267 -0.431 -0.466 -0.187 -0.449 
R-AGLU -0.758 0.501 -0.405 -0.474 -0.852 -0.687 -0.326 -0.57 
BGLU -0.842 0.415 -0.558 -0.310 -0.810 -0.574 -0.218 -0.567 
AMY -0.481 0.069 0.045 -0.450 -0.405 -0.444 -0.227 -0.437 
PL -0.767 0.449 -0.18 -0.312 -0.811 -0.753 -0.348 -0.597 
Berries TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.477 -0.525 -0.041 -0.451 -0.170 -0.192 0.748 -0.231 
R-AGLU -0.589 -0.550 -0.101 -0.416 -0.362 -0.200 0.586 -0.379 
BGLU -0.889 -0.869 -0.381 -0.187 -0.185 -0.110 0.780 -0.562 
AMY -0.300 -0.216 -0.225 -0.429 -0.510 -0.136 0.424 -0.302 
PL -0.579 -0.502 0.073 -0.273 -0.397 -0.042 0.696 -0.509 
Leaves TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.776 -0.024 0.025 -0.466 -0.676 -0.569 -0.408 -0.498 
R-AGLU -0.908 -0.189 -0.245 -0.309 -0.669 -0.425 -0.319 -0.332 
BGLU -0.983 -0.371 -0.618 -0.079 -0.490 -0.061 -0.111 -0.187 
AMY -0.619 -0.050 -0.138 -0.458 -0.660 -0.577 -0.362 -0.471 
PL -0.583 -0.131 -0.207 -0.670 -0.653 -0.692 -0.442 -0.345 
 
To further understand the main compounds responsible for the reported bioactivities, the 
conclusions about the analysis of correlation were divided for the whole tested materials (berries and 
leaves) and also to specific species (Table 27). In the case of berries, glucosidases seemed mainly 
inhibited by anthocyanins (ANTCs) (r ≥ -0.525), AMY by flavonols (r = -0.510) and PL by 
ellagitannins (r ≥ -0.509) (Table 27). Flavonols (r ≤ -0.669) and HCAs (r = -0.618) were the main 
inhibitors of glucosidases by leaves extracts, while flavonols (r = -0.660) and flavan-3-ols (r = -0.692) 
were key inhibitors of AMY and PL, respectively (Table 27). Correlations between TIPC and 
inhibitory activities by separated species (M. faya, R. grandifolius and Vaccinium spp.) was improved: 
glucosidases (r ≥ -0.919), AMY (r ≥ -0.709) and PL (r ≥ -0.850) (Table 27). This is due to the 
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similarities between samples and lower number of samples. A general analysis revealed that 
ellagitannins and flavan-3-ols were the main contributors for the observed activities of M. faya and 
R. grandifolius (Table 27). HCAs and flavonols were the main active compounds of Vaccinium spp. 
(Table 27).  
Table 27 - Pearson’s correlation coefficients (r) between digestive enzymes inhibitory assays and phenolic 
composition of analysed berry-producing plants. TIPC: total individual phenolic content; ANTCs: 
anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: flavonols; FLAVAs: 
flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins;Y: yeast; R: rat. 
M. faya TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.995 0.956 0.886 -0.861 -0.932 -0.975 -0.559 -0.985 
R-AGLU -0.992 0.966 0.850 -0.855 -0.943 -0.974 -0.553 -0.979 
BGLU -0.996 0.953 0.868 -0.859 -0.928 -0.980 -0.543 -0.987 
AMY -0.928 0.843 0.766 -0.823 -0.872 -0.879 -0.517 -0.894 
PL -0.993 0.947 0.857 -0.855 -0.929 -0.975 -0.540 -0.979 
R. grandifolius TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.947 0.988 -0.952 - -0.982 -0.719 - -0.994 
R-AGLU -0.919 0.982 -0.922 - -0.961 -0.765 - -0.984 
BGLU -0.939 0.992 -0.947 - -0.979 0.736 - -0.996 
AMY -0.709 0.906 -0.724 - -0.802 -0.947 - -0.881 
PL -0.850 0.890 -0.838 - -0.812 -0.520 - -0.898 
Vaccinium spp. TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Y-AGLU -0.938 0.818 -0.864 0.622 -0.835 -0.158 0.037 0.824 
R-AGLU -0.937 0.962 -0.904 0.624 -0.921 -0.356 0.240 0.943 
BGLU -0.957 0.945 -0.926 0.650 -0.897 -0.297 0.178 0.930 
AMY -0.498 0.863 -0.427 0.155 -0.943 -0.860 0.179 0.814 
PL -0.938 0.851 -0.867 0.620 -0.865 -0.210 0.089 0.854 
 
Present data suggested that enzyme inhibition is more influenced by specific phenolic types 
rather than the total amounts, which agrees with previous works [10,18,61,90]. Different 
concentrations, molecular weight, size, number and position of substitution (hydroxylation, 
glycosylation), polymerization, polarity and structural conformations of PCs play a role in enzyme 
inhibition [6,20]. The structural diversity influence their stability, solubility and binding ability with 
digestive enzymes [18]. Interaction between PCs and digestive enzymes occur between similar 
chemical groups (aromatic rings, hydroxyl groups, etc) by non-covalent binding, mainly van der-
Waals forces, hydrogen binding, hydrophobic binding, and other electrostatic forces [20,174]. These 
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inhibitory interactions are mainly by non-competitive mode and are dependent on the chemical 
structure of PCs [20]. Overall, the PCs-enzymes affinity seem to increase with the complexity of the 
structures of the PCs (number of hydroxyl groups, polymerization) or the number of hydrophilic sites 
on the enzyme [6]. This is why flavonoids, usually, display higher inhibitory activities compared to 
phenolic acids [6,20]. In the case of tannins, their strong ability to bind to proteins can also originate 
insoluble and indigestible complexes, resulting in the deactivation of digestive enzymes [50,174].  
Most studies are conducted with berries crude extracts with a high variety of compounds that 
may show synergistic and/or antagonistic effects and influence the assay measurements 
[61,64,65,85,89,93,97,98]. For example, among several fruits chokeberry extract was the most active 
PL inhibitor [18], while in other study [97] no inhibition was observed when chokeberry extract was 
used. Fractionation and /or purification of crude extracts improved their inhibitory activities towards 
digestive enzymes [10,64,115]. The inhibitory effect of individual PCs depends also on target enzyme 
[32]. For example, some extracts are potent GLUs inhibitors but have poor AMY or lipase inhibitory 
activities [20,21,32].  
ANTCs present in berries seem the most important inhibitors of AGLU activity 
[18,21,32,89,92,93,98], but a range of different phenolic classes are also effective. Blueberry and 
blackcurrant extracts, which had the highest ANTCs content, were the most effective inhibitors of 
AGLU [21]. The extent of inhibition of AGLU is strongly influenced by chemical structure and the 
sugar units linked to the anthocyanidin [6,42]. Cyanidin showed inhibition of sucrase activity, 
although to a much lesser extent than its monoglycosides (being higher for cyanidin-3-galactoside), 
while cyanidin-3,5-diglucoside showed relatively no inhibition [60]. Hence, different glycoside 
nature at the 3-O position of cyanidin is an important factor for modulating the inhibition of AGLU. 
The mechanism of AGLU inhibition action by ANTCs is not fully understood but it seems 
competitive (just like acarbose) and results from the structural similarity between the normal substrate 
maltose and the glucosyl groups β-linked to the ANTC which bind to the active site but are not 
hydrolysed [32]. Another possibility is that the polar groups present in the active site of the enzyme 
interact with hydroxyl groups on ANTCs, changing the molecular configuration of the enzyme and 
its hydrophilic and hydrophobic properties, leading to a change in enzyme activity [42]. A synergistic 
inhibition due to combination of acarbose and cyanidin glycosides was shown for AGLU [60]. This 
combination may lead to a reduction of the dose of acarbose in the treatment of T2DM, consequently 
reducing side effects that occur by the acarbose intake [42]. 5-O-CQA is another potent AGLU 
inhibitor [21,89]. Inhibition of AGLU by CQAs appears to be non-competitive, suggesting binding 
to, or interaction with, the enzyme at a site other than the active site [5,21]. Interactions between 
different PCs (ANTCs, flavonols, HCAs) can also improve inhibition of AGLU [65,85,89,98]. For 
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example, the relatively higher AGLU inhibitory activities of fractionated extracts from M. rubra 
berries than those of the isolated compounds suggested synergistic effects between different 
compounds [65]. By contrast, it was suggested that the inhibitory effect of blueberries extracts 
towards AGLU are mainly attributed to phenolic acids rather than ANTCs [85].  
While AGLU activity is largely modulated by a wide range of PCs, AMY inhibition seems 
more specific [5,21,89,98]. AMY activity is primarily affected by condensed (ellagitannins) and 
hydrolysable tannins (gallotannins and proanthocyanidins, PACs) [21,32,61,89,90,93]. In general, the 
larger and more complex tannins show higher degree of inhibition against AMY [6]. Raspberry 
extract was much more effective against AMY than equivalent extracts of blueberry [21,162], 
suggesting that ellagitannins were the main active components. This trend is similar to that observed 
in analysed extracts (Rubus >> Vaccinium)(Table 24). Although ANTCs are not crucial for AMY 
inhibition, their presence can modulate the effectiveness of tested extracts [5,61,97]. For example, a 
higher ellagitannins content in yellow raspberries did not increase AMY inhibition in comparison 
with red counterparts [61,90]. This suggested that a synergetic effect between ANTCs and 
ellagitannins occurred and potentiated the inhibitory activity of red raspberries [32,61]. The same 
authors reported also a synergetic interaction with combination of rowanberry PACs and acarbose, 
reducing the acarbose concentration required for AMY inhibition. The management of 
hyperglycaemia linked to T2DM through plant extracts that have high AGLU and moderate/lower 
AMY inhibition is desirable [90,115]. Excessive AMY inhibition can lead to abnormal bacterial 
fermentation of undigested starch in the colon and consequent stomach distention and discomfort 
(flatulence and diarrhea) [61,89,172]. Hence, berries with low AMY and high AGLU inhibitory 
activities are preferable candidates as part of a dietary approach to manage early stages of 
hyperglycaemia linked to T2DM. 
The activity of PL seems to be most affected by flavan-3-ols (monomers and oligomers) 
[18,23,32,64]. The presence of the galloyl group in tannins seems important to enhance their 
inhibitory activity towards PL [6,32]. For example, polymers of epigallocatechin-3-O-gallate (ECGC) 
were the main hypolipidaemic agents from M. rubra leaves [23]. Additionally, extracts with the 
highest PACs content and degree of polymerization exhibited the strongest PL inhibitory activity 
[23]. Ellagitannins are also reported to be the main active compounds from for PL inhibition in Rubus 
berries [18,21,64,90,93]. Similar to present work, cloudberries, raspberries and artic bramble were 
more potent than blueberries against PL [93]. The inhibitory activity of different ANTCs-containing 
foodstuffs towards PL was positively correlated with their  ANTCs content [171]. Among ANTCs, 
C3G showed the highest PL inhibitory activity (IC50 value = 1.17 mg mL-1 [97]. By contrast, 
McDougall and collaborators [64] suggested that just like for AMY, ANTCs are not necessary for PL 
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inhibition. Nevertheless, it is possible that synergistic interactions between ANTCs and other PCs 
could occur. 
Considering that C3G, 5-O-CQA and MCT were the most abundant compounds of some 
extracts and they were available on the laboratory, their individual inhibitory potential towards 
digestive enzymes was further evaluated. C3G displayed significant inhibitory activities towards 
digestive enzymes, with lower IC50 values than positive controls in yeast AGLU and PL assays (p < 
0.05). For rat AGLU and BGLU, C3G showed stronger activities than extracts (being comparable to 
1-DNJ in the latter assay). In the case of AMY, its efficiency was similar to R. grandifolius berries 
extracts Previously, C3G has demonstrated potent inhibitory activities towards AGLU and LIP 
[60,65,89,93,97,171]. The positive effects of ANTCs, including C3G, on the management of T2DM 
are very well summarised in [42]. 
5-O-CQA was a powerful inhibitor of targeted enzymes, with higher efficiency than positive 
controls in yeast AGLU, BGLU and PL assays (p > 0.05). In the case of mammalian AGLU, it was 
more effective than extracts. For AMY, it showed comparable activities to M. faya berries extracts. 
5-O-CQA seems a more effective inhibitor of GLUs and PL, as suggested by literature [89,115], even 
though Worsztynowickz and co-workers [97] found no inhibition of 5-O-CQA over PL activity. 
These findings add to the extensive list of mechanisms through wich CQA exerts a positive action on 
regulating glucose and lipid metabolism, as previously reviwed [175]. 
In the case of MCT standard, its higher potency was verified towards BGLU with lower IC50 
values than positive controls and extracts. It showed comparable to 1-DNJ and V. padifolium (mature 
leaves) extracts in yeast AGLU and AMY assays. Previously [65], MCT was found to be a more 
effective AGLU inhibitor than C3G and quercetin glycosides. However, an opposite trend was 
described in the present work (Table 23). Nevertheless, our findings suggest that MCT is an active 
inhibitor of GLUs, although other compounds (like tannins) could also contributed for the measured 
activity of M. faya extracts. For example, fractions from M. rubra extracts showed higher inhibitory 
activities than isolated C3G and MCT, which indicated the involvement or the synergistic effects of 
different PCs for the inhibitory effects [65].  
In general, the present data demonstrate that C3G > 5-O-CQA > MCT can be considered as 
main active hypoglycaemic and hypolypidaemic agents present in analysed extracts. Nevertheless, 
the action of other components cannot be ruled out since they could interact to additively or 
synergistically inhibit digestive enzymes. The following phase would be fractionation of extracts to 
better understand which classes and/or mixtures of PCs are more involved in the inhibitory activities 
of digestive enzymes. 
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All analysed extracts inhibited targeted digestive enzymes in a dose-dependent manner, 
although with different potencies. Overall, the most promising results were obtained from R. 
grandifolius berries extracts and, therefore, this species deserve a special attention as a dietary 
complementary approach for the control/management of diabetes and obesity. The unique phenolic 
composition (ANTCs and ellagitannins) in this species (Chapter III) could justify the present data. It 
is known that these particular classes of PCs could act synergistically to influence digestive enzymes 
activity [32,61,93]. In the case of Vaccinium berries, observed differences could be related to 
genotype × environment factors that affect the phenolic composition and, therefore, the anti-diabetic 
effects of blueberries [154]. 
As for leaves, the results varied according to the tested digestive enzyme. For yeast AGLU, 
R. grandifolius extracts displayed the best inhibitory activities. V. padifolium extracts were the 
strongest samples against AGLU from rat and BGLU, which could be attributed to their high contents 
in 5-O-CQA. Previously, a synergetic inhibition towards AGLU was observed for the combination 
of ANTCs and 5-O-CQA [18,21,89]. It is to be noted that higher effect of V. cylindraceum (leaves) 
on AMY in comparison with V. padifolium (Table 24) is a result of its higher flavan-3-ols content 
(Chapter III). The most active extracts towards AMY and PL were M. faya. The higher diversity of 
tannins (gallo- and ellagitannins) in M. faya by comparison with other species seems to be the main 
factor for the observed activities. The lower activities of Vaccinium extracts (Table 24 and Table 25) 
was directly related to their low tannins content (Chapter III). In this view, leaves of M. faya, R. 
grandifolius and Vaccinium species are interesting alternative sources of bioactive compounds for the 
development of infusions, food supplements, nutraceuticals and/or functional foods with anti-diabetic 
purposes. 
Although the analysed extracts seemed capable of decreasing post-prandial 
hyperglycaemia/hyperlipidaemia through inhibition of key digestive enzymes, it is unclear whether 
they would be effective in vivo. Despite some dissonant views [16], the available literature suggest 
that PCs-rich berries might provide a mechanism for regulating glucose digestion and absorption in 
the gut and thereby providing an effective management of pre-diabetes symptoms and associated 
complications. However, one crucial issue that needs to be clarified is whether the ingested PCs that 
go through gastrointestinal digestion (GID) still maintain their bioactivity. On Chapter III the stability 
of PCs from targeted BPPs was evaluated in a simulated digestion and a substantial decrease of PPs 
amounts was observed. However, it is known that most of PCs are stable on the gastric phase 
[48,49,51,53,54,140,147,153] and therefore reach the duodenum intact where they potentially exert 
their inhibitory activities towards intestinal digestive enzymes [21,32]. A shortcoming of this work 
was that the in vitro GID was not performed in separated phases (oral, gastric, intestinal) and in that 
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case the potential effect of post-gastric extracts towards digestive enzymes could be determined and 
compared with the undigested samples. Nevertheless, since the effects of oral and gastric digestion 
seem minimal on foodstuufs, it can be expected similar results to those found in undigested samples 
towards digestive enzymes since they reach the colon with minimal tranformations. 
Large ingested PCs from berries (PACs, ellagitannins, etc) are not taken up into the 
circulation and remain resident in the small intestine where their potential interactions with digestive 
enzymes can be physiologically relevant [21,41]. However, it is possible that effects in the 
gastrointestinal (GI) tract may be short–lived due mild-alkaline intestinal conditions and interaction 
with salts and bile acids that promote their degradation and/or structural changes [49,51,54,56,146]. 
The few conducted in vivo studies indicated that berries PCs may modulate glucose availability 
through the inhibition of carbohydrate-hydrolysing enzymes, which could influence blood glucose 
control [5,16]. 
The obtained results are only indicative, therefore, more research is required to confirm that 
PCs of BPPs beneficially impact glycaemic responses in vivo, through digestive enzymes inhibition, 
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1. Inhibition of Human Aldose Reductase (HAR) activity 
Inhibition of digestive enzymes (Chapter IV) is the first significant approach to control 
glucose levels in the bloodstream. However, the use of a single therapeutic procedure has 
unfortunately not been successful in overcoming all the complications caused by the high level of 
glucose in blood [2,4,14]. Hyperglycaemia-induced complications (retinopathy, neuropathy, 
nephropathy, etc) are mainly associated with the increased activity of the polyol pathway and 
accumulation of advanced glycation end-products (AGEs) that cause oxidative stress (OS) and 
vascular damages [66,69].  
In this view, the first part of this chapter was to evaluate the ability of berry-producing plants 
(BPPs) extracts to inhibit HAR, using glyceraldehyde and NADPH as substrate and cofactor, 
respectively. 
1.1. Pre-in vitro gastrointestinal digestion 
The activity of HAR was reduced by the non-digested extracts in a dose-dependent manner, 
with IC50 values ranging between 0.29 and 4.46 mg mL-1 (Table 28). Significant differences (p < 
0.05) were found in the inhibitory activities among analysed extracts (inter and intra-species). Leaves 
were the morphological part with strongest effects (p < 0.05). Among berries, R. grandifolius (FX > 
MX) showed the highest inhibitory activities, followed by M. faya > V. padifolium ≈ V. cylindraceum 
> E. umbellata >> S. lanceolata (Table 28). A slight different trend was observed for leaves: R. 
grandifolius (MX > FX) > V. padifolium (YLs > MLs) > M. faya > V. cylindraceum > E. umbellata 
>> S. lanceolata. 
With regard to the activity of the standard compounds, all of them exhibited remarkable 
inhibition of HAR. Quercetin stands out by its superior inhibitory activity among tested samples (p < 
0.05) (Table 28). Quercetin aglycone and its mono-glycosides were highly effective towards the 
activity of aldose reductase (AR) [68,69]. 5-O-CQA displayed a similar effect to quercetin and was 
more effective than other standards (cyanidin-3-O-glucoside, C3G > myricitrin, MCT). C3G and 
MCT showed comparable inhibitory activities to M. faya leaves extracts. In different studies, 
caffeoylquinic acids (CQAs) (3-O-CQA, 3,4-di-O-CQA, 1,3,5-tri-O-CQA and 3,4,5-tri-O-CQA) and 
C3G displayed a greater activity towards AR inhibition than quercetin [68,69]. Previously, MCT 
showed a lower effect than quercetin  (IC50: 3.80 and 0.15 µg mL-1, respectively) [176], which agrees 
with the present data (Table 28).  
Studies regarding the inhibition of AR by BPPs are scarce in literature, being mostly 
conducted with medicinal plants and isolated compounds. Two studies on blueberries (V. myrtillus 
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and V. cyanococcus) were found [69,173] and a low activity (IC50 = 16.80 mg mL-1 DE) was reported 
for the latter species [173]. 
Table 28 - In vitro inhibitory activities of analysed extracts towards human aldose reductase (expressed as IC50 
value, mg mL-1). Data represent the mean ± standard deviation (n = 3). 
  Berries   Leaves  
  Non-Digested Digested  Non-Digested Digested 
E. umbellata  2.19 ± 0.10s 9.34 ± 0.50y  0.86 ± 0.02k 2.51 ± 0.10t 
M. faya MX 0.91 ± 0.04k N.D.  0.50 ± 0.02fg N.D. 
 FL 0.84 ± 0.03j N.D.  0.45 ± 0.02e N.D. 
 ASJ 0.80 ± 0.02j N.D.  0.40 ± 0.03cd N.D. 
 BV 0.72 ± 0.03i 4.79 ± 0.17w  0.37 ± 0.01c 1.09 ± 0.03o 
 SX 0.98 ± 0.02n N.D.  0.40 ± 0.01cd N.D. 
 RJ 1.05 ± 0.02o N.D.  0.52 ± 0.02g N.D. 
 PM 0.88 ± 0.03k N.D.  0.43 ± 0.01de N.D. 
 TC 0.74 ± 0.03i N.D.  0.36 ± 0.01c N.D. 
R. grandifolius FX 0.52 ± 0.02g 1.97 ± 0.09r  0.35 ± 0.01c 0.89 ± 0.03k 
 MX 0.64 ± 0.03h N.D.  0.26 ± 0.01b N.D. 
S. lanceolata  4.46 ± 0.17u 12.41 ± 0.59z  3.61 ± 0.14t 9.07 ± 0.38x 
V. cylindraceum  0.90 ± 0.03kl 3.50 ± 0.12u  0.73 ± 0.03i 1.70 ± 0.07k 
V. padifolium  0.93 ± 0.04l 3.58 ± 0.11u  0.29 ± 0.01b* 0.93 ± 0.02m* 
     0.43 ± 0.02de** 1.24 ± 0.04p** 
Reference Compounds      
Quercetin 0.10 ± 0.01a N.D.    
Cyanidin-3-glucoside 0.38 ± 0.01c N.D.    
5-O-Caffeoylquinic acid 0.13 ± 0.01a N.D.    
Myricetin  0.49 ± 0.02f N.D.    
*Young leaves; **Mature leaves. N.D.: Not determined. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: 
Boaventura; SX: Seixal; RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. Means not sharing 
the same letter are significantly different at p < 0.05 probability level. 
1.2. Post in vitro gastrointestinal digestion 
After simulated gastrointestinal digestion (GID), the HAR inhibitory activity of analysed 
samples was significantly decreased (p < 0.05). The IC50 values ranged from 0.89 – 12.41 mg mL-1 
(Table 28). The increase of IC50 values (from 2.28 up to 6.66-fold) mean that after in vitro GID 
extracts displayed much lower inhibitory activities against HAR. This should be linked with the 
reduced amounts of phenolic compounds (PCs) present in the digested extracts (Chapter III). 
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Moreover, possible alterations on the PCs structure could also justify the obtained results. Although 
in lower potency, PCs present in digested extracts still displayed inhibitory effects against HAR. 
Significant differences were between morphological parts and targeted species (p < 0.05). Berries of 
R. grandifolius showed the highest activity, followed by V. padifolium ≈ V. cylindraceum > M. faya 
> E. umbellata > S. lanceolata. For leaves, R. grandifolius was still the most active sample and the 
order of the most potent HAR inhibitors was as follows: V. padifolium > M. faya > V. cylindraceum 
> E. umbellata > S. lanceolata. No studies regarding the effect of simulated digestion in AR activity 
were found in literature to establish a comparison with present data. 
1.3. General Discussion 
A moderate correlation was observed between total individual phenolic content (TIPC) and 
HAR inhibitory activity (r = -0.605) (Table 29), higher than that (r ≥ 0.435) presented by Wu and 
co-workers [173]. From this correlational analysis, it can be inferred that as for previous enzymatic 
assays (Chapter IV) the type of PCs is more important than total amounts for inhibition of HAR. In 
the case of berries, low correlations were observed (Table 29). Flavonols (r = -0.610) seemed key 
compounds for the observed inhibitory activities of berries and leaf extracts. Analysis by species, 
showed an improvement of correlation values (Table 29). Ellagitannins were main contributors for 
M. faya and R. grandifolius, while HCAs were relevant for Vaccinium spp. (Table 29). After in vitro 
digestion, TIPC x HAR correlations were improved (r = -0.825) compared to pre-digestion (Table 
29), which might be linked to the small number of analysed samples. After digestion, anthocyanins 
(ANTCs) and flavonols were the main contributors for berries and leaves, respectively (Table 29).  
HAR is the first enzyme in the polyol pathway, which in hyperglycaemia condition, reduces 
the excessive glucose to sorbitol with consumption of co-factor NADPH. Accumulation of sorbitol 
in tissues is implicated in the development of degenerative complications of type-2 diabetes (T2DM) 
(retinopathy, neuropathy, nephropathy, etc) due to osmotic stress (Figure 8) [66–68,173]. The 
increased activity of the polyol pathway also contributes to the formation of fructose (by oxidation of 
sorbitol) and dicarbonyls, which later conjugate with proteins and promotes AGEs formation (Figure 
8) [12,66–68]. Moreover, depletion of NADPH could intensify cellular OS, since it is necessary for 
ghutathione regeneration (Figure 8) [4,12,17,67]. So, reduction of the polyol pathway activity by 
inhibition of HAR seems to offer the possibility of reducing long-term diabetic complications 
[3,6,67,68]. Currently, epalrestat (a carboxylic acid derivative) is the only commercial HAR inhibitor, 
available in Japan, China and India, for the treatment of diabetic neuropathy [67,100]. Other synthetic 
drugs (alrestatin, tolrestat, sorbinil, etc) have been developed, but show relatively low efficiency and 
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safety issues (liver toxicity) [69,100]. Thus, there is an urgent need for development of new effective 
agents [69].  
Table 29 - Pearson’s correlation coefficients (r) between human aldose reductase (HAR) inhibitory assay and 
phenolic composition of analysed berry-producing plants (BPPs) (pre- and post in vitro digestion). TIPC: total 
individual phenolic content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic 
acids; FLAVOs: flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Pre-digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
General -0.605 0.089 -0.164 -0.366 -0.464 -0.394 -0.171 -0.424 
Berries -0.409 -0.357 0.085 -0.42 0.517 -0.244 0.399 -0.277 
Leaves -0.738 -0.121 -0.086 -0.31 -0.661 -0.403 -0.287 -0.402 
M. faya -0.962 0.879 0.768 -0.826 -0.887 -0.921 -0.574 -0.945 
R. grandifolius -0.856 0.917 -0.806 - -0.867 -0.84 - -0.913 
Vaccinium spp. -0.967 0.859 -0.936 0.782 -0.819 -0.13 0.005 0.892 
Post-digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
General -0.825 -0.069 -0.446 -0.247 -0.596 -0.339 -0.19 -0.413 
Berries -0.864 -0.804 -0.326 - 0.026 -0.352 0.412 -0.489 
Leaves -0.781 -0.24 -0.367 -0.215 -0.692 -0.278 -0.358 0.32 
 
Various natural compounds (PCs, alkaloids, terpenoids) have proven effective in vitro AR 
inhibitors [3,67,69]. The molecular structures of PCs have a great impact on the inhibition of HAR 
[68]. Kinetic studies suggest that PCs exert their HAR inhibition in both competitive and                             
non-competitive binding [67,68,100]. Flavan-3-ols seem weaker than flavones, flavonols, and 
flavanones type compounds towards inhibition of AR. However, galloylation of catechins seem to 
improve their efficiency [68]. Ellagitannins were the main active compounds of Indian gooseberry, 
with activities comparable to that of quercetin [100]. Among PCs isolated from plant sources, 
quercetin, kaempferol, CQAs, (epi)gallocatechin-O-gallate (EGCG) and ellagic acid are the most 
promising AR inhibitors and have shown a great potential in the treatment of AR-dependent diabetic 
complications [3,67,69]. 
The diverse phenolic composition of analysed extracts (Chapter III) seems to be linked to the 
different potencies against HAR activity. ANTCs, ellagitannins and 5-O-CQA seem to be the major 
contributors for the inhibition of HAR since R. grandifolius (berries and leaves) and V. padifolium 
(leaves) exhibited the most promising results.  
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2. Inhibition of Advanced Glycation End-Products (AGEs) Formation 
Due to the close link between AGEs generation and the increased activity of the polyol 
pathway, the in vitro anti-glycation properties of BPPs extracts, as well as their major constituents, 
was also studied. In the present study, two models were assayed using ribose and fructose as glycation 
agents of bovine serum albumin (BSA). 
2.1. Pre-in vitro gastrointestinal digestion 
All analysed extracts inhibited AGEs formation through inhibition of BSA glycation (Table 
30) in a dose-dependent manner. Different potencies were verified between extracts (p < 0.05) with 
the IC50 values ranging between 0.41 and 6.04 mg mL-1 DE (Table 30). Among berries, R. 
grandifolius (FX > MX) showed the highest inhibitory activities, followed by V. padifolium > V. 
cylindraceum > M. faya >> E. umbellata > S. lanceolata (Table 30). In the case of leaves the order 
of the most potent extract was as follows: V. padifolium (YL > ML) > R. grandifolius > V. 
cylindraceum > M. faya > E. umbellata > S. lanceolata. Leaves extracts showed the best inhibitory 
activities, regardless of the model (p < 0.05). 
In the ribose model, all samples were more effective than aminoguanidine (AMG) (Figure 
55), an investigational AGEs inhibitor drug (p < 0.05). The same behaviour was documented before 
for V. macrocarpon [76]. This is might be due to the fact that AMG is not effective in the early stage 
of protein glycation since it acts as a carbonyl scavenger [70,76,177].  
 
Figure 55 – Chemical structure of aminoguanidine (AMG), an experimental drug for the treatment of 
nephropathy. 
For the fructose model, some differences were observed. In this case, higher glycation rates 
were found in BSA-ribose assay (p < 0.05). It is known that glycation ability occurs in the following 
increasing order: D-glucose < D-fructose < D-ribose [66,71,74]. This is explained by the almost 
planar structure of the aldofuranose ring of ribose which causes its instability and high rate of 
anomerization; the unstable ring is thus susceptible to reactions with nucleophiles, such as amino 
groups, giving rise to its high efficiency in protein glycation [71]. In the present study, a good 
correlation was observed between results of both models (r = 0.850).  
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AMG inhibitory activity was similar to that of S. lanceolata leaves, but higher than E. 
umbellata and S. lanceolata berries (p < 0.05) (Table 30). On a previous study [74], AMG was more 
effective than different extracts (blueberries, blackberries, strawberries, raspberries, cranberries, and 
grapes) in a fructose-BSA model. Such anti-glycation effects of different berries extracts were 
attributed to their carbonyls scavenging activity [74].  
Despite the known antioxidant activity (AOA) of berries and anti-glycation activity of related 
PCs, only a few works have assessed their effects on AGEs generation. Previously [74], different 
berries extracts (blueberries, blackberries, strawberries, raspberries, cranberries, and grapes) were 
capable to inhibit AGEs generation. However, no IC50 values were documented. The potency of 
analysed extracts was inferior to those reported for other Vaccinium species (≤ 0.06 mg mL-1 DE) 
[75–77,159,164]. By contrast, cloudberry showed an IC50 value of 4.01 mg mL-1 DE [159] only 
inferior to that of E. umbellata and S. lanceolata (Table 30). In previous works, Vaccinium berries 
were more potent than Rubus species [74,159]. However, that was no the case for the species of the 
presen study (Table 30). Discrepancies can arise from different phytochemical compositions but the 
anti-glycation capacities mainly depends on the model system employed [72,177]. There is a great 
variety of methods with various combinations and dosages/type of protein and sugar, glycation agents 
(glyoxal, methylglyoxal, fructose, ribose, glucose, etc) as well as incubation periods and temperatures 
[177]. 
Standards of C3G, 5-O-CQA and MCT were also evaluated for their anti-glycation activities 
and demonstrated stronger activities than extracts (p < 0.05). In the ribose model, 5-O-CQA was the 
most effective (comparable to quercetin inhibitory activity) while C3G and MCT displayed similar 
effects. In the case of fructose assay, all standards showed alike inhibitory activities (slightly higher 
for C3G). A previous work [178] reported a similar trend on the inhibition of protein glycation among 
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Table 30 - In vitro inhibitory activities of analysed extracts towards BSA glycation (expressed as IC50 value, 
mg mL-1). Data represent the mean ± standard deviation (n = 3). 
  Ribose   Fructose  
  Berries Leaves  Berries Leaves 
E. umbellata   5.35 ± 0.21u 2.38 ± 0.10n  2.75 ± 0.15t 1.22 ± 0.05m 
M. faya MX 3.23 ± 0.08r 1.53 ± 0.02j  1.85 ± 0.03r 0.77 ± 0.02i 
 FL 2.99 ± 0.09pq 1.42 ± 0.04i  1.72 ± 0.04q 0.83 ± 0.01j 
 ASJ 2.72 ± 0.03o 1.38 ± 0.02i  1.59 ± 0.02o 0.67 ± 0.01g 
 BV 2.67 ± 0.11o 1.15 ± 0.05g  1.66 ± 0.05p 0.68 ± 0.02g 
 SX 3.07 ± 0.08q 1.33 ± 0.04h  1.80 ± 0.04r 0.73 ± 0.01h 
 RJ 3.35 ± 0.09s 1.58 ± 0.03j  1.79 ± 0.03qr 0.87 ± 0.02j 
 PM 2.94 ± 0.07p 1.30 ± 0.04h  1.74 ± 0.03q 0.76 ± 0.01hi 
 TC 2.86 ± 0.05op 1.21 ± 0.02g  1.69 ± 0.02p 0.65 ± 0.02g 
R. grandifolius  FX 1.77 ± 0.05k 0.96 ± 0.05e  0.88 ± 0.02k 0.55 ± 0.01f 
 MX 1.87 ± 0.04l 1.07 ± 0.04fg  0.94 ± 0.04l 0.68 ± 0.02g 
S. lanceolata  7.04 ± 0.30v 4.47 ± 0.16t  4.10 ± 0.15u 2.30 ± 0.08s 
V. cylindraceum  2.35 ± 0.11n 1.21 ± 0.11g  1.53 ± 0.10o 0.57 ± 0.01f 
V. padifolium   2.09 ± 0.11m 0.75 ± 0.04c*  1.35 ± 0.06n 0.41 ± 0.01d* 
   0.88 ± 0.03d**   0.49 ± 0.01e** 
Reference compounds      
Aminoguanidine 9.56 ± 0.36v   2.29 ± 0.13s  
Quercetin 0.11 ± 0.01a   0.24 ± 0.02b  
Cyanidin-3-glucoside 0.24 ± 0.01b   0.18 ± 0.01a  
5-O-Caffeoylquinic acid 0.14 ± 0.01a   0.20 ± 0.01a  
Myricetin 0.27 ± 0.02b   0.22 ± 0.01ab  
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: Boaventura; SX: Seixal; 
RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. Means from the same model not sharing 
the same letter are significantly different at p < 0.05 probability level. 
 
2.2. Post in vitro gastrointestinal digestion 
After simulated GID, the anti-glycation activity of analysed samples was significantly 
decreased (p < 0.05). The IC50 values of assayed extracts ranged from 0.41 – 11.21 mg mL-1 DE 
(Table 31) and significant differences were observed among samples (p < 0.05). The increase of IC50 
values (from 1.74 up to 3.59-fold) suggested that digested extracts displayed lower anti-glycation 
activities. This is believed to be linked to the reduced levels of PCs present in the digested extracts 
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(Chapter III). Additionally, possible alterations on the PCs structure and could also justify the 
obtained results. Nevertheless, PCs present in digested extracts were still able to prevent the in vitro 
glycation of BSA. Digested R. grandifolius berries showed the highest activity in both assays, 
followed by V. padifolium ≈ V. cylindraceum > M. faya > E. umbellata > S. lanceolata. After GID, 
V. padifolium leaves remained the most potent extracts (YLs > MLs) > R. grandifolius > M. faya > 
V. cylindraceum > E. umbellata > S. lanceolata.  
The strong correlation (r = 0.907) between the two sugar models was maintained after the in 
vitro digestion. Unfortunately, no studies regarding the effect of simulated digestion in AGEs 
formation were found in literature to establish a comparison with present data.  
Table 31 – In vitro inhibitory activities of analysed extracts towards BSA-glycation, pre- and post in vitro 
gastrointestinal digestion (expressed as IC50 value, mg mL-1). Data represent the mean ± standard deviation (n 
= 3). 
  Ribose   Fructose  
Berries  Non-Digested Digested  Non-Digested Digested 
E. umbellata   5.35 ± 0.21m 9.34 ± 0.21r  2.75 ± 0.15l 6.31 ± 0.25p 
M. faya  2.67 ± 0.11i 7.09 ± 0.31p  1.47 ± 0.05h 4.28 ± 0.12o 
R. grandifolius   1.77 ± 0.05e 5.43 ± 0.24mn  0.88 ± 0.02d 3.16 ± 0.17m 
S. lanceolata  7.04 ± 0.34p 11.21 ± 0.25s  3.10 ± 0.15l 8.15 ± 0.31q 
V. cylindraceum  2.35 ± 0.15h 6.24 ± 0.30o  1.53 ± 0.11hi 3.63 ± 0.11n 
V. padifolium   2.09 ± 0.14h 6.03 ± 0.21o  1.35 ± 0.06g 3.71 ± 0.13n 
Leaves       
E. umbellata  2.38 ± 0.10i 5.69 ± 0.22n  1.22 ± 0.05f 3.25 ± 0.14m 
M. faya   1.15 ± 0.05d 3.03 ± 0.07j  0.61 ± 0.02c 1.60 ± 0.03i 
R. grandifolius   0.96 ± 0.05c 2.62 ± 0.10i  0.55 ± 0.01b 1.52 ± 0.06h 
S. lanceolata  4.47 ± 0.16l 7.41 ± 0.33pq  2.30 ± 0.08k 4.48 ± 0.10o 
V. cylindraceum  1.21 ± 0.11d 3.58 ± 0.12k  0.57 ± 0.01b 1.90 ± 0.04j 
V. padifolium  YLs 0.75 ± 0.04a 1.92 ± 0.08f  0.41 ± 0.01a 1.09 ± 0.02e 
  MLs 0.88 ± 0.03b 2.36 ± 0.09h  0.49 ± 0.01a 1.42 ± 0.05gh 
YLs; young leaves; MLs: mature leaves. Means from the same model not sharing the same letter are    
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2.3. General Discussion 
In the present study, a good correlation was observed between TIPC and AGEs inhibitory 
activity (r ≥ -0.861)(Table 32).  
Table 32 - Pearson’s correlation coefficients (r) between protein glycation inhibitory assays and phenolic 
composition of analysed berry-producing plants (BPPs) (pre-in vitro digestion). TIPC: total individual phenolic 
content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: 
flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Pre-digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.882 0.231 -0.390 -0.374 -0.706 -0.546 -0.190 -0.545 
Fructose -0.861 0.302 -0.370 -0.405 -0.747 -0.585 -0.240 -0.555 
Berries TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.761 -0.726 -0.293 -0.340 -0.300 -0.192 0.619 -0.470 
Fructose -0.700 -0.658 -0.132 -0.304 -0.431 -0.127 0.623 -0.529 
Leaves TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.892 -0.230 -0.311 -0.188 -0.650 -0.329 -0.238 -0.289 
Fructose -0.865 -0.219 -0.267 -0.256 -0.687 -0.392 -0.229 -0.244 
M. faya TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.993 0.943 0.85 -0.844 -0.931 -0.970 -0.545 -0.978 
Fructose -0.994 0.957 0.865 -0.862 -0.940 -0.973 -0.529 -0.982 
R. grandifolius TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.959 0.986 -0.964 - -0.985 -0.690 -0.996 -0.995 
Fructose -0.994 0.957 0.865 -0.862 -0.990 -0.562 -0.529 -0.982 
Vaccinium spp. TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.953 0.935 -0.910 -0.592 -0.900 -0.302 -0.190 0.907 
Fructose -0.906 0.966 -0.860 -0.533 -0.945 -0.427 -0.320 0.930 
 
A moderate correlation (r ≥ -0.760) was also found in a previous work [159], indicating that 
total amounts of PCs is more pertinent to anti-glycation actitivy than individual compositions 
[74,76,159]. In general, flavonols (r ≥ -0.706) seem the main responsible for the inhibition of AGEs 
formation. ANTCs (r ≥ -0.658) and flavonols (r ≥ -0.650) were the main anti-glycation agents from 
berries and leaves, respectively (Table 32). Analysis by species revealed that ellagitannins (r ≥ -
0.978) seem the main contributors for results obtained for M. faya and R. grandifolius. HCAs (r ≥ -
0.910) were the key PCs for observed inhibitory activities of Vaccinium species (Table 32). 
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Table 33 - Pearson’s correlation coefficients (r) between protein glycation inhibitory assays and phenolic 
composition of analysed berry-producing plants (BPPs) (post in vitro digestion). TIPC: total individual 
phenolic content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; 
FLAVOs: flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Post-digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.918 0.220 -0.695 -0.201 -0.761 -0.360 -0.222 -0.342 
Fructose -0.929 0.202 -0.654 -0.292 -0.779 -0.410 -0.265 -0.379 
Berries TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.812 -0.752 -0.314 - -0.098 -0.293 0.220 -0.458 
Fructose -0.824 -0.767 -0.275 - -0.028 -0.367 0.399 -0.479 
Leaves TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
Ribose -0.990 -0.461 -0.741 -0.016 -0.691 -0.153 -0.045 -0.105 
Fructose -0.953 -0.390 -0.694 -0.209 -0.687 -0.260 -0.341 -0.191 
 
After in vitro digestion, TIPC x AGEs correlations were slightly improved (r ≥ -0.918) (Table 
33) compared to pre-digestion (Table 32); flavonols remained the main AGEs inhibitors (r ≥ -0.761). 
ANTCs (r ≥ -0.752) and HCAs (r ≥ -0.694) were the main anti-glycation agents of berries and leaves, 
respectively (Table 33).  
One of the inevitable consequences of hyperglycemia is the enhanced accumulation of AGEs 
due to prolonged exposure of plasma proteins (hemoglobin, serum albumin and transferrin) to 
elevated blood glucose [70]. Glycation is a series of non-enzymatic reactions between a reducing 
sugar and protein to yield, at a final stage, AGEs adducts [66,70–73]. Because the human body does 
not contain any enzymes capable of their structural degradation, AGEs tend to accumulate [179]. 
Consequently, AGEs lead to damage of protein structure and impairing intracellular physiological 
functions, while their extracellular presence result in abnormal protein cross-linking (Figure 56) 
[66,70,75]. Additionally, interaction with specific cell surface receptors (RAGEs) triggers the 
production of ROS, transcription factors (NF-kB) and pro-inflammatory agents (TNF-α, VEGF) 
[66,70,74,76,159,179]. The combination of these events leads to the increase of OS and a variety of 
diabetic complications, such as atherosclerosis, diabetic retinopathy, nephropathy, neuropathy, and 
wound healing (Figure 56) [66,70,74,76,159,179].  
Thus, agents that inhibit the formation of AGEs have therapeutic potential in management of 
T2DM [66,70,72,180]. AMG (Figure 55) was the first synthetic AGE inhibitor explored in clinical 
trials [70]. It acts as a nucleophilic trap of reactive carbonyl intermediates such as glyoxal (GO), 
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methyl-glyoxal (MGO) and 3-deoxyglucosone (3-DG) (Figure 9) to form relatively non-toxic 
adducts, thus preventing their conversion to AGEs [70,177]. 
 
Figure 56 – Simplified mechanism of  advanced glycation end-products (AGEs) pathology (adapted from [66]). 
However, this drug was not ultimately approved for commercial production because of its 
low efficiency and hepatotoxic effect and is currently being used as a prototype for obtaining new 
anti-glycation compounds [70,74]. Hence, there is a great need to find/develop new compounds with 
higher anti-glycation therapeutics. 
Terpenoids, PCs, polysaccharides, among other phytochemicals, have been proven to exhibit 
anti-glycation effects confirmed by in vitro and in vivo studies [3,66,70,180–182]. Therefore, 
inhibition of glycation by natural products can be utilized for pharmacological actions and possibly 
help in minimizing the pathogenesis of glycation-associated disorders [70,180].  
The effective anti-glycation features of PCs are mainly associated with their antioxidant 
properties and capacity to scavenge reactive carbonyls, which are strongly linked to their molecular 
structure [6,66,72,74,75,77,159]. Hence, the observed anti-glycation activities (Table 30 and Table 
31) are attributed to the different phenolic compositions of analysed extracts. Moreover, inhibition of 
HAR by PCs is beneficial to prevent production of AGEs since, in hyperglycaemia, the polyol 
pathway contributes to fructose formation (Figure 8) [66,67]. 
Berries intake has been suggested as a dietary approach to reduce or prevent the formation of 
AGEs [77,159,164,183]. The overall anti-glycation of berries seems related with the presence of other 
PCs including, but not limited, to ANTCs [74,76,77,159,164,177]. For example, quercetin and 
quercetin-3-O-galactoside ≈ cyanidin-3-O-galactoside were documented as main active principles of 






Apoptosis → vascular pathology
IntracellularExtracellular
matrix
Nephropathy, Atherosclerosis, Retinopathy, Neuropathy
Chapter III.C – Aldose Reductase and Protein Glycation 
 
 
164  Vítor Spínola (2018) 
5-O-CQA and other CQAs are active anti-glycation compounds, more potent than AMG 
[70,177,179]. In fact, V. padifolium leaves (composed mainly of 5-O-CQA) showed the strongest 
inhibitions compared with other species with lower CQAs content (Chapter III). The anti-glycation 
effect of CQAs seems achieved by free radicals scavenging and preventing protein crosslinking 
through interaction with reactive dicarbonyl compounds [66,179]. 
In the case of flavonoids, hydroxylation on the positions 3’, 4’, 5 and 7 increases the AGEs 
inhibitiory ability of the compounds [6,66]. Quercetin is a potent anti-glycation agent [70,73,159] and 
proved to be the best tested inhibitor (p < 0.05) (followed closely by 5-O-CQA) (Table 30). Other 
authors found similar results [77,159]. Quercetin strongly inhibits AGEs formation through trapping 
MGO and GO [70,72,77,177]. Quercetin and other structural similar flavonols (kaempferol, 
myricetin, etc) seem more effective than other flavonoids and AMG towards inhibition of AGEs 
generation [70,72,73,184].  
Flavan-3-ols have been reported to possess considerable anti-glycation activities, with more 
significant effects than ANTCs and quercetin [6,70,74,76,77,177]. In fact, proanthocyanidins(PACs)-
rich extracts of different Vaccinium species have shown the greater inhibitions [74–76]. Trapping and 
scavenging carbonyls functions are the main anti-glycation mechanisms of PACs [72]. The presence 
of galloyl groups enhances the anti-glycation activity of flavan-3-ols [6,177], which could justify the 
inhibitory effects of M. faya (Table 30). 
Both ellagic acids and ellagitannins showed significant inhibitory activities on AGEs 
generation [6,177]. Still, the total amounts of PCs seem more relevant for the anti-glycation activities 
than individual components [70,74,76,159], as oppose to enzymatic inhibitory assays. 
In this study, AGEs formation was evaluated by BSA-ribose and fructose models. Although 
ribose presented a higher reactivity, inhibition of fructose-protein glycation is of greater importance 
since this model closer mimics the human system [74]. Fructose is produced through the oxidation of 
sorbitol (polyol pathway) (Figure 8). Hence, hyperglycaemia contributes for the accumulation of 
fructose in some cells and tissues (ocular lens, peripheral nerves, blood vessels, etc) [66,71,74].  
In conclusion, the obtained results suggested that analysed extracts and major components 
exerted anti-diabetic activity by double action i.e. via simultaneous inhibition of polyol pathway and 
protein glycation. Furthermore, this study indicates the another potential therapeutic target of BPPs 
as possible protective agents against long-term diabetic complications, besides hypoglycaemic effects 
through modulation of digestive enzymes activity (Chapter IV). However, in vivo studies to provide 
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1. Antioxidant Activity (AOA) 
Type-2 diabetes melittus (T2DM) is associated with oxidative stress (OS), resulting from an 
imbalance between free-radical-generating and the antioxidant systems of the body [2,31,42,92]. The 
mythocondrial dysfunction, overactivity of the polyol pathway and increased AGEs formation, 
induced by hyperglycaemia, involves several oxidative processes that causes ROS production. 
Therefore, inhibition or reduction of ROS formation is proposed as a key mechanism for the 
management/control of hyperglycaemia associated with T2DM [42,65,185].  
There are several methods reported for the overall measurement of the AOA of plant extracts 
[2,27,29,51]. In this work, the AOA of each sample (undigested and digested) was determined by 
four distinct in vitro assays using synthetic (ABTS•+ and DPPH•) and biological (NO• and O2•-) 
radicals. Results are shown in the following sections and their discussion will be separated by 
experimental assays.  
1.1. ABTS Radical (ABTS•+) Scavenging Assay 
1.1.1. Pre-in vitro gastrointestinal digestion 
The AOA of tested samples was estimated as scavenging potential towards ABTS•+ (Table 
28). Significant differences (p < 0.05) were observed among analysed extracts in this assay. The 
values varied from 0.59 to 8.72 mmol TE g-1 DE (Table 28). The order of the most potent berries 
extracts was as follows: R. grandifolius (FX > MX) > V. padifolium > V. cylindraceum > M. faya > 
E. umbellata > S. lanceolata. Leaves extracts were the most active samples (2.61 to 8.35 times fold): 
M. faya > V. padifolium (YLs) > R. grandifolius (FX > MX) > V. padifolium (MLs) > E. umbellata > 
V. cylindraceum > S. lanceolata. 
Previously [106], higher and lower activities were documented for M. faya berries and leaves 
(2.50 and 4.81 mmol TE g-1 DE), respectively. Leaves of M. rubra showed inferior values (2.58 - 
3.43 mmol TE g-1 DE)[117,186]. Other authors [65,82,116] have reported the in vitro antioxidant 
activities of M. rubra extracts, but in different units.  
The AOA of R. grandifolius against ABTS•+ was reported in a previous work [107]. Contrary 
to obtained data (Table 28), berries were more active than leaves, which could be related to the lack 
of ellagitannins. By comparison, analysed berries presented higher activities than other Rubus species 
(0.01 - 0.09 mmol TE g-1 DE) [114]; but lower than leaves extracts (80.00 – 212.69 mmol TE g-1 
DE)[87]. 
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From a previous study (Mandrone et al., 2014), S. nigra berries extracts were more active 
towards ABTS•+ (1.74 – 2.20 mmol TE g-1 DE) than S. lanceolata (Table 28). A different trend was 
documented for S. nigra (0.33 mmol TE g-1 DE) by other authors [24,25].  
By comparison, V. myrtillus and V. macrocarpon extracts presented lower scavenging 
activities (0.14– 0.35 and 0.79 – 0.96 mmol TE g-1 DE for berries and leaves, respectively) 
[80,131,158]. An opposite trend was observed in other work [79] for berries and leaves of V. 
macrocarpon (2.23 – 2.34 and 9.59 – 10.26 mmol TE g-1 DE, respectively).  
Table 34 - In vitro antioxidant activities of analysed extracts measured by the ABTS•+ scavenging assay 
(expressed as mmol TE g-1 DE). Data represent the mean ± standard deviation (n = 3). 
  Berries   Leaves  
  Non-Digested Digested  Non-Digested Digested 
E. umbellata  0.68 ± 0.02d 0.17 ± 0.01a  4.71 ± 0.18r 1.90 ± 0.04l 
M. faya MX 1.20 ± 0.04gh N.D.  7.89 ± 0.37v N.D. 
 FL 1.30 ± 0.04i N.D.  7.95 ± 0.19v N.D. 
 ASJ 1.43 ± 0.05j N.D.  8.33 ± 0.17x N.D. 
 BV 1.50 ± 0.04k 0.61 ± 0.02c  8.65 ± 0.22y 3.64 ± 0.08q 
 SX 1.32 ± 0.04i N.D.  8.15 ± 0.24xw N.D. 
 RJ 1.14 ± 0.04g N.D.  7.59 ± 0.32tu N.D. 
 PM 1.36 ± 0.04i N.D.  7.95 ± 0.14v N.D. 
 TC 1.45 ± 0.05j N.D.  8.82 ± 0.18y N.D. 
R. grandifolius FX 2.89 ± 0.04o 0.80 ± 0.02e  7.54 ± 0.20u 3.46 ± 0.10p 
 MX 2.79 ± 0.13no N.D.  7.17 ± 0.13t N.D. 
S. lanceolata  0.59 ± 0.02c 0.45 ± 0.01b  2.92 ± 0.17o 1.50 ± 0.05k 
V. cylindraceum  1.63 ± 0.03l 0.92 ± 0.03f  5.53 ± 0.17s 2.67 ± 0.05n 
V. padifolium  2.10 ± 0.02m 1.22 ± 0.06h  7.91 ± 0.40vw* 5.10 ± 0.21s* 
     7.08 ± 0.25t** 3.47 ± 0.10p** 
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: Boaventura; SX: Seixal; 
RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. N.D.: not determined. Means not sharing 
the same letter are significantly different at p < 0.05 probability level. 
1.1.2. Post in vitro gastrointestinal digestion 
After in vitro digestion, the AOA of analysed extracts was reduced (p < 0.05). The values 
varied from 0.17 to 5.10 mmol TE g-1 DE (Table 28). AOA of berries was more affected by the in 
vitro GID (24.18 – 75.12% decrease) than leaves (35.49 – 59.57% decrease). The order of the most 
potent berries extracts was as follows: V. padifolium > V. cylindraceum > R. grandifolius > M. faya 
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> S. lanceolata > E. umbellata. Leaves extracts displayed the highest activities (1.82 to 11.32 times 
fold): V. padifolium (YLs) > > M. faya > R. grandifolius ≈ V. padifolium (MLs) > V. cylindraceum > 
E. umbellata > S. lanceolata. 
Similarly to the present work (Table 28), the AOA of M. rubra and S. nigra berries was 
decreased after GID [24,25,116]. In the latter species, lower values (0.18 mmol TE g-1 DE) were 
obtained compared to that of digested S. lanceolata  (Table 28). On another study [153], a decrease 
of AOA (-83%) was observed in Vaccinium spp digested berries. 
1.2. DPPH• Radical Scavenging Assay 
1.2.1. Pre-in vitro gastrointestinal digestion 
The AOA of tested samples was estimated as scavenging potential towards DPPH• radical 
(Table 35). Significant differences (p < 0.05) were found among analysed extracts in this test. The 
values varied from 0.13 to 1.94 mmol TE g-1 DE (Table 35). Berries of R. grandifolius (FX > MX) 
showed the highest activity, followed by V. padifolium > V. cylindraceum > M. faya > S. lanceolata 
> E. umbellata. Leaves extracts were the strongest radical scavengers (1.52 to 3.39 times fold): M. 
faya > R. grandifolius (FX) > V. padifolium > R. grandifolius (MX) > V. cylindraceum > E. umbellata 
> S. lanceolata. 
Previous studies [103,105,129,157] have reported the radical scavenging activity of E. 
umbellata extracts (berries, leaves and stems) against DPPH• radical. However, the results are 
expressed as the IC50 values which makes it impossible to establish a comparison with present data 
(Table 35).  
In another work [106], similar and higher activities were documented for M. faya berries and 
leaves (1.90 and 4.07 mmol TE g-1 DE), respectively. Berries and leaves of M. rubra showed superior 
activities (2.92 – 3.97 and 3.00 – 4.93 mmol TE g-1 DE) [62,117,186] than analysed M. faya extracts 
(Table 35). Other works [65,82,116] have reported the in vitro antioxidant activities of M. rubra 
extracts, but in different units.  
By comparison with literature [98,115,160], R. grandifolius berries presented higher 
activities than other Rubus species (0.30 - 0.63 mmol TE g-1 DE). After XAD-7 purification for 
removal of sugars and organic acids, higher values were obtained for blackberries (1.59 mmol TE g-
1 DE)[115]. Previously works [31,98,107] on Rubus species have determined their antioxidant 
activities, but results were expressed in different units.  
Berries of S. nigra were more active (0.62– 0.71 mmol TEg-1 DE)[150] than S. lanceolata 
(Table 35).  
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V. myrtillus and V. macrocarpon berries and leaves presented lower scavenging activity 
towards DPPH• radical (0.02– 0.40 and 0.39 – 0.60 mmol TE g-1 DE, respectively) 
[80,84,115,131,158] than analysed Vaccinium species (Table 35). However, after XAD-7 
purification, superior values were obtained for blueberries (2.01 mmol TE g-1 DE)[115]. 
Table 35 – In vitro antioxidant activities of analysed extracts measured by the DPPH• radical scavenging assay 
(expressed as mmol TE g-1 DE). Data represent the mean ± standard deviation (n = 3). 
  Berries   Leaves  
  Non-digested Digested  Non-digested Digested 
E. umbellata   0.13 ± 0.01ab 0.14 ± 0.01b  0.84 ± 0.02s 0.33 ± 0.01f 
M. faya MX 0.35 ± 0.01g N.D.  1.72 ± 0.03v N.D. 
 FL 0.43 ± 0.01i N.D.  1.75 ± 0.04vw N.D. 
 ASJ 0.47 ± 0.01j N.D.  1.78 ± 0.04w N.D. 
 BV 0.54 ± 0.02l 0.20 ± 0.01c   1.94 ± 0.04z 0.59 ± 0.02m 
 SX 0.43 ± 0.01i N.D.  1.76 ± 0.01vw N.D. 
 RJ 0.35 ± 0.01g N.D.  1.84 ± 0.03u N.D. 
 PM 0.41 ± 0.01h N.D.  1.58 ± 0.04w N.D. 
 TC 0.50 ± 0.02k N.D.  1.66 ± 0.02y N.D. 
R. grandifolius  FX 0.77 ± 0.02q 0.28 ± 0.01d  1.68 ± 0.03y 0.57 ± 0.01m 
 MX 0.73 ± 0.02r N.D.  1.11 ± 0.06t N.D. 
S. lanceolata  0.22 ± 0.01c 0.11 ± 0.01a  0.41 ± 0.02h 0.12 ± 0.01a 
V. cylindraceum  0.65 ± 0.02o 0.28 ± 0.01d  0.92 ± 0.03st 0.42 ± 0.01hi 
V. padifolium   0.70 ± 0.02p 0.30 ± 0.01e  1.61 ± 0.02x* 0.69 ± 0.01op* 
     1.42 ± 0.03u** 0.60 ± 0.01n** 
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: Boaventura; SX: Seixal; 
RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. N.D.: not determined. Means not sharing 
the same letter are significantly different at p < 0.05 probability level. 
1.2.2. Post in vitro gastrointestinal digestion 
After in vitro digestion, the AOA of analysed extracts was decreased (p < 0.05); values  varied 
from 0.11 to 0.69 mmol TE g-1 DE (Table 35). In this case, leaves were more affected by the in vitro 
GID (52.22 – 71.28% decrease) than berries (50.78 – 66.10% decrease). The order of the most potent 
berries extracts was as follows: V. padifolium > V. cylindraceum ≈ R. grandifolius > M. faya > E. 
umbellata > S. lanceolata. Leaves extracts displayed the highest activities (2.03 to 3.48 times fold): 
V. padifolium > M. faya > R. grandifolius > V. cylindraceum > E. umbellata > S. lanceolata. 
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The AOA of digested M. rubra leaves decreased about 74.32% compared with initial values 
[117]. A slightly higher value was documented (0.65 mmol TE g-1 DE) compared to digested M. faya 
leaves (Table 35). In another work, a loss of AOA was verified after digestion of M. rubra berries 
[116]. A significant reduction (-57.60%) was observed after GID of V. angustifolium [54]. 
1.3. NO• Radical Scavenging Assay 
1.3.1. Pre-in vitro gastrointestinal digestion 
The AOA of tested samples was measured as scavenging potential towards NO• radical 
(Table 36). Significant differences (p < 0.05) were found between analysed extracts. The values 
varied from 0.08 to 0.95 mmol TE g-1 DE (Table 36). The order of potency of berries extracts was as 
follows: R. grandifolius (FX > MX) ≈ V. padifolium > V. cylindraceum > M. faya > E. umbellata ≈ 
S. lanceolata. Leaves displayed the highest activities (1.10 to 3.26 times fold): R. grandifolius (FX > 
MX) > M. faya > V. padifolium > V. cylindraceum > E. umbellata > S. lanceolata. 
Previously [144,187], S. nigra and R. adenotrichus berries were also effective NO• 
scavengers, suggesting a potential beneficial effect against inflammation induced by OS. However, 
results were expressed as IC50 values and is difficult to establish a comparison with present data 
(Table 36).  
Table 36 - In vitro antioxidant activities of analysed extracts measured by the NO radical scavenging assay 
(expressed as mmol TE g-1 DE). Data represent the mean ± standard deviation (n = 3). 
  Berries   Leaves  
  Non-digested Digested  Non-digested Digested 
E. umbellata   0.08 ± 0.01d 0.02 ± 0.01a   0.39 ± 0.01o 0.14 ± 0.01g 
M. faya MX 0.21 ± 0.02i N.D.  0.82 ± 0.02t N.D. 
 FL 0.24 ± 0.02j N.D.  0.84 ± 0.02tu N.D. 
 ASJ 0.31 ± 0.01l N.D.  0.89 ± 0.02vw N.D. 
 BV 0.25 ± 0.01j 0.10 ± 0.01e  0.94 ± 0.01w 0.42 ± 0.01o 
 SX 0.23 ± 0.01ij N.D.  0.84 ± 0.03t N.D. 
 RJ 0.19 ± 0.01h N.D.  0.79 ± 0.02s N.D. 
 PM 0.22 ± 0.02ij N.D.  0.85 ± 0.02u N.D. 
 TC 0.28 ± 0.01k N.D.  0.88 ± 0.02v N.D. 
R. grandifolius  FX 0.40 ± 0.01o 0.12 ± 0.01f  0.95 ± 0.02x 0.43 ± 0.01p 
 MX 0.37 ± 0.01n N.D.  0.88 ± 0.01v N.D. 
S. lanceolata  0.08 ± 0.01d 0.03 ± 0.01b  0.18 ± 0.01h 0.06 ± 0.01c 
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V. cylindraceum  0.36 ± 0.01n 0.14 ± 0.01g  0.69 ± 0.02qr 0.32 ± 0.01l 
V. padifolium   0.39 ± 0.02o 0.14 ± 0.01h  0.84 ± 0.02tu* 0.42 ± 0.02o* 
     0.80 ± 0.02s** 0.37 ± 0.01n** 
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: Boaventura; SX: Seixal; 
RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. N.D.: not determined. Means not sharing 
the same letter are significantly different at p < 0.05 probability level. 
1.3.2. Post in vitro gastrointestinal digestion 
After simulated GID, the AOA of analysed extracts diminished (p < 0.05). The values varied 
from 0.02 to 0.42 mmol TE g-1 DE (Table 36). The AOA of berries was more affected by the in vitro 
digestion (52.22 – 71.28% decrease) than leaves (61.35 – 76.17% decrease). The order of the most 
potent berries extracts was as follows: V. padifolium ≈ V. cylindraceum > R. grandifolius > M. faya 
> S. lanceolata > E. umbellata. Leaves extracts displayed the highest activities (1.09 to 4.79 times 
fold): R. grandifolius > V. padifolium (YLs) > M. faya > V. padifolium (MLs) > V. cylindraceum > 
E. umbellata > S. lanceolata. 
1.4. O2•- Radical Scavenging Assay 
1.4.1. Pre-in vitro gastrointestinal digestion 
The AOA of tested samples was measured as scavenging potential towards O2•-  radical 
(Table 37). Significant variations (p < 0.05) were observed between analysed extracts in this assay. 
The values varied from 0.03 to 0.81 mmol TE g-1 DE (Table 37). The order of potency of berries 
extracts was as follows: R. grandifolius (FX > MX) > V. padifolium ≈ V. cylindraceum > M. faya > 
S. lanceolata > E. umbellata. Leaves extracts were the most effective (1.19 to 3.43 times fold higher): 
V. padifolium (YLs > MLs) > M. faya > R. grandifolius (MX > FX) > V. cylindraceum > E. umbellata 
> S. lanceolata. 
Similarly, V. angustifolium berries extract was also effective to scavenge O2•- radical (59.06% 
inhibition at 10 µg mL-1) [54]. 
1.4.2. Post in vitro gastrointestinal digestion 
After in vitro GID, the AOA of analysed extracts was reduced (p < 0.05). The values varied 
from 0.01 to 0.29 mmol TE g-1 DE (Table 37). The AOA of berries was more affected by the in vitro 
GID (59.32 – 78.36% decrease) than leaves (51.15 – 63.34% decrease). A lower loss was reported 
for V. angustifolium berries after simulated digestion [54]. 
The order of the most potent berries extracts was as follows: V. padifolium > V. cylindraceum 
> R. grandifolius > M. faya > S. lanceolata > E. umbellata. Leaves extracts displayed the highest 
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activities (1.97 to 8.05 times fold): V. padifolium (YLs) > M. faya >V. padifolium (MLs) > R. 
grandifolius > V. cylindraceum > E. umbellata > S. lanceolata. 
Table 37 - In vitro antioxidant activities of analysed extracts measured by the O2
•- radical scavenging assay 
(expressed as mmol TE g-1 DE). Data represent the mean ± standard deviation (n = 3). 
  Berries   Leaves  
  Non-digested Digested  Non-digested Digested 
E. umbellata   0.03 ± 0.01c  0.01 ± 0.01a  0.22 ± 0.01n 0.09 ± 0.01h 
M. faya MX 0.19 ± 0.01kl N.D.  0.43 ± 0.01u N.D. 
 FL 0.20 ± 0.01l N.D.  0.45 ± 0.02v N.D. 
 ASJ 0.21 ± 0.01m N.D.  0.49 ± 0.02w N.D. 
 BV 0.23 ± 0.02n 0.06 ± 0.01e  0.54 ± 0.02y 0.28 ± 0.01o 
 SX 0.19 ± 0.01kl N.D.  0.47 ± 0.01v N.D. 
 RJ 0.17 ± 0.01j N.D.  0.42 ± 0.02tu N.D. 
 PM 0.18 ± 0.01k N.D.  0.45 ± 0.02v N.D. 
 TC 0.21 ± 0.01m N.D.  0.51 ± 0.01x N.D. 
R. grandifolius  FX 0.33 ± 0.01r 0.07 ± 0.01f  0.45 ± 0.02v 0.22 ± 0.01n 
 MX 0.31 ± 0.01q N.D.  0.41 ± 0.01t N.D. 
S. lanceolata  0.05 ± 0.01d 0.02 ± 0.01b  0.11 ± 0.01i 0.04 ± 0.01c 
V. cylindraceum  0.29 ± 0.01p 0.08 ± 0.01g  0.37 ± 0.02s 0.16 ± 0.01j 
V. padifolium   0.30 ± 0.01pq 0.08 ± 0.01g  0.62 ± 0.03z* 0.29 ± 0.01p* 
Leaves   N.D.  0.55 ± 0.02y** 0.24 ± 0.01o** 
*Young leaves; **Mature leaves. MX: Machico; FL: Faial; ASJ: Arco de S. Jorge; BV: Boaventura; SX: Seixal; 
RJ: Ribeira da Janela; PM: Porto Moniz; TC: Terceira; FX: Funchal. N.D.: not determined. Means not sharing 
the same letter are significantly different at p < 0.05 probability level. 
1.5. General Discussion 
Hyperglycaemia condition induce OS mostly through glucose autoxidation, overactivity of 
the polyol pathway and increased non-enzymatic glycation of proteins [12,17,62,65,70,72,154]. An 
overproduction of ROS/RNS caused plays a key role in the initiation, promotion and progression of 
diabetic complications and other pathological conditions [2,17,24,27,28,31,42,56,92]. Once formed, 
free radicals overwhelm endogenous antioxidant defences (SOD, CAT, GPx, GR), rendering the 
affected cells and tissues more susceptible to oxidative damage by reacting with biological 
macromolecules (lipids, nucleic acids and proteins) leading to impaired cellular structure and 
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functions [2,12,17,26]. Among these reactive molecules, NO•, O2•- and ONOO- are the most widely 
studied species and play important roles in T2DM progression [12,17]. 
It has been suggested that a regular intake of berries would be beneficial to reduce chronic 
OS and inflammation commonly experienced in T2DM, due to their rich amounts of antioxidants 
[5,12,35,42,83]. Exogenous antioxidants, such as PCs, may be of great value in the prevention and/or 
reduction of OS by neutralization or trapping of free radicals [2,12,28,115,144,154]. The free 
hydroxyls groups of PCs can restore the chemical balance in free radicals by providing hydrogen or 
electrons and making the molecule stable [2,12,83]. Additionally, PCs can improve the endogenous 
antioxidant system and prevent the onset and development of long-term diabetic complications 
[1,15,27,172] (Figure 18). Hence, attention has been paid on the AOA of this class of phytochemicals 
[27].  
In the present study, a strong correlation was observed between TIPC and AOA measured by 
four distinctive assays (r ≥ 0.795); flavonols being the main contributors (r ≥  0.764) (Table 38). The 
same was found in previous works [18,48,51,74,76,80,82,84,92,116,131,141,154,159,160,188] 
suggesting that phenolic-richer extracts usually exhibit stronger inhibitory effects. The high 
antioxidant values of leaves are associated with the higher amounts of PCs, such as flavonols, flavan-
3-ols, ellagitannins and phenolic acids (Chapter III). It is known that solar radiation, temperature, and 
other weather conditions affect accumulation of PCs in leaves due to the increased expression of 
genes related to their biosynthesis [79,80,132]. Anthocyanins (ANTCs) (r ≥ 0.775) and flavonols (r 
≥ 0.610) were the key antioxidant agents of berries and leaves, respectively (Table 38). Ellagitannins 
(r ≥ 0.979) and flavonols (r ≥ 0.947), seem the main contributors for M. faya and R. grandifolius 
AOAs (Table 38). In the case of Vaccinium extracts, HCAs (r ≥ 0.851) were the main antioxidant 
compounds (Table 38).  
After in vitro digestion (Table 39), TIPC x AOA results was improved (r ≥ 0.879) compared 
to pre-digestion (Table 38). Flavonols (r ≥ 0.754) remained the main contributors for the observed 
activities. ANTCs (r ≥ 0.939) and flavonols (r ≥ 0.686) were the key antioxidant compounds of 
digested berries and leaves, respectively (Table 39). A strong correlation was also found by other 
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Table 38 - Pearson’s correlation coefficients (r) between antioxidant activity (AOA) assays and phenolic 
composition of analysed berry-producing plants (BPPs) (pre-in vitro digestion). TIPC: total individual phenolic 
content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: 
flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Pre-Digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.795 -0.696 0.357 0.490 0.933 0.760 0.436 0.628 
DPPH• 0.850 -0.554 0.355 0.640 0.875 0.751 0.424 0.585 
NO• 0.935 -0.344 0.427 0.449 0.791 0.653 0.347 0.571 
O2
•- 0.962 -0.276 0.424 0.376 0.764 0.601 0.298 0.622 
Berries TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.929 0.723 0.287 -0.195 0.441 -0.176 -0.496 0.878 
DPPH• 0.862 0.775 0.282 0.195 0.369 0.051 -0.671 0.636 
NO• 0.891 0.913 0.581 0.289 0.089 0.210 -0.658 0.438 
O2
•- 0.957 0.843 0.387 0.012 0.328 0.031 -0.634 0.731 
Leaves TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.815 0.168 -0.020 0.472 0.610 0.468 0.432 0.460 
DPPH• 0.863 0.197 0.084 0.491 0.630 0.484 0.377 0.310 
NO• 0.913 0.292 0.254 0.280 0.665 0.386 0.332 0.395 
O2
•- 0.921 0.309 0.292 0.236 0.684 0.358 0.305 0.320 
M. faya TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.975 -0.983 -0.893 0.858 0.957 0.981 0.562 0.989 
DPPH• 0.977 -0.980 -0.889 0.863 0.951 0.985 0.547 0.989 
NO• 0.964 -0.950 -0.872 0.843 0.398 0.973 0.563 0.983 
O2
•- 0.973 -0.956 -0.805 0.836 0.951 0.969 0.553 0.979 
R. grandifolius TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.929 -0.998 0.943 - 0.976 0.752 - 0.998 
DPPH• 0.984 -0.845 0.978 - 0.947 0.298 - 0.884 
NO• 0.967 -0.986 0.973 - 0.993 0.670 - 0.996 
O2
•- 0.987 -0.961 0.985 - 0.995 0.589 - 0.981 
Vaccinium spp. TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.964 -0.918 0.922 -0.661 0.886 0.254 0.132 -0.912 
DPPH• 0.984 -0.782 0.947 -0.738 0.735 -0.014 -0.140 -0.798 
NO• 0.922 -0.683 0.851 -0.685 0.696 -0.570 -0.181 -0.717 
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O2
•- 0.919 -0.749 0.843 -0.672 0.777 0.067 -0.059 -0.782 
 
The AOA of berries is mainly due to the high amounts of phenolic acids and flavonoids 
[5,35,51,83]. ANTCs and 5-O-CQA are potent radical scavengers and known as the key contributors 
to the in vitro antioxidant properties of Vaccinium spp. [79,81,85,92,133].  The strong AOAs of M. 
rubra have been attributed to C3G and glycosides of quercetin and myricetin [62,65,82,99,185] and 
the same for M. faya can be speculated. Additionally, the presence of galloyl esters enhance such 
properties [185] and this could justify the obtained results. ANTCs and ellagitannins have been 
described in the literature as main contributors to antioxidant capacity of Rubus species [83,144,160]. 
ANTCs are known to possess high AOA and radical scavenging activity [133,144]. It is known that 
the AOA of berries is directly proportional to their  ANTCs content [43], which could justify the 
observed potency among analysed berry species. Ellagitannins, characterised by the presence of 
several hydroxy functions in ortho position, exhibit a greater ability to donate an hydrogen atom and 
scavenging unpaired electrons as compared to other phenolic classes [87,144].  
Table 39 - Pearson’s correlation coefficients (r) between antioxidant activity (AOA) assays and phenolic 
composition of analysed berry-producing plants (BPPs) (post in vitro digestion). TIPC: total individual phenolic 
content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: 
flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Post-digestion TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.879 -0.444 0.756 0.303 0.838 0.334 0.299 0.312 
DPPH• 0.943 -0.226 0.713 0.353 0.754 0.341 0.338 0.355 
NO• 0.977 -0.144 0.690 0.346 0.775 0.482 0.326 0.308 
O2
•- 0.953 -0.287 0.677 0.380 0.816 0.442 0.458 0.448 
Berries TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.954 0.970 0.816 - -0.445 0.248 -0.698 0.139 
DPPH• 0.968 0.939 0.576 - -0.219 0.354 -0.511 0.360 
NO• 0.996 0.974 0.709 - -0.354 0.265 -0.576 0.310 
O2
•- 0.985 0.970 0.633 - -0.365 0.398 -0.636 0.318 
Leaves TIPC ANTCs HCAs HBAs FLAVOs FLAVAs FLAVNs ELGTs 
ABTS•+ 0.864 0.721 0.642 0.158 0.707 0.009 0.266 0.107 
DPPH• 0.989 0.481 0.592 0.266 0.686 0.129 0.367 0.196 
NO• 0.961 0.349 0.580 0.271 0.747 0.368 0.394 0.142 
O2
•- 0.945 0.319 0.510 0.295 0.695 0.268 0.540 0.345 
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The chemical structure of PCs plays a predominant role in their intrinsic reactivity towards 
ROS/RNS and hence the AOA [2,29,35,37,66,79]. The presence of aromatic rings and the highly 
conjugated system with multiple hydroxyl groups, makes PCs good electron or hydrogen atom donors 
to reactive species [2,66,83]. It seems that these effects are proportional to the number and position 
of hydroxyl groups on the aromatic rings in the molecules [2,35,53,54,79]. In fact, PCs displaying a 
catechol (o-dihydroxyphenyl) moiety are generally more potent than those containing a simple phenyl 
group [2,79,84].  
Regarding phenolic acids, HCAs present a more potent AOA than HBAs mainly due to the 
larger distance between the carbonyl group and the aromatic ring. Additionally, the presence of a 7,8-
double bond in HCAs also contributes for their higher antioxidant potencial [2].  
The higher AOA of flavonoids relative to phenolic acids is linked to the increase number of 
hydroxyl groups in the aromatic rings [2,79]. The AOA of flavonoids is determined by the 
configuration of B-, A- and C-rings [2,35]. The presence of a 3’,4’-o-catechol group in the B-ring 
significantly enhances the potency of flavonoids (Figure 57).  
 
Figure 57 – Main structure-activity relationship of flavonoids (green arrows: enhances the antioxidant activity; 
red arrows: decreases the antioxidant activity) (adapted from [2]). 
In the case of A-ring, a 5,7-m-dihydroxy group strongly increases the AOA of flavonoids 
(Figure 57) [2]. Increasing the number of hydroxyl groups in A- and B-rings improves the AOA, 
while methoxylation decreases it [2,35]. The conjugation of the B-ring catechol group along with a 
C-3 hydroxyl group in the C-ring is determinant for the potent AOA of flavonols and flavan-3-ols 
(Figure 57). This conformation allows the formation of intramolecular hydrogen bonds, thus aligning 
the B-ring with the heterocycle C-ring. This gives planarity to the structure of these compounds, 
promoting conjugation and electron dislocation to free radicals and improving AOA. By contrast, the 
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in the case of flavones and flavanones [2]. Furthermore, the presence of a double 2,3-double bond in 
conjugation with a 4-oxo function in the C-ring improves the AOA, due to electron delocalization 
into the B-ring (Figure 57) [2,35,117]. In this regard, flavonols seem potentially more active 
antioxidants than ANTCs [35]. In fact, with the exception of flavonols, in all other flavonoids classes 
the hydroxyl groups in B-ring are the main contributors for their AOAs [2,189]. For flavonols, the C-
3 hydroxyl group is determinant for their antioxidant potency, which is potentiated by the 2,3-double 
bond in the C-ring [189]. 
Additionally, glycosylation usually decreases the antioxidant potential of PCs [2,35]. 
Generally, aglycones have strongest AOAs than their corresponding glycosides. The degree of 
polymerization also influences the AOA. For that reason, PACs (dimers and trimers) and ellagitannis 
are more potent free radical scavengers than monomeric flavonoids [2,87,144]. 
Several in vitro chemical-based assays have been developed to determine the AOA of natural 
products based on multiple reaction characteristics and different mechanisms  [2,26,27,29,51]. Each 
methodology only provides an estimate of AOA that is subjective to its conditions and reagents 
[26,51]. To study the potential antioxidant effects of natural products, it is highly recommended to 
combine more than one test [26,27,51]. Therefore, the potential anti-radical activities of analysed 
extracts were evaluated through four distinctive in vitro methodologies. ABTS•+ and DPPH• are 
simple and reproducible assays frequently used for preliminary screening of the AOA [27,29,150]. 
The higher obtained values in the ABTS assay are mainly due to differences in the sensitivity of the 
method and also because it measures both hydrophilic and lipophilic antioxidants [29]. Another 
positive aspect of this assay is that it is performed in aqueous media at physiological pH [26,27]. The 
benefit of employing DPPH• assay is related to the higher stability of the radical and its commercial 
form being ready to use [27,29]. However, these two methodologies have been criticized for their 
lack of biological relevance, since they make use of artificial radicals [29]. Hence, NO• and O2•- assays 
were also conducted in this study, involving biological radicals. These methodologies seem to provide 
more relevant information since these radicals are found in biological systems. Also, the observed 
simultaneous scavenging activity of extracts towards NO• and O2•- suggest the prevention OH•− and 
ONOO− generation, which are more reactive species linked to lipid peroxidation [12,27,28]. However, 
the results reported in the literature on the antioxidant potential may be considered as varied and 
difficult to compare, because of the differences in analytical methods and sample preparation, as well 
as variable forms of expression of the results. Additionally, the high variability in antioxidant capacity 
is highly dependent on the species/genotype, cultivar, edaphoclimatic conditions, agricultural 
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processes, harvest time and post-harvest practices which are important determinants of the phenolic 
composition [18,35,81]. 
Most of the studies evaluate the AOA of berries PCs in their native form, ignoring the 
intensive metabolism and chemical aterations occurring during digestion, with a consequential impact 
on their bioactivity. Thus, the physiochemical changes occurring in the GI tract should be considered 
when evaluating the potential AOA of PCs. Information on the changes of antioxidant effects of BPPs 
after GID are still scarce in the literature. It should be reminded that after the in vitro digestion, 
phenolic amounts of analysed samples decreased significantly (Chapter III), thus giving an overall 
loss in AOA. Since PCs are highly sensitive to the mild-alkaline conditions in the intestinal step, 
during GID studies a fraction of the PCs undergo structural transformations and/or extensive 
degradation and their bioactivities are affected [48,49,54,56,58,117]. The lower AOAs noted after 
digestion could arise from the quantitative decrease of the major PCs (Chapter III), as suggested in 
previous works [24,25,48,51,54,55,116,117,141].  
The AOA of berries was, in general, more affected by GID than that of leaves. Notably, 
extracts with the highest initial AOA did not lead to the highest AOA after simulated digestion. 
Hence, the AOA after in vitro digestion seems dependent on the food matrix and the class of PCs 
since some compounds are more stable than others [40,141]. We speculate that the degradation of 
ANTCs after GID was the main cause for the reduced activities of berries extracts. The same was 
reported by several authors [25,48,54,56,58,59,117,140,141,156]. When exposed to mild-alkaline 
pH, PCs undergo structural transformations that result in metabolites with different chemical 
structures/properties and, in general, lower bioactivities than precursor molecules [40,48,49,51,54–
56]. The pH variations during digestion may affect the racemisation of molecules creating 
enantiomers with different biological reactivity [51]. Finally, PCs may also interact with other 
phytochemicals or macromolecules liberated from the food matrix during digestion, altering their 
native antioxidant properties [35,53,54]. As a result of digestion process, the antioxidants could not 
react effectively or their reducing capacities are impaired [54,156]. Nevertheless, despite extensive 
degradation following digestion, analysed extracts were still active having the capacity to scavenge 
free radicals (although in minor extent) indicating their potential protective role in the progression of 
OS-related pathologies after passage through the alimentary tract.  
The present work clearly demonstrated the in vitro AOA of analysed extracts. However, these 
results may not be relevant in vivo since the applied antioxidant assays do not considered the 
bioavailability of PCs [26,35]. Animal models and human studies are more appropriate but more 
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expensive and time-consuming [27,29]. Cell cultures systems have been suggested as intermediate 
testing methods used to obtain a more meaningful biological information and better correlation with 
in vivo performance [26,27,29,35]. Cellular AOA assays provide cost-effective and relatively fast 
approach that they take into consideration certain physicochemical aspects (uptake, distribution, and 
metabolism) that are crucial to the effectiveness of the antioxidant in vivo [26,27,29,116,117]. Hence, 
the antioxidant capacity of an extract is dependent on the bioavailability of their constituents, their 
synergistic interactions to yield the final antioxidant response at the cellular level [27,29]. 
Understanding the fate of dietary antioxidants in a real context will clarify the indirect mechanisms 
by which they may exert beneficial effects in human health [35].
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1. Cytotoxicity evaluation of the methanolic extracts 
The anti-tumor activity of berries is widely documented [83], but no data are available 
supporting the extracts from analysed species (except for E. umbellata). Therefore, we decided to 
study the cytotoxic activity of selected berry-producing plants (BPPs) (before and after in vitro 
digestion) in human epithelial colorectal adenocarcinoma cells (Caco-2) and resazurin reduction 
assay. This assay assumes that only cells that are alive are metabolically active and can transform 
rezasurin into resorufin, which is a fluorescent molecule [128]. This part of the work was a first 
preliminary toxicological evaluation of the analysed extracts intended for development of 
formulations for human consumption. 
Caco-2 cells culture is the most popular in vitro model across the pharmaceutical industry 
because it exhibits the same biological functions and structure as the human gut [19]. Hence, it is very 
useful to predict the uptake mechanisms and metabolism of bioactive compounds from foods and 
drugs [46,140]. Additionally, Caco-2 cell culture have also been coupled to in vitro digestion models 
to study the bioacessibility of food components [46,47]. 
1.1. Pre-in vitro gastrointestinal digestion 
The exposure of cells to plant extracts (0.05 – 1.5 mg mL-1) for 24 hours caused a decrease 
of cell viability in a dose-dependent manner in relation to control (100% of cell viability, cells 
cultured only in the presence of cell culture medium). Different degrees of potency were observed 
between morphological parts and species (Table 40). Leaves extracts were more effective than the 
fruit extracts, which presented higher IC50 values. The potency of berries extracts was as follows: M. 
faya > V. padifolium ≈ V. cylindraceum > R. grandifolius > S. lanceolata > E. umbellata (Table 40). 
For leaves, a different trend was observed: M. faya > R. grandifolius > V. padifolium ≈ V. 
cylindraceum > E. umbellata > S. lanceolata. 
For a better understanding of these results, a comparison with alike berry species was 
established with literature data. Lower activities were documented for E. umbellata fruit and leaves 
extracts (76% and 93% inhibition at 1 mg mL-1, respectively) in HepG2 cells [105]. Alike IC50 results 
were obtained for M. rubra leaves in Hep2-G cells [117]. M. faya leaves extract was more potent than 
those of M. rubra (IC50: 0.14 – 0.61 mg mL-1)[186]. S. nigra berries extracts were less active against 
human colon (NCM460) cells (IC50 = 10.71 mg mL-1)[24].  Similar cytotoxicity effects were observed 
for R. idaeus (berries and shoots) in Caco-2, HL-60 and HeLa cell lines (0.11 – 0.30 mg mL-
1)[190,191]. Blackberries and black raspberries extracts were more active against different cell lines 
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(IC50: 0.05 – 0.19 mg mL-1) [192] than analysed species (Table 40). Lower IC50 values were also 
found in literature for different Vaccinium berries and cell lines [192–195].  
Table 40 – Cytotoxicity of analysed methanolic extracts towards Caco-2 cell lines after 24 hours of exposure. 
Values are expressed as IC50 (mg mL-1).  
 Berries  Leaves  
 Non-Digested Digested Non-Digested Digested 
E. umbellata 1.41 ± 0.08gh > 1.5 0.67 ± 0.05c > 1.5 
M. faya 0.60 ± 0.02c 1.48 ± 0.10h 0.10 ± 0.01a 1.04 ± 0.08e 
R. grandifolius 0.99 ± 0.04e 1.45 ± 0.10gh 0.17 ± 0.01ab 1.30 ± 0.06g 
S. lanceolata 1.32 ± 0.09g > 1.5 0.83 ± 0.06d > 1.5 
V. cylindraceum 0.80 ± 0.02d > 1.5 0.25 ± 0.02b 1.21 ± 0.07f 
V. padifolium 0.80 ± 0.05d > 1.5 0.20 ± 0.02b* 0.86 ± 0.06d* 
   0.23 ± 0.01b** 1.11 ± 0.05ef** 
Data were obtained from two independent experiments with eight replicates (n = 8). *Young leaves; 
**Mature leaves. Means not sharing the same letter are significantly different at p < 0.05 probability level. 
1.2. Post in vitro gastrointestinal digestion 
The cytotoxicity effect of analysed extracts was reduced after in vitro gastrointestinal 
digestion (GID), with increased IC50 values (Table 40). Nevertheless, digested extracts were still able 
to affect cell viability at the assayed concentrations. For the berries extracts it was only possible to 
achieve 50% of inhibition within the tested concentrations for M. faya and R. grandifolius. An 
increase from 4 to 10 times-fold was verified for IC50 values of leaves extracts before and after in 
vitro digestion (Table 40). This time, YLs of V. padifolium showed the highest activities, followed 
by M. faya > V. padifolium (mature leaves) > V. cylindraceum > R. grandifolius. S. lanceolata and E. 
umbellata leaves showed the lowest effects (IC50 > 1.5 mg mL-1). 
The same behaviour was verified for similar berries species upon in vitro digestion. The first 
cytotoxic dose of S. nigra digested extract was verified at 2.55 mg mL-1, at which cell viability was 
reduced by 10% [25]. In a follow-up investigation, the IC50 of digested S. nigra extract was increased 
from 10.71 to 12.7 mg mL-1 (+18.67%)[24]. The IC50 of digested M. rubra leaves extract was about 
19 times higher than before digestion (from 0.09 to 1.73 mg mL-1)[117]; it was less effective than M. 
faya (Table 40). The cytotoxic effects of V. angustifolium extracts towards HT-29 and CRL-1790 
cell lines were also decreased after simulated GID [54].  
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The significant decline of cell cytotoxicity and much higher IC50 values of analysed extracts 
is linked with the significant losses of phenolic compounds (PCs) upon simulated digestion 
[25,54,117].  
1.3. General Discussion 
In the present study, analysed extracts showed a cytotoxicity effect in a dose-dependent 
manner, suggesting that the inhibition of cell growth was associated with the phenolic composition. 
A moderate correlation was obtained for the total individual phenolic content (TIPC) x cytotoxic 
effects (r ≥ - 0.619)(Table 41), which suggests the role of individual or the combination of specific 
PCs in the presented activities. In general, flavonols were the main contributors (r = - 0.847) (Table 
41). Anthocyanins (ANTCs) (r = - 0.728) and flavonols (r = - 0.897) seemed the key compounds 
responsible for the cytotoxic effects of berries and leaves extracts, respectively (Table 41).  
Table 41 - Pearson’s correlation coefficients (r) between cytotoxicity assay and phenolic composition of 
analysed berry-producing plants (BPPs) (pre- and post in vitro digestion). TIPC: total individual phenolic 
content; ANTCs: anthocyanins; HCAs: hydroxycinnamic acids; HBAs: hydroxybenzoic acids; FLAVOs: 
flavonols; FLAVAs: flavan-3ols; FLAVNs: flavanones; ELGTs: ellagitannins. 
Pre-Digestion TIPC ANTCs HBAs HCAs FLAVOs FLAVAs FLAVNs ELGTs 
General -0.787 0.347 -0.327 -0.614 -0.847 0.575 -0.180 -0.289 
Berries -0.619 -0.728 -0.454 -0.711 0.070 -0.423 0.826 -0.042 
Leaves -0.922 -0.235 -0.445 -0.434 -0.897 -0.524 -0.539 -0.259 
 
PCs are considered among most important plant secondary metabolites due to their potent 
activities to attenuate the initiation, progression and spread of cancers in in vitro cellular assays [196]. 
These anti-cancer properties are mainly attributed to their antioxidant and anti-inflammatory activities 
[83]. The potential anti-cancer mechanisms of dietary PCs are summarised in Figure 58. For a more 
detailed review please check reference [196]. 
Berries have been shown to have cytotoxic effects in human cancer cells [83,192]. Among 
berry phenolics, ANTCs have been shown to be major contributors toward the induction of apoptosis 
in cancer cells [83,190,192–194]. The cytotoxic and anti-proliferative effects of blueberries 
(Vaccinium spp.) are mainly attributed to their ANTCs content [54,83,193,194]. Their inhibitory 
effects include two main potential mechanisms, namely redox status modification (antioxidant and 
anti-inflammatory) and interference with multiple molecular events involved in carcinogenesis (cell-
growth, apoptosis, angiogenesis, invasion and metastasis) (Figure 58) [194,196]. Non-acylated 
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mono-glycosylated ANTCs seem to possess higher inhibitory activities towards cell growth, while 
ANTCs with pelargonidin aglycone and tri-glycosylation have lower effects [196]. 
 
 
Figure 58 – Potential mechanisms of the anti-cancer activities of dietary phenolic compounds (red arrows: 
inhibition; green arrows: activation; grey arrow: regulation) (adapted from [196]). 
It is also possible that these activities are due to synergetic action of ANTCs with other PCs, 
such as hydroxycinnamic acids (HCAs) or flavan-3-ols [83,194]. In fact, 5-O-CQA, the main 
compound of Vaccinium leaves, has shown significant anti-cancer properties involving different 
mechanisms such as cell growth reduction, cycle arrest, and apoptosis [193]. By contrast, ANTCs 
were not responsible for the cytotoxic effects induced by S. nigra extract in the cells of colonic 
mucosa [24]. On another study [195], the ANTCs-rich fraction of V. vitis-idaea was considerably less 
effective than the original extract, the cytotoxic activity being attributed to PACs instead. 
Flavonoids were reported to exhibit anticancer effects through several mechanisms, such as 
inhibiting pro-carcinogen molecules, scavenging of electrophilic molecules, regulating cancer cell 
signaling pathways, promotion of apoptosis and modulating enzyme activities [117,196] (Figure 58). 
Myricitrin (MCT) is an effective inhibitor of cell proliferation and induced apoptosis in several cancer 
cell-lines [117,196]. The cytotoxicity of M. faya leaves may be related to the high amounts of this 
compounds. Quercetin and its conjugates (in particular quercetin-O-glucoside) have shown powerful 
cytotoxicity activities [196]. These compounds along with hydrolysable tannins were the main 
cytotoxic agents on S. nigra extracts [24]. 
Hydrolysable tannins (like (epi)gallocatechin-O-gallate) exhibited strong cytotoxic effects 
against different cancer cells types [24,185,186,196]. Their interaction with cell membrane affects 
various membrane-dependent cellular processes, such as cell proliferation, cell-cycle and apoptosis 
[186]. The cytotoxicity effect of Rubus species is mainly associated to its high ellagitannins content, 
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previous study [191], sanguiin H-6 (ellagitannin) isolated from R. idaeus showed a high cytotoxic 
potential (IC50 = 0.02 - 0.04 mg mL-1). ANTCs played also a role in the reported activities of Rubus 
berries [83].  
Discrepancies with reported result could be due to factors such as cell type, cell density, 
assayed sample concentrations, stability and/or potential transformation of PCs given the pH of cell 
culture media, duration of cell exposure to samples, uptake of PCs or metabolites into cells, among 
others [192].  
In the present study, the cytotoxicity effects of BPPs were associated with their phenolic 
composition/amounts. Considering the obtained results, analysed extracts seem safe to be applied in 
food/phytopharmaceuticals intended for human intake. However, this was only tested in one cancer 
cell line. Whether the cytotoxic effects are specific to cancer cell lines in general should be elucidated 
in future studies. Additionally, the molecular mechanisms involved in this study requires deeper 
investigation as well as the HPLC analysis of cell lysates to identify which compounds were absorbed 
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1. Conclusions 
The main goal of this dissertation was to study six berry-producing plants (BPPs) (native and 
non-native of Macaronesia region) and evaluate their potential in the control and management of 
T2DM and obesity, contributing to their economic and commercial valorisation and/or application in 
the development of phytopharmaceuticals or functional foods. Currently, there is none scientific 
evidence to clarify their anti-diabetic potential, which leads to the urgent need to perform biochemical 
studies which promote their consumption and use in large scale in the form of nutraceutical 
formulations. 
From this work, the main conclusions we can withdraw are: 
 The mineral composition is varied among the different berry species. The ICP-MS analysis 
indicated that analysed berries are good sources of essential minerals (K, Ca, P, Na and Mg). 
Additionally, E. umbellata, R. grandifolius, and S. lanceolata ingestion may potentially 
contribute to management/control of hyperglycaemia due to their relevant levels of Ca, Mg, 
and Zn. 
 Analysed extracts presented diverse qualitative/quantitative phenolic compositions. In the 
case of berries, E. umbellata showed the lowest TIPC, while R. grandifolius the highest. 
ANTCs were absent in E. umbellata, while in the remaining cases they were the main PCs. 
Flavonols were dominant in E. umbellata berries. Based on ANTCs type, analysed berries 
can be divided into two main groups: cyanidin derivatives (M. faya, R. grandifolius and S. 
lanceolata) and delphinidin/malvidin derivatives (Vaccinium spp.). In the first case, the 
phenolic profile was composed mainly by one ANTC: C3G for M. faya and R. grandifolius; 
cyanidin-3-O-sambubioside for S. lanceolata. Regarding Vaccinium species, it presented a 
more complex composition: delphinidin, petunidin and malvidin glycosides. It is also worth 
highlighting the high content of ellagitannins in R. grandifolius. 
In the case of leaves, a more diverse and richer phenolic profile was found. Leaves of S. 
lanceolata showed the lowest phenolic amounts and R. grandifolius the highest. Ellagitannins 
were main compounds of E. umbellata and R. grandifolius. M. faya presented the most 
diverse phenolic composition: flavonols > flavan-3-ols ≈ ellagitannins. S. lanceolata was 
composed by HCAs and flavonols. V. cylindraceum had high amounts of flavan-3-ols and 
HCAs, being the latter category dominant in V. padifolium. Anthocyanins (cyanidin 
derivatives) were detected only in YLs of V. padifolium. 
 Berries of R. grandifolius showed the best inhibitory effects towards digestive enzymes and 
HAR, which the conjugation of ANTCs and ellagitannins contributed greatly. In the case of 
leaves, different patterns were observed. For glucosidases (α- and β-), V. padifolium were the 
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most active samples. The high amounts of 5-O-CQA can justify the strongest inhibitory 
activities of V. padifolium. M. faya showed the most potent inhibitory activities towards AMY 
and PL. Hydrolysable and condensed tannins of M. faya seemed the most important inhibitory 
agents. Leaves of R. grandifolius showed the highest inhibitory activity towards HAR, which 
was attributed to the high ellagitannins content. 
Regarding protein glycation, berries of R. grandifolius and leaves of V. padifolium showed 
the best inhibitory results (in both models). Again, ellagitannins and ANTCs could play a 
major role in berries; while the appreciable amounts of 5-O-CQA in V. padifolium leaves 
makes it the most important contributors.  
 Berries of R. grandifolius displayed the strongest free radical scavenging activities in all 
assays, which ANTCs were the main contributors. In the case of leaves, M. faya were the 
most active against ABTS•+ and DPPH• free radicals. R. grandifolius showed the highest anti-
radical activities towards NO•; while V. padifolium was the most potent sample against O2•- 
formation. Ellagitannins, flavonols, flavan-3-ols and 5-O-CQA played a major role in the 
displayed activities.  
 M. faya extracts (berries and leaves) showed the highest cytotoxicity effects towards Caco-2 
cells. For this case, ANTCs and flavonols were the main compounds responsible for the 
observed activities. 
 After simulated digestion, there was a considerable decrease in the amounts of PCs in all 
cases. Berries (in particular S. lanceolata) were more affected than leaves, which could be 
related with the higher susceptibility of ANTCs to the mild-alkaline conditions of the small 
intestine step. Flavan-3-ols and ellagitannins were also greatly affected by the in vitro 
digestion. Differences in food matrix microstructure may also have contributed for the 
observed differences on stability of berries and leaves submitted to GID.  
The antioxidant activities of analysed samples remained, although weakened after in vitro 
GID, and extracts were still able to modulate several processes relevant to the control of 
T2DM. 
In conclusion, this study demonstrated the beneficial effects of different BPPs in the 
management/control of T2DM, since the performed assays related to physiologically important 
functions in the regulation of carbohydrates metabolism in the body, with anti-glycation and 
antioxidant properties. These beneficial properties are greatly attributed to the phenolic composition 
of analysed extracts. In this sense, berries could offer a good dietary strategy to prevent or ameliorate 
T2DM and associated disorders and provide benefits without the side effects presented by most 




Vítor Spínola   2018                                                      193 
 
 
available drugs. In call cases, the leaves showed much higher activity than the berries. However, in 
terms of potential nutraceutical use it must be considered that berries are a food product than can be 
consumed in larger quantities than the leaves that are ingested in the form of infusions. Hence, leaves 
should be considered for inclusion in food or phytopharmaceutical supplements in the form of dragees 
or capsules, enriched or not with extract. Nevertheless, these results are only indicative and 
confirmatory studies in animals or humans are required to validate obtained data. 
2. Future Perspectives 
The work developed in this thesis opened some new questions and further studies are 
necessary to extend the knowledge about these BPPs and their bioactive properties. 
 A complete separation/purification, characterization and identification of the main active 
fractions or compounds of the methanolic extracts must be performed. Additional extractions 
with less polar solvents (n-hexane, chloroform, and ethyl acetate) could also be developed to 
investigate other potential bioactive molecules (besides PCs) in targeted BPPs for the control 
and management of T2DM. 
 In silico studies (molecular modelling and docking) could help to elucidate the type of 
interaction behaviour and mechanisms of action of extracts towards digestive and HAR 
enzymes with regards to the probable implications for synthesis of new natural-based drugs. 
 Additional in vitro tests could be conducted to identify new therapeutic targets of analysed 
samples, namely DPP-4 inhibitory assay, glucose-6-phosphatase inhibitory assay, LDL 
oxidation inhibitory assay, angiotensin-converting enzyme (ACE) inhibitory assay, protein 
tyrosine phosphatase-1B (PTP-1B) inhibitory assay, etc. Cell-based assays, such as 
evaluation of glucose uptake by Caco-2, HepG2 cell lines, etc, or cellular protection against 
induced OS toxicity, could demonstrate other beneficial effects of extracts. 
 The high AOA revealed by analysed samples requires deeper investigation. Cellular 
antioxidant assay (CAA) would give more relevant biological information and provides a 
better predictor for the AOA of extracts at cellular level. Further HPLC-MS analysis of cell 
lysates could help to identify which compounds were absorbed by the cells and contribute the 
most for the antioxidant effects. 
 The cytotoxicity of extracts should also be tested in other cancer or normal cell lines to 
elucidate if these effects are specific to cancer cell lines or not. The anti-proliferative activities 
of extracts against cancer cells is another possible study. 
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 The in vitro digestion model could be improved and simulation of the different steps (oral, 
stomach and small intestine) should be performed separately to better understand the stability 
of PPs under different stages of GID. 
 Finally, the most promising extracts should be further tested using STZ or ALX-induced 




































Vítor Spínola   2018                                                      197 
  
1.  Anhê FF, Desjardins Y, Pilon G, Dudonné S, Genovese MI, Lajolo FM, et al. Polyphenols and type 2 
diabetes: a prospective review. PharmaNutrition. 2013;1(4):105–14.  
2.  Dias TR, Alves MG, Casal S, Oliveira PF, Silva BM. Promising potential of dietary (poly)phenolic 
compounds in the prevention and treatment of diabetes mellitus.  Curr. Med. Chem. 2017;24(4):334–
54.  
3.  Solayman M, Ali Y, Alam F, Asiful Islam M, Alam N, Ibrahim Khalil M, et al. Polyphenols: potential 
future arsenals in the treatment of diabetes. Curr. Pharm. Des. 2016;22:549–65.  
4.  El-Abhar HS, Schaalan MF. Phytotherapy in diabetes: review on potential mechanistic perspectives. 
World J. Diabetes. 2014;5(2):176–97.  
5.  Edirisinghe I, Burton-Freeman B. Anti-diabetic actions of berry polyphenols - review on proposed 
mechanisms of action. J. Berry Res. 2016;6(2):237–50.  
6.  Xiao J, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. 
Curr Med Chem. 2015;22(1):23–38.  
7.  World Health Organization (WHO) Media Centre Diabetes Fact Sheet. 2017. Available from: 
www.who.int/mediacentre/factsheets/fs312/en/ 
8.  IDF Diabetes Atlas - 8th Edition. International Diabetes Federation. 2017;150 pages.  
9.  Diabetes: factos e números - o ano de 2015. Relatório Anual do Observatório Nacional da Diabetes. 
Sociedade Portuguesa de Diabetologia. 2016;68 pages.  
10.  Kang B-H, Racicot K, Pilkenton S, Apostolidis E. In-vitro evaluation of bioactive fractions of blueberry 
extract for phenolic-mediated inhibition of carbohydrate hydrolyzing enzymes. Int. J. Appl. Res. Nat. 
Prod. 2016;9(2):33–8.  
11.  Arulselvan P, Ghofar HAA, Karthivashan G, Halim MFA, Ghafar MSA, Fakurazi S. Anti-diabetic 
therapeutics from natural source: a systematic review. Biomed. Prev. Nutr. 2014;4(4):607–17.  
12.  Marrazzo G, Barbagallo I, Galvano F, Gazzolo D, Frigiola A, Orazio ND, et al. Role of dietary and 
endogenous antioxidants in diabetes. Crit. Rev. Food Sci. Nutr. 2014;54:1599–616.  
13.  Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents 
based approach. J. Ethnopharmacol. 2013;150(1):51–70.  
14.  Hung H-Y, Qian K, Morris-Natschke SL, Hsu C-S, Lee K-H. Recent discovery of plant-derived anti-
diabetic natural products. Nat. Prod. Rep. 2012;29(5):580.  
15.  Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of 
diabetes: a review. J. Diabetes Metab. Disord. 2013;12:43.  
16.  Kim Y, Keogh JB, Clifton PM. Polyphenols and Glycemic Control. Nutrients. 2016;8(1):17.  
17.  Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. 
World J. Diabetes. 2015;6(3):456–80.  
18.  Podsędek A, Majewska I, Redzynia M, Sosnowska D, Koziołkiewicz M. In vitro inhibitory effect on 
digestive enzymes and antioxidant potential of commonly consumed fruits. J. Agric. Food Chem. 
2014;62(20):4610–7.  




198  Vítor Spínola (2018) 
Food Res. 2013;57(1):48–57.  
20.  Martinez-Gonzalez AI, Díaz-Sánchez ÁG, Rosa LA de la, Vargas-Requena CL, Bustos-Jaimes I, 
Alvarez-Parrilla  AE. Polyphenolic compounds and digestive enzymes: in vitro non-covalent 
interactions. Molecules. 2017;22:669–93.  
21.  McDougall GJ, Kulkarni NN, Stewart D. Current developments on the inhibitory effects of berry 
polyphenols on digestive enzymes. BioFactors. 2008;34(1):73–80.  
22.  Kim YS, Lee YM, Kim H, Kim J, Jang DS, Kim JH, et al. Anti-obesity effect of Morus bombycis root 
extract: anti-lipase activity and lipolytic effect. J. Ethnopharmacol. 2010;130(3):621–4.  
23.  Zhang Y, Chen S, Wei C, Chen J, Ye X. Proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. 
et Zucc.) leaves regulate lipid metabolism and glucose consumption by activating AMPK pathway in 
HepG2 cells. J. Funct. Foods. 2017;29:217–25.  
24.  Olejnik A, Olkowicz M, Kowalska K, Rychlik J, Dembczyński R, Myszka K, et al. Gastrointestinal 
digested Sambucus nigra L. fruit extract protects in vitro cultured human colon cells against oxidative 
stress. Food Chem. 2016;197:648–57.  
25.  Olejnik A, Kowalska K, Olkowicz M, Rychlik J, Juzwa W, Myszka K, et al. Anti-inflammatory effects 
of gastrointestinal digested Sambucus nigra L. fruit extract analysed in co-cultured intestinal epithelial 
cells and lipopolysaccharide-stimulated macrophages. J. Funct. Foods. 2015;19:649–60.  
26.  Apak R, Özyürek M, Güçlü K, Çapanoğlu E. Antioxidant activity/capacity measurement. 3. Reactive 
oxygen and nitrogen species (ROS/RNS) scavenging assays, oxidative stress biomarkers, and 
chromatographic/chemometric assays. J. Agric. Food Chem.2016;64(5):1046–70.  
27.  López-Alarcón C, Denicola A. Evaluating the antioxidant capacity of natural products: A review on 
chemical and cellular-based assays. Anal. Chim. Acta. 2013;763:1–10.  
28.  Sousa C, Valentão P, Ferreres F, Seabra RM, Andrade PB. Tronchuda cabbage (Brassica oleracea L. 
var. costata DC): scavenger of reactive nitrogen species. J. Agric. Food Chem. 2008;56:4205–11.  
29.  Shahidi F, Zhong Y. Measurement of antioxidant activity. J. Funct. Foods. 2015;18:757–81.  
30.  Fan J, Johnson MH, Lila MA, Yousef G, De Mejia EG. Berry and citrus phenolic compounds inhibit 
dipeptidyl peptidase IV: implications in diabetes management. Aritlce ID 479505. Evidence-based 
Complement. Altern. Med. 2013;13 pages.  
31.  Sarkar D, Orwat J, Hurburt T, Woods F, Pitts JA, Shetty K. Evaluation of phenolic bioactive-linked 
functionality of blackberry cultivars targeting dietary management of early stages type-2 diabetes using 
in vitro models. Sci. Hortic. 2016;212:193–202.  
32.  McDougall GJ, Stewart D. The inhibitory effects of berry polyphenols on digestive enzymes. 
BioFactors. 2005;23(4):189–95.  
33.  Borges de Melo E, da Silveira Gomes A, Carvalho I. α- and β-Glucosidase inhibitors: chemical structure 
and biological activity. Tetrahedron. 2006;62(44):10277–302.  
34.  Ferlemi A-V, Lamari F. Berry leaves: an alternative source of bioactive natural products of nutritional 
and medicinal value. Antioxidants. 2016;5(17):20 pages.  





Vítor Spínola   2018                                                      199 
 
 
benefits. J. Sci. Food Agric. 2014;94(5):825–33.  
36.  Hidalgo G-I, Almajano M. Red fruits: extraction of antioxidants, phenolic content, and radical 
scavenging determination: a review. Antioxidants; 2017;6(1):7.  
37.  Oroian M, Escriche I. Antioxidants: characterization, natural sources, extraction and analysis. Food 
Res. Int. 74:10–36.  
38.  Ignat I, Volf I, Popa VI. A critical review of methods for characterisation of polyphenolic compounds 
in fruits and vegetables. Food Chem. 2011;126(4):1821–35.  
39.  Nile SH, Park SW. Edible berries: bioactive components and their effect on human health. 
Nutrition.30(2):134–44.  
40.  Karaś M, Jakubczyk A, Szymanowska U, Złotek U, Zielińska E. Digestion and bioavailability of 
bioactive phytochemicals. Int. J. Food Sci. Technol. 2017;52(2):291–305.  
41.  Carbonell-Capella JM, Buniowska M, Barba FJ, Esteve MJ, Frígola A. Analytical methods for 
determining bioavailability and bioaccessibility of bioactive compounds from fruits and vegetables: a 
review. Compr. Rev. Food Sci. 2014;13(2):155–71.  
42.  Sancho RAS, Pastore GM. Evaluation of the effects of anthocyanins in type 2 diabetes. Food Res. Int. 
2012;46(1):378–86.  
43.  Castañeda-Ovando A, Pacheco-Hernández M de L, Páez-Hernández ME, Rodríguez JA, Galán-Vidal 
CA. Chemical studies of anthocyanins: a review. Food Chem. 2009;113(4):859–71.  
44.  Parada J, Aguilera JM. Food microstructure affects the bioavailability of several nutrients. J. Food Sci. 
2007;72(2).  
45.  Bohn T. Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 2014;72(7):429–52.  
46.  Hur SJ, Lim BO, Decker EA, McClements DJ. In vitro human digestion models for food applications.  
Food Chem. 2011;125(1):1–12.  
47.  Alminger M, Aura A-M, Bohn T, Dufour C, El SN, Gomes A, et al. In vitro models for studying 
secondary plant metabolite digestion and bioaccessibility. Compr. Rev. Food Sci. 2014;13(4):413–36.  
48.  Tagliazucchi D, Verzelloni E, Bertolini D, Conte A. In vitro bio-accessibility and antioxidant activity 
of grape polyphenols. Food Chem. 2010;120(2):599–606.  
49.  Bermúdez-Soto M-J, Tomás-Barberán F-A, García-Conesa M-T. Stability of polyphenols in 
chokeberry (Aronia melanocarpa) subjected to in vitro gastric and pancreatic digestion. Food Chem. 
2007;102(3):865–74.  
50.  Jakobek L. Interactions of polyphenols with carbohydrates, lipids and proteins. Food Chem. 2015 
15;175:556–67.  
51.  Gullon B, Pintado ME, Fernández-López J, Pérez-Álvarez JA, Viuda-Martos M. In vitro 
gastrointestinal digestion of pomegranate peel (Punica granatum) flour obtained from co-products: 
changes in the antioxidant potential and bioactive compounds stability. J. Funct. Foods. 2015;19:617–
28.  




200  Vítor Spínola (2018) 
compounds (phenolics and antioxidants) under in vitro digestion and colonic fermentation. Food Chem. 
2016;201:120–30.  
53.  Bouayed J, Hoffmann L, Bohn T. Total phenolics, flavonoids, anthocyanins and antioxidant activity 
following simulated gastro-intestinal digestion and dialysis of apple varieties: bioaccessibility and 
potential uptake. Food Chem. 2011;128(1):14–21.  
54.  Correa-Betanzo J, Allen-Vercoe E, McDonald J, Schroeter K, Corredig M, Paliyath G. Stability and 
biological activity of wild blueberry (Vaccinium angustifolium) polyphenols during simulated in vitro 
gastrointestinal digestion. Food Chem. 2014;165:522–31.  
55.  Bouayed J, Deußer H, Hoffmann L, Bohn T. Bioaccessible and dialysable polyphenols in selected apple 
varieties following  in vitro  digestion vs. their native patterns. Food Chem. 2012;131(4):1466–72.  
56.  Tavares L, Figueira I, Macedo D, McDougall GJ, Leitão MC, Vieira HLA, et al. Neuroprotective effect 
of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion. Food 
Chem. 2012;131(4):1443–52.  
57.  Guerra A, Etienne-Mesmin L, Livrelli V, Denis S, Blanquet-Diot S, Alric M. Relevance and challenges 
in modeling human gastric and small intestinal digestion. Trends Biotechnol. 2012;30(11):591–600.  
58.  Liang L, Wu X, Zhao T, Zhao J, Li F, Zou Y, et al. In vitro bioaccessibility and antioxidant activity of 
anthocyanins from mulberry (Morus atropurpurea Roxb.) following simulated gastro-intestinal 
digestion. Food Res. Int. 2012;46(1):76–82.  
59.  Brown EM, Nitecki S, Pereira-Caro G, Mcdougall GJ, Stewart D, Rowland I, et al. Comparison of in 
vivo and in vitro digestion on polyphenol composition in lingonberries: potential impact on colonic 
health. BioFactors. 2014;40(6):611–23.  
60.  Akkarachiyasit S, Charoenlertkul P, Yibchok-Anun S, Adisakwattana S. Inhibitory activities of 
cyanidin and its glycosides and synergistic effect with acarbose against intestinal α-glucosidase and 
pancreatic α-amylase. Int. J. Mol. Sci. 2010;11(9):3387–96.  
61.  Grussu D, Stewart D, McDougall GJ. Berry polyphenols inhibit α-amylase in vitro: identifying active 
components in rowanberry and raspberry. J. Agric. Food Chem. 2011;59(6):2324–31.  
62.  Zhang X, Huang H, Zhao X, Lv Q, Sun C, Li X, et al. Effects of flavonoids-rich Chinese bayberry 
(Myrica rubra Sieb. et Zucc.) pulp extracts on glucose consumption in human HepG2 cells. J. Funct. 
Foods. 2015 Apr;14:144–53.  
63.  Martineau LC, Couture A, Spoor D, Benhaddou-Andaloussi A, Harris C, Meddah B, et al. Anti-diabetic 
properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine. 
2006;13(9–10):612–23.  
64.  McDougall GJ, Kulkarni NN, Stewart D. Berry polyphenols inhibit pancreatic lipase activity in vitro. 
Food Chem. 2009;115:193–9.  
65.  Yan S, Zhang X, Wen X, Lv Q, Xu C, Sun C, et al. Purification of flavonoids from chinese bayberry 
(Morella rubra Sieb. et Zucc.) fruit extracts and α-glucosidase inhibitory activities of different 
fractionations. Molecules.2016;21(9):1148.  





Vítor Spínola   2018                                                      201 
 
 
advanced glycation end products formation through polyphenols in hyperglycemic condition. Planta 
Med. 2016;82:32–45.  
67.  Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS. Updates on aldose reductase inhibitors for 
management of diabetic complications and non-diabetic diseases. Mini-Reviews Med. Chem. 
2016;16(2):120–62.  
68.  Xiao J, Ni X, Kai G, Chen X. Advance in dietary polyphenols as aldose reductases inhibitors : structure-
activity relationship aspect. Crit. Rev. Food Sci. Nutr. 2015;55:16–31.  
69.  Veeresham C, Rama Rao A, Asres K. Aldose reductase inhibitors of plant origin. Phytother. Res. 
2014;28(3):317–33.  
70.  Chinchansure AA, Korwar AM, Kulkarni MJ, Joshi SP. Recent development of plant products with 
anti-glycation activity: a review. RSC Adv. 2015;5(39):31113–38.  
71.  Sompong W, Meeprom A, Cheng H, Adisakwattana S. A comparative study of ferulic acid on different 
monosaccharide-mediated protein glycation and oxidative damage in bovine serum albumin. 
Molecules;18(11):13886–903.  
72.  Yeh W, Hsia S, Lee W, Wu C. Polyphenols with antiglycation activity and mechanisms of action : a 
review of recent findings. J. Food Drug Anal. 2017;25:84–92.  
73.  Séro L, Sanguinet L, Blanchard P, Dang BT, Morel S, Richomme P, et al. Tuning a 96-well microtiter 
plate fluorescence-based assay to identify AGE inhibitors in crude plant extracts. 
Molecules.2013;18(11):14320–39.  
74.  Wang W, Yagiz Y, Buran TJ, Nunes CDN, Gu L. Phytochemicals from berries and grapes inhibited the 
formation of advanced glycation end-products by scavenging reactive carbonyls. Food Res. Int. 
2011;44(9):2666–73.  
75.  McIntyre KL, Harris CS, Saleem A, Beaulieu LP, Chieu AT, Haddad PS, et al. Seasonal phytochemical 
variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med. 
2009;75(3):286–92.  
76.  Liu H, Liu H, Wang W, Khoo C, Taylor J, Gu L. Cranberry phytochemicals inhibit glycation of human 
hemoglobin and serum albumin by scavenging reactive carbonyls. Food Funct. 2011;2(8):475–82.  
77.  Beaulieu L-P, Harris CS, Saleem A, Cuerrier A, Haddad PS, Martineau LC, et al. Inhibitory effect of 
the Cree traditional medicine Wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation 
endproduct formation: identification of active principles. Phyther. Res. 2010;24(5):741–7.  
78.  Khoddami A, Wilkes M, Roberts T. Techniques for analysis of plant phenolic compounds. Molecules. 
2013;18(2):2328–75.  
79.  Oszmiański J, Wojdyło A, Lachowicz S, Gorzelany J, Matłok N. Comparison of bioactive potential of 
cranberry fruit and fruit-based products versus leaves. J. Funct. Foods. 2016;22:232–42.  
80.  Teleszko M, Wojdyło A. Comparison of phenolic compounds and antioxidant potential between 
selected edible fruits and their leaves. J. Funct. Foods. 2015;14:736–46.  




202  Vítor Spínola (2018) 
Variations in antioxidant capacity and phenolics in leaf extracts isolated by different polarity solvents 
from seven blueberry (Vaccinium L.) genotypes at three phenological stages. Acta Physiol. Plant. 
2016;38(2):1–13.  
82.  Zhang X, Huang H, Zhang Q, Fan F, Xu C, Sun C, et al. Phytochemical characterization of chinese 
bayberry (Myrica rubra Sieb. et Zucc.) of 17 cultivars and their antioxidant properties. Int. J. Mol. Sci. 
2015;16(6):12467–81.  
83.  Baby B, Antony P, Vijayan R. Antioxidant and anticancer properties of berries. Crit. Rev. Food Sci. 
Nutr. 2017;8398:1–17.  
84.  Bujor O-C, Le Bourvellec C, Volf I, Popa VI, Dufour C. Seasonal variations of the phenolic constituents 
in bilberry (Vaccinium myrtillus L.) leaves, stems and fruits, and their antioxidant activity. Food Chem. 
2016;213:58–68.  
85.  Wu Y, Zhou Q, Chen X, Li X, Wang Y, Zhang J. Comparison and screening of bioactive phenolic 
compounds in different blueberry cultivars: evaluation of anti-oxidation and α-glucosidase inhibition 
effect. Food Res. Int. 2017;100(P1):312–24.  
86.  Vrhovsek U, Masuero D, Palmieri L, Mattivi F. Identification and quantification of flavonol glycosides 
in cultivated blueberry cultivars. J. Food Compos. Anal. 2012;25(1):9–16.  
87.  Oszmiański J, Wojdyło A, Nowicka P, Teleszko M, Cebulak T, Wolanin M. Determination of phenolic 
compounds and antioxidant activity in leaves from wild Rubus  L. Species. Molecules. 
2015;20(3):4951–66.  
88.  Mertz C, Cheynier V, Gunata Z, Brat P. Analysis of phenolic compounds in two blackberry species 
(Rubus glaucus and Rubus adenotrichus) by high-performance liquid chromatography with diode array 
detection and electrospray ion trap mass spectrometry. J. Agric. Food Chem. 2007;55(21):8616–24.  
89.  Boath AS, Stewart D, McDougall GJ. Berry components inhibit α-glucosidase in vitro: synergies 
between acarbose and polyphenols from black currant and rowanberry. Food Chem. 2012 
1;135(3):929–36.  
90.  Cheplick S, Kwon Y-I, Bhowmik P, Shetty K. Clonal variation in raspberry fruit phenolics and 
relevance for diabetes and hypertension management. J. Food Biochem. 2007;31(5):656–79.  
91.  Kang B-H, Racicot K, Pilkenton SJ, Kwon Y-I, Apostolidis E. Blueberry extract inhibits carbohydrate-
hydrolyzing enzymes and these inhibitory activities are not proanthocyanidin dependent. J. Korean Soc. 
Appl. Biol. Chem. 2015;58(1):127–36.  
92.  Wang SY, Camp MJ, Ehlenfeldt MK. Antioxidant capacity and α-glucosidase inhibitory activity in peel 
and flesh of blueberry (Vaccinium spp.) cultivars. Food Chem. 2012;132(4):1759–68.  
93.  Boath AS, Grussu D, Stewart D, McDougall GJ. Berry polyphenols inhibit digestive enzymes: a source 
of potential health benefits? Food Dig. 2012;2;3(1–3):1–7.  
94.  McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. Different polyphenolic components 
of soft fruits inhibit α-amylase and α-glycosidase. J. Agric. Food Chem. 2005;53(7):2760–6.  
95.  Nickavar B, Amin G. Bioassay-guided separation of an α-amylase inhibitor anthocyanin from 





Vítor Spínola   2018                                                      203 
 
 
96.  Nickavar B, Amin G. Enzyme assay guided isolation of an α-amylase inhibitor flavonoid from 
Vaccinium arctostaphylos leaves. Iran. J. Pharm. Res. 2011;10(4):849–53.  
97.  Worsztynowicz P, Napierała M, Białas W, Grajek W, Olkowicz M. Pancreatic α-amylase and lipase 
inhibitory activity of polyphenolic compounds present in the extract of black chokeberry (Aronia 
melanocarpa L.). Process Biochem. 2014;49(9):1457–63.  
98.  Zhang L, Li J, Hogan S, Chung H, Welbaum GE, Zhou K. Inhibitory effect of raspberries on starch 
digestive enzyme and their antioxidant properties and phenolic composition. Food Chem. 
2010;119(2):592–9.  
99.  Sun C-D, Zhang B, Zhang J-K, Xu C-J, Wu Y-L, Li X, et al. Cyanidin-3-glucoside-rich extract from 
Chinese bayberry fruit protects pancreatic β cells and ameliorates hyperglycemia in streptozotocin-
induced diabetic mice. J. Med. Food. 2012;15(3):288–98.  
100.  Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB. Inhibition of aldose reductase by 
tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol. Vis. 
2004;10:148–54.  
101.  Press JR, Short MJ. Flora of Madeira. London: HMSO; 1994.  
102.  Hussain I. Physiochemical and sensory characteristics of Elaeagnus umbellata ( Thunb ) fruit from 
Rawalakot ( Azad Kashmir ) Pakistan. African J. Food Sci. Technol. 2011;2(7):151–6.  
103.  Khattak KF. Free radical scavenging activity, phytochemical composition and nutrient analysis of 
Elaeagnus umbellata berry. J. Med. Plants Res. 2012;6(39):5196–203.  
104.  Pei R, Yu M, Bruno R, Bolling BW. Phenolic and tocopherol content of autumn olive (Elaeagnus 
umbellate) berries. J. Funct. Foods. 2015;16:305–14.  
105.  Kim M, Lim J, Yang S. Component analysis and anti-proliferative effects of ethanol extracts of fruits , 
leaves , and stems from Elaeagnus umbellata in HepG2 cells. J. Korean Soc. Food Sci. Nutr. 
2016;45(6):828–34.  
106.  Spínola V, Llorent-Martínez EJ, Gouveia S, Castilho PC. Myrica faya : a new source of antioxidant 
phytochemicals. J. Agric. Food Chem. 2014;62:9722–9735.  
107.  Gouveia-Figueira SC, Castilho PC. Phenolic screening by HPLC–DAD–ESI/MSn and antioxidant 
capacity of leaves, flowers and berries of Rubus grandifolius Lowe. Ind. Crops Prod. 2015;73:28–40.  
108.  Rivera D, Obón C. The ethnopharmacology of Madeira and Porto Santo Islands, a review. J. 
Ethnopharmacol. 1995;46(2):73–93.  
109.  Lima EC, Baptista JB, Albuquerque LM. Antioxidant capacity versus total phenolic, total flavonoid 
and anthocyanin content of endemic azorean Vaccinium cymindraceum: comparison with commercial 
bilberry and highbush blueberry. Acta Hortic. 2009;810:901–10.  
110.  Schäfer H. Flora of the Azores. A Field Guide. Backhuys Publishers; 2005.  
111.  Base de Dados da Biodiversidade dos Açores. Universidade dos Açores. 2008. Available from: 
http://www.azoresbioportal.angra.uac.pt/imagens/Imagenes/GruposCAutores_11Jun08/Plantas_Vascu




204  Vítor Spínola (2018) 
112.  Cabrita L, Andersen ØM. Anthocyanins in blue berries of Vaccinium padifolium. Phytochem. 1999; 
52(8):1693–6.  
113.  Cabrita L, Frøystein NÅ, Andersen ØM. Anthocyanin trisaccharides in blue berries of Vaccinium 
padifolium. Food Chem. 2000 Apr;69(1):33–6.  
114.  Oszmiański J, Nowicka P, Teleszko M, Wojdyło A, Cebulak T, Oklejewicz K. Analysis of phenolic 
compounds and antioxidant activity in wild blackberry fruits. Int. J. Mol. Sci. 2015;16(7):14540–53.  
115.  Tan Y, Chang SKC. Digestive enzyme inhibition activity of the phenolic substances in selected fruits, 
vegetables and tea as compared to black legumes. J. Funct. Foods. 2017;38:644–55.  
116.  Huang H, Sun Y, Lou S, Li H, Ye X. In vitro digestion combined with cellular assay to determine the 
antioxidant activity in Chinese bayberry (Myrica rubra Sieb. et Zucc.) fruits: a comparison with 
traditional methods. Food Chem. 2014;146:363–70.  
117.  Zhang Y, Chen S, Wei C, Gong H, Li L, Ye X. Chemical and cellular assays combined with in vitro 
digestion to determine the antioxidant activity of flavonoids from Chinese bayberry (Myrica rubra Sieb. 
et Zucc.) leaves. PLoS One. 2016;11(12):e0167484.  
118.  Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying 
an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999;26(9):1231–7.  
119.  Dudonné S, Vitrac X, Coutière P, Woillez M, Mérillon J-M. Comparative study of antioxidant 
properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, 
FRAP, SOD, and ORAC assays. J. Agric. Food Chem. 2009;57:1768–74.  
120.  Ewing JF, Janero DR. Microplate superoxide dismutase assay employing a nonenzymatic superoxide 
generator. Anal. Biochem. 1995;232(2):243–8.  
121.  Llorent-Martínez EJ, Spínola V, Castilho PC. Evaluation of the inorganic content of six underused wild 
berries from Portugal: potential new sources of essential minerals. J. Food Compos. Anal. 2017;59:153–
60.  
122.  Flores FP, Singh RK, Kerr WL, Pegg RB, Kong F. Total phenolics content and antioxidant capacities 
of microencapsulated blueberry anthocyanins during in vitro digestion. Food Chem. 2014;153:272–8.  
123.  Pinto J, Spínola V, Llorent-Martínez EJ, Fernández-de Córdova ML, Molina-García L, Castilho PC. 
Polyphenolic profile and antioxidant activities of Madeiran elderberry (Sambucus lanceolata) as 
affected by simulated in vitro digestion. Food Res. Int. 2017;100(P3):404–10.  
124.  Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food 
Chem. 2001 (11):5165–70.  
125.  Spínola V, Llorent-Martínez EJ, Gouveia-Figueira S, Castilho PC. Ulex europaeus: from noxious weed 
to source of valuable isoflavones and flavanones. Ind. Crops Prod. 2016;90:9–27.  
126.  Akkol EK, Göger F, Koşar M, Başer KHC. Phenolic composition and biological activities of Salvia 
halophila and Salvia virgata from Turkey. Food Chem. 2008;108(3):942–9.  
127.  Muthenna P, Suryanarayana P, Gunda SK, Petrash JM, Reddy GB. Inhibition of aldose reductase by 






Vítor Spínola   2018                                                      205 
 
 
128.  Xiao S, Castro R, Maciel D, Gonçalves M, Shi X, Rodrigues J, et al. Fine tuning of the pH-sensitivity 
of laponite–doxorubicin nanohybrids by polyelectrolyte multilayer coating. Mater. Sci. Eng. C. 
2016;60:348–56.  
129.  Ishaq S, Rathore HA, Sabir SM, Maroof MS. Antioxidant properties of Elaeagnus umbellata berry 
solvent extracts against lipid peroxidation in mice brain and liver tissues. Food Sci. Biotechnol. 
2015;24(2):673–9.  
130.  Lee J, Finn CE. Anthocyanins and other polyphenolics in American elderberry (Sambucus canadensis) 
and European elderberry (S. nigra) cultivars. J Sci Food Agric. 2007;87(14):2665–75.  
131.  Oszmianski J, Kolniak-Ostek J, Lachowicz S, Gorzelany J, Matlok N. Phytochemical compounds and 
antioxidant activity in different cultivars of cranberry (Vaccinium macrocarpon L ). J. Food Sci. 
2017;82(11):2569–75.  
132.  Jaakola L, Määttä-Riihinen K, Kärenlampi S, Hohtola A. Activation of flavonoid biosynthesis by solar 
radiation in bilberry (Vaccinium myrtillus L.) leaves. Planta. 2004;218(5):721–8.  
133.  Garzón GA, Narváez CE, Riedl KM, Schwartz SJ. Chemical composition, anthocyanins, non-
anthocyanin phenolics and antioxidant activity of wild bilberry (Vaccinium meridionale Swartz) from 
Colombia. Food Chem. 2010;122(4):980–6.  
134.  De Souza VR, Pereira PAP, Da Silva TLT, De Oliveira Lima LC, Pio R, Queiroz F. Determination of 
the bioactive compounds, antioxidant activity and chemical composition of Brazilian blackberry, red 
raspberry, strawberry, blueberry and sweet cherry fruits. Food Chem.; 2014;156:362–8.  
135.  McCarty MF. Nutraceutical resources for diabetes prevention - An update. Med. Hypotheses. 
2005;64:151–8.  
136.  Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J. Diabetes. 2015;6(10):1152–
7.  
137.  Koh ES, Kim SJ, Yoon HE, Chung JH, Chung S, Park CW, et al. Association of blood manganese level 
with diabetes and renal dysfunction: a cross-sectional study of the Korean general population. BMC 
Endocr. Disord. 2014;14:24–36.  
138.  Commision of the European Communities. Directive 2008/100/EC on nutrition labelling for foodstuffs 
as regards recommended daily allowances, energy conversion factors and definitions. Off. J. Eur. 
Union. 2008;L285:9.  
139.  Fang Z, Zhang M, Tao G, Yunfei Sun A, Sun J. Chemical composition of clarified bayberry (Myrica 
rubra Sieb. et Zucc.) juice sediment. J Agric Food Chem. 2006;54(20):7710–6.  
140.  Liu Y, Zhang D, Wu Y, Wang D, Wei Y, Wu J, et al. Stability and absorption of anthocyanins from 
blueberries subjected to a simulated digestion process. Int. J. Food Sci. Nutr. 2014;65(4):440–8.  
141.  Marhuenda J, Alemán MD, Gironés-Vilaplana A, Pérez A, Caravaca G, Figueroa F, et al. Phenolic 
composition, antioxidant activity, and in vitro availability of four different berries. J. Chem. 2016; 
Article ID 5194901:7 pages.  




206  Vítor Spínola (2018) 
phenolic compounds in bayberry (Myrica rubra Sieb. et Zucc.) leaves by HPLC-DAD and HPLC-UV-
ESIMS. Food Chem. 2011;128(4):1128–35.  
143.  Fang Z, Zhang M, Wang L. HPLC-DAD-ESIMS analysis of phenolic compounds in bayberries (Myrica 
rubra Sieb. et Zucc.). Food Chem. 2007;100(2):845–52.  
144.  Azofeifa G, Quesada S, Boudard F, Morena M, Cristol J-P, Pérez AM, et al. Antioxidant and anti-
inflammatory in vitro activities of phenolic compounds from tropical highland blackberry (Rubus 
adenotrichos). J. Agric. Food Chem. 2013;61:5798–804.  
145.  Chen W, Xu Y, Zhang L, Su H, Zheng X. Blackberry subjected to in vitro gastrointestinal digestion 
affords protection against ethyl carbamate-induced cytotoxicity. Food Chem. 2016;212:620–7.  
146.  Chen W, Xu Y, Zhang L, Li Y, Zheng X. Wild raspberry subjected to simulated gastrointestinal 
digestion improves the protective capacity against ethyl carbamate-induced oxidative damage in Caco-
2 cells. Oxid. Med. Cell. Longev. 2016; Article ID 3297363:12 pages.  
147.  McDougall GJ, Dobson P, Smith P, Blake A, Stewart D. Assessing potential bioavailability of raspberry 
anthocyanins using an in vitro digestion system. J. Agric. Food Chem. 2005;53(15):5896–904.  
148.  Dawidowicz AL, Wianowska D, Baraniak B. The antioxidant properties of alcoholic extracts from 
Sambucus nigra L. (antioxidant properties of extracts). LWT - Food Sci. Technol. 2006;39(3):308–15.  
149.  Sidor A, Gramza-Michałowska A. Advanced research on the antioxidant and health benefit of 
elderberry (Sambucus nigra) in food - a review. J. Funct. Foods. 2015;18:941–58.  
150.  Mandrone M, Lorenzi B, Maggio A, La Mantia T, Scordino M, Bruno M, et al. Polyphenols pattern 
and correlation with antioxidant activities of berries extracts from four different populations of Sicilian 
Sambucus nigra L. Nat. Prod. Res. 2014;28(16):1246–53.  
151.  Duymuş HG, Göger F, Başer KHC. In vitro antioxidant properties and anthocyanin compositions of 
elderberry extracts. Food Chem. 2014;155:112–9.  
152.  Zhou N, Zhu W, Yang F, Zhou K. In vitro gastrointestinal digestion model to monitor the antioxidant 
properties and bioavailability of phenolic antioxidants from elderberry. React. Oxyg. Species. 
2016;2(6):421–31.  
153.  Jiao X, Li B, Zhang Q, Gao N, Zhang X, Meng X. Effect of in vitro-simulated gastrointestinal digestion 
on the stability and antioxidant activity of blueberry polyphenols and their cellular antioxidant activity 
towards HepG2 cells. Int. J. Food Sci. Technol. 2018;53(1):61–71.  
154.  Sarkar D, Agustinah W, Woods F, Coneva E, Vinson E, Shetty K. In vitro screening and evaluation of 
phenolic antioxidant-linked anti-hyperglycemic functions of rabbit-eye blueberry (Vaccinium ashei) 
cultivars. J. Berry Res. 2017;7(3):163–77.  
155.  Chiang C-J, Kadouh H, Zhou K. Phenolic compounds and antioxidant properties of gooseberry as 
affected by in vitro digestion. LWT - Food Sci. Technol. 2013;51(2):417–22.  
156.  Podsędek A, Redzynia M, Klewicka E, Koziolkiewicz M. Matrix effects on the stability and antioxidant 
activity of red cabbage anthocyanins under simulated gastrointestinal digestion. Biomed Res. Int. 
2014;11 pages.  





Vítor Spínola   2018                                                      207 
 
 
wild edible plants in eastern Himalayas, India.Int. Sci. Index. 2014;8(3):238–43.  
158.  Namiesnik J, Vearasilp K, Leontowicz H, Leontowicz M, Ham KS, Kang SG, et al. Comparative 
assessment of two extraction procedures for determination of bioactive compounds in some berries used 
for daily food consumption. Int. J. Food Sci. Technol. 2014;49(2):337–46.  
159.  Harris CS, Cuerrier A, Lamont E, Haddad PS, Arnason JT, Bennett SAL, et al. Investigating wild 
berries as a dietary approach to reducing the formation of advanced glycation endproducts: chemical 
correlates of in vitro antiglycation activity. Plant foods Hum. Nutr. 2014;69(1):71–7.  
160.  Bobinaitė R, Viškelis P, Šarkinas A, Venskutonis PR. Phytochemical composition, antioxidant and 
antimicrobial properties of raspberry fruit, pulp, and marc extracts. CyTA - J. Food. 2013;11(4):334–
42.  
161.  Topuzović MD, Stanković MS, Jakovljević DZ, Bojović BM. Plant part variability of Sambucus ebulus 
L. secondary metabolites content and antioxidant activity. Agro Food Ind. Hi. Tech. 2016;27(2):60–3.  
162.  Salehi P, Asghari B, Esmaeili MA, Dehghan H, Ghazi I. α -Glucosidase and α -amylase inhibitory effect 
and antioxidant activity of ten plant extracts traditionally used in Iran for diabetes. J. Med. Plants Res. 
2013;7(6):257–66.  
163.  Zhu L, Liu X, Tan J, Wang B. Influence of harvest season on antioxidant activity and constituents of 
rabbiteye blueberry (Vaccinium ashei) leaves. J. Agric. Food Chem. 2013;61(47):11477–83.  
164.  Ferrier J, Djeffal S, Morgan HP, Vander Kloet SP, Redžić S, Cuerrier A, et al. Antiglycation activity 
of Vaccinium spp. (Ericaceae) from the Sam Vander Kloet collection for the treatment of type II 
diabetes. Botany. 2012;90:401–6.  
165.  Kimura A, Lee JH, Lee IS, Lee HS, Park KH, Chiba S, et al. Two potent competitive inhibitors 
discriminating alpha-glucosidase family I from family II. Carbohydr. Res. 2004;339(6):1035–40.  
166.  Babu KS, Tiwari AK, Srinivas P V., Ali AZ, Raju BC, Rao JM. Yeast and mammalian α-glucosidase 
inhibitory constituents from Himalayan rhubarb Rheum emodi Wall.ex Meisson. Bioorganic Med. 
Chem. Lett. 2004;14(14):3841–5.  
167.  Shai J. L, Magano R. S, Lebelo L. S, Mogale M. A. Inhibitory effects of five medicinal plants on rat 
alpha-glucosidase: comparison with their effects on yeast alpha-glucosidase. J. Med. Plants Res. 
2011;5(13):2863–7.  
168.  Oki T, Matsui T, Osajima Y. Inhibitory effect of alpha-glucosidase inhibitors varies according to its 
origin. J. Agric. Food Chem. 1999;47:550–3.  
169.  Sancheti S, Sancheti S, Seo S-Y. Chaenomeles sinensis: a potent α-and β-Glucosidase inhibitor. Am. J. 
Pharmacol. Toxicol. 2009;4(1):8–11.  
170.  Balaji M, Ganjayi MS, Hanuma Kumar GEN, Parim BN, Mopuri R, Dasari S. A review on possible 
therapeutic targets to contain obesity: the role of phytochemicals. Obes. Res. Clin. Pract. 
2016;10(4):363–80.  
171.  Fabroni S, Ballistreri G, Amenta M, Romeo F V., Rapisarda P. Screening of the anthocyanin profile 




208  Vítor Spínola (2018) 
legumes and cereals. J. Sci. Food Agric. 2016;96(14):4713–23.  
172.  Lin D, Xiao M, Zhao J, Li Z, Xing B, Li X, et al. An overview of plant phenolic compounds and their 
importance in human nutrition and management of type 2 diabetes. Molecules. 2016;21(10):1374–93.  
173.  Wu T, Luo J, Xu B. In vitro anti-diabetic effects of selected fruits and vegetables against glycosidase 
and aldose reductase. Food Sci. Nutr. 2015;3(6):495–505.  
174.  de Sales PM, de Souza PM, Simeoni LA, Magalhães PDO, Silveira D. α-Amylase inhibitors: a review 
of raw material and isolated compounds from plant source. J. Pharm. Sci. 2012;15(1):141–83.  
175.  Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of chlorogenic acid on regulating glucose and lipids 
metabolism: a review. Evidence-Based Complement. Altern. Med. 2013; Article ID 801457: 11 pages. 
176.  Matsuda H, Morikawa T, IwaoToguchida, Yoshikawa M. Structural requirements of flavonoids and 
related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 2002;50(6):788–95.  
177.  Xie Y, Chen X. Structures required of polyphenols for inhibiting advanced glycation end products 
formation. Curr. Drug Metab. 2013;14:414–31.  
178.  Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of 
protein glycation and radical scavenging activities. Bioorganic Med. Chem. 2003;11(24):5317–23.  
179.  Kim J, Jeong I-H, Kim C-S, Lee YM, Kim JM, Kim JS. Chlorogenic acid inhibits the formation of 
advanced glycation end products and associated protein cross-linking. Arch. Pharm. Res. 
2011;34(3):495–500.  
180.  Singh P, Jayaramaiah RH, Agawane SB. Potential dual role of eugenol in inhibiting advanced glycation 
end products in diabetes : proteomic and mechanistic insights. Sci. Rep. 2016;(6):18798.  
181.  Joglekar MM, Bavkar LN, Sistla S, Arvindekar AU. Effective inhibition of protein glycation by 
combinatorial usage of limonene and aminoguanidine through differential and synergistic mechanisms. 
Int. J. Biol. Macromol. 2017;99:563–9.  
182.  West BJ, Deng S, Uwaya A, Isami F, Abe Y, Yamagishi S, et al. Iridoids are natural glycation inhibitors. 
Glycoconj. J. 2016;33:671–81.  
183.  Wang W, Yagiz Y, Buran TJ, Nunes C do N, Gu L. Phytochemicals from berries and grapes inhibited 
the formation of advanced glycation end‐products by scavenging reactive carbonyls.  Food Res. Int. 
2011;44(9):2666–73.  
184.  Li X, Zheng T, Sang S, Lv L. Quercetin inhibits advanced glycation end product formation by trapping 
methylglyoxal and glyoxal. J. Agric. Food Chem. 2014;62(50):12152–8.  
185.  Sun C, Huang H, Xu C, Li X, Chen K. Biological activities of extracts from Chinese bayberry (Myrica 
rubra Sieb. et Zucc.): a review. Plant Foods Hum. Nutr. 2013;68(2):97–106.  
186.  Zhang Y, Zhou X, Tao W, Li L, Wei C, Duan J, et al. Antioxidant and antiproliferative activities of 
proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves. J. Funct. Foods. 
2016;27:645–54.  
187.  Denev P, Ciz M, Ambrozova G, Lojek A, Yanakieva I, Kratchanova M. Solid-phase extraction of 






Vítor Spínola   2018                                                      209 
 
 
188.  Chen L, Xin X, Yuan Q, Su D, Liu W. Phytochemical properties and antioxidant capacities of various 
colored berries. J. Sci. Food Agric. 2014;94(2):180–8.  
189.  Pérez-González A, Rebollar-zepeda AM, León-carmona JR, Galano A. Reactivity indexes and O-H 
bond dissociation energies of a large series of polyphenols : implications for their free radical 
scavenging activity. J. Mex. Chem. Soc. 2012;56(3):241–9.  
190.  Nowak A, Sójka M, Klewicka E, Lipińska L, Klewicki R, Kołodziejczyk K. Ellagitannins from Rubus 
idaeus L. exert geno- and cytotoxic effects against Human colon adenocarcinoma cell line Caco-2. J. 
Agric. Food Chem. 2017;65:2947–55.  
191.  Krauze-Baranowska M, Głód D, Kula M, Majdan M, Hałasa R, Matkowski A, et al. Chemical 
composition and biological activity of Rubus idaeus shoots – a traditional herbal remedy of Eastern 
Europe. BMC Complement. Altern. Med. 2014;14(1):480.  
192.  Seeram N, Adams L, Zhang Y, Rupo L, Sand D, Scheuller H, et al. Blackberry, black raspberry, bluerry, 
cranberry, red raspberry and strawberry extracts inhibit growth stimulate apoptsis of human cancer in 
vitro. J. Agric. Food Chem. 2006;54(ii):9329–39.  
193.  Maldonado-Celis ME, Arango-Varela SS, Rojano BA. Free radical scavenging capacity and cytotoxic 
and antiproliferative effects of Vaccinium meridionale Sw. agains colon cancer cell lines. Rev. Cuba. 
Plantas Med. 2014;19(2):172–84.  
194.  Massarotto G, Barcellos T, Garcia CSC, Brandalize APC, Moura S, Schwambach J, et al. Chemical 
characterization and cytotoxic activity of blueberry extracts (cv. Misty) cultivated in Brazil. J. Food 
Sci. 2016;81(8):H2076–84.  
195.  McDougall GJ, Ross HA, Ikeji M, Stewart D. Berry extracts exert different antiproliferative effects 
against cervical and colon cancer cells grown in vitro. J. Agric. Food Chem. 2008;56(9):3016–23.  
196.  Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen YM, et al. Natural polyphenols for prevention and treatment 
of cancer. Nutrients. 2016;8:515–50.  
197.  Engels C, Schieber A, Ganzle MG. Sinapic acid derivatives in defatted Oriental mustard (Brassica 
juncea L.) seed meal extracts using UHPLC-DAD-ESI-MSn and identification of compounds with 
antibacterial activity. Eur. Food Res. Technol. 2012;234(3):535–42.  
198.  Spínola V, Pinto J, Castilho PC. Identification and quantification of phenolic compounds of selected 
fruits from Madeira Island by HPLC-DAD–ESI-MSn and screening for their antioxidant activity. Food 
Chem. 2015;173:14–30.  
199.  Calani L, Beghè D, Mena P, Del Rio D, Bruni R, Fabbri A, et al. Ultra-HPLC-MS(n) (poly)phenolic 
profiling and chemometric analysis of juices from ancient Punica granatum L. cultivars: a nontargeted 
approach. J. Agric. Food Chem. 2013;61(23):5600–9.  
200.  Bresciani L, Calani L, Cossu M, Mena P, Sayegh M, Ray S, et al. (Poly)phenolic characterization of 
three food supplements containing 36 different fruits, vegetables and berries. PharmaNutrition. 
2015;3(2):11–9.  




210  Vítor Spínola (2018) 
of four underutilized fruits from the Amazon region. J. Agric. Food Chem. 2011;59(14):7688–99.  
202.  Qiao X, He W, Xiang C, Han J, Wu L, Guo D, et al. Qualitative and quantitative analyses of flavonoids 
in Spirodela polyrrhiza by high-performance liquid chromatography coupled with mass spectrometry. 
Phytochem. Anal.;22(6):475–83.  
203.  Ferreres F, Magalhães SCQ, Gil-Izquierdo A, Valentão P, Cabrita ARJ, Fonseca AJM, et al. HPLC-
DAD-ESI/MSn profiling of phenolic compounds from Lathyrus cicera L. seeds. Food Chem. 
2017;214:678–85.  
204.  Ye M, Yan Y, Guo D-A. Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi 
by liquid chromatography coupled to electrospray ionization mass spectrometry. Rapid Commun. Mass 
Spectrom. 2005; (11):1469–84.  
205.  Cuyckens F, Claeys M. Mass spectrometry in the structural analysis of flavonoids. J. Mass Spectrom. 
2004;39(1):1–15.  
206.  Mena P, Calani L, Dall’Asta C, Galaverna G, Garcia-Viguera C, Bruni R, et al. Rapid and 
comprehensive evaluation of (poly)phenolic compounds in pomegranate (Punica granatum L.) juice by 
UHPLC-MSn. Molecules. 2012;17(12):14821–40.  
207.  Verardo G, Duse I, Callea A. Analysis of underivatized oligosaccharides by liquid 
chromatography/electrospray ionization tandem mass spectrometry with post-column addition of 
formic acid. Rapid Commun. Mass Spectrom. 2009 (11):1607–18.  
208.  Harbaum B, Hubbermann EM, Wolff C, Herges R, Zhu Z, Schwarz K. Identification of flavonoids and 
hydroxycinnamic acids in pak choi varieties (Brassica campestris L. ssp. chinensis var. communis) by 
HPLC-ESI-MSn and NMR and their quantification by HPLC-DAD. J Agric Food Chem. 
2007;55(20):8251–60.  
209.  Spínola V, Castilho PC. Phytochemical profile, chemotaxonomic studies and in vitro antioxidant 
activities of two endemisms from Madeira archipelago: Melanoselinum decipiens and Monizia edulis 
(Apiaceae). Chem. Biodivers. 2016;13(10):1290–306.  
210.  Sun J, Liu X, Yang T, Slovin J, Chen P. Profiling polyphenols of two diploid strawberry (Fragaria 
vesca) inbred lines using UHPLC-HRMS(n.). Food Chem. 2014;146:289–98.  
211.  Gao J, Shi J, Lu X, Sun C, Pan Y. Differentiation of common diastereoisomeric ursane-type 
triterpenoids by high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. 
Mass Spectrom. 2011;25(10):1349–55.  
212.  Mikulic-Petkovsek M, Slatnar A, Stampar F, Veberic R. HPLC-MSn identification and quantification 
of flavonol glycosides in 28 wild and cultivated berry species. Food Chem. 2012;135(4):2138–46.  
213.  Mena P, Ascacio-Valdés JA, Gironés-Vilaplana A, Del Rio D, Moreno DA, García-Viguera C. 
Assessment of pomegranate wine lees as a valuable source for the recovery of (poly)phenolic 
compounds. Food Chem. 2014;145:327–34.  
214.  Latti AK, Kainulainen PS, Hayirlioglu-Ayaz S, Ayaz FA, Riihinen KR. Characterization of 
anthocyanins in caucasian blueberries (Vaccinium arctostaphylos L.) native to Turkey. J. Agric. Food 





Vítor Spínola   2018                                                      211 
 
 
215.  Steingass CB, Glock MP, Schweiggert RM, Carle R. Studies into the phenolic patterns of different 
tissues of pineapple (Ananas comosus [L.] Merr.) infructescence by HPLC-DAD-ESI-MS (n) and GC-
MS analysis. Anal. Bioanal. Chem. 2015;407(21):6463–79.  
216.  Sentandreu E, Cerdán-Calero M, Halket JM, Navarro JL. Rapid screening of low molecular weight 
phenols from persimmon (Diospyros kaki) pulp using liquid chromatography-UV/Vis-electrospray 
mass spectrometry analysis. J. Sci. Food Agric. 2014;95:1648–54.  
217.  Fischer UA, Dettmann JS, Carle R, Kammerer DR. Impact of processing and storage on the phenolic 
profiles and contents of pomegranate (Punica granatum L.) juices. Eur. Food Res. Technol. 
2011;233(5):797–816.  
218.  Ieri F, Pinelli P, Romani A. Simultaneous determination of anthocyanins, coumarins and phenolic acids 
in fruits, kernels and liqueur of Prunus mahaleb L. Food Chem. 2012;135(4):2157–62.  
219.  Del Bubba M, Checchini L, Chiuminatto U, Doumett S, Fibbi D, Giordani E. Liquid 
chromatographic/electrospray ionization tandem mass spectrometric study of polyphenolic composition 
of four cultivars of Fragaria vesca L. berries and their comparative evaluation. J. Mass Spectrom. 
2012;47(9):1207–20.  
220.  Li J, Kuang G, Chen X, Zeng R. Identification of chemical composition of leaves and flowers from 
Paeonia rockii by UHPLC-Q-exactive orbitrap HRMS. Molecules. 2016;21(7):947.  
221.  Clifford MN, Knight S, Kuhnert N. Discriminating between the six isomers of dicaffeoylquinic acid by 
LC-MSn. J. Agric. Food Chem. 2005;53(10):3821–32.  
222.  Simirgiotis MJ, Silva M, Becerra J, Schmeda-Hirschmann G. Direct characterisation of phenolic 
antioxidants in infusions from four Mapuche medicinal plants by liquid chromatography with diode 
array detection (HPLC-DAD) and electrospray ionisation tandem mass spectrometry (HPLC-ESI–MS). 
Food Chem. 2012;131(1):318–27.  
223.  Yang M, Wang X, Guan S, Xia J, Sun J, Guo H, et al. Analysis of triterpenoids in Ganoderma lucidum 
using liquid chromatography coupled with electrospray ionization mass spectrometry. J. Am. Soc. Mass 
Spectrom. 2007;18(5):927–39.  
224.  Mikulic-Petkovsek M, Ivancic A, Todorovic B, Veberic R, Stampar F. Fruit phenolic composition of 
different elderberry species and hybrids. J. Food Sci. 2015;80(10):C2180–90.  
225.  Gouveia SC, Castilho PC. Characterisation of phenolic acid derivatives and flavonoids from different 
morphological parts of Helichrysum obconicum by a RP-HPLC–DAD-(−)–ESI-MSn method. Food 
Chem. 2011;129(2):333–44.  
226.  Qiu X, Zhang J, Huang Z, Zhu D, Xu W. Profiling of phenolic constituents in Polygonum multiflorum 
Thunb. by combination of ultra-high-pressure liquid chromatography with linear ion trap-orbitrap mass 
spectrometry. J. Chromatogr. A. 2013;1292:121–31.  
227.  Eklund PC, Backman MJ, Kronberg LA, Smeds AI, Sjöholm RE. Identification of lignans by liquid 





212  Vítor Spínola (2018) 
228.  Simirgiotis MJ. Antioxidant capacity and HPLC-DAD-MS profiling of Chilean peumo (Cryptocarya 
alba) fruits and comparison with German peumo (Crataegus monogyna) from southern Chile. 
Molecules. 2013;18(2):2061–80.  
229.  Gu W-Y, Li N, Leung EL-H, Zhou H, Luo G-A, Liu L, et al. Metabolites software-assisted flavonoid 
hunting in plants using ultra-high performance liquid chromatography-quadrupole-time of flight mass 
spectrometry. Molecules. 2015;20(3):3955–71.  
230.  Zanutto F, Boldrin P, Varanda E, Souza S, Sano P, Vilegas W, et al. Characterization of flavonoids and 
naphthopyranones in methanol extracts of Paepalanthus chiquitensis Herzog by HPLC-ESI-IT-MSn 
and their mutagenic activity. Molecules. 2013;18(1):244–62.  
231.  Sánchez-Rabaneda F, Jáuregui O, Lamuela-Raventós RM, Bastida J, Viladomat F, Codina C. 
Identification of phenolic compounds in artichoke waste by high-performance liquid chromatography–
tandem mass spectrometry. J. Chromatogr. A. 2003;1008(1):57–72.  
232.  Stephens JM, Schlothauer RC, Morris BD, Yang D, Fearnley L, Greenwood DR, et al. Phenolic 
compounds and methylglyoxal in some New Zealand manuka and kanuka honeys. Food Chem. 
2010;120(1):78–86.  
233.  Wang Y-F, Hu L-M, Liu Y-N, Pan X-P, Pan G-X, Chang Y-X, et al. A rapid method for qualitative and 
quantitative analysis of major constituents in dengzhanxixin injection by LC-DAD-ESI–MSn. 
Chromatographia. 2010;71(9–10):845–53.  
234.  Spínola V, Pinto J, Castilho PC. Hypoglycemic, anti-glycation and antioxidant in vitro properties of 


































Vítor Spínola   2018                                                      215 
  
Table S 1 - Nomenclature of berry species mentioned in this thesis. 
Scientific name Common name 
Adoxaceae family  
Sambucus nigra Elderberry 
Sambucus lanceolata Madeira elderberry 
Caprifoliaceae family  
Lonicera caerulea var. kamtschatica Blue honeysuckle cv. Wojtek 
Elaeagnaceae family  
Elaeagnus umbellata Autumn olive 
Elaeagnus angustifolia Wild olive 
Ericaceae family  
Vaccinium corymbosum High-bush blueberry 
Vaccinium angustifolium Low-bush blueberry 
Vaccinium myrtillus Bilberry 
Vaccinium macrocarpon Cranberry (American) 
Vaccinium oxycoccos Cranberry (European) 
Vaccinium vitis-idaea Lingonberry 
Vaccinium arctostaphylos Whortleberry 
Vaccinium cylindraceum Azores blueberry 
Vaccinium padifolium Madeira blueberry 
Glossulariaceae family  
Ribes nigrum Black currant 
Ribes rubrum Red currant 
Ribes uva-crispa Gooseberry 
Aronia melanocarpa Black chokeberry 
Aronia arbutifolia Red chokeberry 
Rosaceae family  
Fragaria × ananassa Cultivated strawberry 
Rubus articus Artic bramble 
Rubus fruticosus Blackberry 
Rubus idaeus Red raspberry 
Rubus chamaemorus Cloudberries 
Rubus grandifolius Wild blackberries 
Moraceae family  
Morus alba Mulberry 
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Myricaceae family  
Myrica rubra Bayberry 
Myrica faya Wax-myrtle 
Phyllanthaceae family  
Emblica officinalis Indian gooseberry 
 
 
Table S 2 - Standard compounds and chemicals/reagents compounds used in this work. 
Name Supplier 
Standard compounds  
Gallic acid (> 98%); Rutin (≥ 98%, HPLC) Panreac (Barcelona, Spain) 
Ellagic acid (≥ 96%); Luteolin (≥ 98%); Sinapic acid (> 99%) Fluka (Lisbon, Portugal) 
Caffeic acid (≥ 98%) Sigma-Aldrich (St. Louis, MO, USA) 
5-O-Caffeoylquininc acid (5-O-CQA, > 95%); 3,5-O-
Dicaffeoylquinic acid (> 98%) Cyanidin-3-glucoside (C3G) 
chloride (> 98%), Hesperidin (95-99%) 
Biopurify phytochemicals LTD  
(Chengdu, China) 
Apigenin (≥ 99%); (+)-Catechin hydrated (>99%); 
Protocatechuic acid (≥ 99%); p-Coumaric acid (>99%); Ferulic 
acid (>99%) 
Extrasynthese (Genay, France) 
Quercetin dihydrate (> 99%)  Riedel-de Haen (Hanover, Germany) 
Myricitrin (MCT) (> 98%) Carbosynth (Berkshire, UK) 
Cranberry fruit SRM-3281 National Institute of Standards and 
Technology (NIST) 
Chemicals/Reagents  
Folin–Ciocalteu’s phenol reagent (FCR); Sodium chloride (> 
99.0%); Potassium chloride (99.5 – 100.5%); Potassium acetate 
(> 99.5%); Calcium chloride (99 - 105 %); 
Panreac (Barcelona, Spain) 
6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
(Trolox), 2,2′-azinobis-(3-ethylbenzthiazoline-6-sulfonic acid) 
(ABTS); 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
Fluka (Lisbon, Portugal) 
N-(1-Naphthyl)ethylene-diamine dihydrochloride (NEDA, ≥ 
98%); β-mercaptoethanol (≥ 99%); Quinic acid (98%); 
Phenazine methosulfate (PMS, ≥ 90%); Sulfanilamide (≥ 99%); 
β-Nicotinamide adenine dinucleotide reduced disodium salt 
hydrate (NADH, ≥94%); Ammonium sulphate (≥99%); 
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Potassium persulfate (99%); Sodium carbonate (100%); -
Glucosidase from Saccharomyces cerevisiae (type I); Intestinal 
acetone powder from rat source of -glucosidase; BGLU 
from almonds; -Amylase from porcine pancreas (type VI-B); 
Lipase (type II; from porcine pancreas); p-Nitrophenyl-α-D-
glucopyranoside (α-pNPG); p-Nitrophenyl-β-D-
glucopyranoside (β-pNPG); p-Nitrophenyl butyrate (pNPB); 
DL-Glyceraldehyde (≥98%); Bovine serum albumin (BSA, ≥  
98%); D-(-)-Ribose (≥ 99%); Aminoguanidine hydrochloride 
(AMG, ≥ 98%); Conduritol B epoxide (≥ 95 %); Acarbose; 
Orlistat; Formic acid (98%); Potassium dihydrogen phosphate 
(99.5%); Disodium hydrogen phosphate (99%); Ammonium 
chloride (99.8%);  Mucin (type II; from porcine stomach); 
Pepsin (porcine gastric mucosa); Pancreatin (porcine pancreas); 
Porcine bile extract (contains glycine and taurine conjugates of 
hyodeoxycholic acid and other bile salts); Resazurin sodium salt; 
Phosphate buffered saline (10 x); In, P and Sn solutions (1000 
µg mL-1); Hydrogen peroxide solution for ultratrace analysis; 
Nitric acid solution (65%) 
Human aldose reductase (HAR) Prozomix (Northumberland, UK) 
1-Deoxynojirimycin (1-DNJ, 95-99%) Biopurify phytochemicals LTD  
(Chengdu, China) 
β-Nicotinamide adenine dinucleotide reduced tetrasodium salt 
hydrate (NADPH, ≥ 97%) 
Calbiochem (EMD Milliipore Corp.; 
Billerica, MA, USA) 
Nitroblue tetrazolium chloride (NBT, 90%); Kaempferol (> 
99%) 
Acros Organics (Geel, Belgium) 
o-Phosphoric acid (85%) BDH AnalaR (UK) 
Aluminium chloride (98%); Hydrochloric acid (37%); 
Magnesium chloride hexahydrated (99%) 
Riedel-de Haen  
(Hanover, Germany) 
Acetic acid glacial (100%); Sucrose (> 95%) Fischer Scientific (Bishop Meadow, UK) 
Soluble starch (p.a.); D-(-)-Fructose (≥ 99%); Potassium iodate 
(99.5%); Sodium nitroprusside (99%); 
Ethylenediaminetetraacetic acid (EDTA, > 99%); Sodium azide 
(NaN3, > 99%); Urea (≥ 99%) 
Merck (Darmstadt, Germany) 
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Minimum essential medium; Fetal bovine serum; Penicillin; 
Streptomycin; Amphotericin B; Non-essential amino acids; L-
Glutamine 
Life Technologies, Gibco (Paisley, UK) 
Multi-element standard solution (100 µg mL-1) SCP Science (Paris, France) 
Solvents  
Acetonitrile (LC-MS grade, 99%) Fischer Scientific (Bishop Meadow, UK) 
Methanol (P.A.) Fluka (Lisbon, Portugal) 
 
Table S 3 - Operation conditions for ICP-MS analysis. 
Plasma conditions  
RF power 1.2 kW 
Plasma Ar flow rate 15 L min-1 
Auxiliary Ar flow rate 0.89 L min-1 
Carrier Ar flow rate 0.95 – 1.0 L min-1 
Torch horizontal alignment - (0.5 – 1.0) mm 
Torch vertical alignment 0.2 – 0.5 mm 
Sampling depth 6.0 – 8.0 mm 
Instrument  
Sampler cone Nickel, 1.0 mm orifice diameter 
Skimmer cone Nickel, 0.4 mm orifice diameter 
Isotopes  107,109Ag, 27Al, 75As, 137Ba, 43,44Ca, 111,114Cd, 59Co, 53Cr, 63,65Cu, 
57Fe, 199,202Hg, 115In, 39K, 24,25,26Mg, 55Mn, 95,98Mo, 23Na, 60,62Ni, 
31P, 206,208Pb, 121,123Sb, 82Se, 116,118,120Sn, 47Ti, 203,205Tl, 51V, 66,68Zn 
 
Table S 4 - Initial list of plant species under study. Initial screening for their inhibitory activities (at 
5 mg mL-1 DE) towards digestive enzymes linked to sugar metabolism. 
Family/Species  Yeast α-glucosidase Porcine α-Amylase 
Adoxaceae    
Sambucus lanceolata Leaves 51% 11% 
Fruit 31% 6% 
Aizoaceae    
Tetragonia tetragonoides Leaves 20% N.I. 





Vítor Spínola   2018                                                      219 
 
 
Amaranthanceae    
Beta vulgaris Leaves 76% 23% 
Stems 28% 12% 
Beta vulgaris (var. cicla) Leaves 59 – 67% 13 – 27% 
Stems 13 – 25% 5 – 9% 
Annonaceae    
Annona cherimolla Leaves 21% N.I. 
Apiaceae    
Melanoselinum decepiens* Leaves 19% N.I. 
 Stems 9% N.I. 
Monizia edulis* Leaves 18 - 21% N.I. 
 Stems 11 - 14% N.I. 
Foenicum vulgare Total aerial 
parts 
21% N.I. 
Aquifoliaceae    
Ilex perado Leaves 67% 18% 
Araceae    
Arum italicum  Tubers N.I. N.I. 
Monstera deliciosa* Fruits 13% N.I. 
Asteraceae    
Andryala glandulosa ssp.* Leaves 56% 50% 
Argyranthemum pinnatifidum*  Leaves 64% 49% 
Flowers 69% 36% 
Artemisia argentea*  Leaves 43 – 47% 80% 
Flowers 46 – 48% 44% 
Calendula maderensis* Leaves 16% 23% 
Flowers 21% 19% 





Helichrysum devium*  Leaves 45% 24% 
Flowers 57% 31% 
Helichrysum melaleucum* Leaves 60% 22% 
Flowers 67% 27% 
Helichrysum monizii*  Total aerial 
parts 
53% 21% 
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Phagnalon lowei*  Leaves 65% 37% 
Flowers 79% 29% 
Brassicaceae    
Sinapidendron spp Leaves 13% N.I. 
 Flowers 7% N.I. 
Rorippa nasturtium-aquaticum* Total aerial 
parts 
25% 17% 
Convolvulaceae    
Ipomoea batatas Total aerial 
parts 
83% 31% 
Elaeagnaceae    
Elaeagnus umbellata Leaves 87 – 93% 54% 
 Fruit 79 – 84% 39% 
Ericaceae    
Vaccinium cylindraceum Leaves 92% 55% 
 Fruit 91% 83% 
Vaccinnium padifolium Leaves 97 – 99% 69% 
 Fruit 90 – 93%% 62% 
Fabaceae    
Ulex europaeus*  Leaves 78% 65% 
Flowers 87% 68 % 
Myricaceae    
Myrica faya Leaves >100% 72% 
Fruits 99% 86% 
Myrtaceae    
Eugenia uniflora Leaves 100% 88% 
Polygonaceae    
Rumex maderensis* Leaves 82 % 17% 
Flowers 95% 21% 
Stems 69% 53% 
Rosaceae    
Eriobotrya japonica Leaves 93% 78% 
 Fruit 84% 22% 
Rubus grandifolius Leaves >100% 54% 
 Fruit ≥ 99% 67% 
Scrophulariaceae    





Vítor Spínola   2018                                                      221 
 
 
Tropaeolaceae    
Tropaeolum majus Leaves 30% 8%. 
Flowers 25% 3% 
*This data has been already published in scientific literature. 
Table S 5 - Mineral content of analysed berries collected in different years/collection areas 
determined by ICP-MS. Variation (min-max value) of minerals and trace elements concentration 
levels (µg g-1 of FW) in the analysed berry species. Reprinted (adapted) with permission from [121]. 
 E. umbellata M. faya R. grandifolius V. padifolium 
Ag N.D. N.D. N.D. N.D. 
Al  13 - 86 11 - 200 15 – 260 20.0 – 30.9 
As N.D. N.D. Detected N.D. N.D. 
Ba  1.0 - 1.2 0.14 - 1.6 3.4 – 6.5 3.0 – 3.2 
Ca  925 - 1150 750- 1140 1300 - 2100 770 - 940 
Cd N.D. N.D. N.D. N.D. 
Co  0.03 – 0.04 0.03– 0.31 0.04 – 0.06 0.03 – 0.14 
Cr  Detected Detected – 2.7 Detected – 1.1 Detected 
Cu  5.2– 7.4 1.0 – 3.6 3.1 – 5.9 2.6 – 5.3 
Fe 28 - 40 23 – 302 34 - 273 13.2 - 20.5 
Hg  N.D. N.D. N.D. N.D. 
K  7600 - 8200 3400 – 5800 4300 - 5700 3000 - 3900 
Mg  410 - 440 420 - 770 1350 - 1650 515 - 550 
Mn  8.1 – 12.1 3.7 – 16 23.8 – 43.2 39 - 49 
Mo 0.5 – 0.8 0.06 – 0.34 0.10 – 0.13 N.D. 
Na  60 - 73 1300 - 2600 56 - 88 52 - 66 
Ni  1.2 – 1.6 0.6 – 3.1 0.8 – 1.6 1.0 – 1.1 
P  730 - 1000 275 – 440 610 - 950 510 - 610 
Pb  N.D. N.D. – 0.05 N.D. N.D. 
Sb N.D. N.D. – 0.6 N.D. N.D. 
Se  N.D. N.D. N.D. N.D. 
Sn  N.D. N.D. N.D. N.D. 
Ti  1.4 – 5.2 1.8 – 50.5 2.2 – 48.3 0.33 – 0.79 
Tl  N.D. N.D. N.D. N.D. 
V  Detected Detected – 0.79 Detected – 0.72 N.D. 
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Table S 6 - Mineral content (µg g-1 of FW) of E. umbellata berries collected in consecutive years 
determined by ICP-MS. Data represent the mean ± standard deviation (n = 3). Reprinted (adapted) 
with permission from [121]. 
 2014 2013  2013 2014 
Ag N.D. N.D. Mn 9.08 ± 0.57a 11.83 ± 0.30b 
Al 13.43 ± 0.44a 55.28 ± 31.42b Mo 0.55 ± 0.07a 0.81 ± 0.04b 
As N.D. N.D. Na 65.26 ± 4.22a 73.73 ± 1.11a 
Ba 1.17 ± 0.03 a 1.03 ± 0.02a Ni 1.20 ± 0.01a 1.51 ± 0.10b 
Ca 1038.17 ± 110.89a 974.52 ± 21.78a P 757.44 ± 17.09a 967.82 ± 39.87b 
Cd N.D. N.D. Pb N.D. N.D. 
Co 0.01 ± 0.01a 0.01 ± 0.01a Sb N.D. N.D. 
Cr 0.26 ± 0.02b 0.19 ± 0.01a Se N.D. N.D. 
Cu 5.26 ± 0.10a 6.68 ± 0.69b Sn N.D. N.D. 
Fe 36.11 ± 3.82b 28.48 ± 1.07a Ti 1.77 ± 0.34a 1.71 ± 0.10a 
Hg N.D. N.D. Tl N.D. N.D. 
K 7648.39 ± 7.71a 8228.94 ± 41.14b V 0.09 ± 0.01a 0.08 ± 0.01a 
Mg 415.03 ± 1.84a 430.21 ± 13.20a Zn 5.06 ± 0.57a 15.85 ± 1.51b 
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Table S 7 - Mineral content (µg g-1 of FW) of M. faya berries collected in diferent locations of Madeira Island determined by ICP-MS. Data represent 
the mean ± standard deviation (n = 3). Reprinted (adapted) with permission from [121]. 
 Machico Faial Arco São Jorge Boaventura Seixal Ribeira da Janela Porto Moniz 
Ag N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
Al 71.45 ± 0.22b 187.03 ± 11.08d 169.57 ± 5.45d 13.64 ± 0.44a 12.84 ± 1.07a 83.33 ± 0.38c 67.87 ± 7.15b 
As N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
Ba 0.82 ± 0.01d 0.41 ± 0.01c 0.97 ± 0.58e 0.31 ± 0.01b 0.16 ± 0.02a 0.27 ± 0.02b 0.30 ± 0.02b 
Ca 829.68 ± 25.58bc 757.90 ± 4.40a 800.80 ± 5.50b 874.23 ± 22.28cd 911.63 ± 87.18d 1106.33 ± 29.43e 940.23 ± 34.93de 
Cd N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
Co 0.09 ± 0.01b 0.20 ± 0.02d 0.29 ± 0.02e 0.06 ± 0.01a 0.04 ± 0.01a 0.31 ± 0.01e 0.13 ± 0.01c 
Cr 0.28 ± 0.05b 0.70 ± 0.05d 2.67 ± 0.05e 0.83 ± 0.51d 0.09 ± 0.01a 0.56 ± 0.07cd 0.52 ± 0.05cd 
Cu 2.01 ± 0.03d 1.61 ± 0.20c 2.57 ± 1.00f 1.28 ± 0.01a 1.38 ± 0.02b 2.17 ± 0.09e 2.00 ± 0.05d 
Fe 108.65 ± 3.11b 289.11 ± 14.05d 277.23 ± 22.91d 25.58 ± 2.26a 26.02 ± 2.59a 136.81 ± 19.61c 100.82 ± 8.69b 
Hg N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
K 5471.68 ± 64.08c 3581.05 ± 162.80a 4899.13 ± 23.38b 5756.85 ± 25.30c 3783.45 ± 257.95a 3837.35 ± 92.40a 3862.93 ± 226.33a 
Mg 474.16 ± 11.83b 477.73 ± 23.76b 735.82 ± 34.68e 572.91 ± 15.98c 479.46 ± 24.67b 706.31 ± 2.81d 460.19 ± 21.51a 
Mn 4.59 ± 0.08a 10.31 ± 0.30c 9.60 ± 0.52c 10.15 ± 0.03c 7.56 ± 0.19b 15.46 ± 0.61d 10.59 ± 0.69c 
Mo 0.32 ± 0.02e 0.18 ± 0.01d 0.14 ± 0.01c 0.07 ± 0.01ab 0.08 ± 0.01a 0.10 ± 0.01b 0.11 ± 0.01b 
Na 1718.89 ± 28.46b 2493.98 ± 100.93d 1309.28 ± 9.08a 2253.63 ± 9.08c 2130.15 ± 191.40c 2304.50 ± 112.75cd 1819.68 ± 175.05b 
Ni 2.31 ± 0.06c 2.34 ± 0.14c 2.78 ± 0.08d 2.75 ± 0.33cd 0.58 ± 0.03a 1.51 ± 0.03b 1.47 ± 0.06b 
P 339.35 ± 35.20b 329.45 ± 15.40b 388.30 ± 8.25c 455.13 ± 15.68d 282.43 ± 9.08a 392.98 ± 2.48c 335.50 ± 4.95b 
Pb 0.04 ± 0.01 N.D. N.D. N.D. N.D. N.D. N.D. 
Sb 0.02 ± 0.01a N.D. 0.13 ± 0.02b 0.27 ± 0.06c N.D. 0.02 ± 0.01a 0.53 ± 0.07d 
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Sn N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
Ti 12.13 ± 0.19c 48.46 ± 2.04e 26.46 ± 1.71d 1.87 ± 0.11a 2.12 ± 0.03b 12.95 ± 0.03c 12.93 ± 0.72c 
Tl N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
V 0.27 ± 0.01b 0.76 ± 0.04d 0.65 ± 0.04c 0.06 ± 0.01a 0.07 ± 0.01a 0.31 ± 0.02b 0.26 ± 0.02b 
Zn 5.06 ± 0.50c 4.18 ± 0.17a 5.67 ± 0.55d 5.14 ± 0.25c 4.81 ± 0.08b 4.62 ± 0.22bc 4.18 ± 0.22a 
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Table S 8 - Mineral content (µg g-1 of FW) of R. grandifolius berries collected in diferent locations 
of Madeira Island determined by ICP-MS. Data represent the mean ± standard deviation (n = 3). 
Reprinted (adapted) with permission from [121]. 
 Funchal Machico  Funchal Machico 
Ag N.D. N.D. Mn 24.99 ± 1.09a 42.62 ± 0.62b 
Al 15.71 ± 1.30a 192.62 ± 77.14b Mo 0.11 ± 0.01a 0.12 ± 0.01a 
As N.D. N.D. Na 58.88 ± 2.39a 82.51 ± 5.04b 
Ba 6.11 ± 0.36b 3.41 ± 0.05a Ni 0.95 ± 0.19a 1.29 ± 0.26b 
Ca 1422.75 ± 83.79a 2055.84 ± 47.52b P 629.79 ± 14.49a 902.54 ± 51.55b 
Cd N.D. N.D. Pb N.D. N.D. 
Co 0.05 ± 0.01a 0.06 ± 0.01a Sb N.D. N.D. 
Cr 0.42 ± 0.02a 0.81 ± 0.29b Se N.D. N.D. 
Cu 3.70 ± 0.63a 5.71 ± 0.24b Sn N.D. N.D. 
Fe 35.28 ± 1.18a 214.13 ± 59.86b Ti 2.18 ± 0.04a 34.18 ± 14.11b 
Hg N.D. N.D. Tl N.D. N.D. 
K 4382.70 ± 107.94a 5597.38 ± 95.23b V 0.06 ± 0.01a 0.55 ± 0.17b 
Mg 1384.36 ± 16.30a 1664.47 ± 19.13b Zn 6.41 ± 0.69a 10.75 ± 0.58b 








Table S 9 - Mineral content (µg g-1 of FW) of V. padifolium berries collected in consecutive years i 
determined by ICP-MS. Data represent the mean ± standard deviation (n = 3). Reprinted (adapted) 
with permission from [121]. 
 2013 2014  2013 2014 
Ag N.D. N.D. Mn 48.05 ± 0.66b 40.26 ± 0.86a 
Al 29.47 ± 1.22b 20.76 ± 1.09a Mo N.D. N.D. 
As N.D. N.D. Na 57.09 ± 4.36a 62.34 ± 3.66a 
Ba 3.07 ± 0.10a 3.14 ± 0.03a Ni 1.12 ± 0.01a 1.06 ± 0.07a 
Ca 930.60 ± 3.96b 785.73 ± 12.87a P 583.44 ± 20.46b 532.29 ± 25.41a 
Cd N.D. N.D. Pb N.D. N.D. 
Co 0.01 ± 0.01a 0.05 ± 0.01a Sb N.D. N.D. 
Cr 0.13 ± 0.01a 0.28 ± 0.01b Se N.D. N.D. 
Cu 3.88 ± 0.08a 3.93 ± 1.35a Sn N.D. N.D. 
Fe 13.66 ± 0.07a 19.54 ± 0.79b Ti 0.40 ± 0.02a 0.67 ± 0.11b 
Hg N.D. N.D. Tl N.D. N.D. 
K 3772.23 ± 96.03a 3148.86 ± 72.60b V N.D. N.D. 
Mg 538.86 ± 6.04a 533.61 ± 13.27a Zn 5.97 ± 0.43a 4.88 ± 0.92a 
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1. Identification of phytochemicals of methanolic extracts 
The aim of this part of the work was to characterize the phytochemical composition of methanolic 
extracts by HPLC-ESI/MSn. An essential step in these analyses was to determine the molecular weight of each 
compound. In general, in the negative ionization mode (ESI−) MS1 spectrum, the most intense peak 
corresponded to the deprotonated molecular ion [M-H]; this permitted to perform further MSn analysis. 
Moreover, this assignment was more consistent if adduct ions and dimers were present. Most compounds were 
observed in their glycosylated form. The mass spectra of the conjugated phenolic compounds showed the 
aglycone ion as result of the loss of sugar moieties like glucuronyl, hexosyl, deoxyhexosyl, pentosyl, and 
rutinosyl (-176, −162, −146, −132 and −308 Da, respectively). Data from the positive ionization (ESI+) mode 
was used for identification of ANTCs and confirmation purposes.  
When reference substances were available, extract components were identified by comparing the 
HPLC retention time, UV and mass spectra, with those obtained for the standard. However, since the access to 
pure reference compounds was limited, characterization of most of the PCs was assigned based on comparison 
of the MSn fragmentation patterns and UV-vis spectra with information available in scientific literature. 
Additionally, some derivatives of phytochemicals were putatively assigned, on the basis of analogous 
fragmentations. 
The results of HPLC-DAD-ESI/MSn screening will be presented for each plant individually. 
Compounds were numbered by their order of elution and this numeration was kept identical for berries and 
leaves, so the same compounds may have different numbers in different extracts. Identification will be presented 
in the next subsections, grouping the compounds by the family of the respective aglycones. Some of the 
compounds were present in all analysed extracts while some were absent. For clarity’s sake, the discussion of 
available data for each compound will be presented for the first plant in which it appears and not repeated for 
subsequent plant species. 
 
1.1. Elaeagnus umbellata 
Following is a brief explanation for the identification of the compounds in E.umbellata extracts 
collected in 2013 and 2014 (Table S 10). For a more detailed explanation, please check the mentioned 
references. 
1.1.1. Phenolic compounds 
Compound 23 displayed [M-H]- ion at m/z 551 and MS2 base peak at m/z 529 (by loss of 22 Da). 
Further MSn fragmentation gave origin to product ions at m/z 169 and 125, typical of gallic acid (corroborative 
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Compounds 25 and 28 exhibited [M-H+HCOO]- ions at m/z 563. Sequential fragmentation gave origin to 
product ion at m/z 517. The 46 Da residue can be attributed to a formate adduct from the mobile phase. After 
loss of 132 Da, fragment ions at m/z 385 [M-H-sinapoyl+162]-, 223 [M-H-sinapoyl]- , 208 [M-H-sinapoyl-15]- 
and 164 [M-H-sinapoyl-44]- were detected [197]. Therefore, 25 was tentatively identified as sinapic acid-O-
(pentosyl)hexoside. Sinapic acid-O-hexoside (compounds 29 and 35) was also identified in analyzed extracts 
[197]. Compound 34, with [M-H]- ion at m/z 489, showed a loss of 266 Da at MS2. Fragment ion at m/z 223 
was identified as sinapic acid [197], hence, 34 was tentatively characterized as a derivative. Similarly, 
compound 41 showed [M-H]- ion at m/z 503 and was identified as another derivative of sinapic acid. Compound 
31, with [M-H]- ion at m/z 565 was identified a caffeic acid-O-(sinapoyl-O-hexoside) [198]. Compounds 46 
and 78 displayed [M-H]- ions at m/z 389 and 429, respectively. They followed different fragmentation patterns 
but had in common fragment ion at m/z 179 and 135, which are characteristic of caffeic acid (compared with 
analytical standard). Based only on the available data it was not possible to fully characterize these compounds; 
46 and 78 were assigned as derivatives. 3,5-O-dicaffeoylquinic acid (compound 70) was identified based on 
comparison with a reference standard solution. 
Digalloyl-O-glucoside (compound 66) was identified in leaves extract [199]. Compound 68 exhibited 
[M-H]- ion at m/z 689 and suffered a loss of 224 Da. The presence of product ions at m/z 635 at MS2 and 465, 
313, 169 and 125 at MS3 was indicative of trigalloylglucose [200,201]. Hence, 68 was tentatively characterize 
as a derivative. 
1.1.2. Flavonols 
Several quercetin glycosides (compounds 14, 27, 30, 43, 48, 49, 51 and 61) were characterized in the 
methanolic extracts of E. umbellata, based on literature data [84,200,202,203].  Compound 67, with [M-H]- ion 
at m/z 839, yielded fragment ion at m/z 625 (by loss of 214 Da). Sequential fragmentation was corroborative 
with that of quercetin-O-dihexoside [200]. With no more available information, 67 was tentatively characterized 
as a derivative. 
Kaempferol derivatives were abundant in the analyzed extracts. Their identification (compounds 26, 
36, 37, 50, 69, 73, 76, 87 and 89) was achieved based on previous works [125,200,203]. Compound 63, with 
[M-H]- ion at m/z 579, suffered a loss of 294 Da at MS2. This could be attributed to a combined pentose 
(arabinose, xylose or apiose) plus hexose (glucose, mannose and galactose) (132 + 162 Da) moiety. 
Fragmentation of product ion at m/z 285 was consistent with MSn data of kaempferol standard (fragment ions 
at m/z 257, 255, and 229). Hence, 63 was tentatively characterized as kaempferol-O-
(pentosyl)hexoside.Compound 80 showed [M-H]- ion at m/z 755. It presented the same fragmentation pattern 
as compound 26. However, due to the latter retention time, the loss of 146 Da is assigned to a coumaroyl residue 
rather than a rhamnosyl. Generally, flavonoid glycosides esterified with aromatic acids have higher retention 
times than their diglycosides, monoglycosides and aglycones [204]. Thus, 80 was tentatively characterized as 
kaempferol-O-(coumaroyl)dihexoside. Similarly, compounds 87 and 89 with [M-H]- ions at m/z 593, were 
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coumaroyl(hexoside) group (146 + 162 Da) instead of a rutinoside due to the presence of fragment ion at m/z 
447 [M-H-146]-. 
Many isorhamnetin derivatives were found in this analysis (Table S 10). Compound 33 displayed [M-
H]- ion at m/z 759 and suffered a loss of 210 Da at MS2. Further fragmentation gave origin to product ion at 
m/z 491 (by loss of a 58 Da residue). Finally, it resulted in isorhamnetin aglycone at m/z 315 (after loss of 176 
Da) and its typical fragment ions at m/z 299 and 271 [200]. With no more available information, 33 was 
tentatively characterized as derivative of isorhamnetin-O-glucuronide. Compound 38, with [M-H]- ion at m/z 
755, gave origin to MS2 base peak at m/z 609 (by loss of 146 Da). Sequential fragmentation showed a loss of 
294 Da to produce isorhamnetin aglycone (at m/z 315). Hence, 38 was tentatively identified as isorhamnetin-
O-(pentosyl)hexoside-O-rhamnoside. Compounds 60 and 65 showed [M-H]- ions at m/z 609 and, by analogy, 
were characterized as isorhamnetin-O-(pentosyl)hexoside. Compound 75 displayed [M-H]- ion at m/z 845. It 
gave origin to MS3 base peak at m/z 639, after loss of 206 Da. This residue can be attributed to a sinapoyl unit 
attached to the molecule [205]. Fragmentation pattern of product ion at m/z 639 matched that of isorhamnetin-
O-dihexoside [200]. Thus, 75 was tentatively characterized as isorhamnetin-O-(sinapoyl)dihexoside. 
Isorhamnetin-O-dipentoside (compound 77) was also characterized. After a combined loss of two pentoside 
units (132 + 132 Da) from [M-H]- ion at m/z 579, it gave origin to isorhamnetin (at m/z 315). Compound 79 
presented [M-H]- ion at m/z 815. After loss of  176 Da, it gave origin to isorhamnetin-O-dihexoside at m/z 639 
[200]; it was tentatively characterized as isorhamnetin-O-(glucuronyl)dihexoside-O-glucuronide. Compound 
84, with [M-H]- ion at m/z 805, suffered a loss of 166 Da at MS2 to yield product ion at m/z 639 (previously 
identified as isorhamnetin-O-dihexoside). By analogy, 84 was tentatively identified as a derivative. 
Compound 39 displayed [M-H]- ion at m/z 611. Fragmentation gave origin to product ions at m/z 317, 
217 and 179 (after loss of 294 Da), characteristic of myricetin [200]. Hence, 39 was tentatively characterized 
as myricetin-O-(pentosyl)hexoside. 
1.1.3. Flavones 
Compounds 88 and 91 were characterized as diosmetin-8-C-dihexoside. They presented [M-H]- ions 
at m/z 581 and suffered a neutral loss of 120 Da to yield product ion at m/z 461. Sequential fragmentation 
showed another 120 Da loss, typical of C-glycosides flavonoids [205]. Based on previous publications 
[198,200], fragment ion at m/z 461 was identified as diosmetin-8-C-hexoside. Compound 90, with [M-H]- ion 
at m/z 623, gave origin to MS2 base peak at m/z 299 (after a combined loss of 324 Da). This main product ion 
was identified as diosmetin [198], hence, 90 was tentatively characterized as diosmetin-O-dihexoside. 
1.1.4. Ellagic acid derivatives/Ellagitannins 
Ellagitannins were common on E. umbellata extracts and their identification was achieved by 
comparison with literature [199,200,206]: hexahydroxydiphenoyl(HHDP)-O-glucose (compound 7 and 12), 
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Compound 40 exhibited [M-H]- ion at m/z 463 was identified as ellagic acid-O-hexoside [107]. With an [M-H]- 
ion at m/z 475, compound 42 was tentatively characterized as ellagic acid-O-(acetyl)pentoside. The direct loss 
of 174 Da (132 + 42 Da) can be associated with a pentoside plus acetyl moiety. 
1.1.5. Other compounds 
Additionally, some non-phenolic compounds (saccharides, organic acids, terpenoids) were also 
identified in this analysis.Compound 1 displayed [M-H]- ion at m/z 179. Fragmentation yielded product ions at 
m/z 161, 143, 131, 119, 113 and 89, which was consisted with that of hexosides [207]. Similarly, compound 4 
was characterized as a polymer of hexoses. Compound 2, with [M–H]- ion at m/z 473, was identified as a 
trisaccharide, containing a pentose and two hexose units [125]. Other compounds with similar fragmentation 
ions (19, 47, 52, 53, 55, 57 - 59, 62, 64 and 94) were tentatively characterized as saccharides. 
Compound 3 showed [M-H]- ion at m/z 295. After loss of 116 Da, characteristic of malic acid 
derivatives [208], it gave origin to a hexose at m/z 179. Thus, 3 was tentatively characterized as hexosyl-malic 
acid. With an extra 295 Da moiety, compound 5 was identified as a dimmer. Compound 8 was identified as 
quinic acid, by comparison with analytical standard (data not shown). Compound 6, with [M-H]- ion at m/z 533, 
was characterized as a derivative [106]. Malic and citric acids (compounds 10 and 11) were identified based on 
literature data [198]. 
Compound 32 presented [M-H+HCOO]- at m/z 431 and suffered the loss of 46 Da (formate) to produce 
the ion at m/z 385, which was identified as a roseoside (vomifoliolglucoside) [209]. 
Compound 71 showed a [M-H]- ion at m/z 649. It suffered a loss of 180 Da to yield base peak at m/z 
469. Further fragmentation resulted in product ion at m/z 187 (after loss of 282 Da). By comparison with 
literature [210], fragment ion at m/z 187 was identified as 2-methylaconitate. With no further information about 
its structure, 71 was tentatively characterized as a derivative. 
Compound 81 exhibited [M-H+HCOOH]- ion at m/z 711. The combined loss of 208 Da (162 + 46 Da), 
generated product ion at m/z 503. Further fragmentation was corroborative with that of triterpene acid [211]. 
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m/z (% base peak) 
Assigned identity Berries Leaves References 
1 3.1 179 MS2 [179]: 161 (76.9), 149 (17.8), 143 (76.5), 131 (24.7), 119 (47.6), 113 (57.6). 101 
(27.8). 89 (100) 
Hexose   [207] 
2 3.2 473 MS2 [473]: 342 (17.3), 341 (100), 221 (12.9), 179 (46.0), 132 (26.5) 
MS3 [473→341]: 323(27.9), 281 (11.0), 179 (100), 161 (32.8), 143 (11.4) 
MS4 [473→341→179]: 161 (13.5), 131 (53.7), 119 (37.6), 113 (19.6), 107 (23.3), 89 
(100) 
Oligosaccharide 
(Pentose + dihexose) 
  [125] 
3 3.3 295 MS2 [295]: 235 (20.6), 205 (21.9); 179 (99.4). 161 (13.5), 133 (100); 115 (11.4) 
MS3 [295→179]: 161 (581), 149 (12.1), 143 (72.6), 131 (25.7), 119 (50.8), 113 (23.3), 89 
(100) 
Hexosyl-malic acid    
4 3.3 683 
[3M-H]- 
MS2 [683]: 342 (14.4), 341 (100) 
MS3 [683→341]: 179 (100), 161 (30.2), 143 (18.1), 119 (13.2), 113 (20.3), 101 (14.3) 
MS4 [683→341→179]:161 (58.6), 143 (43.6), 131 (15.4), 119 (46.9), 113 (20.2), 101 
(39.8), 89 (100), 71 (35.8), 59 (26.7) 
Hexose polymer   [207] 
5 3.4 591 
[2M-H]- 
MS2 [591]: 295 (100) 
MS3 [591→295]: 235 (21.8), 205 (19.6), 179 (100); 161 (11.1), 143 (11.2), 133 (71.3), 
119 (10.7), 113 (12.1), 89 (13.3) 
Hexosyl-malic acid dimer    
6 3.5 533 MS2 [533]: 191 (100.0) 
MS3 [533→191]: 153 (11.4), 127 (100.0), 111 (26.6), 93 (74.5), 85 (66.5) 
Quinic acid derivative   [106] 
7 3.6 481 MS2 [481]: 301 (100), 275 (19.2) 
MS3 [481→301]: 257 (38.3), 245 (23.8), 185 (100) 
HHDP-O-glucose   [206] 
8 3.7 191 MS2 [191]: 173 (76.9), 171 (13.8), 127 (100.0), 111 (77.5), 109 (37.4), 93 (47.9), 87 
(28.2), 85 (82.9), 81 (17.6) 
MS3 [191→127]: 109 (21.1), 85 (100) 
Quinic acid   Standard 
9 3.9 133 MS2 [133]: 115 (100) 
MS3 [133→115]: 71 (100) 
Malic acid   [198] 
10 4.0 783 MS2 [783]: 765 (10.8), 721 (10.4), 481 (41.7), 301 (100), 275 (23.7) 
MS3 [783→301]: 299 (100), 257 (22.8), 256 (24.5), 240 (14.6), 230 (21.0), 157 (10.1) 
bis-HHDP-O-glucose 
(Pedunculagin I) 
  [200] 
11 4.4 191 MS2 [191]: 173 (18.7), 111 (100) 
MS3 [191→111]: 67 (100) 
Citric acid   [198] 
12 4.6 481 MS2 [481]:301 (100), 275 (12.8) 
MS3 [481→301]:257 (100), 242 (54.5), 229 (41.9), 214 (51.5), 186 (72.9), 173 (84.1), 
147 (38.0) 
HHDP-O-glucose   [206] 
13 4.9 783 MS2 [783]:765 (12.5), 721 (13.0), 481 (38.4), 301 (100), 275 (28.7) 
MS3 [783→301]:299 (100), 284 (19.8), 257 (19.4), 245 (18.9), 229 811.7), 213 (77.9) 
MS4 [783→301→299]: 281 (100) 
bis-HHDP-O-glucose  
(Pedunculagin I) 
  [200] 
14 5.2 757 MS2 [757]: 596 (25.2), 595 (100) 
MS3 [757→595]: 445 (17.9), 301 (49.8), 300 (100), 271 (14.9), 255 (11.0) 
MS4 [757→595→301]: 273 (11.5), 272 (27.2), 271 (100), 256 (11.6), 255 (30.0), 201 
(11.0), 179 (32.4), 151 (40.1) 
Quercetin-O-(pentosyl)dihexoside   [202] 
15 5.4 783 MS2 [783]: 669 (11.6), 481 (11.3), 301 (100), 275 (18.5), 249 (22.4), 243 (12.6) bis-HHDP-O-glucose  
(Pedunculagin I) 
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16 5.7 305 MS2 [305]: 261 (12.2), 221 (47,7), 219 (56.0), 179 (100), 165 (28.1), 137 (30.8), 125 
(40.2) 
MS3 [305→179]: 165 (66.9), 164 (53.2), 152 (35.0), 151 (100), 135 (76.1) 
Gallo(epi)catechin   [106] 
17 5.8 783 MS2 [783]:481 (30.5), 301 (100), 275 (17.8) 
MS3 [783→301]: 300 (10.5), 285 (15.7), 283 (24.3), 273 (14.8), 257 (87.8), 245 (34.6), 
241 (23.9), 229 (100), 213 (29.7) 
MS4 [783→301→257]:185 (100) 
bis-HHDP-O-glucose  
(Pedunculagin I) 
  [200] 
18 6.1 583 MS2 [583]:538 (25.6), 537 (100) 
MS3 [583→537]:491 (60.2), 406 (16.0), 405 (100), 293 (29.0), 243 (34.4), 225 (10.4), 
191 (71.3), 168 (21.4), 161 (25.3), 149 (55.7) 
Unknown    
19 6.5 451 MS2 [451]:405 (100) 
MS3 [451→405]: 243 (46.7), 179 (25.7), 167 (20.5), 161 (12.7), 153 (44.0), 149 (100), 
143 (11.6), 119 (22.2) 
Saccharide    
20 7.0 783 MS2 [783]: 481 (27.0), 301 (100), 275 (16.3) 
MS3 [783→301]: 273 (25.5), 258 (23.9), 257 (100), 229 (35.8), 227 (22.3), 213 815.4), 
202 (22.8), 186 (38.4), 169 (30.4), 145 (27.1) 
bis-HHDP-O-glucose  
(Pedunculagin I) 
  [200] 
21 7.4 633 MS2 [633]: 614 (17.1), 463 (13.2), 301 (100), 273 (10.7), 271 (13.9) 
MS3 [633→301]: 299 (53.5), 257 (100) 
Galloyl-HHDP-O-hexoside   [199] 
22 7.9 633 MS2 [633]: 301 (100) 
MS3 [633→301]: 286 (12.1), 275 (27.6), 258 (60.9), 257 (100), 245 (20.1), 230 (27.7), 
229 (32.8), 202 (48.9), 201 (14.9), 186 (44.1) 
Galloyl-HHDP-O-hexoside   [199] 
23 8.0 551 MS2 [551]: 529 (100) 
MS3 [551→529]: 467 (100), 458 (20.6), 301 (10.6) 
MS4 [551→529→467]: 301 (100), 299 (53.0), 289 (14.3), 285 (50.0), 277 (43.5), 169 
(84.6), 125 (38.1) 
Gallic acid derivative    
24 8.3 935 MS2 [935]: 917 (20.9), 659 (21.2), 633 (100), 615 (36.7), 571 (18.5), 329 (25.4), 301 
(21.9), 299 (49.4) 
MS3 [935→633]: 615 (76.5), 571 (70.3), 481 (44.3), 383 (31.7), 329 (76.1), 301 (28.7), 
299 (100), 275 (26.5) 
Galloyl-bis-HHDP hexoside  
(Casuarinin) 
  [106] 
25 8.5 563 
 
MS2 [563]: 517 (100) 
MS3 [563→517]: 385 (93.1), 223 (89.7), 208 (100), 164 (52.3),  
MS4 [563→517→208]: 164 (100) 
Sinapic acid-O-pentosyl(hexoside) 
(formate adduct) 
   
26 8.6 755 MS2 [755]: 610 (23.7), 609 (100) 
MS3 [755→609]: 430 (11.9), 429 (57.4), 285 (100), 284 (55.4), 257 (17.2), 255 (15.2) 
MS4 [755→609→285]: 257 (64.6), 255 (79.8), 229 (43.9), 164 (18.6), 151 (100) 
Kaempferol-O-dihexoside-O-rhamnoside   [203] 
27 8.7 741 MS2 [741]: 595 (100), 446 (11.3), 271 (10.6) 
MS3 [741→595]: 475 (33.1), 449 (22.3), 301 (44.4), 300 (100), 271 (15.5), 215 (11.0), 
179 (11.1) 
MS4 [741→595→300]: 271 (22.7), 255 (42.5), 179 (100) 
Quercetin-O-(pentosyl)hexoside-O-
rhamnoside 
  [203] 
28 8.8 563 
 
MS2 [563]: 518 (24.4), 517 (100)  
MS3 [563→517]: 387 (25.0), 385 (90.7), 365 (45.5), 293 (26.3), 223 (90.1), 208 (100), 
164 (46.1) 
Sinapic acid-O-(pentosyl)hexoside  
(formate adduct) 
   
29 9.0 385 MS2 [385]: 223 (100), 205 (73.6), 163 (10.5) 
MS3 [385→223]: 208 (17.0), 164 (100), 149 (12.1) 
Sinapic acid-O-hexoside 
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30 9.1 741 MS2 [741]: 595 (100), 446 (12.0), 300 (17.0) 
MS3 [741→595]: 463 (20.2), 445 (43.7), 368 (19.3), 343 (36.2), 301 (38.0), 300 (100), 
273 (42.1), 257 (10.1), 179 (15.4) 
MS4 [741→595→300]: 271 (100), 179 (36.7) 
Quercetin-O-(pentosyl)hexoside-O-
rhamnoside 
  [203] 
31 9.3 565 MS2 [565]: 520 (13.0), 519 (17.8), 403 (100), 385 (14.7), 325 (10.9), 223 (66.9), 221 
(15.4), 179 (16.6) 
MS3 [565→403]: 223 (89.5), 149 (27.5), 135 (100) 
Caffeic acid-O-(sinapoyl-O-hexoside)   [198] 
32 9.5 431 
 
MS2 [431]: 385 (100), 223 (13.5) 
MS3 [431→385]: 223 (64.4), 206 (11.7), 205 (48.9), 161 (21.2), 153 (100), 138 (18.5) 
MS4 [431→385→153]: 138 (100), 136 (56.9), 114 (40.8), 97 (26.7) 
Roseoside 
(formate adduct) 
  [209] 
33 9.8 759 MS2 [759]: 651 (16.0), 639 (30.8), 621 (20.3), 579 (53.8), 549 (100) 
MS3 [759→549]: 531 (21.1), 519 (49.8), 491 (100), 477 (83.4), 315 (52.0), 271 (15.2) 
MS4 [759→549→491]: 315 (100), 300 (76.9), 299 (40.8), 271 (36.7) 
Isorhamnetin-O-glucuronide derivative    
34 10.5 489 MS2 [489]: 446 (10.6), 295 (15.0), 283 (11.9), 265 (18.5), 223 (100), 208 (11.6), 205 
(45.3), 190 (30.4), 175 (20.7), 164 (34.1), 149 (37.5) 
MS3 [489→223]: 208 (77.7), 179 (100), 164 (43.9) 
Sinapic acid derivative    
35 10.6 385 MS2 [385]: 325 (100), 295 (92.3), 265 (84.6), 223 (25.8) 
MS3 [385→325]: 307 (34.3), 265 (82.0), 223 (100), 206 (48.1) 
MS4 [385→325→223]:164 (100) 
Sinapic acid-O-hexoside   [197] 
36 10.7 725 MS2 [725]: 622 (12.8), 580(35.0), 579 (100) 




  [203] 
37 10.9 449 MS2 [449]: 287 (100), 269 (32.4), 259 (53.9) 
MS3 [449→287]: 259 (100), 243 (27.0), 201 (17.2), 173 (20.6), 151 (63.6), 125 (40.1), 
119 (10.6) 
Dihydrokaempferol-O-hexoside   [125] 
38 11.1 755 MS2 [755]: 609 (100) 
MS3 [755→609]: 459 (25.7), 315 (100), 300 (13.4), 299 (13.6), 271 (16.9), 243 (13.3) 
MS4 [755→609→315]: 301 (21.1), 300 (100), 299 (91.8), 298 (16.1), 259 (20.9) 
Isorhamnetin-O-(pentosyl)hexoside-O-
rhamnoside 
   
39 11.2 611 MS2 [611]: 474 (15.9), 463 (22.8), 447 (17.0), 329 (12.3), 317 (100), 272 (11.0), 
270(20.0), 251 (18.4) 
MS3 [611→317]: 272 (76.2), 271 (100), 179 (25.0) 
Myricetin-O-(pentosyl)hexoside    
40 11.4 463 MS2 [463]: 301 (100), 300 (35.6) 
MS3 [463→301]: 300 (90.9), 257 (100), 229 (61.3), 207 (27.7), 172 (33.3) 
Ellagic acid-O-hexoside   [107] 
41 11.8 503 MS2 [503]: 223 (100), 205 (56.7), 191 (22.0), 164 (14.1), 149 (25.9) 
MS3 [503→223]: 179 (100), 164 (65.5), 149 (76.1) 
Sinapic acid derivative    
42 12.7 475 MS2 [475]: 301 (100), 275 (11.3) 
MS3 [475→301]: 257 (100), 230 (22.3), 213 (27.5), 201 (29.8), 200 (29.0), 192 (34.7), 
186 (14.7), 185 (34.0) 
Ellagic acid-O-(acetyl)pentoside    
43 13.0 625 MS2 [625]: 505 (15.6), 463 (12.0), 445 (38.2), 301 (100), 300 (97.6), 271 (21.3), 255 
(22.0) 
MS3 [625→300]: 284 (13.6), 271 (100), 199 (13.4), 179 (50.6), 151 (41.5), 121 (15.5) 
Quercetin-O-dihexoside   [200] 
44 13.2 371 MS2 [371]: 249 (100) 
MS3 [371→249]: 231 (41.1), 113 (100), 99 (12.5), 95 (27.3), 85 (49.4) 
Unknown   [209] 
45 13.9 371 MS2 [371]: 249 (100) 
MS3 [371→249]: 231 (47.1), 175 (10.9), 113 (100), 111 (12.2), 99 (20.5), 85 (36.3) 
Unknown   [209] 
46 14.0 389 MS2 [389]: 209 (100), 181 (19.1), 179 (76.2), 135 (35.8) 
MS3 [389→209]: 135 (100) 
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47 14.3 725 MS2 [725]: 545 (100), 313 (12.9) 
MS3 [725→545]: 351 (13.0), 313 (100), 295 (20.2), 249 (11.4), 247 (12.5), 231 (26.8), 
229 (18.2), 187 (16.5), 179 (10.8), 161 (13.9) 
MS4 [725→545→313]: 179 (100), 161 (85.9), 115 (40.7), 113 (63.4), 101 (63.4), 89 
(49.0) 
Saccharide    
48 14.4 595 MS2 [595]: 445 (14.8), 301 (46.2), 300 (100), 271 (20.6) 
MS3 [595→301]: 271 (100), 257 (12.2), 255 (89.0), 243 (10.0), 179 (42.8), 151 (52.1) 
Quercetin-O-(pentosyl)hexoside   [84] 
49 14.8 433 MS2 [433]: 301 (100), 300 (52.3 
MS3 [433→301]: 300 (100), 257 (40.7), 179 (53.8), 151 (55.5) 
Quercetin-O-pentoside   [84] 
50 15.1 609 MS2 [609]: 576 (57.3), 447 (72.2), 301 (48.2), 285 (100), 255 (25.1) 
MS3 [609→285]: 255 (100) 
Kaempferol-O-dihexoside   [203] 
51 15.1 595 MS2 [595]: 445 (10.9), 301 (57.6), 300 (100), 271 (15.4), 255 (11.9) 
MS3 [595→300]: 271 (100), 255 (59.9), 179 (36.9), 151 (34.4) 
Quercetin-O-pentosyl(hexoside)   [84] 
52 15.5 547 MS2 [547]:503 (10.6), 311 (100), 265 (10.9), 221 (13.6) 
MS3 [547→311]: 293 (23.9), 275 (36.0), 251 (62.5), 233 (50.0), 221 (22.0), 179 (29.5), 
161 (16.7), 149 (100), 113 (46.6) 
Saccharide    
53 15.7 551 MS2 [551]: 505 (100) 
MS3 [551→505]: 373 (100), 179 (22.3), 161 (54.4) 
MS4 [551→505→373]: 161 (100), 119 (11.6), 113 (15.9) 
Saccharide    
54 16.1 639 MS2 [639]: 477 (21.0), 315 (100), 300 (22.6), 299 (17.3), 271 (16.2) 
MS3 [639→315]: 301 (11.0), 300 (100), 299 (22.6) 
Isorhamnetin-O-dihexoside   [200] 
55 16.3 547 MS2 [547]: 311 (100), 191 (14.1), 161 (21.8) 
MS3 [547→311]: 293 (15.1), 251 (22.0), 179 (42.4), 161 (78.9), 149 (100), 119 (10.3), 
101 (85.1) 
Saccharide    
56 16.6 597 MS2 [597]:489 (15.1), 477 (49.4), 459 (17.2), 417 (15.9), 387 (67.8), 357 (100) 
MS3 [597→357]: 209 (100), 139 (11.0), 123 (27.6) 
MS3 [597→387]: 315 (100), 239 (37.1), 221 (14.8), 191 (18.5), 167 (12.0), 161 (11.0), 
153 (10.4) 
MS4 [597→357→209]: 165 (28.3), 164 (63.7), 123 (100), 121 (23.6) 
MS4 [597→357→315]: 209 (41.4), 190 (21.3), 167 (100), 139 (28.5) 126 (37.7) 
Unknown    
57 17.1 551 MS2 [551]: 505 (100) 
MS3 [551→505]: 373 (100), 161 (22.7) 
MS4 [551→505→373]: 179 (17.9), 161 (100), 143 (18.3), 113 (25.9) 
Saccharide    
58 17.4 547 MS2 [547]: 311 (100), 179 (14.1), 161 (21.8) 
MS3 [547→311]: 293 (15.1), 251 (22.0), 179 (42.4), 161 (78.9), 149 (100), 119 (10.3), 
101 (85.1) 
Saccharide    
59 18.0 415 MS2 [415]: 370 (51.9), 227 (75.2), 225 (81.0), 187 (67.1), 179 (100), 161 (23.9), 131 
(14.5) 
MS3 [415→179]: 161 (100), 143 (14.2), 119 (15.3) 
Saccharide    
60 18.9 609 MS2 [609]: 578 (10.7), 477 (43.7), 357 (11.1), 315 (100), 314 (82.8), 300 (29.7) 
MS3 [609→315]: 301 (20.6), 300 (100), 299 (72.2), 287 (10.1), 271 (58.1), 255 (39.7), 
243 (39.6) 
Isorhamnetin-O-(pentosyl)hexoside    
61 19.0 463 MS2 [463]: 415 (99.4), 301 (100), 299 (37.1) 
MS3 [463→301]: 151 (100) 
Quercetin-O-hexoside   [84] 
62 19.0 549 MS2 [549]: 503 (100) 
MS3 [549→503]: 417 (10.0), 371 (100), 353 (11.6), 191 (14.3), 173 (10.1), 161 (37.5), 
149 (25.5), 143 (10.5) 
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MS4 [549→503→371]:161 (100) 
63 19.5 579 MS2 [579]: 429 (28.1), 339 (10.6), 285 (100), 284 (47.0), 257 (12.3), 255 (14.9) 
MS3 [579→285]: 257 (94.1), 255 (100), 229 (83.2), 199 (28.9), 151 (54.8) 
Kaempferol-O-pentosyl(hexoside)    
64 19.6 549 
 
MS2 [549]: 504 (16.9), 503 (100) 
MS3 [549→503]: 372 (28.9), 371 (100), 293 (17.3), 179 (15.4), 161 (22.3) 
MS4 [549→503→371]: 179 (49.8), 161 (100), 131 (15.8), 119 (23.3), 113 (55.1) 
Saccharide 
(formate adduct) 
   
65 20.4 609 MS2 [609]: 577 (10.7), 459 (35.1), 315 (100), 300 (25.9), 299 (21.1), 271 (14.8) 
MS3 [609→315]:300 (100), 299 (72.2), 271 (45.8), 255 (45.9), 243 (11.5) 
Isorhamnetin-O-pentosyl(hexoside)    
66 20.6 483 MS2 [483]: 434 (15.8), 413 (21.6), 410 (31.9), 331 (50.3), 313 (32.7), 211 (90.9), 177 
(75.7), 169 (100), 151 (24.1) 
MS3 [483→169]: 125 (100) 
Digalloyl-O-glucoside   [199] 
67 21.3 839 MS2 [839]: 639 (14.4), 625 (100), 300 (11.5) 
MS3 [839→625]: 505 (26.6), 463 (11.8), 445 (67.8), 301 (55.2), 300 (100), 299 (11.1), 
271 (45.6), 179 (22.3) 
MS4 [839→625→301]: 271 (100), 257 (11.4), 179 (66.0), 151 (26.6) 
Quercetin-O-dihexoside derivative    
68 24.5 689 MS2 [689]: 635 (57.5), 519 (27.4), 465 (100), 313 (21.5) 
MS3 [689→465]:313 (100), 295 (25.8), 169 (12.2), 125 (19.8) 
MS4 [689→465→313]: 169 (100), 125 (21.5) 
Trigalloylglucose derivative    
69 24.7 447 MS2 [447]: 285 (59.3), 284 (100), 255 (26.5) 
MS3 [447→285]: 255 (100), 229 (21.4) 
Kaempferol-O-hexoside   [200] 
70 25.8 515 MS2 [515]: 353 (100) 
MS3 [515→353]: 191 (100), 179 (29.3), 161 (10.8), 135 (15.7) 
3,5-O-Dicaffeoylquinic acid   Standard 
71 25.7 649 MS2 [649]: 469 (100) 
MS3 [649→469]:425 (27.8), 237 (18.0), 231 (12.7), 205 (37.0), 187 (79.7), 161 (100) 
MS4 [649→469→161]:129 (100) 
MS4 [649→469→187]:143 (100) 
2-Methylaconitate derivative    
72 25.8 477 MS2 [477]: 467 (20.9) 358 (26.0), 315 (100), 301 (14.9), 287 (42.3), 257 (10.9), 244 
(14.0), 173 (42.9) 
MS3 [477→315]: 300 (100), 285 (17.1), 271 (31.9) 
Isorhamnetin-O-hexoside   [212] 
73 26.1 447 MS2 [447]:327 (10.2), 285 (100), 255 (16.2) 
MS3 [447→285]: 255 (100), 229 (10.9), 201 (25.3) 
Kaempferol-O-hexoside   [200] 
74 26.9 477 MS2 [477]: 357 (10.3), 315 (100), 301 (10.5), 285 (27.4), 271 (14.1) 
MS3 [477→315]: 301 (51.7), 300 (22.2), 299 (76.9), 286 (86.6), 285 (54.7), 271 (100), 
257 (52.6), 243 (23.3) 
Isorhamnetin-O-hexoside    [212] 
75 27.0 845 MS2 [845]: 653 (82.1), 639 (100), 515 (18.0), 459 (12.8), 413 (11.1), 330 (11.0), 315 
(23.0), 300 (10.4) 
MS3 [845→639]: 607 (12.6), 491 (21.9), 477 (14.4), 459 (40.4), 417 (18.4), 393 (21.1), 
315 (100), 300 (41.9) 
MS4 [845→639→315]: 301 (24.4), 300 (100), 299 (49.6), 257 (13.2) 
Isorhamnetin-O-(sinapoyl)dihexoside     
76 27.1 447 MS2 [447]:285 (100), 284 (97.4), 255 (29.8) 
MS3 [447→285]: 255 (100), 229 (10.3) 
Kaempferol-O-hexoside    [200] 
77 27.9 579 MS2 [579]: 533 (14.3), 315 (100), 299 (13.4), 271 (14.8) 
MS3 [579→315]: 300 (100), 299 (15.1), 271 (34.9), 151 (15.6) 
Isorhamnetin-O-dipentoside    
78 28.0 429 MS2 [429]: 249 (100), 205 (89.2), 179 (13.7), 161 (63.7), 135 (17.2) Caffeic acid derivative    
79 28.7 815 MS2 [815]: 653 (63.0), 639 (100), 485 (11.4), 329 (11.0), 315 (18.9) 
MS3 [815→639]: 607 (18.8), 580 (23.4), 491 (20.7), 459 (46.1), 433 (18.3), 357 (53.8), 
315 (100), 301 (25.7), 300 (46.2), 299 (16.1), 271 (26.5) 
Isorhamnetin-O-(glucuronyl)dihexoside-O-
glucuronide 
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MS4 [815→639→315]: 300 (100), 299 (42.9), 285 (16.3) 
80 29.3 755 MS2 [755]: 609 (100) 
MS3 [755→609]: 429 (57.5), 285 (100), 284 (33.9), 255 (11.2) 
MS4 [755→609→285]: 257 (25.0), 255 (100) 
Kaempferol-O-(coumaroyl)dihexoside    
81 30.5 711 
 
MS2 [711]:665 (10.5), 505 (10.2), 503 (100) 
MS3 [711→503]: 485 (55.0), 453 (100), 421 (78.3), 417 (61.3), 410 (53.2), 409 (92.0), 
380 (50.4) 
MS4 [711→503→453]: 409 (100) 
Triterpene acid-O-hexoside 
(formate adduct) 
   
82 31.1 727 MS2 [727]: 681 (100), 619 (27.7) 
MS3 [727→681]:619 (100) 
MS4 [727→681→619]:457 (100), 425 (25.3) 
Unknown    
83 31.9 711 MS2 [711]: 665 (100) 
MS3 [711→665]:621 (100), 589 (27.5), 459 (13.4) 
MS3 [711→665→621]: 590 (100), 459 (26.7), 428 (54.5); 459 (100) 
Unknown    
84 32.7 805 MS2 [805]: 639 (100), 459 (30.1), 315 (87.2), 300 (26.0), 271 (11.4) 
MS3 [805→315]: 300 (100), 299 (33.8), 287 (17.9), 151 (23.0) 
Isorhamnetin-O-dihexoside derivative    
85 33.0 591 MS2 [591]:567 (52.0), 544 (30.7), 367 (24.9), 265 (28.4, 223 (100), 205 (28.1), 190 
(14.9), 164 (12.8) 
MS3 [591→223]:208 (88.8), 179 (17.0), 164 (100) 
Disinapoyl-O-hexoside   [197] 
86 34.9 581 MS2 [581]:559 (100), 558 (31.9) 
MS3 [581→559]: 535 (21.4), 477 (10.4), 455 (20.2), 454 (100) 
MS4 [581→559→454]: 373 (100) 
Unknown    
87 35.8 593 MS2 [593]:447 (12.1), 284 (100),  
MS3 [593→285]: 267 (19.1), 257 (56.0), 255 (32.7), 229 (31.2), 213 (28.1), 163 (20.6), 
151 (100) 
Kaempferol-O-(coumaroyl)hexoside    
88 36.2 581 MS2 [581]: 461 (100), 341 (29.4)  
MS3 [581→461]: 341 (100) 
MS4 [581→461→341]: 299 (100), 284 (37.4), 271 (26.0), 151 (44.6) 
Diosmetin-C-dihexoside   
  
89 36.6 593 MS2 [593]: 447 (10.5), 286 (12.5), 285 (100) 
MS3 [593→285]: 257 (35.5), 241 (24.1), 229 (18.9), 213 (18.3), 151 (1000), 123 (11.9) 
Kaempferol-O-(coumaroyl)hexoside    
90 36.8 623 MS2 [623]: 461 (78.3), 323 (56.9), 315 (11.0), 301 (15.8), 299 (100), 285 (98.4), 256 
(21.4) 
MS3 [623→299]: 284 (100), 271 (40.4), 256 (47.3) 
MS4 [623→299→284]: 256 (100), 151 (43.1) 
Diosmetin-O-dihexoside  
  
91 37.4 581 MS2 [581]:461 (100), 341 (28.5) 
MS3 [581→461]: 341 (100) 
MS4 [581→461→341]: 299 (100), 284 (17.6), 151 (68.8) 
Diosmetin-C-dihexoside  
  
92 37.5 613 MS2 [613]:492 (100), 476 (39.9), 466 (40.0), 462 (20.8), 342 (10.3) 
MS3 [613→492]: 451 (16.5), 449 (100), 373 (22.8), 343 (47.3), 342 (62.6), 299 (14.3), 
160 (11.7) 
MS4 [613→492→449]: 303 (23.4), 299 (100), 149 (55.5), 145 (17.2) 
Unknown    
93 38.3 613 MS2 [613]: 492 (100), 476 (39.9), 466 (40.0), 462 (20.8), 342 (10.3) 
MS3 [613→492]: 451 (16.5), 449 (100), 373 (22.8), 357 (12.3), 343 (47.3), 342 (62.6), 
299 (14.3), 288 (14.6), 145 (10.3) 
MS4 [613→492→372]: 357 (100), 175 (51.1) 
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MS4 [613→492→449]: 376 (23.8), 329 (25.8), 314 (49.6), 303 (23.0), 299 (21.5), 289 
(14.1), 157 (100), 149 (14.1), 135 (16.8) 
MS4 [612→492→449]: 275 (100), 233 (36.6), 174 (88.5), 145 (41.7), 134 (20.2) 
94 39.0 533 MS2[533]: 487 (100) 
MS3 [533→487]: 451 (24.4), 427 (53.3), 355 (46.0), 221 (51.3), 191 (45.1), 161 (41.7), 
149 (100), 143 (52.8) 
MS4 [533→487→149]:131 (12.4), 85 (100) 








1.2. Myrica faya 
Identification of phytochemicals of M. faya extracts is presented in Table S 11 and Table S 12. 
Following is a brief explanation and for a more details about their characterization, please check the mentioned 
references. 
1.2.1. Phenolic acids 
Caffeoylisocitrate (compound 10) and caffeic acid-O-hexoside (compounds 35 and 52) were the only 
caffeic acid derivatives detected (Table S11).Compound 25 exhibited [M-H]- ion at m/z 333. After loss of 180 
Da, it yielded protocatechuic acid at m/z 153 (by comparison with analytical standard). With no more data, it 
was tentatively characterized as a derivative. Compound 64, [M-H]- ion at m/z 285, suffered a loss of 132 Da 
to produce protocatechuic acid at MS2. Hence, it was identified as protocatechuic acid-O-pentoside. Compound 
56 and 61 displayed [M-H]- ion at m/z 325 and were identified as coumaric acid-O-hexoside [84]. With an extra 
112 Da residue, compound 138 was tentatively characterized as a derivative. Conjugates of coumaric acid with 
octulopyranosonic acid (compounds 142, 144, 163 and 165) were identified in M. faya extracts based on a 
previous study [106]. Compound 63 showed a [M-H]- ion at m/z 353 and was plausibly identified as 5-O-
caffeoylquinic acid (confirmed by a standard solution). Ferulic acid-O-hexoside (compound 68), with [M-H]- 
ion at m/z 355, was identified [80]. With an additional 126 Da residue, compound 148 was tentatively identified 
as a derivative. Compound 105, with [M-H]- ion at m/z 403, produced fragment ion at m/z 385 [M-H-
sinapoylhexoside]- after loss of 18 Da (probably loss of a molecule of water); it was tentatively identified as a 
derivative. 
Glycosides of gallic acid were very common in M. faya extracts (compounds 4, 12, 20, 27 and 29) and 
identified by comparison with literature (Table S 11). All these compounds presented different sugar residues 
esterified with gallic acid at m/z 169 (compound 18), confirmed through a commercial standard. Compound 17 
displayed [M-H]- ion at m/z 441. After suffering a neutral loss of 98 Da, it produced galloylquinic acid at m/z 
343 (compound 15) [200]. With no more available data, 17 was tentatively identified as a derivative. Compound 
28, with [M-H]- ion at m/z 391, exhibited gallic acid in its fragmentation pattern after a loss of 222 Da; it was 
tentatively characterized as a derivative. Compound 66 was tentatively identified as a C-glycoside flavonoid-
(galloyl)hexoside. It presented an [M-H]- ion at m/z 451 and product ion at m/z 331 [M-H-120]-, consistent with 
(galloyl)hexoside [213]. The 120 Da loss is attributed to C-glycoside flavonoids. Compound 78 displayed [M-
H]- ion at m/z 609. After a neutral loss 290 Da, yielded MS2 base peak at m/z 319. Additional fragmentation 
produced gallic acid; it was tentatively characterized as a derivative. Tri- and tetragalloyl-O-hexoside, with [M-
H]- ions at m/z 635 and 787, were identified in M. faya extracts (compounds 88 and 106, respectively). 
Compound 100, with [M-H]- ion at m/z 553, suffered a loss of 384 Da to produce gallic acid. A full 
characterization was not achieved, hence, 100 was tentatively identified as a derivative. Compounds 111 and 
116, both with [M-H]- ions at m/z 413, yielded gallic acid in their fragmentation pattern, after two sequential 
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Several quercetin glycosides were present in M. faya extracts and identified by previous assignments 
(Table S 11). Quercetin (compound 161), with [M-H]- ion at m/z 301, was confirmed by an analytical standard. 
Compound 120 showed [M-H]- ion at m/z 499. Further fragmentation gave origin to quercetin-O-hexoside core 
at m/z 463 [84]. The neutral loss of 36 Da could be attributed to two molecules of water (2 x 18 Da); 120 was 
tentatively identified as a derivative. 
Compounds 107, 113 and 118 showed [M-H]- ions at m/z 597. It exhibited fragment ions at m/z 477 
[M-H-120]- and 357 [M-H-120120]-, characteristic of C-glycoside flavonoids [205]. Glucaric acid was observed 
at m/z 209, with typical fragments at m/z 191 and 147 [198]. Thus, 107, 113 and 118 were tentatively 
characterized as C-(glucaroyl)glycoside flavonoids. 
Several myricetin conjugates (compounds 91, 92, 95, 101, 112, 140, 146 and 151) were identified in 
M. faya extracts (Table S 11), with aglycone at m/z 317 [82]. Compound 125, with [M-H]- ion at m/z 601, 
showed myricetin-O-pentoside at m/z 449 [M-H-152]- (compounds 108 and 114) [79] at MS2; it was tentatively 
characterized as myricetin-O-(galloyl)pentoside. 
Compound 141 showed an [M-H]- ion at m/z 505. Isorhamnetin aglycone at m/z 315 (compound 150) 
was observed after loss of 190 Da. With no further information, it was characterized as a derivative. 
1.2.3. Flavan-3-ols 
Catechin aglycone was observed (compound 79) and confirmed by analytical standard. Compound 45, 
with [M-H]- ion at m/z 611, displayed product ion at m/z 305 after loss of other 305 Da residue. This fragment 
was attributed to a gallo(epi)catechin unit [206];  45 was identified as a dimer. Compound 115 showed [M-H]- 
ion at m/z 441 and was identified as catechin-O-gallate [200]. Compound 87 displayed a [M-H]- ion at m/z 569. 
It showed a MS2 base peak at m/z 417 after loss of 152 Da (probably a galloyl residue). Further fragmentation 
resulted in product ion at m/z 305, which is consistent with gallocatechin [206]. The chemical nature of 112 Da 
residue could not be elucidated, hence, 87 was tentatively characterized as derivative of digalloyl(+)catechin. 
1.2.4. Flavones 
Compounds 77, 82 and 86, with [M-H]- ion at m/z 575, suffered a loss of 36 Da to yield product ion at 
m/z 539. After another loss of 48 Da, it presented a base peak at m/z 491 and fragment ions at m/z 329 and 314. 
This fragment pattern was consistent with tricin-O-hexoside [106]. Thus, compounds 77, 82 and 86 were 
tentatively characterized as derivatives. Compound 85 displayed an [M-H+HCOOH]- ion at m/z 537 and it gave 
origin to tricin-O-hexoside (after loss of 46 Da). Other derivatives of tricin-O-hexoside (compounds 94, 102, 
155, and 157) were also tentatively characterized in analysed samples. 
Compound 147, with [M-H]- ion at m/z 575, suffered a loss of 306 Da (162 Da + 144 Da) to give base 
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analytical standard). The loss of 144 Da was attributed previously to a 3-hydroxy-3- methylglutaryl moiety 
[125]. Hence, 147 was characterized as apigenin-O-3-hydroxy-3- methylglutaryl(hexoside). 
Compound 156, with [M-H]- ion at m/z 555, displayed the same fragmentation pattern as described 
before for a derivative of baicalein [106]. 
1.2.5. Ellagic acid derivatives/Ellagitannins 
In this analysis, ellagic acid conjugates formed the main group of phenolic compounds detected in M. 
faya (Table S 11). Compounds 19 and 25 displayed [M-H]- ions at m/z 815 and MS2 base peak at m/z 783 [M-
H-32]-. Further fragmentation of this ion was consistent with bis-HHDP-O-glucoside [200]. Hence, these 
compounds were tentatively characterized as derivatives. Compound 36 exhibited [M-H]- ion at m/z 473. In its 
MS2 fragmention yielded product ion at m/z 457 (by loss of 16 Da). Sequential fragmentation gave origin to 
ellagic acid at m/z 301 (by comparison with analytical standard). The loss of 156 Da could not be identified 
based in the available data. Hence, 36 was characterized as an ellagic acid derivative. Compound 67 was 
tentatively characterized as an ellagitannin. It exhibited an [M-H]- ion at m/z 949 and MS2 base peak at m/z 917 
(by loss of 32 Da). Further decarboxylation (-44 Da), gave origin to product ion at m/z 873, which fragmented 
into ellagic acid (at m/z 301). The presence of Casuarinin typical fragments (at m/z 935, 633 and 301) [87] 
indicates the potential presence of an ellagitannin. 
1.2.6. Anthocyanins 
Analysis performed in positive mode ionization (ESI+) resulted in the identification of 14 anthocyanins 
in berries extracts (Table S 12). Cyanidin-O-hexoside (compound 13) was plausibly identified by comparison 
with analytical standard. Other compounds (6, 16, 33, 42, 47, 50 and 60) presented similar fragmentation 
patterns but this MSn analysis did not allow to discriminate sugar moieties. Thus, they were characterized as 
isomers. With [M-H]- ion at m/z 419, compound 48 was identified as cyanidin-O-pentoside [188,214]. 
Glycosides of delphinidin and pelargonidin were also identified based on previous analysis on M. rubra [82]. 
1.2.7. Other compounds 
Besides PCs, other phytochemicals were also identified in the analysed extracts, namely saccharides, 
lignans and oxylipins. Saccharides (compounds 124 and 128) were tentatively identified based on typical 
hexose fragment ions (at m/z 179, 161, and 119). Compounds 119 and 123 exhibited [M-H]- ion at m/z 559. It 
showed a loss of 36 (probably two water molecules) to produce fragment ion at m/z 523. Further fragmentation 
was consistent with secoisolariciresinol-O-hexoside [209]. Thus, 119 and 123 were tentatively characterized as 
derivatives. Hexosides of phylligenin (compounds 126 and 132) and conidendrin (compound 152) were 
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m/z (% base peak) 
Assigned identity Berries Leaves References 
1 3.1 683 MS2 [683]: 341 (100) 
MS3 [683→341]: 179 (100), 161 (35.5), 143 (17.0), 119 (30.1), 113 (44.4), 101 (13.8) 
Hexose polymer   [207] 
2 3.5 533 MS2 [533]: 191 (100)  
MS3 [533→191]: 173 (100), 127 (64.9), 109 (32.8), 99 (50.1), 93 (59.0), 85 (42.1) 
MS4 [533→191→173]: 109 (100) 
Quinic acid derivative   [106] 
3 3.7 191 MS2 [191]: 173 (69.3), 127 (100) 
MS3 [191→127]: 109 (100) 
Quinic acid   Standard 
4 3.7 331 MS2 [331]: 271 (30.5), 169 (100), 125 (29.7) 
MS3 [331→169]: 125 (100) 
Galloyl-O-hexoside   [206] 
7 3.9 383  
[2M-H]− 
MS2 [383]: 191 (100)  
MS3 [383→191]: 127 (100), 85 (69.8), 93 (58.4), 109 (60.4), 111 (43.0), 173 (24.5) 
Quinic acid dimer   [106] 
8 3.9 481 MS2 [481]: 301 (100)  
MS3 [481→301]: 275 (100), 257 (29.3) 
HHDP-O-hexoside   [201] 
9 4.1 133 MS2 [133]: 115 (100) Malic acid   [206] 
10 4.3 353 MS2 [353]: 111 (76.1), 173 (100) 
MS3 [353→173]: 111 (100) 
Caffeoylisocitrate   [215] 
12 4.5 331 MS2 [331]: 271 (30.5), 169 (100), 125 (29.7) 
MS3 [331→169]: 125 (100) 
Galloyl-O-hexoside   [206] 
14 4.8 191 MS2 [133]: 115 (100) Citric acid   [206] 
15 4.8 343 MS2 [343]: 169 (100) 
MS3 [343→169]: 125 (100) 
Galloylquinic acid   [200] 
17 5.0 441 MS2 [441]: 343 (100), 169 (46.7) 
MS3 [441→343]: 169 (100), 125 (77.3) 
Galloylquinic acid derivative    
18 5.0 169 MS2 [169]: 125 (100) Gallic acid   Standard 
19 5.2 815 MS2 [815]: 783 (100), 481 (37.5), 301 (66.2), 299 (22.1) 
MS3 [815→783]: 721 (32.0), 507 (33.8), 481 (100), 301 (77.2), 299 (25.8) 
MS4 [815→783→ 481]: 437 (52.7), 419 (33.1), 329 (11.8), 299 (100)  
bis-HHDP-O-hexoside 
(Pedunculagin I) derivative  
   
20 5.2 609 MS2 [609]: 493 (30.5), 331 (100), 169 (43.5) 
MS4 [609→331]: 169 (100), 125 (43.7) 
Diacyl-galloyl-O-hexoside   [216] 
21 5.3 359 MS2 [359]: 197 (100), 181 (17.6) 
MS3 [359→197]: 181 (100), 153 (13.3) 
MS4 [359→197→182]: 166 (86.0), 153 (89.0), 123 (100) 
Syringic acid-O-hexoside   [84] 
22 5.3 783 MS2 [783]: 721 (22.5), 481 (100), 301 (66.2), 299 (22.1) 
MS3 [783→481]: 437 (33.5), 419 (28.9), 301 (77.5), 299 (100), 275 (61.0) 
bis-HHDP-O-hexoside  
(Pedunculagin I) 
  [200] 
23 5.6 935 MS2 [935]: 917 (20.9), 799 (100), 633 (53.7), 615 (33.7) 
481 (73.4), 301 (21.9), 299 (49.4) 
MS3 [935→799]: 633 (62.5), 517 (15.0), 481 (100), 457 (36.7), 329 (76.1), 301 (58.7), 299 




  [87] 
24 5.5 815 MS2 [815]: 783 (100), 301 (47.2), 299 (33.1) 
MS3 [815→783]: 721 (25.5), 481 (72.9), 301 (100), 299 (22.1) 
bis-HHDP-O-hexoside  
(Pedunculagin I)derivative 
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25 5.6 333 MS2 [333]: 153 (100), 109 (47.2) 
MS3 [333→153]: 109 (100), 79 (65.2) 
Protocatechuic acid derivative    
26 5.7 467 MS2 [467]: 458 (33.6), 301 (100), 299 (77.2) 
MS3 [467→301]: 299 (100), 283 (43.2) 
Ellagic acid derivative   [217] 
27 5.7 483 MS2 [483]: 313 (15.2), 331 (100), 193 (10.6), 169 (47.2) 
MS3 [483→331]: 169 (100), 125 (62.1) 
Digalloyl-O-hexoside   [199] 
28 5.8 391 MS2 [391]: 169 (100), 125 (35.7) Gallic acid derivative    
29 5.8 483 MS2 [483]: 313 (15.2), 331 (100), 193 (10.6), 169 (47.2) 
MS3 [483→331]: 271 (33.3), 169 (100), 125 (62.1) 
Digalloyl-O-hexoside   [199] 
30 5.9 305 MS2 [305]: 261 (54.6), 221 (34.0), 219 (85.6), 204 (21.7), 179 (100), 166 (17.0), 139 (16.5), 
137 (63.1) 
MS3 [305→179]: 163 (100), 152 (45.5), 151 (77.3), 135 (32.1) 
(+)Gallo(epi)catechin   [206] 
31 6.1 783 MS2 [783]: 721 (22.5), 481 (87.6), 301 (100), 299 (22.1) 
MS3 [783→301]: 299 (100), 275 (32.7) 
bis-HHDP-O-hexoside 
 (Pedunculagin I) 
  [200] 
32 6.2 305 MS2 [305]: 179 (100) 
MS3 [305→179]: 135 (100) 
Gallocatechin   [206] 
35 6.5 341 MS2 [341]: 179 (100), 161 (49.3), 135 (12.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside   [84] 
36 6.6 473 MS2 [473]: 457 (100), 301 (62.4), 299 (19.2) 
MS3 [473→457]: 301 (85.3), 299 (100), 289 (31.3), 273 (50.4) 
Ellagic acid derivative    
37 6.8 935 MS2 [935]: 917 (20.9), 659 (21.2), 633 (100), 615 (36.7), 571 (18.5), 329 (25.4), 301 (21.9), 
299 (49.4) 
MS3 [935→633]: 615 (76.5), 571 (100), 481 (44.3), 383 (31.7), 329 (76.1), 301 (28.7), 299 




  [87] 
38 6.7 481 MS2 [481]: 301 (100), 275 (33.4) 
MS3 [481→301]: 257 (100), 229 (33.8) 
HHDP-O-hexoside   [201] 
39 7.0 783 MS2 [783]: 481 (37.6), 301 (100), 299 (28.1) 
MS3 [783→301]: 299 (100), 257 (47.7), 229 (33.4) 
bis-HHDP-O-hexoside  
(Pedunculagin I) 
  [200] 
40 7.0 315 MS2 [315]: 269 (60.9), 223 (20.6), 161 (47.3), 153 (100)  
MS3 [315→153]: 135 (31.6), 109 (100), 79 (42.1) 
Protocatechuic acid-O-hexoside   [199] 
41 7.1 935 MS2 [935]: 917 (20.9), 799 (43.2), 633 (100), 615 (33.7) 
329 (25.4), 301 (21.9), 299 (49.4) 
MS3 [935→799]: 633 (62.5), 517 (15.0), 481 (44.3), 457 (36.7), 329 (76.1), 301 (58.7), 299 




  [87] 
43 7.2 305 MS2 [305]: 179 (100) 
MS3 [305→179]: 135 (100) 
Gallocatechin   [206] 
44 7.2 633 MS2 [633]: 481 (60.1), 331 (33.5), 301 (100), 299 (65.8), 275 (21.2) 
MS3 [633→301]: 299 (82.3), 257 (100) 
Galloyl HHDP-O-hexoside   [199] 
45 7.3 611 
[2M-H]− 
MS2 [611]: 485 (33.2), 305 (100) 
MS3 [611→305]: 287 (27.2), 219 (13.5), 179 (100) 
Gallocatechin dimer    
46 7.5 761 
[2M-H]− 
MS2 [761]: 635 (17.8), 609 (69.0), 575 (36.6), 591 (51.2), 593 (33.8), 423 (100), 305 (38.4) 




  [142] 
49 7.9 467 MS2 [467]: 458 (100), 343 (41.5), 249 (13.2) 
MS3 [467→458]: 436 (17.8), 413 (25.1), 343 (32.2), 315 (28.1), 301 (100)  





Vítor Spínola   2018                                                                                                                                 243 
MS4 [467→458→301]: 299 (63.2), 289 (31.3), 273 (50.4) 
51 8.1 633 MS2 [633]: 481 (60.1), 331 (33.5), 301 (100), 299 (65.8), 275 (21.2) 
MS3 [633→301]: 299 (82.3), 257 (100) 
Galloyl-HHDP-O-hexoside   [199] 
52 8.1 341 MS2 [341]: 179 (100), 161 (49.3), 135 (12.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside   [84] 
53 8.1 935 MS2 [935]: 917 (100), 799 (43.2), 633 (80.2), 615 (33.7) 
329 (25.4), 301 (21.9), 299 (49.4) 
MS3 [935→917]: 873 (62.5), 633 (100), 481 (44.3), 457 (36.7), 329 (76.1), 301 (58.7), 299 
(100), 275 (22.2) 




  [87] 
54 8.2 595 MS2 [595]: 385 (100), 355 (43.2), 313(80.2), 235 (33.7) 
MS3 [595→385]: 341 (44.3), 355 (36.7), 313 (100), 235 (33.2), 223 (58.7), 175 (22.2) 
5,7,4′-Trihydroxyflavanone 6,8-di-C-
hexoside 
  [202] 
55 8.3 467 MS2 [467]: 458 (100), 343 (41.5), 249 (13.2) 
MS3 [467→458]: 436 (17.8), 413 (25.1), 343 (32.2), 315 (28.1), 301 (100)  
MS4 [467→458→301]: 299 (63.2), 289 (31.3), 273 (50.4) 
Ellagic acid derivative   [217] 
56 8.4 325 MS2 [325]: 163 (100), 119 (13.2) 
MS3 [325→163]: 119 (100)  
Coumaric acid-O-hexoside   [84] 
57 8.4 649 MS2 [649]: 497 (37.3), 463 (55.3), 301 (100) 
MS3 [649→301]: 299 (62.3), 275 (33.5), 257 (100), 229 (42.7) 
Galloyl-HHDP-O-gluconate  
(Lagerstannin C) 
  [206] 
58 8.5 595 MS2 [595]: 475 (77.5), 385 (100), 355 (43.2), 313(80.2), 235 (33.7) 
MS3 [595→385]: 367 (44.3), 341 (24.3), 339 (45.7), 355 (36.7), 313 (100), 235 (33.2), 223 
(58.7), 175 (22.2) 
5,7,4′-Trihydroxyflavanone 6,8-di-C-
hexoside 
  [202] 
59 8.6 633 MS2 [633]: 481 (60.1), 331 (33.5), 301 (100), 299 (65.8), 275 (21.2) 
MS3 [633→301]: 299 (82.3), 257 (100) 
Galloyl-HHDP-O-hexoside   [206] 
61 8.7 325 MS2 [325]: 163 (100), 119 (13.2) 
MS3 [325→163]: 119 (100) 
Coumaric acid-O-hexoside   [84] 
62 8.8 935 MS2 [935]: 917 (100), 799 (43.2), 633 (80.2), 615 (33.7) 
329 (25.4), 301 (21.9), 299 (49.4) 
MS3 [935→917]: 873 (62.5), 633 (100), 481 (44.3), 457 (36.7), 329 (76.1), 301 (58.7), 299 
(100), 275 (22.2) 




  [87] 
63 9.1 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (24.7), 127 (100), 111 (16.1), 109 (28.7), 93 (46.4), 85 (50.1) 
MS4 [353→191→127]: 109 (100), 85 (17.0) 
5-O-caffeoylquinic acid   Standard 
64 9.2 285 MS2 [285]: 269 (60.9), 223 (20.6), 161 (43.9), 153 (100)  
MS3 [285→153]: 135 (29.6), 109 (100) 
Protocathechuic acid-O-pentoside    
65 9.3 935 MS2 [935]: 917 (56.7), 799 (43.2), 633 (100), 615 (33.7) 
329 (25.4), 301 (21.9), 299 (49.4) 
MS3 [935→633]: 481 (44.3), 457 (36.7), 329 (76.1), 301 (88.7), 299 (100), 275 (22.2) 




  [87] 
66 9.3 451 MS2 [451]: 331 (60.9), 169 (100)  
MS3 [451→331]: 169 (100), 125 (62.1) 
C-glycoside flavonoid-
(galloyl)hexoside 
   
67 9.6 949 MS2 [949]: 935 (33.8), 917 (100), 799 (43.2), 633 (77.5), 615 (33.7) 
329 (25.4), 301 (21.9), 299 (49.4) 
MS3 [949→917]: 873 (100), 799 (13.2), 633 (56.5), 615 (47.7) 
329 (35.4), 301 (88.6) 
MS4 [949→917→873]: 301 (92.5), 299 (100), 283 (41.3), 273 (34.5) 
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68 9.7 355 MS2 [355]: 193 (100)  
MS3 [355→193]: 149 (31.5), 134 (100) 
Ferulic acid-O-hexoside   [80] 
70 9.9 431 MS2 [431]: 385 (100), 223 (60.2), 186 (15.0) 
MS3 [431→385]: 223 (79.7), 153 (100)  
MS4 [431→385→153]: 109 (100) 
Roseoside 
(formate adduct) 
  [106] 
71 10.5 913 
[2M-H]− 
MS2 [913]: 761 (100), 609 (69.0), 575 (36.6), 591 (51.2), 593 (33.8), 
423 (55.8), 305 (38.4) 
MS3 [913→761]: 609 (100), 305 (38.4), 297 (61.7), 283 (100), 255 (77.4) 
MS4 [913→761→609]: 305 (100), 287 (27.2), 219 (13.5), 179 (100) 
Digalloyl(epi)gallocatechin dimer   [201] 
72 10.6 489 MS2 [489]: 454 (32.3), 447 (36.5), 445 (39.0), 403 (38.6), 285 (100), 
257 (25.8) 
MS3 [489→285]: 257 (100), 255 (84.2), 243 (63.0), 239 (32.5), 229 (52.5), 197 (30.7), 163 
(19.4) 
Kaempferol-O-(acetyl)hexoside   [87] 
73 10.8 785 MS2 [785]: 767 (38.9) 633 (37.5), 615 (26.5), 483 (71.3), 331 (19.3), 301 (100), 275 (21.1) 
MS3 [785→301]: 283 (24.7), 257 (100), 229 (39.5) 
Digalloyl-HHDP-O-hexoside 
(Pedunculagin II) 
  [199] 
75 11.0 913 
[2M-H]− 
MS2 [913]: 761 (100), 609 (69.0), 575 (36.6), 591 (51.2), 593 (33.8), 
423 (55.8), 305 (38.4) 
MS3 [913→761]: 609 (100), 305 (38.4), 297 (61.7), 283 (100), 255 (77.4) 
MS4 [913→761→609]: 305 (100), 287 (27.2), 219 (13.5), 179 (100) 
Digalloyl(epi)gallocatechin dimer   [201] 
76 11.1 327 MS2 [327]: 165 (100), 121 (24.2) 
MS3 [327→165]: 147 (100), 121 (33.2), 113 (19.2) 
Dihydro-O-coumaric acid-O-hexoside   [218] 
77 11.7 575 MS2 [575]: 539 (100) 
MS3 [575→539]: 491 (100), 329 (63.2), 314 (27.2) 
MS4 [575→539→491]: 371 (12.9), 329 (100), 314 (27.2), 181 (31.5) 
Tricin-O-hexoside derivative     
78 11.7 609 MS2 [609]: 319 (100), 169 (37.5) 
MS3 [609→319]: 169 (84.7), 125 (100) 
Gallic acid derivative    
79 11.8 289 MS2 [289]: 246 (20.6), 245 (100), 179 (20.7), 105 (32.6) 
MS3 [289→245]: 227 (27.8), 203 (100), 185 (22.3), 175 (66.2), 161 (22.4) 
Catechin   Standard 
80 11.9 481 MS2 [481]: 301 (100)  
MS3 [481→301]: 275 (100), 257 (29.3) 
HHDP-O-hexoside   [201] 
81 12.4 457 MS2 [457]: 331 (19.8), 319 (14.8), 305 (12.4), 193 (16.3), 169 (100)  
MS3 [457→169]: 125 (100) 
Gallo(epi)catechin-O-gallate   [142] 
82 12.1 575 MS2 [575]: 539 (100) 
MS3 [575→539]: 491 (100), 329 (63.2), 314 (27.2) 
MS4 [575→539→491]: 371 (12.9), 329 (100), 314 (27.2), 181 (31.5) 
Tricin-O-hexoside derivative    
83 12.3 449 MS2 [449]: 421 (33.5), 327 (35.6), 287 (100) 
MS3 [449→287]: 259 (100), 253 (63.2), 201 (27.1), 187 (19.5), 125 (22.7) 
Dihydrokaempferol-O-hexoside   [206] 
84 12.4 457 MS2 [457]: 331 (19.8), 319 (14.8), 305 (12.4), 193 (16.3), 169 (100) MS3  MS3 [457→169]: 
125 (100) 
Gallo(epi)catechin-O-gallate   [142] 
85 12.6 537 MS2 [537]: 491 (100) 
MS3 [537→491]: 357 (35.6), 329 (100), 314 (54.2), 181 (28.4) 
Tricin-O-hexoside  
(formate adduct) 
   
86 13.1 575 MS2 [575]: 539 (100) 
MS3 [575→539]: 491 (100), 329 (63.2), 314 (27.2) 
MS4 [575→539→491]: 371 (12.9), 329 (100), 314 (27.2), 181 (31.5) 
Tricin-O-hexoside derivative    
87 13.6 569 MS2 [569]: 417 (100) 
MS3 [569→417]: 305 (100) 
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MS4 [569→417→305]: 261 (54.6), 221 (34.0), 219 (85.6), 204 (21.7), 179 (100), 169 (17.0), 
137 (16.5), 125 (11.5) 
88 13.7 635 MS2 [635]: 617 (35.2), 483 (52.7), 465 (100), 313 (25.8) 
MS3 [635→465]: 313 (100), 169 (76.2), 125 (32.8) 
MS4 [635→465→313]: 169 (100), 125 (55.1) 
Trigalloyl-O-hexoside   [201] 
89 14.1 467 MS2 [467]: 391 (53.2), 313 (32.4), 301 (100) 
MS3 [467→301]: 287 (100), 275 (33.5), 257 (45.2) 
Casurictin/Potentillin like ellagitannin   [219] 
90 14.1 761 
 
MS2 [761]: 635 (17.8), 609 (69.0), 575 (36.6), 591 (51.2), 593 (33.8), 423 (100), 305 (38.4) 
MS3 [761→423]: 305 (51.2), 297 (61.7), 283 (100), 255 (77.4), 243 (36.5) 




  [142] 
91 14.8 479 MS2 [479]: 317 (100), 316 (92.3), 179 (16.0) 
MS3 [479→317]: 287 (30.6), 271 (81.6), 193 (40.6), 179 (100) 
Myricetin-O-hexoside   [142] 
92 15.5 631 MS2 [631]: 479 (39.7), 318 (12.7), 317 (100) 
MS3 [631→317]: 179 (100), 151 (39.1) 
Myricetin-O-(galloyl)hexoside   [106] 
93 16.0 433 MS2 [433]: 301 (100), 299 (52.9) 
MS3 [433→301]: 299 (100), 257 (39.1), 229 (41.4) 
Ellagic acid-O-pentoside   [206] 
94 16.6 567 MS2 [567]: 491 (33.5), 329 (100) 
MS3 [567→329]: 341 (25.8), 314 (100), 269 (52.7), 181 (18.4) 
Tricin-O-hexoside derivative    
95 16.9 631 MS2 [631]: 479 (39.7), 318 (12.7), 317 (100) 
MS3 [631→317]: 179 (100), 151 (39.1) 
Myricetin-O-(galloyl)hexoside   [106] 
96 17.0 197 MS2 [197]: 169 (100), 125 (37.2) Ethyl-gallate   [213] 
97 17.1 467 MS2 [467]: 423 (36.6), 313 (52.4), 169 (100)  
MS3 [467→423]: 313 (27.5), 169 (100), 125 (51.5) 
Gallic acid derivative 
 
  [106] 
98 17.3 167 MS2 [167]: 151 (100) Vanillic acid   [125] 




  [142] 
100 17.4 553 MS2 [553]: 169 (100)  
MS3 [553→169]: 125 (100) 
Gallic acid derivative    
101 17.5 631 MS2 [631]: 479 (39.7), 318 (12.7), 317 (100) 
MS3 [631→317]: 179 (100), 151 (39.1) 
Myricetin-O-(galloyl)hexoside 
 
  [106] 
102 17.7 567 MS2 [567]: 491 (33.5), 329 (100) 
MS3 [567→329]: 341 (25.8), 314 (100), 299 (47.9), 181 (18.4) 
Tricin-O-hexoside derivative    
103 18.0 457 MS2 [457]: 331 (19.8), 319 (66.8), 305 (12.4), 193 (16.3), 169 (100) MS3 [457→169]: 125 
(100) 
Gallo(epi)catechin-O-gallate   [142] 
104 18.3 609 MS2 [609]: 539 (39.5), 301 (100), 300 (11.3), 255 (24.5) 
MS3 [609→301]: 273 (35.1), 179 (100), 151 (77.7), 107 (19.0) 
Quercetin-O-rutinoside 
(Rutin) 
  [200] 
105 18.3 403 MS2 [403]: 385 (31.4), 287 (29.3), 269 (12.8), 223 (100), 163 (13.5) 
MS3 [403→223]: 208 (69.4), 179 (100), 164 (32.3) 
Sinapic acid-O-hexoside derivative    
106 18.5 787 MS2 [787]: 617 (100), 483 (52.7), 465 (62.4), 313 (25.8) 
MS3 [787→617]: 465 (100), 313 (59.7), 169 (76.2) 
MS4 [635→617→465]: 313 (72.1), 295 (18.4), 169 (100), 125 (55.1) 
Tetragalloyl-O-hexoside   [201] 
107 18.9 597 MS2 [597]: 477 (45.0), 459 (15.3), 417 (25.2), 388 (17.3), 387 (53.6), 358 (20.0), 357 (100) 
MS3 [597→357]: 300 (15.3), 209 (100), 123 (12.1),121 (25.4)  
MS4 [597→357→209]: 191 (70.5), 165 (48.0), 147 (100) 
C-(glucaroyl)glycoside flavonoid    
108 18.9 449 MS2 [449]: 317 (100), 316 (92.3), 179 (16.0) 
MS3 [449→317]: 287 (30.6), 271 (81.6), 193 (40.6), 179 (100) 
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109 18.9 477 MS2 [477]: 315 (100) 
MS3 [477→315]: 301 (45.1), 300 (55.6), 299 (14.7), 285 (77.6), 271 (100), 255 (17.2), 243 
(50.7) 
Isorhamentin-O-hexoside   [212] 
110 19.0 609 MS2 [609]: 255 (100), 539 (39.5), 301 (22.3), 301 (11.3), 255 (24.5) 
MS3 [609→301]: 273 (35.1), 179 (100), 151 (77.7), 107 (19.0) 
Quercetin-O-rutinoside 
(Rutin) 
  [200] 
111 19.3 413 MS2 [413]: 311 (100), 169 (62.3) 
MS3 [413→311]: 169 (100), 125 (37.8) 
Gallic acid derivative    
112 19.4 463 MS2 [463]: 318 (10.1), 317 (100), 316 (64.5) 




  Standard 
113 19.7 597 MS2 [597]: 477 (45.0), 459 (15.3), 417 (25.2), 388 (17.3), 387 (53.6), 358 (20.0), 357 (100) 
MS3 [597→357]: 300 (15.3), 209 (100), 123 (12.1),121 (25.4)  
MS4 [597→357→209]: 191 (70.5), 165 (48.0), 147 (100) 
C-(glucaroyl)glycoside flavonoid    
114 19.7 449 MS2 [449]: 317 (100), 316 (92.3), 179 (16.0) 
MS3 [449→317]: 287 (30.6), 271 (81.6), 193 (40.6), 179 (100) 
Myricetin-O-pentoside   [79] 
115 20.1 441 MS2 [441]: 289 (100), 290 (21.5), 169 (17.5), 331 (11.6) 
MS2 [441→289]: 245 (100), 203 (39.7), 205 (43.4), 179 (28.3), 161 (27.4), 135 (17.6) 
(epi)Catechin-O-gallate   [200] 
116 20.2 413 MS2 [413]: 311 (100), 169 (60.1) 
MS3 [413→311]: 169 (100), 125 (35.3) 
Gallic acid derivative    
117 20.5 463 MS2 [463]: 301 (100) 
MS3 [463→301]: 299 (51.4), 179 (59.7), 151 (100) 
Quercetin-O-hexoside   [84] 
118 20.6 597 MS2 [597]: 477 (45.0), 459 (15.3), 417 (25.2), 388 (17.3), 387 (53.6), 358 (20.0), 357 (100) 
MS3 [597→357]: 300 (15.3), 209 (100), 123 (12.1),121 (25.4)  
MS4 [597→357→209]: 191 (70.5), 165 (48.0), 147 (100) 
C-(glucaroyl)glycoside flavonoid   [106] 
119 20.9 559 MS2 [559]: 523 (100) 
MS3 [559→523]: 508 (16.8), 488 (43.2), 361 (100), 343 (15.9), 299 (15.7), 165 (32.1), 147 
(12.0) 
MS4 [559→523→361]: 347 (43.1), 346 (96.1), 313 (80.4), 222 (47.1), 205 (85.0), 192 
(84.3), 165 (100), 109 (94.8) 
Secoisolariciresinol-O-hexoside 
derivative 
   
120 21.3 499 MS2 [499]: 463 (100), 301 (68.3) 
MS3 [499→463]: 301 (100), 299 (51.4), 179 (59.7), 151 (100) 
Quercetin-O-hexoside derivative    
121 22.2 463 MS2 [463]: 301 (100) 
MS3 [463→301]: 299 (51.4), 179 (59.7), 151 (100) 
Quercetin-O-hexoside   [84] 
122 22.7 615 MS2 [615]: 313 (14.7), 301 (100), 313 (16.6)  
MS3 [615→301]: 179 (100), 193 (15.5), 151 (63.4)  
MS4 [615→301→179]: 257 (11.5), 151 (100), 169 (64.3) 
Quercetin-O-(galloyl)hexoside   [143] 
123 22.8 559 MS2 [559]: 523 (100) 
MS3 [559→523]: 508 (16.8), 488 (43.2), 361 (100), 343 (15.9), 299 (15.7), 165 (32.1), 147 
(12.0) 
MS4 [559→523→361]: 347 (43.1), 346 (96.1), 313 (80.4), 222 (47.1), 205 (85.0), 192 




   
124 23.8 415 MS2 [415]: 379 (100) 
MS3 [415 → 379]: 247 (31.5), 179 (21.9), 149 (100), 143 (51.7), 131 (53.9) 
Saccharide    
125 23.9 601 MS2 [601]: 449 (44.7), 317 (100), 316 (92.3), 179 (16.0) 
MS3 [601→317]: 287 (30.6), 271 (81.6), 193 (40.6), 179 (100) 
Myricetin-O-(galloyl)pentoside    
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MS3 [579→533]: 372 (15.9), 371 (100) MS3 [579→371]: 342 (18.1), 341 (100), 340 (61.9), 
297 (13.1) 
MS4 [579→533→371]: 357 (29.2), 356 (100), 342 (18.3), 341 (68.7), 297 (13.1) 
(formate adduct)  
127 24.7 615 MS2 [615]: 301 (100)  
MS3 [615→301]: 193 (15.5), 179 (100) 
MS4 [615→301→179]: 169 (64.3), 151 (100), 125 (35.8) 
Quercetin-O-(galloyl)hexoside   [143] 
128 25.5 567 MS2 [567]: 247 (21.2), 179 (79.8), 161 (100)  
MS3 [567→161]: 149 (100), 143 (51.7), 119 (33.9) 
Saccharide    
129 25.6 615 MS2 [615]: 313 (16.6), 302 (14.7), 301 (100) 
MS3 [615→301]: 179 (100), 151 (63.4)  
MS4 [615→301→179]: 169 (64.3), 151 (100) 
Quercetin-O-(galloyl)hexoside   [143] 
130 26.2 615 MS2 [615]: 301 (100) 
MS3 [615→301]: 179 (100), 169 (47.6), 151 (63.4), 125 (65.2) 
Quercetin-O-(galloyl)hexoside   [143] 
131 26.3 447 MS2 [447]: 285 (91.8), 284 (100), 255 (22.0) 
MS3 [447→285]: 257 (17.4), 255 (100), 227 (42.3), 239 (16.1), 223 (103.), 167 (46.0) 
Kaempferol-O-hexoside   [82] 
132 26.8 579 MS2 [579]: 534 (16.7), 533 (100), 372 (22.5), 371 (99.5) 
MS3 [579→533]: 372 (15.9), 371 (100) MS3 [579→371]: 342 (18.1), 341 (100), 340 (61.9), 
297 (13.1) 
MS4 [579→533→371]: 357 (29.2), 356 (100), 342 (18.3), 341 (68.7), 297 (13.1) 
Phylligenin-O-hexoside  
(formate adduct) 
  [106] 
133 27.1 525 MS2 [525]: 169 (100) 
MS3 [525→169]: 125 (100) 
Gallic acid derivative    
134 27.5 447 MS2 [447]: 315 (100) 300 (29.7), 299 (73.6) 
MS3 [447→315]: 300 (100), 251 (10.4), 221 (27.3), 191 (48.1), 161 (49.8), 151 (13.5) 
Isorhamnetin-O-pentoside   [212] 
135 27.6 593 MS2 [593]: 285 (100), 286 (18.8) 
MS3 [593→285]: 257 (100), 241 (58.8), 229 (35.9), 197 (17.6), 169 (23.2), 163 (39.6), 93 
(30.3) 
Kaempferol-O-rutinoside   [200] 
136 28.3 447 MS2 [447]: 285 (91.8), 284 (100), 255 (22.0) 
MS3 [447→285]: 257 (17.4), 255 (100), 227 (42.3), 239 (16.1), 223 (103.), 167 (46.0) 
Kaempferol-O-hexoside   [82] 
137 28.7 447 MS2 [447]: 301 (100), 300 (24.9), 302 (14.8) 
MS3 [447→301]: 273 (22.8), 271 (14.8), 255 (10.7), 211 (21.3), 179 
Quercetin-O-deoxyhexoside   [142] 
138 28.8 437 MS2 [437]: 325 (100) 
MS3 [437→325]: 163 (100), 119 (42.8) 
Coumaric acid-O-hexoside derivative    
139 29.2 599 MS2 [599]: 313 (100), 285 (98.5), 314 (22.6), 286 (12.3) 
MS3 [599→313]: 169 (100), 125 (36.0), 152 (34.0), 211 (29.3) 
Kaempferol-O-(galloyl)hexoside   [106] 
140 30.1 477 MS2 [477]: 331 (100) 
MS3 [477→331]: 315 (100) 
MS4 [477→331→315]: 193 (100) 
Dimethylmyricetin-O-pentoside   [201] 
141 30.2 505 MS2 [505]: 315 (100) 300 (29.7), 299 (73.6) 
MS3 [505→315]: 300 (65.1), 271 (100), 251 (10.4), 221 (27.3), 191 (48.1), 161 (49.8), 151 
(13.5) 
Isorhamnetin derivative    
142 30.4 633 MS2 [633]: 488 (16.5), 487 (12.2), 470 (18.7), 469 (100), 347 (50.7) MS3 [633→469]: 347 
(76.0), 323 (56.3), 303 (20.4), 259 (33.1), 235 (15.7), 163 (100), 145 (50.9) 
MS4 [633→469→163]: 119 (100) 
Benzoyl-p-dicoumaryl- 2,7-anhydro-3-
DOA 
  [106] 
143 30.4 599 MS2 [599]: 313 (100), 285 (98.5), 314 (22.6), 286 (12.3) 
MS3 [599→313]: 169 (100), 125 (36.0), 152 (34.0), 211 (29.3) 
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144 31.3 633 MS2 [633]: 488 (16.5), 487 (12.2), 470 (18.7), 469 (100), 347 (50.7) MS3 [633→469]: 347 
(76.0), 323 (56.3), 303 (20.4), 259 (33.1), 235 (15.7), 163 (100), 145 (50.9), 119 (55.1) 
Benzoyl-p-dicoumaryl- 2,7-anhydro-3-
DOA 
  [106] 
145 31.7 615 MS2 [615]: 463 (41.8), 318 (16.8), 317 (100)  
MS3 [615→317]: 227 (11.6), 193 (16.2), 191 (12.6), 180 (12.4), 179 (100), 151 (33.3), 137 
(16.7) 
MS4 [615→317→179]: 151 (100) 
Myricetin-O-(galloyl)deoxyhexoside   [82] 
146 31.8 575 MS2 [575]: 269 (100) 
MS3 [575→269]: 241 (16.9), 225 (100), 149 (62.9) 
Apigenin-O-3-hydroxy- 3-
methylglutaroyl(hexoside) 
   
147 32.1 481 MS2 [481]: 463 (22.2), 355 (19.3), 193 (100) 
MS3 [481→355]: 193 (100), 149 (46.5). 134 (100) 
Ferulic acid-O-hexoside derivative    
148 32.4 431 MS2 [431]: 286 (16.7), 285 (100), 284 (28.4), 255 (10.5)  
MS3 [431→285]: 257 (61.7), 255 (100), 239 (32.5), 229 (52.5), 197 (30.7), 163 (19.4) 
Kaempferol-O-rhamnoside   [106] 
149 32.7 315 MS2 [315]: 301 (100), 299 (28.6), 271 (77.1) Isorhamnetin   [212] 
150 33.0 615 MS2 [615]: 317 (100) 
MS3 [615→317]: 227 (11.6), 193 (16.2), 191 (12.6), 180 (12.4), 179 (100), 151 (33.3) 
Myricetin-O-(galloyl)deoxyhexoside   [82] 
151 34.9 599 MS2 [599]: 553 (28.3), 485 (25.8), 447 (45.6), 301 (100), 299 (11.1), 297 (18.7) 
MS3 [599→301]: 273 (15.5), 187 (12.9), 179 (57.7), 151 (100) 
Quercetin-O-(galloyl)deoxyhexoside   [106] 
152 35.3 489 MS2 [489]: 454 (32.3), 447 (36.5), 445 (39.0), 403 (38.6), 301 (100) 
MS3 [489→301]: 271 (84.2), 243 (63.0), 151 (100) 
Quercetin-O-(acetyl)rhamnoside   [106] 
153 35.5 599 MS2 [599]: 553 (28.3), 485 (25.8), 447 (45.6), 301 (100), 299 (33.1) 
MS3 [599→301]: 273 (15.5), 187 (12.9), 179 (57.7), 151 (100) 
Quercetin-O-(galloyl)deoxyhexoside   [106] 
154 36.2 527 MS2 [527]: 491 (100) 
MS3 [527→491]: 371 (12.9), 330 (28.5), 330 (20.3), 329 (100), 314 (10.7) 
MS4 [527→491→329]: 314 (100) 
Tricin-O-hexoside derivative    
155 36.4 555 MS2 [555]: 417 (21.7), 305 (32.9), 287 (27.1), 269 (100), 267 (22.4), 223 (54.3), 161 (22.2) 
MS3 [555→269]: 251 (20.5), 241 (38.8), 227 (45.9), 226 (51.3), 225 (32.3), 223 (100), 197 
(68.9), 195 (33.5), 179 (17.1) 
Baicalein derivative 
 
  [106] 
156 36.7 527 MS2 [527]: 491 (100) 
MS3 [527→491]: 371 (12.9), 330 (28.5), 330 (20.3), 329 (100), 314 (50.7) 
Tricin-O-hexoside derivative    
157 36.8 297 MS2 [297]: 183 (100) 
MS3 [297→183]: 169 (100), 125 (52.7) 
Methyl-gallate derivative 
 
  [220] 
158 37.3 563 MS2 [563]: 356 (11.0), 355 (100)  
MS3[563→355]: 341 (12.8), 340 (100), 325 (43.4) 
MS4 [563→355→340]: 326 (15.2), 325 (100), 296 (79.8), 281 (36.7), 212 (27.6) 
Conidendrin-O-hexoside   [106] 
159 37.6 284 MS2 [284]: 242 (57.4), 222 (100), 142 (35.8) 
MS3 [284→222]: 157 (100), 142 (41.5) 
Unknown    
160 38.0 301 MS2 [301]: 271 (23.7), 179 (100), 151 (44.7) Quercetin   Standard 
161 38.0 297 MS2 [297]: 183 (100) 
MS3 [297→183]: 169 (100), 125 (52.7) 
Methyl-gallate derivative   [220] 
162 38.5 779 MS2 [779]: 634 (26.5), 633 (100), 616 (26.2), 615 (74.3), 469 (38.7) MS3 [779→633]: 488 
(18.7), 487 (17.9), 470 (35.0), 469 (100), 325 (17.3), 265 (11.1) 
MS4 [779→633→469]: 307 (88.9), 163 (100), 145 (49.5), 119 (24.8) 
Benzoyl-p-tricoumaryl- 2,7-anhydro-3-
DOA 
  [106] 
163 39.9 327 MS2 [327]: 311 (27.9), 294 (13.1), 293 (18.7), 229 (100), 211 (72.1), 183 (14.5), 171 (12.4) 
MS3 [327→229]: 211 (100), 209 (32.3), 165 (16.9), 127 (32.2), 125 (67.3) 
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tR: retention time; HHDP: Hexahydroxydiphenoyl; DOA: deoxy-2-octulopyranosonic acid. 
 
 














tR: retention time 
 
164 40.0 779 MS2 [779]: 633 (100), 615 (75.2), 469 (39.1)  
MS3 [779→633]: 487 (19.3), 470 (33.2), 469 (100), 325 (18.5), 265 (13.5) 
MS4 [779→633→469]: 307 (83.6), 163 (100), 145 (47.9), 119 (31.3) 
Benzoyl-p-tricoumaryl- 2,7-anhydro-3-
DOA 






m/z (% base peak) 
Assigned identity References 
5 3.7 465 MS2 [465]: 303 (100) 
MS3 [465→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-hexoside [82] 
6 3.9 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside   
11 4.2 465  MS2 [465]: 303 (100) 
MS3 [465→303]: 275 (16.9), 257 (100), 229 (29.4), 201 (25.3), 165 (24.3), 161 (21.8), 151 (10.3) 
Delphinidin-O-hexoside [82] 
13 4.4 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside   
16 4.9 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-3-O-glucoside Standard 
33 6.3 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside   
34 6.4 433 MS2 [433]: 271 (100) 
MS3 [433→271]: 187 (100), 173 (12.6), 149 (30.0), 131 (10.3) 
Pelargonidin-O-hexoside [82] 
42 7.2 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside  
47 7.5 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside  
48 7.5 419 MS2 [419]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [419→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-pentoside [188,214] 
50 8.0 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside  
60 8.6 449  MS2 [449]: 287 (100) 
MS3 [449→287]: 231 (100), 213 (50.5), 165 (16.5), 161 (32.1), 137 (59.6) 
Cyanidin-O-hexoside  
69 9.9 491 MS2 [491]: 449 (41.4), 303 (31.9), 287 (100) 
MS3 [491→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-(acetyl)hexoside [153] 
74 10.9 491 MS2 [491]: 449 (41.4), 303 (31.9), 287 (100) 









1.3. Rubus grandifolius 
The phytochemical profile of R. grandifolius collected at two different locations of Madeira Island 
(Funchal and Machico) was established. Following is a brief explanation about the identification of 
phytochemicals Table S 13 and Table S 14 and for more details about the characterization, please check the 
mentioned references. 
1.3.1. Phenolic acids 
Glycosides of caffeic acid were identified in analysed samples (compounds 19, 22, 75, 84, 88 and 96) 
(Table S 13). Compound 11, with [M-H]- ion at m/z 371, showed a loss of 174 (probably a quinic acid moiety) 
to yield MS2 base peak at m/z 197. This ion fragmentation was consistent with syringic acid [199], however, 
the presence of fragment ions at m/z 353, 191, 179 and 135 is also indicative of CQA [221]. Therefore, 11 was 
tentatively identified as caffeic/syringic acid derivative. Several derivatives of caffeic acid (compounds 24, 49, 
54, 65, 67, 69, 77, 102 and 109) were detected in extracts. The tentatively characterization resulted from the 
observation of characteristic ions at m/z 179 and 135. Compound 31 exhibited an [M-H]- ion at m/z 457. It 
showed an MS2 base peak at m/z 341[M-H-116]-, consistent with caffeic acid-O-hexoside (compounds 19 and 
22)[84]. The loss of 116 Da is indicative of mallic acid, hence, 31 was tentatively characterized as 
caffeoylhexoside-mallic acid. By analogy, compound 44 with an [M-H]- ion at m/z 537, was characterized as a 
derivative of caffeic acid-O-hexoside. Compound 56 displayed [M-H]- ion at m/z 493 and was tentatively 
identified as caffeic acid-O-(galloyl)hexoside. The presence of product ions at m/z 341 [M-H-152]-, 179 [M-H-
152-162]- and 135 [M-H-152-162-44]- supported this characterization. Compound 104 exhibited an [M-H]- ion 
at m/z 487. At MS2 fragmentation, it showed caffeic acid-O-hexoside and caffeic acid at m/z 341 [M-H-146]- 
and 179 [M-H-146-162]-, respectively. At this retention time, the 146 Da loss is attributed to a coumaroyl unit. 
Hence, 104 was tentatively characterized as caffeic acid-O-(coumaroyl)hexoside. Discrimination of 3-O and 5-
O-CQA isomers (compounds 14, 18 and 29) was explained in previous sample. Compounds 86 and 89 displayed 
both [M-H]- ions at m/z 515 and were identified as 4,5-O and 3,5-O-diCQAs, respectively. Their 
characterization was confirmed by analytical standards. 
Salvianolic acid (compound 27), with [M-H]- ion at m/z 537, was plausibly identified in leaves extracts 
[222]. 
Compound 52 displayed [M-H]- ion at m/z 493. Gallic acid was observed (at m/z 169) after two 
separated losses of 162 Da. Therefore, 52 was identified as galloyl-O-dihexoside. Compound 94 displayed [M-
H]- ion at m/z 477. Protocatechuic acid was observed at m/z 153 [M-H-162-162]-. Thus, 94 was identified as 
protocatechuic acid-O-dihexoside. 
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1.3.2.  Flavonols 
Different quercetin glycosides were detected in analysed extracts (Table S 13), in all cases with 
aglycone at m/z 301 (compound 115). Their characterization was explained in previous samples. Compound 81 
exhibited an [M-H]- ion at m/z 477 and suffered a loss of 176 Da at MS2. It was identified as quercetin-O-
glucuronide [212]. Compound 82 with [M-H]- ion at m/z 607 was identified previously in R. grandifolius as 3-
hydroxy-3-methylglutaroyl-quercetin-O-hexoside [107]. 
Compound 62 showed [M-H]- ion at m/z 491 and MS2 base peak at m/z 315 [M-H-176]-. It was 
identified as isorhamnetin-O-glucuronide [212]. Compound 92 showed an [M-H]- ion at m/z 533. Further 
fragmentation showed isorhamnetin aglycone at m/z 315 [M-H-218]-; it was tentatively characterized as a 
derivative. 
Kaempferol conjugates (compounds 76, 80, 83, 91, 97 and 114) had in common aglycone at m/z 285 
and were plausibly identified based on previous studies (Table S 13). 
1.3.3. Flavan-3-ols 
Catechin derivatives (compounds 45 – 47) were common in samples collected in Machico. In all cases, 
they showed catechin aglycone (at m/z 289) (compound 39) after loss of different moieties. Compound 32 
displayed an [M-H]- ion at m/z 577 and it followed the same fragmentation pattern as described for PAC dimer 
(B type) [84]. Compound 72, with [M-H]- ion at m/z 483, showed catechin aglycone after direct loss of 194 Da. 
The presence of fragment ion at m/z 451 was consisted with catechin-O-hexoside [M-H-32]- [219], hence, 72 
was tentatively identified as a derivative. 
1.3.4. Flavones 
Compound 78 exhibited [M-H]- ion at m/z 523 and MS2 base peak at m/z 475 [M-H-48]-. Sequential 
fragmentation gave origin to product ion at m/z 329 [M-H-146]-, which was consistent with tricin aglycone 
[106]. Based on the available data, 78 was tentatively characterized as a derivative of tricin-O-coumaroyl. 
Apigenin-O-glucuronide (compound 99) was identified previously in other Rubus species [87]. 
1.3.5. Ellagic acid derivatives/ Ellagitannins 
Ellagic acid alone was found in this analysis (compound 70), but also attached to different sugar 
moieties: ellagic acid-O-glucuronide (compounds 42 and 48), ellagic acid-O-pentoside (compounds 50 and 58) 
and ellagic acid-O-hexoside (compound 73) (Table S 13). Compound 61, with an [M-H]- ion at m/z 513, 
showed ellagic acid at m/z 301 [M-H-212]-. With no further information, 61 was identified as a derivative. 
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1.3.6. Other compounds 
Compounds of non-phenolic nature were also present in methanolic extracts of R. grandifolius 
(saccharides, organic acids, terpenoids and coumarins). Oligosaccharides (compounds 1, 6, 35, 43, 51 and 60) 
were characterized in R. grandifolius extracts based on their fragmentation pattern. Compound 4, with [M-H]- 
ion at m/z 515, showed a loss of 174 Da at MS2. This moiety could indicate the presence of quinic acid. 
Sequential fragmentation of product ion at m/z 341 was consistent with two units of hexose (compound 6) 
[207]. Hence, 4 was tentatively characterized as dihexoside-quinic acid. 
Organic acids (compounds 7 and 8) were also identified in analysed extracts. Compound 16 exhibited 
an [M-H]- ion at m/z 369. It showed citric acid typical fragment ions (at m/z 191, 173 and 111) [206] and was 
tentatively characterized as a derivative. 
Triterpene glycosides were abundant in this analysis. Characterization of triterpene acid-O-hexoside 
(formate adduct) (compounds 79, 95, 100, 105, 111 and 117) was described in a previous sample. Compounds 
101, 113 and 121 displayed [M-H]- ions at m/z 603 and were identified previously in R. grandifolius [107] as 
ganoderic acid C2 hexoside. Compound 120 gave a [M-H]- ion at m/z 663 and in the MS2 spectrum displayed 
base peak at m/z 501 (loss of 162 Da). Fragmentation pattern of this ion was described before for ganolucidic 
acid B [223], hence, 120 was identified as ganolucidi acid B hexoside. 12-Hydroxyganoderic acid C2 
(compound 122) was identified based on previous data [223]. Compound 108, with [M-H]- ion at m/z 839, 
showed a MS2 base peak at m/z 677 [M-H-162]-. Sequential fragmentation yielded product ion at m/z 503 [M-
H-162-174]-, which originated fragment ions at m/z 485, 453 and 409. This pattern was consistent with that of 
a triterpene acid structure [211], thus, 108 was tentatively characterized as a derivative. 
Fragmentation pattern of compounds 93, 98 and 109, with [M-H]- ions at m/z 547, was corroborative with 
umbelliferone, previously identified in this species [107]. 
1.3.7. Anthocyanins 
Eleven anthocyanins were identified in R. grandifolius berries in positive mode (Figure 31), all 
conjugates of cyanidin (at m/z 287) (Table S 14). By contrast to a previous analysis [107], no delphinin and 
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m/z (% base peak) 
Assigned identification Berries Leaves References 
FX MX FX MX  
1 3.2 683 MS2 [683]: 341 (100) 
MS3 [683→341]: 179 (100), 161 (23.0), 143 (33.1), 119 (16.9), 113 (45.2) 
Hexose polymer     [207] 
3 3.8 353 MS2 [353]: 173 (100), 155 (11.5), 111 (21.5) 
MS3 [353→173]: 155 (17.9), 111 (100) 
Caffeoylisocitrate     [215] 
4 3.4 515 MS2 [515]: 341 (100) 
MS3 [515→341]:179 (100), 161 (33.9), 149 (15.2), 119 (46.9), 131 (25.1), 113 (28.5) 
Saccharide 
(Dihexose + Quinic acid) 
     
5 3.5 533 MS2 [533]: 191 (100) 
MS3 [533→191]: 173 (100), 153 (18.0), 127 (91.3), 109 (36.1), 93 (55.0), 85 (99.5) 
Quinic acid derivative     [106] 
6 3.6 341 MS2 [341]: 179 (100), 161 (34.0), 149 (23.7), 119 (33.5) Saccharide  
(Dihexose) 
    [207] 
7 3.8 191 MS2 [191]: 173 (100), 111 (36.5) 
MS3 [191→173]: 155 (21.2), 111 (100) 
Citric acid     [206] 
8 4.0 133 MS2 [133]:115 (100) 
MS3 [133→115]:71 (100) 
Malic acid 
 
    [206] 
9 4.2 481 MS2 [481]: 301 (100)  
MS3 [481→301]: 275 (100), 257 (29.3) 
HHDP-O-hexoside     [201] 
11 4.5 371 MS2 [371]: 353 (82.6), 197 (49.2), 191 (47.7), 179 (12.8), 173 (48.5), 153 (22.8), 135 (100) 
MS3 [371→197]: 179 (77.7), 153 (100), 135 (88.1) 
Caffeic/Syringic acid derivative        
14 5.5 707 
[2M-H]− 
MS2 [707]: 615 (27.4), 533 (48.1), 353 (100), 339 (37.7), 315 (38.3), 271 (62.7), 243 (11.2) 
MS3 [707→353]: 191 (100), 179 (30.3) 
3-O-Caffeoylquinic acid dimer     [221] 
15 5.7 783 MS2 [783]: 617 (14,7), 481 (43.0), 301 (100), 275 (11.0) 
MS3 [783→301]: 257 (100), 257 (47.0), 185 (86.0) 
bis-HHDP-O-hexoside  
(Pedunculagin I) 
    [200] 
16 5.7 369 MS2 [369]: 191 (11.8), 173 (100), 111 (23.2) 
MS3 [369→173]: 155 (16.1), 111 (100) 
Citric acid derivative      
18 6.4 353 MS2 [353]: 191 (100), 179 (43.5), 135 (17.2) 
MS3 [353→191]: 173 (48.4), 127 (100), 109 (16.5), 93 (68.1), 85 (70.8) 
3-O-Caffeoylquinic acid     [221] 
19 6.7 341 MS2 [341]: 251 (20.5), 233 (27.2), 203 (19.0), 179 (100), 161 (27.3), 135 (19.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside      [84] 
21 6.9 783 MS2 [783]: 618 (10.3), 617 (45.1), 481 (15.0), 302 (14.2), 301 (100), 257 (24.9) 
MS3 [783→301]: 284 (70.2), 257 (100) 
bis-HHDP-O-hexoside  
(Pedunculagin I) 
    [200] 
22 7.4 341 MS2 [341]: 281 (93.1), 251 (100), 221 (31.9), 179 (76.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside     [84] 
24 8.2 297 MS2 [297]: 179 (100), 135 (15.9) 
MS3 [297→179]: 135 (100) 
Caffeic acid derivative       
27 8.7 537 MS2 [537]: 353 (100), 191 (12.3), 165 (11.0) 
MS3 [537→353]: 191 (100); 165 (58.0), 127 (100), 111 (51.5), 93 (53.9), 85 (45.5) 
Salvianolic acid     [222] 
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[2M-H]− MS3 [707→353]: 191 (31.7), 179 (12.2), 173 (100), 135 (38.4) 
31 9.2 457 MS2 [457]: 439 (37.2), 341 (100), 281 (34.1), 179 (16.8) 
MS3 [457→341]: 281 (80.1), 251 (100), 221 (20.9), 179 (50.9), 135 (35.0) 
Caffeoylhexoside-mallic acid       
32 9.5 577 MS2 [577]: 519 (11.4), 451 (32.6), 425 (100), 407 (96.4), 289 (20.0) 
MS3 [577→425]: 407 (100), 339 (18.8), 285 (25.4) 
Procyanidin (B type)     [84] 
33 9.5 431 MS2 [431]: 385 (100), 223 (12.2) 
MS3 [431→385]: 223 (33.1), 205 (40.5), 161 (13.3), 153 (100) 
Roseoside 
(formate adduct) 
    [106] 
34 9.6 355 MS2 [355]: 193 (100) 
MS3 [355→193]: 149 (62.1), 134 (100) 
Ferulic acid-O-hexoside     [80] 
35 10.0 565 MS2 [565]: 520 (19.7), 519 (100), 341 (10.8) 
MS3 [565→519]: 388 (18.3), 341 (100), 179 (44.7), 161 (33.6), 113 (25.0) 
Saccharide      
37 10.3 635 MS2 [635]: 466 (24.3), 465 (100) 
MS3 [635→465]: 314 (11.6), 313 (100), 241 (12.5), 235 (10.2), 211 (12.8), 169 (63.3) 
MS4 [635→465→313]: 205 (22.6), 193 (46.6), 169 (100), 125 (35.6) 
Trigalloyl-O-hexoside     [201] 
38 10.4 373 MS2 [373]: 337 (100), 319 (23.0), 293 (10.4), 277 (27.9) 
MS3 [373→337]: 293 (100), 277 (90.4), 237 (82.9), 219 (62.8), 177 (38.0), 165 (17,1) 
Unknown      
39 10.8 289 MS2 [289]: 246 (20.6), 245 (100), 179 (20.7), 105 (32.6) 
MS3 [289→245]: 227 (27.8), 203 (100), 185 (22.3), 175 (66.2), 161 (22.4) 
Catechin     Standard 
40 11.0 355 MS2 [355]: 309 (33.1), 161 (100) 
MS3 [355→161]: 133 (100), 117 (10.9) 
Ferulic acid derivative      
41 11.1 565 MS2 [565]: 324 (11.8), 323 (100), 211 (15.2) 
MS3 [565→323]: 280 (12.0), 262 (11.4), 211 (100), 139 (17.5), 124 (15.9) 
Unknown      
42 11.2 477 MS2 [477]: 302 (22.8), 301 (100) 
MS3 [477→301]: 283 (57.6), 257 (100) 
Ellagic acid-O-glucuronide     [107] 
43 11.3 637 MS2 [637]: 356 (10.0), 355 (100), 179 (18.3) 
MS3 [637→355]: 161 (100), 149 (14.4), 119 (26.8) 
Saccharide      
44 11.6 537 MS2 [537]: 519 (100), 341 (11.1), 281 (14.5), 179 (100) 
MS3 [537→519]: 357 (12.9), 341 (76.0), 325 (51.4), 295 (77.4), 179 (100), 135 (49.7) 
Caffeic acid-O-hexoside derivative      
45 11.7 401 MS2 [401]: 301 (20.3), 289 (100), 215 (10.6) 
MS3 [401→289]: 245 (100), 205 (52.2), 203 (13.2), 179 (16.6) 
Catechin derivative      
46 12.0 513 MS2 [513]: 433 (20.2), 401 (100), 301 (14.1), 291 (10.3), 257 (8.8), 215 (15.0) 
MS3 [513→401]: 301 (52.6), 289 (100), 215 (16.9), 195 (20.5) 
MS4 [513→401→289]: 245 (100), 188 (15.6), 175 (26.0), 151 (18.6) 
Catechin derivative      
47 12.3 557 MS2 [557]: 513 (19.6), 445 (100), 255 (21.5), 211 (14.5) 
MS3 [557→445]: 383 (28.1), 301 (47.0), 289 (100), 257 (35.2), 247 (22.9), 215 (47.8), 205 (20.4), 
196 (12.1) 
MS4 [557→445→289]: 245 (100), 205 (71.4) 
Catechin derivative      
48 12.4 477 MS2 [477]: 301 (100) 
MS3 [477→301]: 257 (100), 245 (40.4) 
Ellagic acid-O-glucuronide     [107] 
49 12.5 537 MS2 [537]: 519 (100) 
MS3 [537→519]: 281 (69.6), 265 (22.3), 217 (22.1), 179 (100), 135 (47.6) 
Caffeic acid derivative      
50 12.5 433 MS2 [433]: 301 (100), 300 (62,7) 
MS3 [433→301]: 257 (100) 
Ellagic acid-O-pentoside     [200] 
51 12.8 393 MS2 [393]: 358 (25.2), 348 (21.5), 347 (100), 289 (14.9), 179 (21.5) 
MS3 [393→347]: 329 (71.6), 161 (100), 119 (33.4) 
Saccharide      





Vítor Spínola   2018                                                                                                                                 255 
MS3 [493→331]: 169 (100), 125 (37.3) 
53 13.5 935 MS2 [935]: 915 (15.2), 897 (31.2), 633 (100), 301 (80.2) 
MS3 [935→633]: 469 (11.8), 315 (12.8), 302 (14.7), 301 (100) 




    [87] 
54 14.4 537 MS2 [537]: 519 (44.5), 490 (26.1), 489 (100), 323 (24.3) 
MS3 [537→489]: 324 (12.3), 323 (100), 221 (26.7), 179 (26.6), 161 (12.7), 135 (53.0) 
Caffeic acid derivative      
55 14.4 595 MS2 [595]: 463 (100), 434 (12,1), 433 (47.5), 301 (18.5) 
MS3 [595→463]: 301 (100), 179 (55.2), 151 (28.4) 
Quercetin-O-(pentosyl)hexoside     [84] 
56 14.9 493 MS2 [493]: 433 (20.1), 425 (10.6), 341 (57.1), 232 (26.3), 281 (62.9), 251 (81.3), 221 (45.7), 179 
(100) 
MS3 [493→179]: 135 (100) 
Caffeic acid-O-(galloylhexoside      
57 15.1 595 MS2 [595]: 463 (15.5), 301 (100) 
MS3 [595→301]: 271 (45.5), 179 (50.2), 151 (100) 
Quercetin-O-(pentosyl)hexoside     [84] 
58 15.4 433 MS2 [433]: 301 (100) 
MS3 [433→301]: 300 (74.7), 258 (12.1), 257 (100), 229 (49.4), 217 (17.3)  
Ellagic acid-O-pentoside     [200] 
59 15.7 739 MS2 [739]: 629 (17.1), 587 (100), 569 (21.2), 449 (15.4), 435 (40.8), 417 (16.2), 339 (22.0), 289 
(14.5) 
MS3 [739→587]: 569 (54.8), 477 (32.4), 459 (30.9), 435 (93.1), 417 (100), 339 (43.4), 325 (35.1), 
299 (21.0), 177 (23.0) 
MS4 [739→587→339]: 337 (100), 177 (87.6) 
Unknown      
60 15.9 457 MS2[457]: 296 (13.2), 295 (100) 
MS3 [457→295]: 180 (18.7), 179 (37.0), 149 (24.7), 133 (39.4), 119 (100), 113 (57.4) 
Saccharide      
61 16.4 513 MS2 [513]: 427 (100), 361 (49.5), 301 (52.4), 300 (19.1), 289 (80.4), 257 (29.7) 
MS3 [513→301]: 257 (100) 
Ellagic acid derivative       
62 16.6 491 MS2 [491]: 315 (100), 300 (25.6) 
MS3 [491→315]: 301 (25.5), 300 (100) 
Isorhamnetin-O-glucuronide      [212] 
63 16.9 549 MS2 [549]: 503 (100), 311 (28.7), 221 (15.1), 191 (22.3) 
MS3 [549→503]: 459 (26.5), 311 (53.2), 293 (28.4), 281 (18.0), 275 (30.0), 251 (13.3), 239 (36.2), 
221 (100), 191 (35.3), 161 (10.4), 143 (18.0) 
Unknown      
64 17.2 609 MS2 [609]: 301 (100), 300 (50.8) 
MS3 [609→301]: 179 (54.3), 151 (100) 
Quercetin-O-rutinoside 
(Rutin) 
    [200] 
65 17.5 645 MS2 [645]: 475 (100), 301 (23.9) 
MS3 [645→475]: 323 (97.1), 313 (100), 179 (29.7) 
MS4 [645→475→323]: 179 (12.8), 161 (22.7), 135 (100) 
Caffeic acid derivative      
66 17.8 509 
 
MS2 [509]: 491 (100), 473 (30.0), 461 (42.3), 367 (64.3), 313 (22.7), 311 (36.1) 
MS3 [509→367]: 339 (100), 313 (25.1), 149 (58.4) 
MS3 [509→491]: 473 (100), 462 (25.7), 461 (87.1) 
Unknown      
67 18.3 477 MS2 [477]: 323 (100), 221 (22.4), 179 (25.6), 177 (15.0), 161 (14.0) 
MS3 [477→323]: 275 (12.5), 263 (39.2), 221 (41.2), 203 (37.5), 179 (100), 179 (18.8), 177 (73.2), 
135 (50.2) 
Caffeic acid derivative      
68 18.5 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 323 (11.7), 231 (25.0), 219 (29.2), 217 (100), 189 (17.5), 177 (19.3) 
MS4 [451→341→217]: 191 (88.7), 189 (100), 153 (10.1) 
Unknown      
69 18.7 463 MS2 [463]: 337 (11.4), 323 (98.1), 221 (19.4), 179 (32.9), 135 (12.5) 
MS3 [463→323]: 263 (100), 245 (17.3), 221 (46.1), 179 (97.8) 
MS4 [463→323→179]: 135 (100) 
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70 19.2 301 MS2 [301]: 257 (100), 229 (61,8), 217 (22,0), 185 (95,4), 146 (47,3), 119 (25,7) Ellagic acid     Standard 
71 19.2 463 MS2 [463]: 302 (13,8), 301 (100) 
MS3 [463→301]: 273 (12.3), 271 (32.7), 257 (11.7), 255 (19.3), 179 (82.4), 151 (100) 
Quercetin-O-hexoside     [84] 
72 19.8 483 MS2 [483]: 451 (17.1), 341 (23.6), 289 (100) 
MS3 [483→289]: 245 (100), 205 (20.1), 203 (56.8), 187 (22.5), 179 (10.6) 
Catechin-O-hexoside derivative      
73 20.0 463 MS2 [463]: 323 (100), 301 (96.1) 
MS3 [463→301]: 257 (100) 
Ellagic acid-O-hexoside     [206] 
74 20.3 463 MS2 [463]: 301 (100) 
MS3 [463→301]: 271 (12.2), 179 (83.8), 151 (100) 
Quercetin-O-hexoside     [84] 
75 20.6 503 MS2 [503]: 471 (13.4), 341 (13.9), 329 (29.7), 323 (21.4), 179 (100), 
MS3 [503→179]: 135 (100) 
Caffeic acid-O-dihexoside     [87] 
76 20.9 593 MS2 [593]: 285 (100), 255 (18.1) 
MS3 [593→285]: 257 (100), 241 (40.5), 229 (53.4), 227 (22.9), 199 (22.8), 195 (35.6), 185 (17.0) 
Kaempferol-O-rutinoside      [200] 
77 21.0 491 MS2 [491]: 323 (100), 179 (12.6) 
MS3 [491→323]: 263 (30.2), 251 (22.2), 221 (84.5), 203 (43.1), 179 (100), 135 (94.9) 
Caffeic acid derivative      
78 21.2 523 MS2 [523]: 476 (28.0), 475 (100) 
MS3 [523→475]: 460 (14.3), 443 (24.2), 415 (14.5), 399 (10.1), 387 (11.2), 341 (34.0), 329 (100), 
327 (25.2), 315 (43.3), 297 (10.7), 283 (38.7), 271 (15.6), 195 (18.9) 




     
79 22.1 711 MS2 [711]: 665 (11.9), 503 (100) 
MS3 [711→503]: 439 (100), 427 (70.9), 409 (44.2), 368 (20.4) 
MS4 [711→503→439]: 421 (31.1), 411 (47.2), 409 (100), 393 (25.0), 384 (75.0) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
80 22.9 461 MS2 [461]: 285 (100) 
MS3 [461→285]: 267 (46.0), 255 (43.2), 217 (67.8), 213 (23.4), 199 (18.5), 175 (100), 129 (78.3) 
Kaempferol-O-glucuronide     [212] 
81 23.0 477 MS2 [477]: 302 (15.7), 301 (100) 
MS3 [477→301]: 229 (12.3), 179 (74.2), 151 (100) 
Quercetin-O-glucuronide     [212] 
82 23.6 607 MS2 [607]: 505 (15.6), 464 (17.8), 463 (100) 
MS3 [607→463]: 301 (100), 300 (372) 179 (90.5), 151 (30.0)  
3-Hydroxy-3-methylglutaroyl-
quercetin-O-hexoside 
    [107] 
83 24.0 593 MS2 [593]: 286 (13.4), 285 (100) 
MS3 [593→285]: 267 (35.6), 257 (100), 255 (12.9), 241 (35.1), 229 (75.6), 223 (32.8), 213 (36.9), 
197 (44.1), 195 (25.3), 167 (32.1), 163 (34.4), 151 (17.5) 
Kaempferol-O-rutinoside     [200] 
84 24.1 503 MS2 [503]: 459 (28.0), 341 (14.5), 323 (100), 251 (10.5), 179 (52.2), 177 (10.6), 161 (15.1) 
MS3 [503→179]: 135 (100) 
Caffeic acid-O-dihexoside     [87] 
85 24.5 433 MS2 [433]: 301 (100), 300 (90.7) 
MS3 [433→301]: 271 (100), 257 (13.7), 255 (51.9), 179 (67.5), 151 (60.8) 
Quercetin-O-pentoside     [200] 
86 24.8 515 MS2 [515]: 353 (100), 335 (13.7), 191 (11.1), 179 (22.0), 173 (40.1) 
MS3 [515→353]: 191 (39.9), 179 (62.6), 173 (100), 135 (22.3) 
4,5-O-Dicaffeoylquinic acid     Standard 
87 25.1 321 MS2 [321]: 303 (100), 259 (11.2), 215 (11.5) 179 (59.1), 159 (22.1), 135 (10.6) 
MS3 [321→303]: 241 (56.9), 259 (100), 215 (25.1), 187 (10.0), 149 (11.7) 
Unknown      
88 26.2 503 MS2 [503]: 341 (10.4), 323 (100), 221 (10.9), 179 (29.9) 
MS3 [503→323]: 263 (20.4), 221 (34.4), 179 (100), 135 (29.9) 
Caffeic acid-O-dihexoside     [87] 
89 26.8 515 MS2 [515]: 353 (100) 
MS3 [515→353]: 191 (100), 179 (44.7), 135 (12.5) 
MS4 [515→353→191]: 173 (56.0), 127 (100), 111 (56.7), 85 (61.7) 
3,5-O-Dicaffeoylquinic acid     Standard 
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MS3 [505→301]: 273 (19.4), 255 (37.2), 179 (79.1), 151 (100) 
91 27.2 447 MS2 [447]: 285 (100), 284 (68.1), 255 (28.9) 
MS3 [447→285]: 255 (100) 
Kaempferol-O-hexoside      [200] 
92 27.3 533 MS2 [533]: 315 (100), 300 (34.4), 299 (21.0) 
MS3 [533→315]: 271 (100) 
Isorhamnetin derivative      
93 27.7 547 MS2 [547]: 341 (100), 281 (67.2), 251 (33.6), 221 (15.3), 179 (30.5) 
MS3 [547→341]: 281 (100), 251 (75.8), 221 (21.8), 179 (68.2), 135 (57.3) 
Umbelliferone     [107] 
94 27.9 477 MS2 [477]: 433 (18.8), 315 (100) 
MS3 [477→315]: 153 (100), 109 (36.0) 
Protocatechuic acid-O-dihexoside      
95 28.2 711 MS2 [711]: 503 (100) 
MS3 [711→503]: 487 (13.2), 485 (100), 383 (24.8), 343 (19.7) 
MS4 [711→503→485]: 419 (100), 411 (64.5), 409 (78.1), 381 (47.3), 347 (53.8), 343 (50.9), 135 
(43.2) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
96 28.7 503 MS2 [503]: 341 (96.6), 281 (71.5), 251 (73.6), 221 (40.0), 179 (100) 
MS3 [503→341]: 323 (11.9), 281 (36.0), 251 (57.4), 221 (29.6), 179 (100), 135 (30.0) 
Caffeic acid-O-dihexoside      [87] 
97 28.9 417 MS2 [417]: 285 (100), 255 (10.8) 
MS3 [417→285]: 255 (100), 229 (10.2), 227 (29.4), 163 (13.3) 
Kaempferol-O-pentoside     [107] 
98 29.5 547 MS2 [547]: 387 (12.0), 341 (19.6), 281 (20.0), 179 (26.3), 161 (100) 
MS3 [547→341]: 281 (100), 179 (57.4), 135 (27.5) 
Umbelliferone     [107] 
99 30.0 445 MS2 [445]: 314 (14.5), 269 (100), 175 (16.2) 
MS3 [445→269]: 225 (49.5), 201 (40.7), 169 (100) 
Apigenin-O-glucuronide      [87] 
100 30.7 711 MS2 [711]: 665 (10.7), 504 (30.2), 503 (100) 
MS3 [711→503]: 486 (29.9), 485 (100), 454 (10.7), 453 (32.7) 
MS4 [711→503→485]: 441 (100), 421 (16.5), 403 (11.8), 385 (19.2) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
101 31.3 679 MS2 [679]: 517 (100), 499 (31.3), 455 (13.7) 
MS3 [679→517]: 499 (100), 481 (13.9), 473 (19.6), 455 (42.2), 441 (31.6), 437 (42.1), 397 (13.4), 
379 (17.1) 
MS4 [679→517→499]: 481 (14.5), 455 (70.6), 441 (100), 437 (16.0), 425 (15.5), 409 (11.4), 397 
(46.3), 393 (11.1), 381 (13.7), 379 (10.9) 
Ganoderic acid C2 hexoside     [107] 
102 31.5 459 MS2 [459]: 297 (100), 135 (19.6) 
MS3 [459→297]: 179 (14.4), 135 (100) 
Caffeic acid derivative      
103 31.9 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 231 (22.1), 219 (24.4), 217 (100), 189 (18.5), 177 (16.2) 
MS4 [451→341→217]: 191 (97.0), 189 (100), 145 (10.9) 
Unknown       
104 32.3 487 MS2 [487]: 451 (31.7), 341 (70.6), 323 (61.3), 281 (36.9), 251 (35.3), 179 (100) 
MS3 [487→179]: 135 (100) 
Caffeic acid-O-(coumaroyl)hexoside       
105 32.7 711 MS2 [711]: 665 (14.1), 503 (100) 
MS3 [711→503]: 485 (100), 443 (10.8), 441 (11.6) 
MS4 [711→503→485]: 441 (38.1), 405 (18.3), 403 (25.3), 393 (100), 387 (58.2), 363 (26.1) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
106 32.8 493 MS2 [493]: 447 (80.1), 179 (48.3), 177 (14.8), 161 (100) 
MS3 [493→161]: 133 (49.9), 129 (29.5), 111 (100) 
Unknown      
107 33.4 695 MS2 [695]: 487 (100) 
MS3 [695→487]: 469 (100), 427 (11.4), 407 (21.3) 
MS4 [695→487→469]: 451 (43.9), 437 (28.5), 423 (59.6), 407 (100), 405 (44.2), 371 (21.5) 
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tR: retention time; HHDP: Hexahydroxydiphenoyl 
 
 
108 33.4 839 MS2 [839]: 677 (100), 503 (36.5) 
MS3 [839→677]: 503 (100) 
MS4 [839→677→503]: 485 (100), 453 (30.2), 441 (19.0), 428 (10.8), 409 (25.4), 403 (11.7) 
Triterpene acid derivative 
 
     
109 33.7 547 MS2 [547]: 281 (32.0), 251 (27.6), 221 (12.6), 179 (59.7), 161 (100) 
MS3 [547→179]: 135 (100) 
Umbelliferone     [107] 
110 34.0 709 MS2 [709]: 501 (100) 




     
111 34.8 711 MS2 [711]: 665 (12.6), 503 (100), 501 (29.7) 
MS3 [711→503]: 485 (100), 453 (18.3), 439 (15.4) 
MS4 [711→503→485]: 453 (44.0), 439 (20.1), 421 (57.5), 419 (100), 403 (15.2), 385 (25.3) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
112 35.2 679 MS2 [679]: 519 (11.5), 517 (100) 
MS3 [679→517]: 499 (100), 473 (20.0), 455 (10.8) 
MS4 [679→517→499]: 455 (52.1), 441 (27.1), 419 (35.3), 403 (100), 379 (36.0) 
Ganoderic acid C2 hexoside     [107] 
113 35.7 517 MS2 [517]: 301 (100), 300 (25.8) 
MS3 [517→301]: 283 (97.8), 257 (100) 
Ellagic acid derivative      
114 35.9 593 MS2 [593]: 447 (11.4), 285 (100) 
MS3 [593→285]: 257 (97.8), 255 (23.7), 241 (100), 229 (14.8), 213 (40.2) 
Kaempferol-O-(coumaroyl)hexoside     [212] 
115 36.2 301 MS2 [301]: 273 (15.0), 235 (10.8), 179 (40.4), 151 (100) Quercetin     Standard 
116 37.3 695 MS2 [695]: 649 (10.4), 487 (100), 485 (12.4) 
MS3 [695→487]: 467 (28.5), 425 (55.3), 423 (100), 391 (39.0) 
MS3 [695→487]: 469 (100), 427 (33.7), 425 (40.7), 423 (17.0), 373 (16.5) 
Unknown      
117 37.5 711 MS2 [711]: 503 (100) 
MS3 [711→503]: 485 (100), 459 (13.0), 455 (18.2), 441 (53.2) 
MS4 [711→503→485]: 455 (29.5), 440 (100), 423 (12.1) 
Triterpene acid-O-hexoside  
(formate adduct) 
     
118 37.9 709 MS2 [709]: 501 (100) 
MS3 [709→501]: 483 (11.3), 471 (100), 453 (32.3) 
MS4 [709→501→471]: 453 (100), 428 (11.0), 423 (13.9), 325 (18.6) 
Unknown      
119 38.5 663 MS2 [663]: 503 (12.4), 501 (100), 483 (56.9), 439 (15.8) 
MS3 [663→501]: 483 (100), 465 (10.2), 457 (22.8), 455 (30.9) 
MS4 [663→501→483]: 465 (100), 455 (22.0), 437 (22.6), 391 (87.2), 367 (65.7) 
Ganolucidic acid B hexoside     [223] 
120 38.9 679 MS2 [679]: 633 (10.7), 517 (62.4), 499 (22.2), 471 (100) 
MS3 [679→517]: 499 (100), 473 (72.6), 455 (15.1) 
MS4 [679→517→499]: 455 (89.8), 442 (81.9), 437 (20.5), 425 (13.0), 397 (26.5), 395 (50.2), 393 
(85.1), 381 (100) 
 
Ganoderic acid C2 hexoside     [107] 
121 39.9 163 MS2 [163]: 119 (100) Coumaric acid      Standard 
122 40.1 533 MS2 [533]: 485 (100), 471 (15.4) 
MS3 [533→485]: 467 (100), 441 (83.8), 425 (22.3), 423 (30.2), 381 (31.2), 310 (14.0) 
MS4 [533→485→441]: 423 (100), 379 (49.0) 
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m/z (% base peak) 
Assigned identification Berries References 
FX MX  
2 3.6 449 MS2 [449]: 317 (17,4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9) 
Cyanidin-O-hexoside     
10 4.3 581 MS2 [581]: 449 (51.9), 287 (100) 
MS3 [581→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-pentosyl(hexoside)    [214] 
12 4.4 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-3-O-glucoside   Standard 
13 5.4 419 
 
MS2 [419]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [419→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-pentoside   [214] 
17 6.2 449  MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-hexoside     
20 6.6 419 MS2 [419]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [419→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-pentoside   [214] 
23 7.5 449 
 
MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-hexoside     
26 8.7 449 
 
MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-hexoside     
28 8.9 535 
 
MS2 [535]: 449 (51.3), 287 (100) 
MS3 [535→287]: 257 (100), 213 (55.1), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-(malonyl)hexoside   [188] 
30 9.1 593 
 
MS2 [593]: 287 (100) 
MS3 [593→287]: 257 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 
Cyanidin-O-dioxaloylglucoside   [188] 
36 10.3 491 
 
MS2 [491]: 449 (31.4), 287 (100) 
MS3 [491→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 (19.2) 








1.4. Sambucus lanceolata 
In total, 77 phytochemicals were tentatively identified in S. lanceolata. Following is a brief explanation 
for the characterization of the compounds reported in Table S 15 and Table S 16. For a more detailed 
explanation, please check the mentioned references. 
1.4.1. Phenolic acids 
Compounds 28 and 37 displayed [M-H]- ions at m/z 353. Using the hierarchical key for the 
identification of CQAs [221], 28 was identified as 3-O-CQA and 37 as 5-O-CQA (confirmed by analytical 
standard), respectively. With an extra 98 Da residue, compound 36 was tentatively characterized as a derivative 
of CQA.  
Compound 11 exhibited [M-H]- ion at m/z 397 and MS2 base peak at m/z 361 [M-H-36]-. Syringic acid 
(at m/z 197) [199] was observed at MS4; so 11 was tentatively identified as a derivative. 
Hexosides of ferulic, caffeic and coumaric acids (17, 21 and 25, respectively) were detected in leaves 
[80,84]. Several coumaric acid derivatives (compounds 50, 66, 69, 70, 73, 75 and 78) were tentatively identified 
based on typical 163→119 transition. Compounds 68 and 79 were tentatively characterized as derivatives of 
caffeic and ferulic acids, respectively. It was not possible to achieve a full characterization for the previous 
compounds. Compound 24, with [M-H]- ion at m/z 433, yielded sinapic acid-O-hexoside at m/z 385 [M-H-48]- 
[197]; it was tentatively characterized as a derivative. 5-O-Feruloylquinic acid (compound 42) was identified 
according to the hierarchical scheme for CQAs identification [221]. 
1.4.2. Flavonols 
Several conjugates of quercetin, isorhamnetin and kaempferol were identified in S. lanceolata extracts 
based on previous reports (Table S 15). Compounds 74 and 80 displayed [M-H]- ions at m/z 615. After loss of 
168 Da it showed product ion at m/z 447, consistent with isorhamnetin-O-pentoside [212]. They were 
tentatively characterized as derivatives. Compound 43 displayed [M-H]- ion at m/z 679. It suffered a direct loss 
of 344 Da to produce fragment ion at m/z 335. Myricetin aglycone was observed at m/z 317 after loss of 36 Da 
(probably two molecules of water); it was tentatively identified as a derivative. 
1.4.3. Flavones 
Compound 20 was characterized as a luteolin derivative. It showed an [M-H]- ion at m/z 597 and 
produce luteolin aglycone at m/z 285 (confirmed by reference compound) after direct loss of 312 Da.  
1.4.4. Flavan-3-ols 
Procyanidin dimer (B-type) (compound 23) was characterized based on bibliographic data [224], 
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Compound 49 exhibited [M-H]- ion at m/z  567 and was identified as a derivative of 
dimethoxylflavanone [225].  
1.4.6. Ellagic acid derivatives/Ellagitannins 
Compound 44 was identified as tetramethylellagic acid-O-hexoside [210]. Compound 51, with [M-H]- 
ion at m/z 595, showed ellagic acid at m/z 301 [M-H-294]-. Hence, it was characterized as ellagic acid-O-
(pentosyl)hexoside. With extra 32 Da residues, compounds 26 and 34 were tentatively characterized as 
derivatives. Compound 81 showed an [M-H]- ion at m/z 645. Ellagic acid aglycone was observed at MS3, after 
a direct loss of 344 Da. With no more available data, 81 was identified as a derivative of ellagic acid. 
1.4.7. Other compounds 
The fragmentation of compound 10 matched that of hydrxytyrosol-O-hexoside [200].  
Other non-phenolic compounds were characterized in S. lanceolata extracts, namely saccharides, 
organic acids, anthraquinone, lignans and fatty acids. Oligosaccharides (compounds 1, 2, 32, 40, 53, 57, 58 and 
67) were characterized based on their fragmentation data.  
Compound 9, with [M-H]- ion at m/z 371, suffered a loss of 180 Da (probably 162 + 18 Da) to produce 
quinic acid; it was characterized as a derivative. Compounds 13, 16 and 18 exhibited [M-H]- ions at m/z 515 
and their fragmentation pattern was consistent to 3,5-di-O-CQA [221]. However, this class of compounds tend 
to elute in a latter retention time (by comparison with analytical standards). The successive losses of 162 Da 
were assigned to hexosides instead of caffeoyl residues. Thus, 13, 16 and 18 were tentatively characterized as 
quinic acid-O-dihexoside.  
Compound 11, with [M-H]- ion at m/z 617, suffered losses of 36 Da to yield MS2 base peak at m/z 
581. This product ion was further fragment and showed emodin aglycone at m/z 269 [226] after loss of 312 Da. 
Hence, 11 was tentatively identified as a derivative.  
Compound 19 showed an [M-H+HCOO]- ion at m/z 463. Syringaresinol aglycone at was observed m/z 
417 [199] after loss of 46 Da. 
Compounds 31 and 33 were characterized as formate adducts of dihydroxy-roseoside and roseoside 
(drovomifoliol-O-glucoside) considering previous information [106,209]. Compound 72 displayed [M−H]− ion 
at m/z 561 and MS2 base peak at m/z 357 [M-H-204]-. Fragmentation of this ion was consistent with pinoresinol 
[227]; so 69 was tentatively characterized as pinoresinol-O-(acetyl)hexoside. 
The characterization of oxo-dihydroxy-octadecenoic and trihydroxy-octadecenoic acids (compounds 
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1.4.8. Anthocyanins 
Three anthocyanins (compounds 6, 8 and 12) were identified in S. lanceolata extracts (Table S 16) in 
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m/z (% base peak) 
Assigned identity Berries Leaves References 
 
1 3.0 473 MS2 [473]: 341 (100) 
MS3 [473→341]: 179 (100), 161 (23.0), 143 (33.1), 131 (10.3), 119 (16.9), 113 (45.2) 
Oligosaccharide 
(Pentose + dihexose) 
  [125] 
2 3.2 683 MS2 [683]: 341 (100) 
MS3 [683→341]: 179 (100), 161 (23.0), 143 (33.1), 119 (16.9), 113 (45.2) 
Hexose polymer   [207] 
3 3.3 533 MS2 [533]: 191 (100) 
MS3 [533→191]: 173 (100), 153 (18.0), 127 (91.3), 109 (36.1), 93 (55.0), 85 (99.5) 
Quinic acid derivative   [106] 
4 3.5 353 MS2 [353]: 173 (100), 111 (76.2) 
MS3 [353→173]: 111 (100) 
Caffeoylisocitrate   [215] 
5 3.7 191 MS2 [191]: 173 (100), 111 (38.3) 
MS3 [191→173]: 111 (100) 
Citric acid   [198] 
7 3.8 133 MS2 [133]: 115 (100) 
MS3 [133→115]: 71 (100) 
Malic acid   [198] 
9 4.7 371 MS2 [371]: 353 (45.8), 341 (18.6), 191 (100), 173 (19.3) 
MS3 [371→191]: 173 (50.3), 127 (68.5), 111 (45.1), 109 (54.8), 93 (84.1), 85 (100) 
Quinic acid derivative    
10 4.9 315 MS2 [315]: 153 (100), 135 (14.7), 123 (21.6) 
MS3 [315→153]: 123 (100) 
Hydroxytyrosol-O-hexoside   [200] 
11 5.2 397 MS2 [397]: 559 (81.8), 361 (100), 359 (89.8), 234 (32.8), 198 (82.8), 197 (25.9) 
MS3 [397→361]: 197 (100), 168 (11.0), 139 (47.7) 
MS4 [397→361→197]: 182 (100), 167 (16.4), 123 (12.8) 
Syringic acid derivative    
13 5.5 707 
[2M-H]− 
MS2 [707]: 674 (66.2), 671 (25.0), 533 (47.8), 515 (35.1), 413 (41.6), 353 (100), 324 (15.3), 321 
(10.4), 269 (60.1), 205 (37.0) 
MS3 [707→353]: 191 (100), 173 (20.5) 
Quinic acid-O-dihexoside  
dimer 
   
14 5.8 617 MS2 [617]: 581 (100) 
MS3 [617→581]: 269 (100) 
MS4 [617→581→269]: 241 (94.7), 225 (67.5), 214 (16.2), 201 (25.6), 169 (22.7), 155 (15.7) 
Emodin derivative    
15 5.9 401 MS2 [401]: 239 (100). 179 (25.4) 
MS3 [401→239]: 179 (100) 
MS4 [401→239→179]: 164 (100), 137 (67.6) 
Unknown    
16 6.5 707 
[2M-H]− 
MS2 [707]: 515 (100) 
MS3 [707→515]: 323 (100), 191 (82.0), 173 (55.3) 
Quinic acid-O-dihexoside  
dimer 
   
17 6.7 355 MS2 [355]: 193 (100) 
MS3 [355→193]: 178 (39.2), 149 (100), 134 (20.0) 




264  Vítor Spínola (2018) 
18 6.9 707 
[2M-H]− 
MS2 [707]: 533 (100), 515 (32.3), 353 (48.3), 341 (26.8), 323 (18.8), 271 (22.7), 242 (18.0) 
MS3 [707→353]: 191 (100), 135 (29.3) 
Quinic acid-O-dihexoside 
dimer 
   
19 7.0 463 MS2 [463]: 417 (100), 235 (13.3), 181 (10.8) 
MS3 [463→417]: 235 (41.0), 181 (100), 166 (41.2), 161 (24.4) 
MS4 [463→417→181]: 166 (100) 
Syringaresinol 
(formate adduct) 
   
20 7.2 597 MS2 [597]: 487 (14.9), 285 (100), 241 (14.9) 
MS3 [597→285]: 243 (28.4), 241 (100), 217 (27.2), 215 (16.5), 199 (15.6), 149 (38.6) 
Luteolin derivative    
21 7.6 341 MS2 [341]: 251 (20.5), 233 (27.2), 203 (19.0), 179 (100), 161 (27.3), 135 (19.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside   [84] 
22 7.7 391 MS2 [391]: 373 (15.0), 283 (14.1), 217 (100), 199 (10.1), 173 (10.8), 111 (42.0) 
MS3 [391→217]: 111 (100) 
Citric acid derivative   [198] 
23 7.8 577 
[2M-H]− 
MS2 [577]: 451 (18.4), 425 (96.8), 407 (100), 351 (11.8), 289 (23.2) 
MS3 [577→425]: 407 (100), 339 (16.4) 
MS4 [577→425→407]: 390 (17.1), 321 (16.9), 283 (100), 271 (17.6), 255 (25.6) 
Procyanidin dimer (B type)   [224] 
24 7.8 433 MS2 [433]: 403 (96.5), 385 (100), 340 (44.0), 271 (37.0), 223 (49.7), 199 (16.6), 179 (74.6), 164 
(25.8) 
MS3 [433→385]: 223 (100), 179 (35.7) 
Sinapic acid-O-hexoside 
derivative 
   
25 7.9 325 MS2 [325]: 163 (100), 119 (18.4) 
MS3 [325→163]: 119 (100) 
Coumaric acid-O-hexoside   [84] 
26 7.9 627 MS2 [627]: 595 (100) 
MS3 [627→595]: 433 (10.5), 343 (13.5), 301 (100), 283 (12.8), 257 (58.6) 
MS4 [627→595→301]: 257 (100) 
Ellagic acid-O-
(pentosyl)hexoside derivative 
   
27 8.3 707 
[2M-H]− 
MS2 [707]: 353 (100) 
MS3 [707→353]: 191 (100) 
MS4 [707→353→191]: 173 (12.7), 127 (67.7), 109 (19.9), 93 (100), 85 (11.5) 
3-O-Caffeoylquinic acid dimer  
 
   
28 8.4 353 MS2 [353]: 485 (57.5), 297 (39.2), 289 (35.0), 271 (70.7), 241 (13.6), 191 (100),179 (48.0) 
MS3 [353→191]: 173 (63.1), 127 (100), 111 (47.1), 109 (42.7), 93 (48.5), 85 (50.9) 
3-O-Caffeoylquinic acid   [221] 
29 8.6 289 MS2 [289]: 271 (13.4), 245 (100), 231 (15.4), 205 (31.1), 179 (18.7), 167 (15.2), 151 (16.3) 
MS3 [289→245]: 203 (100), 188 (13.0) 
Catechin   Standard 
30 8.7 341 MS2 [341]: 251 (20.5), 233 (27.2), 203 (19.0), 179 (100), 161 (27.3), 135 (19.6) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside   [84] 
31 8.9 433 MS2 [433]: 387 (100), 179 (25.4), 161 (22.2), 143 (10.1) 
MS3 [433→387]: 207 (100), 189 (12.8), 179 (56.0), 161 (49.7), 159 (25.8), 131 (16.5) 
Dihydroxy-roseoside 
(formate adduct) 
  [209] 
32 9.4 427 MS2 [427]: 381 (100) 
MS3 [427→381]: 249 (100), 161 (25.2) 
MS4 [427→381→249]: 161 (100), 113 (19.3), 101 (18.7), 97 (12.5), 85 (24.3) 
Saccharide     
33 9.5 431 MS2 [431]: 385 (100). 223 (12.2) 
MS3 [431→385]: 223 (33.1), 205 (40.5), 161 (13.3), 153 (100) 
Roseoside 
(formate adduct) 
  [106] 
34 9.9 627 MS2 [627]: 595 (100) 
MS3 [627→595]: 433 (10.5), 343 (13.5), 301 (100), 283 (12.8), 257 (58.6) 
MS4 [627→595→301]: 257 (100) 
Ellagic acid-O-
(pentosyl)hexoside derivative 
   
35 10.0 435 MS2 [435]: 389 (33.9), 227 (100) 
MS3 [435→227]: 101 (100) 
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36 10.1 451 MS2 [451]: 353 (57.6), 191 (100) 
MS3 [451→353]: 191 (100), 135 (12.7) 
Caffeoylquinic acid derivative    
37 10.4 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 339 (10.1), 173 (36.6), 127 (100), 111 (47.0), 93 (42.1), 85 (69.5) 
5-O-Caffeoylquinic acid   Standard 
38 10.6 537 MS2 [537]: 491 (100), 179 (19.9) 
MS3 [537→491]: 476 (14.9), 357 (78.0), 329 (100), 314 (11.1), 301 (36.7), 297 (27.0), 255 (22.2), 
181 (88.8), 150 (13.8) 
MS4 [537→491→329]: 314 (100), 283 (68.0), 264 (29.5), 183 (32.3), 164 (17.8) 
Tricin-O-hexoside 
(formate adduct) 
   
39 11.2 435 MS2 [435]: 390 (27.4), 389 (100) 
MS3 [435→389]: 436 (51.6), 321 (23.4), 311 (27.9), 161 (43.8), 159 (100), 147 (31.4), 143 (11.3), 
113 (58.1) 
Unknown    
40 11.5 539 MS2 [539]: 491 (10.3), 179 (100), 161 (11.1) 
MS3 [539→179]: 161 (43.1), 131 (34.5), 119 (48.5), 113 (24.2), 101 (50), 89 (100) 
Saccharide     
41 12.8 755 MS2 [755]: 609 (34.4), 591 (66.6), 489 (23.9), 343 (14.0), 301 (100), 271 (25.3) 
MS3 [755→301]: 271 (100), 255 (56.5), 179 (19.3), 151 (19.2) 
Quercetin-O-
(rhamnosyl)rutinoside 
  [198] 
42 13.1 367 MS2 [367]: 191 (100), 173 (15.8) 
MS3 [367→191]: 127 (100), 111 (30.1), 93 (20.6), 85 (38.4) 
5-O-Feruloylquinic acid   [221] 
43 13.7 679 MS2 [679]: 649 (10.4), 647 (19.8), 619 (16.2), 575 (23.2), 335 (100), 275 (11.2), 273 (30.4) 
MS3 [679→335]: 317 (100), 299 (14.3), 273 (64.7), 245 (11.8), 229 (21.6) 
MS4 [679→335→317]: 273 (100), 229 (58.2), 213 (63.1), 186 (40.9), 151 (20.4) 
Myricetin derivative    
44 14.0 521 MS2 [521]: 359 (100), 344 (11.0) 
MS3 [521→359]: 344 (100), 313 (16.6) 
MS4 [521→359→344]: 329 (22.2), 313 (100), 265 (29.6), 255 (13.7), 219 (12.7), 203 (25.2), 189 
(18.3), 159 (54.9)  
Tetramethyl-ellagic acid-O-
hexoside 
  [210] 
45 14.3 611 MS2 [611]: 431 (100), 251 (83.9), 207 (19.7) 
MS3 [611→431]: 269 (16.6), 251 (100), 207 (24.2), 189 (12.7) 
MS4 [611→431→251]: 208 (49.3), 189 (100) 
Unknown    
46 14.6 595 MS2[595]: 548 (11.7), 511 (11.9), 475 (14.7), 463 (35.6), 445 (26.9), 301 (34.5), 300 (100), 295 
(13.9), 271 (49.2), 255 (15.1), 227 (19.0) 
MS3 [595→301]: 271 (48.8), 255 (23.9), 179 (100), 151 (51.0) 
Quercetin-O-(pentosyl)hexoside   [84] 
47 15.1 739 MS2 [739]: 593 (15.3), 575 (100), 327 (12.7), 284 (45.6), 255 (11.5) 
MS3 [739→575]: 547 (11.2), 429 (53.6), 393 (73.8), 369 (26.8), 339 (100), 327 (30.5), 323 (20.3), 
309 (49.3), 297 (22.9), 285 (22.2), 283 (17.5), 227 (25.5), 192 (10.2) 
Unknown    
48 15.4 595 MS2[595]: 548 (11.7), 511 (11.9), 475 (14.7), 463 (35.6), 445 (26.9), 301 (34.5), 300 (100), 295 
(13.9), 271 (49.2), 255 (15.1), 227 (19.0) 
MS3 [595→301]: 271 (48.8), 255 (23.9), 179 (100), 151 (51.0) 
Quercetin-O-(pentosyl)hexoside   [84] 
49 15.8 567 MS2 [567]: 535 (13.9), 521 (15.8), 447 (14.8), 341 (100), 330 (11.9), 329 (86.0) 
MS3 [567→341]: 325 (40.5), 324 (29.4), 312 (10.5) 
MS4 [567→341→325]: 311 (100), 309 (10.8), 145 (15.5) 
Dimethoxylflavanone derivative   [225] 
50 16.1 323 MS2 [323]: 305 (64.0), 203 (41.0), 163 (100), 145 (57.5), 119 (22.5) 
MS3 [323→163]: 119 (100) 
Coumaric acid derivative    
51 16.3 595 MS2 [595]: 475 (10.7), 343 (30.2), 301 (100), 283 (24.7), 255 (13.9) 
MS3 [595→301]: 258 (16.9), 257 (100), 255 (35.6) 
Ellagic acid-O-
(pentosyl)hexoside 
   
52 16.8 609 MS2 [609]: 301 (100), 300 (19.2) 
MS3 [609→301]: 271 (34.7), 255 (26.2), 229 (27.4), 179 (85.0), 151 (100) 
Quercetin-O-rutinoside 
(Rutin) 
  [200] 
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MS3 [521→179]: 88 (100) 
54 18.5 463 MS2 [463]: 316 (100) 
MS3 [463→316]: 287 (22.8), 272 (21.9), 271 (100), 242 (11.8), 179 (43.3), 163 (11.6), 151 (48.6) 
Myricetin-O-deoxyhexoside   Standard 
55 18.6 405 MS2 [405]: 226 (13.0), 225 (100), 181 (16.5) 
MS3 [405→225]: 182 (10.1), 181 (100) 
MS4[405→225→181]: 163 (100) 
Unknown    
56 19.0 463 MS2 [463]: 301 (100), 300 (18.0) 
MS3 [463→301]: 271 (12.8), 257 (62.3), 255 (25.1), 213 (13.5), 193 (22.8), 179 (92.8), 151 (100) 
Quercetin-O-hexoside   [84] 
57 19.7 415 MS2 [415]: 370 (23.1), 281 (11.6), 255 (11.5), 179 (100), 162 (10.0), 143 (32.0), 119 (11.2) 
MS3 [415→179]: 161 (24.1), 143 (81.2), 131 (77.8), 119 (100), 97 (27.7), 89 (18.1) 
Saccharide     
58 21.0 567 MS2 [567]: 521 (100), 179 (78.5) 
MS3 [567→179]: 161 (100), 149 (11.7), 113 (33.5)  
Saccharide     
59 22.8 663 MS2[663]: 647 (35.2), 633 (48.4), 615 (27.2), 605 (100), 587 (28.3), 573 (30.7), 508 (16.3) 
MS3 [663→587]: 570 (30.2), 569 (100), 558 (27.0), 551 (11.0), 5111 (25.7), 446 (23.3), 415 (23.2), 
281 (31.3) 
Unknown    
60 23.7 623 MS2 [623]: 315 (100), 300 (20.9), 271 (18.4), 255 (10.9) 
MS3 [623→315]: 301 (18.3), 300 (100) 
Isorhamnetin-O-rutinoside   [224] 
61 24.0 593 MS2 [593]: 285 (100) 
MS3 [593→285]: 267 (75.3), 257 (100), 255 (31.0), 241 (47.8), 229 (65.4), 213 (52.0), 199 (23.0), 
197 (38.4), 195 (17.6), 174 (14.3), 169 (15.9), 163 (38.8) 
Kaempferol-O-rutinoside   [224] 
62 25.8 505 MS2 [505]: 463 (14.4), 301 (100), 300 (38.0), 271 (18.3), 151 (16.5) 
MS3 [505→301]: 271 (22.5), 255 (70.6), 179 (29.2), 151 (100) 
Quercetin-O-(acetyl)hexoside   [212] 
63 26.0 549 MS2 [549]: 505 (100) 
MS3 [549→505]: 463 (100), 301 (88.4), 300 (21.0) 
MS4 [549→505→301]: 179 (54.1), 151 (100) 
Quercetin-O-(malonyl)hexoside    [212] 
64 26.3 447 MS2 [447]: 285 (100), 255 (28.2), 221 (25.2), 157 (20.0), 151 (17.2) 
MS3 [447→285]: 255 (100), 243 (31.6), 239 (14.0), 187 (20.2) 
Kaempferol-O-hexoside   [82] 
65 27.0 477 MS2 [477]: 406 (20.4), 315 (100), 300 (19.9), 286 (41.9), 271 (33.6), 270 (36.1), 205 (22.5), 176 
(28.4), 151 (29.7) 
MS3 [477→315]: 300 (14.4), 299 (13.1), 285 (100), 271 (71.2) 
Isorhamnetin-O-hexoside 
 
  [224] 
66 27.2 815 MS2 [815]: 507 (100) 
MS3 [815→507]: 345 (57.6), 288 (19.2), 287 (19.2), 201 (15.5), 163 (100) 
MS4 [815→507→163]: 119 (100) 
Coumaric acid derivative    
67 27.7 447 MS2 [447]: 375 (100), 207 (18.3) 
MS3 [447→375]: 327 (18.0), 195 (64.9), 191 (20.9), 179 (100), 146 (24.9) 
MS4 [447→375→179]: 164 (48.7), 161 (100), 147 (47.5), 146 (32.9), 122 (18.9) 
Saccharide     
68 28.4 523 MS2 [523]: 361 (57.9), 303 (100), 217 (10.9), 179 (76.8) 
MS3 [523→179]: 135 (100) 
Caffeic acid derivative    
69 28.7 653 MS2 [653]: 507 (100) 
MS3 [653→507]: 345 (59.3), 287 (44.6), 163 (100) 
MS4 [653→507→163]: 119 (100) 
Coumaric acid derivative    
70 29.0 699 MS2 [699]: 653 (53.7), 507 (100) 
MS3 [699→507]: 345 (66.2), 287 (31.1), 163 (100) 
MS4 [699→507→163]: 119 (100) 
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71 29.3 663 MS2 [663]: 632 (23.4), 631 (64.9), 587 (100), 569 (19.0) 
MS3 [663→587]: 569 (100), 557 (11.8), 327 (15.0) 
MS4[663→587→569]: 551 (56.4), 509 (45.2), 447 (23.4), 429 (10.6), 327 (100), 309 (35.7), 280 
(12.6), 215 (25.4) 
Unknown 
 
   
72 29.6 561 MS2 [561]: 545 (10.2), 533 (11.1), 358 (43.9), 357 (100) 
MS3 [561→357]: 342 (17.5), 151 (34.8), 136 (100) 
Pinoresinol-O-(acetyl)hexoside    
73 29.9 551 MS2 [551]: 520 (11.5), 507 (22.0), 505 (60.7), 480 (21.3), 449 (16.7), 325 (39.2), 265 (100), 243 
(44.4), 235 (25.6), 206 (24.6), 187 (15.3), 163 (53.4) 
MS3 [551→265]: 187 (10.5), 163 (100), 119 (80.3) 
Coumaric acid derivative    
74 30.5 615 MS2 [615]: 447 (100), 429 (68.3) 
MS3 [615→447]: 403 (39.8), 315 (40.4), 271 (65.5), 207 (89.3), 193 (74.9), 189 (36.9), 177 (71.9), 
263 (46.0), 161 (100), 153 (73.8), 143 (36.4), 135 (63.6) 
Isorhamnetin-O-pentoside 
derivative 
   
75 31.2 507 MS2 [507]: 345 (99.0), 287 (42.2), 163 (100), 145 (14.7) 
MS3 [507→163]: 119 (100) 
Coumaric acid derivative    
76 31.5 433 MS2 [433]: 271 (100), 151 (13.5) 
MS3 [433→271]: 227 (11.5), 169 (10.6), 151 (100) 
Naringenin-O-hexoside   [224] 
77 31.7 519 MS2 [519]: 315 (100) 
MS3 [519→315]: 301 (16.9), 300 (100), 271 (18.6), 255 (14.0) 
MS4 [519→315→300]: 271 (100), 255 (78.5) 
Isorhamnetin-O-(acetyl)hexoside   [224] 
78 32.0 507 MS2 [507]: 345 (97.5), 163 (100) 
MS3 [507→163]: 119 (100) 
Coumaric acid derivative    
79 32.5 537 MS2[537]: 522 (32.7), 519 (20.6), 491 (36.3), 375 (66.2), 362 (12.7), 317 (54.6), 285 (20.6), 202 
(34.0), 193 (100) 
MS3 [537→193]: 134 (100) 
Ferulic acid derivative    
80 33.0 615 MS2 [615]: 447 (100), 429 (80.7), 297 (11.3) 
MS3 [615→447]: 315 (47.9), 271 (55.7), 225 (15.4), 179 (12.1), 163 (47.6), 159 (61.9), 152 (75.8) 
Isorhamnetin-O-pentoside 
derivative 
   
81 34.1 645 MS2 [645]: 613 (23.4), 570 (12.4), 569 (15.1), 343 (25.5), 325 (13.3), 301 (100), 258 (22.6), 257 
(54.2), 242 (11.0) 
MS3 [645→301]: 258 (16.8), 257 (100) 
Ellagic acid derivative    
82 36.5 629 MS2 [629]: 598 (35.5), 597 (80.0), 579 (12.2), 554 (31.2), 553 (100), 535 (38.8) 
MS3 [629→331]: 313 (100), 182 (65.4), 150 (47.1), 125 (27.9) 
MS3 [629→553]: 535 (100), 523 (11.0), 413 (10.2), 293 (23.2) 
MS4 [629→553→535]: 517 (40.2), 503 (18.3), 437 (15.0), 413 (18.0), 412 (39.5), 293 (100), 277 
(10.3), 215 (26.6) 
Unknown    
83 37.1 301 MS2 [301]: 257 (11.6), 229 (22.2), 179 (70.3), 151 (100), 121 (10.3) Quercetin   Standard 
84 37.5 631 MS2 [631]: 599 (100), 581 (18.9), 555 (21.5), 537 (24.6), 508 (31.2) 
MS3 [631→599]: 581 (68.9), 555 (20.8), 537 (34.0), 477 (100), 460 (10.3), 459 (26.9) 
MS4 [631→599→477]: 462 (48.1), 459 (100), 444 (36.6), 434 (26.0), 403 (30.3), 337 (34.1), 293 
(15.1) 
Unknown    
85 37.8 327 MS2 [327]: 291 (49.0), 229 (100), 221 (23.7), 211 (49.0), 209 (19.6), 193 (15.0), 171 (76.0), 165 
(10.9), 155 (10.4) 
MS3 [327→171]: 127 (100), 125 (15.6) 
MS4 [327→171→127]: 83 (100) 
Oxo-dihydroxy-octadecenoic acid   [106] 
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tR: retention time 
 
Table S 16 - Characterization of anthocyanins of S. lanceolata (berries) methanolic extracts by HPLC-ESI+/MSn. 
 




tR: retention time 
 
 
MS3 [329→229]: 213 (17.8), 211 (69.1), 209 (21.8), 193 (20.7), 185 (14.1), 183 (14.1), 171 (19.8), 
167 (37.9), 125 (100) 
87 40.5 629 MS2 [629]: 597 (88.2), 554 (27.6), 553 (100), 535 (32.4) 
MS3 [629→597]: 579 (60.9), 567 (13.5), 555 (13.0), 553 (100), 535 (50.1) 







m/z (% base peak) 
Assigned identity References 
6 3.7 581 MS2 [581]: 287 (100) 
MS3 [581→287]: 257 (34.3), 241 (100), 232 (31.0), 213 (46.6), 
200 (36.7), 189 (83.5), 185 (34.5), 171 (11.6), 162 (10.3), 157 





8 4.5 581 MS2 [581]: 287 (100) 
MS3 [581→287]: 257 (34.3), 241 (100), 232 (31.0), 213 (46.6), 
200 (36.7), 189 (83.5), 185 (34.5), 171 (11.6), 162 (10.3), 157 





12 5.2 449 MS2 [449]: 287 (100) 
MS3 [449→287]: 269 (15.2), 259 (29.3), 231 (34.1), 213 (100), 
193 (18.9), 169 (25.5), 161 (14.2), 151 (11.4), 143 (15.2), 137 
(52.7) 








1.5. Vaccinium cylindraceum 
The phytochemical profile of different morphological parts of V. cylindraceum are here described for 
the first time. This species was collected at Ilha das Flores (Azores archipelago) and it was selected to establish 
a comparison with Madeira Island counterpart. Following is a brief explanation for the characterization of the 
compounds reported in Table S 17 and Table S 18. For a more detailed explanation, please check the mentioned 
references. 
1.5.1. Phenolic acids 
Phenolic acids (hydroxybenzoic and hydroxycinnamic acids) were identified in analysed extracts. 
Compound 25 exhibited [M-H]- ion at m/z 315 and was identified as protocatechuic acid-O-hexoside [199]. On 
the same basis, compound 34, with an extra 36 Da, was tentatively characterized as a derivative. 
Derivatives of ferulic and coumaric acids (compounds 75 and 85, respectively) were identified based 
on their typical fragments at m/z 163 and 193. Coumaroyl iridoids (compounds 64, and 67), with [M-H]- ions 
at m/z 535, were identified previously on V. myrtillus [84]. The presence of 3-O- and 5-O-CQAs (compounds 
23, 27, 40 and 41) was confirmed by comparison of their MSn spectra with standards and literature [221]. Other 
compounds (13, 36 and 47) showed typical fragment ions at m/z 353 and 191, but their full identification was 
not achieved; being tentatively characterized as CQAs and derivatives. 5-p-Coumaroylquinic acids (compounds 
54 and 58) were also identified following literature data [221]. Compound 59 showed [M-H]- ions at m/z 367 
and could be assigned to feruloylquinic acid [221]. However the presence of caffeic acid instead of quinic acid 
in the MSn spectra led to the assignment of the compound as methyl-(5-caffeoyl)quinate [228]. 
1.5.2. Ellagic acid derivatives 
Tergallagic acid and methyl-ellagic acid-O-pentoside (compounds 16 and 28, respectively) were 
plausibly identified [88,213]. Compounds 29, with [M-H]- ion at m/z 465, was tentatively characterized as a 
derivative. 
1.5.3. Flavones 
Compound 66, with [M-H]- ion at m/z 461, showed tricin aglycone at m/z 324 [M-H-132]- [106]; 66 
was identified as tricin-O-pentoside. Compounds 50 and 53, both with [M-H]- ions at m/z 539, suffered a loss 
of 48 Da to yield tricin-O-hexoside (at m/z 491) [106]. This residue could be attributed to dimethoxy-hydroxy 
(2 x 15 Da + 18 Da). Thus, 50 and 53 were tentatively identified as dimethoxy-hydroxy-tricin-O-hexoside.  
1.5.4. Flavan-3-ols 
Procyanidin dimers (A- and B-types) and trimers (compounds 31, 37, 45, 52, 56, 66 and 73) were 
identified previously in V. mytrillus [84]. Compound 46, with [M-H]- ion at m/z 469, showed catechin at m/z 
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ion at m/z 613 and its fragmentation pattern was consistent with a bis-dihydroxylphenylpropanoid-substituted 
catechin [229]. 
1.5.5. Flavonols 
Several quercetin glycosides were identified in analyzed extracts (Table S 17). Compound 83, with 
[M-H]- ion at m/z 507, was identified as 6-hydroxy-7,4-dimethoxyquercetin-O-hexoside, respectively [230]. 
By analogy, compounds 91 and 95, both with [M-H]- ions at m/z 549, were tentatively characterized as 6-
hydroxy-7,4-dimethoxyquercetin-O-(acetyl)hexoside. Compound 92 exhibited [M-H]- ion at m/z 491. After 
loss of 146 Da, it showed 6-hydroxy-7,4-dimethoxyquercetin core (at m/z 345) [230]. The possibility of a 
rhamnosyl group [M-H-146]- was excluded due to its high retention time; being this moiety attributed to a 
coumaroyl group. Hence, 92 was tentatively characterized as 6-hydroxy-7,4-dimethoxy-quercetin-O-
coumaroyl. By analogy, compound 100, with [M-H]- ion at m/z 585, was tentatively characterized as a 
derivative of 6-hydroxy-7,4-dimethoxy-quercetin. Different myricetin glycosides (compounds 61 and 69) were 
identified based on the nature of its moieties [79,142]. 
Cinchonain-I (compounds 68, 77, 79 and 93) were identified based on earlier reports on V. myrtillus 
[84]. 
Five kaempferol glycosides were identified in this analysis (Table S 17). Compound 90, with [M-H]- 
ion at m/z 533, showed a loss of 44 Da at MS2 to yield kaempferol-O-(acetyl)hexoside core at m/z 489 
(compounds 89 and 97) [87]. Hence, 90 was tentatively characterized as kaempferol-O-(malonyl)hexoside.  
1.5.6. Other compounds 
Compound 20, with [M-H]- ion at m/z 351, displayed hydrxytyrosol-O-hexoside core at m/z 315 [M-
H-36]- (compound 22) [200]. It was tentatively characterized as a derivative. 
Additionally, some other non-phenolic compounds were also identified in this analysis, such as organic 
acids, terpenoids, coumarins, chalcones and saccharides. Based on their fragmentation pattern, compounds 10 
and 32 were characterized as saccharides. Citric acid derivatives (compounds 19 and 26) were identified in 
analysed extracts, based on their fragmentation products. Compound 51 exhibited [M-H]- ion at m/z 553 and 
produced glucaric acid at m/z 209, [198] after losses of different unidentified residues. Thus, 51 was tentatively 
characterized as a derivative. Compound 72 showed [M-H]- ion at m/z 579 and produced syringaresinol at m/z 
417 [M-H-162]- [199] during its fragmentation pattern. Hence, 72 was identified as syringaresinol-O-hexoside. 
Compound 55 exhibited [M-H]- ion at m/z 739 and after loss of different moieties, gave origin to esculin at m/z 
339 [M-H-152-248]- [231]. Hence, 55 was characterized as esculin-O-(malonyl)hexoside gallate. Phloretin-O-
hexoside (compound 87) was found previously in V. macrocarpon [79]. Characterization of triterpene acids 
(compounds 88 and 96) was described in a previous sample.  
1.5.7. Anthocyanins 
The presence of anthocyanins was confirmed by analysis in positive mode (ESI+) in berries extracts 
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287, 331 and 301, which are characteristic of delphinidin, petunidin, cyanidin, malvidin and peonidin, 
respectively.  Compound 39 exhibited [M-H]+ ion at m/z 477. After loss of 146 Da (rhamnosyl unit) it gave 
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m/z (% base peak) 
Assigned identity Berries Leaves References 
1 3.4 683 MS2 [683]: 342 (14.2), 341 (100) 
MS3 [683→341]: 179 (100), 161 (21.8), 143 (21.1), 119 (22.5), 115 (10.89; 113 (41.0), 101 
(16.3) 
MS4 [683→341→179]: 161 (69.4), 143 (100), 131 (43.0), 119 (60.9), 113 (17.4), 101 
(18.6), 89 (66.6), 71 (23.5) 
Hexose polymer   [207] 
2 3.5 533 MS2 [533]: 191 (100) 
MS3 [533→191]: 173 (69.7), 127 (100), 111 (42.1), 109 (25.4), 93 (30.7), 85 (89.5) 
Quinic acid derivative   [106] 
4 3.6 191 MS2 [191]: 173 (34.4), 127 (100), 111 (18.0), 93 (76.7) 
MS3 [191→127]: 85 (100) 
Quinic acid   Standard 
7 4.3 353 MS2 [353]: 111 (76.1), 173 (100) 
MS3 [353→173]: 111 (100) 
Caffeoylisocitrate   [215] 
9 4.4 191 MS2 [191]: 173 (18.5), 111 (100) 
MS3 [191→111]: 67 (100) 
Citric acid   [206] 
10 4.4 337 MS2 [337]: 277 (100), 225 (20.1), 179 (90.6), 161 (11.3), 143 (12.2), 119 (17.0), 113 (11.6) 
MS3 [337→179]: 161 (5.7), 143 (51.9), 131 (13.3), 119 (19.7), 89 (100) 
Saccharide    
13 4.8 369 MS2 [369]: 353 (24.0), 341 (17.3), 225 (16.9), 191 (100), 179 (72.6) 
MS3 [369→191]: 173 (69.7), 127 (100), 93 (70.1), 85 (70.5) 
Caffeoylquinic acid derivative    
16 5.2 451 MS2 [451]: 325 (22.1), 302 (23.3), 301 (100), 257 (12.2), 175 (12.6) 
MS3 [451→301]: 283 (34.4), 273 (32.9), 259 (90.2), 258 (47.7), 257 (100), 233 (40.9), 175 
(24.7), 157 (16.7), 149 (77.9) 
MS4 [451→301→257]: 215 (100), 173 (40.3) 
Tergallagic acid   [213] 
19 5.4 205 MS2 [205]: 191 (77.2), 111 (100), 173 (34.0) 
MS3 [205→111]: 67 (100) 
Citric acid derivative    
20 5.5 351 MS2 [351]: 315 (100), 313 (33.5), 153 (22.7) 
MS3 [351→315]: 153 (100), 123 (29.4) 
Hydroxytyrosol-O-hexoside derivative    
22 5.7 315 MS2 [315]: 153 (100) 
MS3 [315→153]: 123 (100), 109 (32.2), 107 (13.4) 
Hydroxytyrosol-O-hexoside   [200] 
23 5.9 707 
[2M-H]− 
MS2 [707]: 515 (15.4), 353 (100), 323 (16.6), 321 (12.2) 
MS3 [707→353]: 191 (100), 179 (36.2) 
MS4 [707→353→191]: 173 (83.9), 127 (38.0), 111 (94.0), 93 (100), 85 (77.1) 
3-O-Caffeoylquinic acid dimer   [221] 
25 6.4 315 MS2 [315]: 108 (14.4), 152 (24.1), 153 (100) 
MS3 [315→153]: 109 (100) 
Protocatechuic acid-O-hexoside   [199] 
26 6.6 391 MS2 [391]: 373 (22.6), 216 (25.1), 217 (71.5), 191 (22.2), 111 (100), 173 (42.2) Citric acid derivative   [198] 
27 6.6 707 
[2M-H]− 
MS2 [707]: 515 (23.9), 353 (100), 323 (10.9) 
MS3 [707→353]: 191 (100), 179 (50.2) 
MS4 [707→353→191]: 173 (100), 93 (23.8), 87 (100) 
3-O-Caffeoylquinic acid dimer   [221] 
28 6.8 447 MS2 [447]: 568 (15.0), 559 (13.0), 341 (10.9), 327 (12.7), 315 (58.8), 314 (100), 313 
(15.1), 302 (11.1), 301 (17.9), 300 (18.5), 256 (10.5) 
MS3 [447→315]: 300 (85.8), 299 (100), 285 (16.6), 271 (85.5), 255 (41.3), 231 (25.7), 211 
(24.1), 199 (28.5) 
Methyl-ellagic acid-O-pentoside   [88] 





Vítor Spínola   2018                                                                                                                                 273 
MS3 [465→315]: 301 (59.2), 283 (31.6), 257 (100) 
31 7.1 577 
[2M-H]− 
MS2 [577]: 425 (91.2), 407 (100), 289 (25.3), 203 (14.0) 
MS3 [577→407]: 389 (98.3), 335 (100), 297 (79.0), 283 (25.0) 
MS3 [577→425]: 407 (100), 381 (27.3), 339 (52.7), 299 (16.4), 299 (14.9) 
MS4 [577→425→407]: 389 (34.5), 285 (100), 284 (20.5), 281 (24.7), 256 (29.5) 
Procyanidin dimer (B type)   [84] 
32 7.4 451 MS2 [451]: 405 (100), 289 (24.5) 
MS3 [451→405]: 243 (99.7), 179 (100), 161 (73.8), 131 (82.4), 113 (88.2) 
Saccharide 
(formate adduct) 
   
34 7.7 613 MS2 [613]: 459 (16.2), 406 (15.4), 405 (100), 297 (54.6) 
MS3 [613→405]: 297 (12.2), 153 (100), 135 (16.4) 
MS4 [613→405→153]: 109 (100) 
Protocatechuic acid derivative 
 
   
35 8.1 341 MS2 [341]: 179 (100), 135 (43.5) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside   [84] 
36 8.3 533 MS2 [533]: 515 (10.2), 359 (74.1), 243 (51.2), 191 (100) 
MS3 [533→191]: 173 (100), 127 (23.6), 109 (53.7), 93 (42.9) 
Caffeoylquinic acid derivative    
37 8.4 577 
[2M-H]− 
MS2 [577]: 559 (12.6), 451 (22.3), 426 (37.9), 425 (100), 407 (95.1), 381 (10.9), 289 
(30.8), 243 (10.8) 
MS3 [577→407]: 389 (32.1), 374 (14.1), 363 (31.5), 285 (100), 283 (48.4), 257 (38.8), 243 
(77.9), 228 (13.3) 
Procyanidin dimer (B type)   [84] 
38 9.0 461 MS2 [461]: 416 (51.8), 415 (32.0), 341 (33.2), 329 (95.6), 328 (100), 301 (15.1), 299 
(14.6), 272 (16.0) 
MS3 [461→329]: 315 (12.3), 314 (100), 313 (34.6), 313 (41.7), 299 (13.3), 285 (24.9) 
MS4 [461→329→314]: 300 (61.2), 299 (100), 267 (25.3), 226 (33.3) 
Tricin-O-pentoside    
40 9.1 707 
[2M-H]− 
MS2 [707]: 353 (100) 
MS3 [707→353]: 191 (100) 
MS4 [707→353→191]: 173 (83.4), 127 (100), 111 (24.1), 93 (47.7), 85 (65.6) 
5-O-Caffeoylquinic acid dimer    
41 9.4 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (24.7), 127 (100), 111 (16.1), 109 (28.7), 93 (46.4), 85 (50.1) 
MS4 [353→191→127]: 109 (100), 85 (17.0) 
5-O-Caffeoylquinic acid   Standard 
42 9.7 433 MS2 [433]: 387 (100) 
MS3 [433→387]: 205 (100), 153 (95.6), 131 (24.9), 113 (61.1) 
MS3 [433→387]: 225 (52.4), 179 (80.9), 161 (28.7), 143 (100), 113 (19.5) 




  [209] 
43 10.1 431 MS2 [431]: 385 (100), 161 (20.2), 139 (10.6) 
MS3 [431→385]: 337 (28.8), 233 (22.7), 224 (100), 223 (10.3), 205 (18.3), 186 (54.8), 161 
(76.0), 153 (85.4) 
Roseoside 
(formate adduct) 
  [106] 
45 10.3 577 
[2M-H]− 
MS2 [577]: 425 (91.2), 407 (100), 289 (25.3), 203 (14.0) 
MS3 [577→407]: 389 (98.3), 335 (100), 297 (79.0), 283 (25.0) 
MS3 [577→425]: 407 (100), 381 (27.3), 339 (52.7), 299 (16.4), 299 (14.9) 
MS4 [577→425→407]: 389 (34.5), 285 (100), 284 (20.5), 281 (24.7), 256 (29.5) 
Procyanin dimer (B type)   [84] 
46 10.8 469 MS2 [469]: 423 (69.2), 415 (23.7), 315 (34.8), 289 (100), 229 (22.2) 
MS3 [469→289]: 245 (77.4), 231 (45.0), 205 (86.6), 203 (100), 179 (25.5), 125 (17.0), 123 
(20.0) 
Catechin derivative    
47 11.1 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (85.0), 171 (56.1), 127 (100), 111 (65.4), 109 (53.2), 93 (52.2), 85 
(48.4) 
Caffeoylquinic acid    
48 11.6 289 MS2 [289]: 245 (100), 205 (38.2), 203 (18.1), 179 (16.1) 
MS3 [289→245]: 227 (100), 203 (88.8), 188 (19.3), 175 (37.7), 159 (20.2) 
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49 11.7 335 MS2 [335]: 291 (19.1), 179 (74.5), 161 (100), 135 (52.0) Caffeoylshikimic acid   [84] 
50 12.1 539 MS2 [539]: 491 (100) 
MS3 [539→491]: 456 (18.2), 357 (100), 166 (45.4) 
MS3 [539→491]: 448 (21.5), 358 (15.3), 357 (43.3), 329 (100), 314 (12.7) 
MS3 [539→491]: 357 (100), 329 (95.4), 314 (32.9), 297 (13.3) 
MS4 [539→491→329]: 314 (100), 299, 283 (37.5), 265 (21.4), 164 (36.1), 149 (92.9) 
 
Dimethoxy-hydroxytricin-O-hexoside     
51 12.2 553 MS2 [553]: 389 (100), 347 (10.8) 
MS3 [553→389]: 209 (100), 191 (75.8), 179 (35.5), 165 (97.6), 147 (52.3), 135 (54.7), 119 
(46.0), 109 (24.1) 
Glucaric acid derivative    
52 12.7 865  
[3M-H]− 
MS2 [865]: 847 (10.9), 739 (40.9), 695 (100), 578 (23.8), 577 (79.2), 575 (33.0), 543 
(31.0), 525 (11.8), 451 (49.7), 449 (27.1), 425 (24.1), 408 (10.4), 407 (64.6), 405 (24.6), 
289 (12.2), 287 (39.7) 
MS3 [865→695]: 676 (24.4), 677 (54.8), 658 (25.3), 568 (17.2), 543 (100), 529 (30.6), 526 
(31.7), 525 (97.6), 451 (33.0), 407 (22.3), 405 (14.9), 391 (13.7), 363 (21.5), 289 (13.1), 
256 (31.9), 243 (84.5) 
MS4 [865→695→525]: 403 (100), 361 (50.0) 
Procyanidin trimer 
(B type) 
  [84] 
53 12.9 539 MS2 [539]: 343 (12.6), 491 (100), 492 (29.8) 
MS3 [539→491]: 329 (100.0), 357 (50.0) 
MS4 [539→491→329]: 314 (100), 299 (43.2) 
Dimethoxy-hydroxytricin-O-hexoside    
54 13.0 337 MS2 [337]: 191 (100) 
MS3 [337→191]: 173 (27.3), 171 (19.3), 127 (100), 111 (17.2), 109 (39.1), 93 (37.3), 85 
(57.7) 
5-p-Coumaroylquinic acid   [221] 
55 13.3 739 MS2 [739]: 629 (10.5), 587 (100), 451 (21.4), 435 (41.1), 339 (23.4), 289 (16.9) 
MS3 [739→587]: 569 (69.7), 477 (50.9), 449 (24.5), 417 (33.3), 339 (100), 177 (15.7) 
MS4 [739→587→339]: 177 (100) 
Esculin-O-(malonyl)hexoside gallate    
56 13.8 577 
[2M-H]− 
MS2 [577]: 425 (100), 407 (94.0), 289 (93.3), 287 (20.3), 245 (15.0), 231 (11.3) 
MS3 [577→289]: 271 (28.4), 245 (100), 203 (14.7), 179 (26.7), 165 (34.2), 151 (48.4), 125 
(70.4) 
Procyanidin dimer (B type)   [84] 
57 14.6 575 MS2 [575]: 431 (100), 432 (13.7) 
MS3 [575→431]: 143 (38.7), 159 (11.5), 161 (79.9), 221 (14.9), 268 (25.9), 269 (100) 
MS4 [575→431→269]: 113 (100), 158 (10.0), 161 (34.4) 
Unknown    
58 15.0 337 MS2 [337]: 191 (100)  
MS3 [337→191]: 173 (85.7), 127 (100), 111 (24.6), 93 (41.7), 85 (63.8) 
5-p-Coumaroylquinic acid    [221] 
59 15.3 367 MS2 [367]: 349 (10.7), 191 (36.5), 179 (36.5), 135 (33.3) 
MS3 [367→179]: 135 (100) 
Methyl-(5-caffeoyl)quinate   [228] 
60 15.5 391 MS2 [391]: 329 (16.6), 289 (41.5), 221 (16.2), 161 (26.7), 143 (35.0), 125 (100) 
MS3 [391→289]: 125 (100) 
Unknown    
61 16.7 479 MS2 [479]: 318 (17.4), 317 (83.0), 316 (100) 
MS3 [479→317]: 288 (30.0), 287 (98.1), 273 (12.0), 272 (34.3), 271 (100), 255 (100), 179 
(84.8), 151 (36.2) 
MS4 [479→317→271]: 179 (100), 151 (44.5) 
Myricetin-O-hexoside   [142] 
62 17.2 739 MS2 [739]: 629 (16.6), 587 (100), 569 (44.0), 435 (37.1), 339 (32.0) 
MS3 [739→587]: 569 (100), 417 (99.0), 339 (75.0), 325 (22.6), 229 (23.6) 
MS4 [739→587→339]: 229 (32.8), 178 (17.3), 177 (100), 117 (23.4) 
MS4 [739→587→417]: 376 (63.9), 308 (69.0), 281 (100), 255 (10.9), 182 (10.5) 
Unknown    
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MS3 [431→311]:  283 (83.6), 212 (100), 197 (78.6), 183 (71.0), 165 (53.8), 163 (48.6), 
119 (94.9) 
64 18.2 535 MS2 [535]: 491 (18.5), 373 (60.7), 329 (90.6), 191 (66.6), 163 (100) 
MS3 [535→329]: 311 (12.0), 285 (41.0), 163 (100), 145 (36.9), 119 (38.8) 
MS4 [535→329→163]: 119 (100) 
Coumaroyl iridoid   [84] 
65 19.5 609 MS2 [609]: 301 (100), 300 (30.3) 
MS3 [609→301]: 273 (12.0), 272 (16.3), 271 (23.7), 255 (14.2), 193 (10.6), 179 (83.1), 
151 (100), 107 (16.3) 
Quercetin-O-rutinoside 
(Rutin) 
  [200] 
66 19.6 577 
[2M-H]− 
MS2 [577]: 425 (100), 407 (63.1), 289 (12.8) 
MS3 [577→425]: 407 (100), 273 (20.2) 
MS4 [577→425→407]: 285 (100), 281 (79.3), 253 (27.9), 237 (41.0), 200 (22.8) 
Procyanidin dimer (B type)   [84] 
67 19.8 535 MS2 [535]: 491 (13.0), 373 (52.5), 372 (18.4), 371 (73.5), 330 (15.9), 329 (95.0), 311 
(28.6), 267 (11.4), 239 (15.9), 191 (100), 166 (13.6), 165 (54.3), 164 (11.5), 163 (92.1) 
MS3 [535→329]: 267 (41.7), 165 (86.7), 164 (12.2), 163 (100), 147 (18.2), 145 (13.2), 123 
(19.0), 119 (26.1) 
Coumaroyl iridoid   [84] 
68 20.4 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 323 (13.3), 297 (10.5), 217 (100), 177 (15.0) 
MS4 [451→341→217]: 191 (100), 189 (90.7) 
Cinchonain-Ib   [84] 
69 21.6 463 MS2 [463]: 318 (12.2), 317 (100) 
MS3 [463→317]: 288 (23.9), 287 (44.6), 272 (98.2), 271 (100), 269 (50.5), 232 (29.3), 179 
(96.3), 151 (44.6) 
Myricetin-O-deoxyhexoside   Standard 
70 22.6 463 MS2 [463]: 302 (11.4), 301 (100), 300 (30.1) 
MS3 [463→301]: 271 (27.4), 255 (37.0), 179 (96.0), 151 (100) 
Quercetin-O-hexoside   [84] 
71 24.1 463 MS2 [463]: 302 (11.4), 301 (100), 300 (30.1) 
MS3 [463→301]: 271 (27.4), 255 (37.0), 179 (96.0), 151 (100) 
Quercetin-O-hexoside   [84] 
72 24.3 579 MS2 [579]: 417 (100) 
MS3 [579→417]: 403 (15.1), 372 (10.2), 181 (100), 166 (41.3), 151 (15.6) 
MS4 [579→417→181]: 172 (12.3), 166 (100) 
Syringaresinol-O-hexoside    
73 24.5 575 
[2M-H]− 
MS2 [575]: 449 (100), 424 (21.8), 423 (46.9), 289 (1.,4), 285 (17.4) 
MS3 [575→449]: 287 (100) 
Procyanidin dimer (A type)   [84] 
74 26.1 433 MS2 [433]: 301 (100), 300 (92.7) 
MS3 [433→301]: 273 (11.4), 272 (38.0), 271 (100), 256 (15.9), 255 (62.7), 179 (78.7), 151 
(95.5) 
MS4 [433→301→271]: 245 (32.8), 243 (23.1), 229 (100), 227 (14.7), 211 (24.0), 199 
(13.0), 185 (13.0), 163 (18.5), 158 (10.7) 
Quercetin-O-pentoside   [84] 
75 26.1 417 MS2 [417]: 371 (32.5), 331 (12.4), 307 (100), 163 (10.3), 119 (10.5) 
MS3 [417→307]: 163 (45.7), 145 (100), 119 (25.3) 
Coumaric acid derivative 
 
   
76 26.7 593 MS2 [593]: 285 (100) 
MS3 [593→285]: 267 (49.6), 257 (100), 241 (52.0), 229 (41.3), 213 (70.2), 197 (57.2), 163 
(68.9) 
Kaempferol-O-rutinoside   [224] 
77 26.9 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 323 (17.0), 231 (21.2), 218 (15.5), 217 (100), 177 (20.1) 
MS4 [451→341→217]: 191 (39.8), 189 (12.5), 189 (100) 
Cinchonain Ib   [84] 
78 27.3 433 MS2 [433]: 301 (100) 
MS3 [433→301]: 271 (100), 255 (58.5), 179 (95.7), 151 (55.0) 
Quercetin-O-pentoside   [84] 
79 27.5 451 MS3 [451→341]: 323 (17.0), 231 (21.2), 218 (15.5), 217 (100), 177 (20.1) 
MS4 [451→341→217]: 191 (39.8), 189 (12.5), 189 (100) 
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80 28.4 505 MS2 [505]: 301 (100) 
MS3 [505→301]: 271 (74.7), 179 (54.1), 151 (100) 
Quercetin-O-(acetyl)hexoside   [224] 
81 28.7 447 MS2 [447]: 327 (15.5), 285 (100), 255 (31.1) 
MS3 [447→285]: 255 (100), 227 (41.6), 210 (28.7), 184 (53.7), 163 (23.6) 
Kaempferol-O-hexoside   [200] 
82 28.9 447 MS2 [447]: 301 (100), 300 (22.1), 285 (11.1) 
MS3 [447→301]: 272 (12.8), 179 (100), 151 (69.6) 
Quercetin-O-rhamnoside   [84] 
83 29.8 507 MS2 [507]: 345 (100), 301 (13.7) 
MS3 [507→345]: 331 (12.5), 330 (100), 317 (12.9), 315 (58.2), 301 (97.4), 274 (13.0), 273 
(35.4), 259 (15.2), 241 (10.6) 




  [230] 
84 29.9 477 MS2 [477]: 357 (19.5), 315 (100), 285 (15.9), 271 (18.2) 
MS3 [477→315]: 299 (45.5), 287 (15.1), 286 (36.2), 285 (100), 272 (16.6), 271 (68.6), 257 
(14.0), 243 (28.7) 
Isorhamnetin-O-hexoside   [224] 
85 30.0 467 MS2 [467]: 355 (13.1), 265 (100), 235 (23.1), 193 (30.9) 
MS3 [467→265]: 221 (13.4), 217 (29.5), 193 (100), 178 (55.5) 
MS4 [467→265→193]: 149 (100) 
Ferulic acid derivative    
86 30.4 505 MS2 [505]: 445 (67.4), 301 (100), 271 (17.0) 
MS3 [505→301]: 271 (74.7), 255 (81.4), 151 (100) 
Quercetin-O-(acetyl)hexoside   [224] 
87 30.9 435 MS2 [435]: 273 (100) 
MS3 [435→273]: 167 (100), 123 (35.1) 
Phloretin-O-hexoside (Phlorizin)   [79] 
88 31.5 711 MS2 [711]: 665 (12.3), 504 (27.2), 503 (100) 
MS3 [711→503]: 486 (31.5), 485 (100), 454 (11.8), 453 (31.2) 
MS4 [711→503→485]: 453 (100); 387 (100) 
Triterpene acid-O-hexoside 
(formate adduct) 
   
89 31.9 489 MS2 [489]: 285 (100) 
MS3 [489→285]: 255 (68.4), 257 (100), 229 (40.1), 213 (23.2), 197 (26.0) 
Kaempferol-O-(acetyl)hexoside   [87] 
90 32.4 533 MS2 [533]: 489 (100) 
MS3 [533→489]: 285 (100), 267 (18.9), 257 (53.1), 241 (21.6), 229 (34.1), 213 (10.7), 167 
(12.3) 
Kaempferol-O-(malonyl)hexoside    
91 32.7 549 MS2 [549]: 345 (100), 330 (13.5) 
MS3 [549→345]: 330 (100), 315 (30.5), 302 (14.4) 
MS4 [549→345→330]: 315 (100), 287 (39.3), 271 (14.2) 
6-Hydroxy-7,4-dimethoxy-quercetin-O-
(acetyl)hexoside 
   
92 32.9 491 MS2 [491]: 345 (100), 323 (12.4) 
MS3 [491→345]: 330 (100), 315 (27.7), 301 (28.2), 287 (15.3), 274 (20.3), 273 (38.4), 245 
(12.1) 
MS4 [491→345→330]: 315 (100), 287 (35.2), 271 (23.9) 
6-Hydroxy-7,4-dimethoxy-quercetin-O-
coumaroyl 
   
93 32.9 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 231 (12.9), 217 (100), 189 (15.8), 177 (12.4) 
MS4 [451→341→217]: 191 (100), 190 (10.8), 189 (93.8) 
Cinchonain-Ib   [84] 
94 32.9 439 MS2 [439]: 424 (72.8), 359 (100), 343 (10.9), 315 (29.4), 300 (16.7), 203 (12.1) 
MS3 [439→359]: 345 (47.8), 343 (15.9), 311 (100) 
MS4 [439→359→345]: 159 (100) 
Unknown    
95 33.0 549 MS2 [549]: 345 (100), 330 (13.5) 
MS3 [549→345]: 330 (100), 315 (30.5), 302 (14.4) 
MS4 [549→345→330]: 315 (100), 287 (38.8), 271 (14.2) 
6-Hydroxy-7,4-dimethoxy-quercetin-O-
(acety)lhexoside 
   
96 33.2 711 MS2 [711]: 665 (12.3), 504 (27.2), 503 (100) 
MS3 [711→503]: 486 (31.5), 485 (100), 454 (11.8), 453 (31.2) 
Triterpene acid-O-hexoside 
(formate adduct) 
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tR: retention time 
 
 
Table S 18 - Characterization of anthocyanins present on V. cylindraceum (berries) methanolic extracts by HPLC-ESI+/MSn. 
MS4 [711→503→485]: 453 (28.7), 439 (100), 423 (19.9), 421 (18.7), 419 (54.8), 387 
(15.4) 
97 33.4 489 MS2 [489]: 285 (100) 
MS3 [489→285]: 255 (68.4), 257 (100), 229 (40.1), 213 (23.2), 197 (26.0) 
Kaempferol-O-(acetyl)hexoside   [87] 
98 34.8 613 MS2 [613]: 503 (100), 461 (11.7), 393 (12.6), 341 (10.2) 
MS3 [613→503]: 393 (100), 379 (12.2), 351 (25.8), 341 (96.7), 307 (16.7) 
MS4 [613→503→393]: 375 (15.6), 304 (25.8), 285 (47.1), 255 (22.3), 241 (63.5), 239 
(100), 229 (69.1), 225 (18.2), 197 (12.1) 
bis-Dihydroxylphenylpropanoid-
substituted catechin 
  [229] 
99 35.0 543 MS2 [543]: 497 (100) 
MS3 [543→497]: 335 (100), 273 (12.3), 161 (41.8) 
MS4 [543→497→335]: 333 (40.9), 317 (29.5), 273 (100), 257 (63.4), 237 (40.4), 152 
(57.3), 137 (45.5) 
Unkown    
100 35.3 585 MS2 [585]: 371 (41.2), 359 (45.4), 357 (71.0), 345 (100) 
MS3 [585→345]: 330 (100), 299 (14.2) 
MS4 [585→345→330]: 315 (35.6), 297 (100), 256 (37.4), 251 (14.5), 213 (16.4) 
6-Hydroxy-7,4-dimethoxy-quercetin-O-
hexoside derivative 
   
101 40.3 517 MS2 [517]: 499 (17.0), 487 (26.3), 470 (29.8), 469 (100), 451 (17.1) 
MS3 [517→469]: 452 (28.4), 451 (100), 407 (13.3) 
MS4 [517→469→451]: 408 (32.9), 407 (27.5), 390 (19.9), 378 (100), 375 (24.5) 






m/z (% base peak) 
Assigned identity References 
3 3.5 597 MS2 [597]: 303 (100) 
MS3 [597→303]: 257 (59.9), 229 (4100), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-(pentosyl)hexoside [214] 
5 3.6 465 MS2 [465]: 303 (100) 




6 3.8 435 MS2 [435]: 303 (100) 
MS3 [435→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-pentoside [188,214] 
8 4.3 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 




11 4.6 465 MS2 [465]: 303 (100) 




12 4.7 435 MS2 [435]: 303 (100) 
MS3 [435→303]: 257 (100), 229 (42.2), 213 (54.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-pentoside [188,214] 
14 4.8 479 MS2 [479]: 317 (100) 
MS3 [479→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 (27.1), 150 (27.2) 
Petunidin-O-hexoside [200] 
15 4.9 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 




17 5.2 479 MS2 [479]: 317 (100) 
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tR: retention time 
 
 
18 5.3 449 MS2 [449]: 317 (100), 303 (47.7) 




21 5.4 449 MS2 [449]: 303 (100) 
MS3 [449→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
MS4 [449→303→257]: 229 (100), 213 (54.2), 201 (19.9), 147 (21.1), 117 (10.1) 
Delphinidin-O-rhamnoside [214] 
24 6.2 463 MS2 [463]: 301 (100) 




30 6.9 493 MS2 [493]: 331 (100) 




33 7.4 463 MS2 [463]: 331 (100) 
MS3 [463→331]: 315 (53.1), 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-pentoside [188,214] 
39 9.0 477 MS2 [477]: 331 (100) 
MS3 [477→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-rhamnoside  
44 10.2 463 MS2 [463]: 331 (100) 
MS3 [463→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 (27.7) 








1.6. Vaccinium padifolium 
The phytochemical profiles of different morphological parts of V. padifolium, collected in 2013 and 
2014, were determined by HPLC-ESI-MSn. Following is a brief explanation for the characterization of the 
compounds identified in V. padifolium extracts (Table S 19 and Table S 20). For a more detailed explanation, 
please check the mentioned references. 
1.6.1. Phenolic acids 
Phenolic acids (hydroxybenzoic and hydroxycinnamic acids) were identified in analysed species. 
Compound 37 exhibited [M-H]- ion at m/z 447 and protocatechuic acid at m/z 153 [M-H-294]-; it was identified 
as protocatechuic acid-O-(pentosyl)hexoside. 
Hexosides of caffeic, ferulic, coumaric and syringic acids were detected (Table S 19). Syringic acid 
conjugates were not detected in V. cylindraceum extracts. Several coumaric acid derivatives (compounds 85, 
89, 97, 110, 114, 115, 125 and 129) were tentatively characterized based typical 163→119 transition. 
Coumaroyl iridoids were also detected in this species (compounds 84, 88 and 91). Compound 107, with [M-
H+HCOO]- ion at m/z 629, yielded MS2 base peak at m/z 421 [M-H-208]-. Further fragmentation resulted in 
methyl-syringate core at m/z 211 [232]. The loss of 211 Da at MS3 is indicative of a dimer of this compound. 
Hence, 107 was tentatively characterized as di(methyl-syringate)-O-hexoside. Compound 104 showed [M-H]- 
ion at m/z 469 and was identified as 4-benzoyl-9-p-coumaroyl-2,7-anhydro-3-deoxy-2-octulopyranosonic acid 
[233]. 
3-O- and 5-O-CQAs isomers (compounds 30, 56 – 58) were also identified in V. padifolium. Other 
compounds (17, 44, 47, 48, 50, 64, 65, 79 and 93) 18, 20, 51, 55, 61, 76 and 78) with typical fragment ions at 
m/z 353 and 191, were tentatively characterized as CQAs and derivatives. 5-p-Coumaroylquinic acids 
(compounds 71 and 78) and methyl-(5-caffeoyl)quinate (compounds 76 and 83) were were characterized 
previously.  
1.6.2. Ellagic acid derivatives/Ellagitannins 
Compounds 39, with [M-H]- ion at m/z 495, was tentatively characterized as derivative of methyl-
ellagic acid. It showed methyl-ellagic acid core at m/z 315 after loss of 180 Da. 
1.6.3. Flavones 
Tricin-O-pentoside, dimethoxy-hydroxy-tricin-O-hexoside and tricin-O-hexoside (compounds 54, 68 
and 70, respectively) were previously explained.  
1.6.4. Flavan-3-ols 
Catechin oligomers (compounds 43, 63, 69 and 101) and other catechin derivatives (compounds 122 
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1.6.5. Flavonols 
Several quercetin glycosides were identified in analyzed extracts (Table S19). Quercetin-O-hexoside 
derivatives (compounds 75, 77 and 120) exhibited quercetin-O-hexoside core (at m/z 463) (compounds 94, 96 
and 99) after loss of different unidentified moieties.  
Compounds 137 displayed [M-H]- ion at m/z 653 and was identified as of 6,3-dimethoxyquercetin-3-
O--D-6-(p-coumaroyl)glucopyranoside [230]. Other conjugates of 6-hydroxy-7,4-dimethoxyquercetin (at m/z 
345) (compounds 113, 123, 126 and 128) were previously identified in V. cylindraceum. Myricetin glycosides 
(compounds 81, 90 and 95) were identified based on the nature of its moieties [79,142]. 
Laricitrin-O-hexoside (compounds 98) was identified according to literature [212]. By analogy, 
compound 112 showed an [M-H]- ion at m/z 447 and was tentatively characterized as laricitrin-O-rhamnoside. 
These compounds were absent in V. cylindraceum extracts. 
Cinchonain-I (compounds 92, 106 and 121) was also present in this Vaccinium species. 
Different kaempferol glycosides were detected in this analysis (Table S 19) based on previous 
analysis. 
1.6.6. Other compounds 
Other non-phenolic compounds (saccharides, organic acids and lignans) were also identified in the 
methanolic extracts. Compounds 1 and 12 were characterized as saccharides. Compound 14 exhibited [M-H]- 
ions at m/z 389 and glucaric acid core at m/z 209 [198] after loss of different unidentified moieties. It was 
tentatively characterized as derivative. 
1.6.7. Anthocyanins 
Twenty-eight glycosylated anthocyanins were characterized by HPLC-ESI+/MSn in V. padifolium, 
distributed in berries and YLs extracts (Table S 20). Different glycosides of delphinidin, petunidin, cyanidin, 
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m/z (% base peak) 
Assigned identity Berries Young Leaves Mature Leaves References 
2013 2014 2013 2014 2013 2014  
1 3.4 683 MS2 [683]: 342 (14.2), 341 (100) 
MS3 [683→341]: 179 (100), 161 (21.8), 143 (21.1), 119 (22.5), 
115 (10.89; 113 (41.0), 101 (16.3) 
MS4 [683→341→179]: 161 (69.4), 143 (100), 131 (43.0), 119 
(60.9), 113 (17.4), 101 (18.6), 89 (66.6), 71 (23.5) 
Hexose polymer       [207] 
2 3.5 533 MS2 [533]: 191 (100) 
MS3 [533→191]: 173 (69.7), 127 (100), 111 (42.1), 109 (25.4), 
93 (30.7), 85 (89.5) 
Quinic acid derivative       [106] 
4 3.6 191 MS2 [191]: 173 (34.4), 127 (100), 111 (18.0), 93 (76.7) 
MS3 [191→127]: 85 (100) 
Quinic acid       Standard 
6 3.8 383 
[2M-H]− 
MS2 [383]: 191 (100) 
MS3 [383→191]: 127 (100) 
Quinic acid dimer       [106] 
8 4.1 133 MS2 [133]: 115 (100) 
MS3 [133→115]: 71 (48.1) 
Malic acid       [206] 
11 4.4 191 MS2 [191]: 173 (18.5), 111 (100) 
MS3 [191→111]: 67 (100) 
Citric acid       [206] 
12 4.4 337 MS2 [337]: 277 (100), 225 (20.1), 179 (90.6), 161 (11.3), 143 
(12.2), 119 (17.0), 113 (11.6) 
MS3 [337→179]: 161 (5.7), 143 (51.9), 131 (13.3), 119 (19.7), 
89 (100) 
Saccharide        
14 4.5 389 MS2 [389]: 228 (25.9), 227 (18.3), 209 (56.8), 191 (100), 179 
(20.4), 147 (78.7), 135 (51.9), 121 (20.9) 
MS3 [389→191]: 147 (100) 
Glucaric acid derivative        
15 4.6 405 MS2 [405]: 191 (100) 
MS3 [405→191]: 111 (100) 
Citric acid derivative       [198] 
17 4.7 371 MS2 [371]: 353 (35.1), 191 (100), 179 (14.2) 
MS3 [371→191]: 173 (29.6), 127 (100), 111 (37.5), 109 (41.1), 
93 (38.8), 85 (35.4) 
Caffeoylquinic acid derivative        
22 5.0 481 MS2 [481]: 355 (48.3), 301 (100), 239 (10.3), 175 (21.5) 
MS3 [481→301]: 283 (100), 273 (47.1), 273 (10.2), 257 (45.8), 
233 (65.8), 191 (34.7), 175 (88.4) 
HHDP-O-hexoside       [201] 
24 5.2 451 MS2 [451]: 325 (22.1), 302 (23.3), 301 (100), 257 (12.2), 175 
(12.6) 
MS3 [451→301]: 283 (34.4), 273 (32.9), 259 (90.2), 258 (47.7), 
257 (100), 233 (40.9), 175 (24.7), 157 (16.7), 149 (77.9) 
MS4 [451→301→257]: 215 (100), 173 (40.3) 
Tergallagic acid       [213] 
27 5.4 359 MS2 [359]: 197 (100), 181 (17.6) 
MS3 [359→197]: 181 (100), 153 (33.3) 
MS4 [359→197→181]: 166 (86.0), 153 (100) 
Syringic acid-O-hexoside        [84] 
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MS3 [351→315]: 153 (100), 123 (29.4) 
29 5.7 315 MS2 [315]: 153 (100) 
MS3 [315→153]: 123 (100), 109 (32.2), 107 (13.4) 
Hydroxytyrosol-O-hexoside        
30 5.9 707 
[2M-H]− 
MS2 [707]: 515 (15.4), 353 (100), 323 (16.6), 321 (12.2) 
MS3 [707→353]: 191 (100), 179 (36.2) 
MS4 [707→353→191]: 173 (83.9), 127 (38.0), 111 (94.0), 93 
(100), 85 (77.1) 
3-O-Caffeoylquinic acid dimer       [221] 
33 6.1 359 MS2 [359]: 197 (100), 182 (17.6) 
MS3 [359→197]: 182 (100), 153 (13.3) 
MS4 [359→197→182]: 167 (86.0), 153 (89.0), 123 (100) 
Syringic acid-O-hexoside       [84] 
35 6.3 495 MS2 [495]: 369 (15.6), 316 (20.5), 315 (100), 271 (15.4) 
MS3 [495→315]: 301 (44.6), 300 (100), 283 (34.4), 271 (67.2), 
256 (45.2), 233 (16.0), 229 (38.7), 149 (17.8) 
Methyl-ellagic acid derivative        
37 6.7 447 MS2 [447]: 429 (17.4), 315 (100), 271 (26.8), 177 (63.9), 163 
(24.2), 153 (32.2), 149 (22.6) 
MS3 [447→315]: 153 (100), 109 (46.0) 
Protocatechuic acid-O-
(pentosyl)hexoside 
       
38 6.7 515 MS2 [515]: 455 (38.8), 447 (11.6), 395 (27.2), 353 (100), 323 
(47.0), 191 (56.4) 
MS3 [515→353]: 191 (100) 
MS4 [515→353→191]: 173 (47.2), 127 (100) 
Quinic acid-O-dihexoside        
40 6.8 447 MS2 [447]: 568 (15.0), 559 (13.0), 341 (10.9), 327 (12.7), 315 
(58.8), 314 (100), 313 (15.1), 302 (11.1), 301 (17.9), 300 (18.5), 
256 (10.5) 
MS3 [447→315]: 300 (85.8), 299 (100), 285 (16.6), 271 (85.5), 
255 (41.3), 231 (25.7), 211 (24.1), 199 (28.5) 
Methyl-ellagic acid-O-pentoside       [88] 
41 6.9 465 MS2 [465]: 421 (10.2), 419 (15.1), 315 (100), 313 (62.7), 301 
(89.8), 257 (18.1) 
MS3 [465→315]: 301 (59.2), 283 (31.6), 257 (100) 
Methyl-ellagic acid derivative        
43 7.1 577 
[2M-H]− 
MS2 [577]: 425 (91.2), 407 (100), 289 (25.3), 203 (14.0) 
MS3 [577→407]: 389 (98.3), 335 (100), 297 (79.0), 283 (25.0) 
MS3 [577→425]: 407 (100), 381 (27.3), 339 (52.7), 299 (16.4), 
299 (14.9) 
MS4 [577→425→407]: 389 (34.5), 285 (100), 284 (20.5), 281 
(24.7), 256 (29.5) 
Procyanidin dimer (B type)       [84] 
44 7.3 707 MS2 [707]: 533 (100), 515 (74.4), 463 (63.3), 353 (38.9), 323 
(78.8), 321 (12.6) 
MS3 [707→463]: 289 (80.4), 271 (17.9), 191 (100), 173 (19.4), 
127 (33.4) 
Caffeoylquinic acid derivative 
 
       
47 7.7 527 MS2 [527]: 353 (34.6), 191 (100), 179 (17.6) 
MS3 [527→353]: 191 (100), 135 (25.1), 127 (15.4) 
Caffeoylquinic acid derivative        
48 8.1 533 MS2 [533]: 515 (10.2), 353 (74.1), 243 (51.2), 191 (100) 
MS3 [533→191]: 173 (55.0), 127 (79.2), 111 (36.7), 93 (100) 
Caffeoylquinic acid derivative        
49 8.3 341 MS2 [341]: 179 (100), 135 (43.5) 
MS3 [341→179]: 135 (100) 
Caffeic acid-O-hexoside       [84] 
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MS3 [385→191]: 173 (100), 111 (38.5), 109 (16.3), 93 (72.6), 85 
(38.5) 
51 8.5 325 MS2 [325]: 163 (100) 
MS3 [325→163]: 119 (100) 
Coumaric acid-O-hexoside       [84] 
53 8.9 463 MS2 [463]: 417 (100), 364 (13.2), 181 (12.7) 
MS3 [463→417]: 255 (17.4), 181 (100), 166 (25.5) 
MS4 [463→417→181]: 166 (100) 
Syringaresinol 
(Formate adduct) 
       
54 9.0 461 MS2 [461]: 416 (51.8), 415 (32.0), 341 (33.2), 329 (95.6), 328 
(100), 301 (15.1), 299 (14.6), 272 (16.0) 
MS3 [461→329]: 315 (12.3), 314 (100), 313 (34.6), 313 (41.7), 
299 (13.3), 285 (24.9) 
MS4 [461→329→314]: 300 (61.2), 299 (100), 267 (25.3), 226 
(33.3) 
Tricin-O-pentoside        
56 9.2 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (24.7), 127 (100), 111 (16.1), 109 (28.7), 
93 (46.4), 85 (50.1) 
MS4 [353→191→127]: 109 (100), 85 (17.0) 
5-O-Caffeoylquinic acid       Standard 
57 9.6 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (10.0), 171 (57.5), 155 (91.2), 127 (98.3), 
111 (44.4), 109 (12.3), 85 (18.6) 
5-O-Caffeoylquinic acid isomer        
60 10.1 431 MS2 [431]: 385 (100), 161 (20.2), 139 (10.6) 
MS3 [431→385]: 337 (28.8), 233 (22.7), 224 (100), 223 (10.3), 
205 (18.3), 186 (54.8), 161 (76.0), 153 (85.4) 
Roseoside 
(formate adduct) 
      [106] 
62 10.3 577 
[2M-H]− 
MS2 [577]: 425 (91.2), 407 (100), 289 (25.3), 203 (14.0) 
MS3 [577→407]: 389 (98.3), 335 (100), 297 (79.0), 283 (25.0) 
MS3 [577→425]: 407 (100), 381 (27.3), 339 (52.7), 299 (16.4), 
299 (14.9) 
MS4 [577→425→407]: 389 (34.5), 285 (100), 284 (20.5), 281 
(24.7), 256 (29.5) 
Procyanin dimer (B type)       [84] 
63 10.8 707 
[2M-H]− 
MS2 [707]: 353 (100) 
MS3 [707→353]: 191 (100) 
MS4 [707→353→191]: 127 (100), 111 (40.2), 109 (65.8), 93 
(31.8) 
Caffeoylquinic acid dimer        
64 11.1 353 MS2 [353]: 191 (100) 
MS3 [353→191]: 173 (85.0), 171 (56.1), 127 (100), 111 (65.4), 
109 (53.2), 93 (52.2), 85 (48.4) 
Caffeoylquinic acid        
65 11.6 289 MS2 [289]: 245 (100), 205 (38.2), 203 (18.1), 179 (16.1) 
MS3 [289→245]: 227 (100), 203 (88.8), 188 (19.3), 175 (37.7), 
159 (20.2) 
Catechin       Standard 
66 11.8 517 MS2 [517]: 473 (51.6), 343 (85.7), 255 (79.0), 233 (12.5), 193 
(12.2), 191 (100) 
MS3 [517→191]: 173 (100), 127 (43.7), 111 (25.9) 
Quinic acid derivative        
67 12.1 539 MS2 [539]: 491 (100) 
MS3 [539→491]: 456 (18.2), 357 (100), 166 (45.4) 
MS3 [539→491]: 448 (21.5), 358 (15.3), 357 (43.3), 329 (100), 
314 (12.7) 
MS3 [539→491]: 357 (100), 329 (95.4), 314 (32.9), 297 (13.3) 
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MS4 [539→491→329]: 314 (100), 299, 283 (37.5), 265 (21.4), 
164 (36.1), 149 (92.9) 
 
68 12.7 865  
[3M-H]− 
MS2 [865]: 847 (10.9), 739 (40.9), 695 (100), 578 (23.8), 577 
(79.2), 575 (33.0), 543 (31.0), 525 (11.8), 451 (49.7), 449 (27.1), 
425 (24.1), 408 (10.4), 407 (64.6), 405 (24.6), 289 (12.2), 287 
(39.7) 
MS3 [865→695]: 676 (24.4), 677 (54.8), 658 (25.3), 568 (17.2), 
543 (100), 529 (30.6), 526 (31.7), 525 (97.6), 451 (33.0), 407 
(22.3), 405 (14.9), 391 (13.7), 363 (21.5), 289 (13.1), 256 (31.9), 
243 (84.5) 
MS4 [865→695→525]: 403 (100), 361 (50.0) 
Procyanidin trimer 
(B type) 
      [84] 
69 12.8 491 MS2 [491]: 329 (100), 330 (24.1), 331 (10.9), 345 (27.3) 
MS3 [491→329]: 314 (100), 299 (19.6), 285 (18.6), 270 (35.7) 
MS4 [491→329→314]: 271 (18.0), 283 (15.0), 298 (23.8), 299 
(100), 300 (10.1) 
Tricin-O-hexoside       [106] 
70 13.0 337 MS2 [337]: 191 (100) 
MS3 [337→191]: 173 (27.3), 171 (19.3), 127 (100), 111 (17.2), 
109 (39.1), 93 (37.3), 85 (57.7) 
5-p-Coumaroylquinic acid       [221] 
71 13.8 791 MS2 [791]: 679 (100), 619 (29.6), 517 (43.8)  
MS3 [791→679]: 619 (28.4), 589 (15.1), 559 (18.4), 517 (100), 
473 (14.9), 191 (10.4) 
MS4 [791→679→517]: 473 (90.4), 353 (24.2), 191 (100) 
Caffeyolquinic acid derivative        
72 14.2 625 MS2 [625]: 463 (16.9), 301 (100) 
MS3 [625→301]: 272 (41.6), 256 (79.0), 255 (62.9), 179 (100), 
151 (89.1) 
Quercetin-O-dihexoside       [200] 
73 15.0 791 MS2 [791]: 679 (100), 619 (91.4), 589 (23.9), 517 (46.4)  
MS3 [791→679]: 619 (100), 589 (55.6), 517 (66.9), 353 (18.9), 
191 (19.9) 
MS4 [791→679→619]: 517 (88.1), 353 (22.4), 299 (60.7), 256 
(15.8), 227 (16.1), 191 (100) 
Caffeyolquinic acid derivative        
74 15.0 643 MS2 [643]: 463 (100)  
MS3 [643→463]: 301 (100) 
MS4 [643→463→301]: 229 (14.5), 179 (100), 151 (23.8) 
Quercetin-O-hexoside derivative        
75 15.3 367 MS2 [367]: 349 (10.7), 191 (36.5), 179 (36.5), 135 (33.3) 
MS3 [367→179]: 135 (100) 
Methyl-(5-caffeoyl)quinate       [228] 
76 15.9 635 MS2 [635]: 463 (100), 301 (12.9) 
MS3 [635→463]: 301 (100), 151 (45.1) 
Quercetin-O-hexoside derivative        
77 16.2 337 MS2 [337]: 191 (100)  
MS3 [337→191]: 173 (14.2), 127 (100), 109 (41.2), 93 (31.3) 
5-p-Coumaroylquinic acid       [221] 
78 16.3 791 MS2 [791]: 679 (100), 619 (59.4), 589 (14.0), 559 (10.6), 517 
(37.2) 
MS3 [791→679]: 619 (72.9), 589 (18.5), 559 (17.1), 517 (100), 
353 (11.6)  
MS4 [791→679→517]: 353 (35.4), 289 (47.9), 255 (71.0), 191 
(100), 173 (10.7) 
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79 16.4 595 MS2 [595]: 445 (18.4), 301 (47.4), 301 (100), 271 (16.1), 255 
(10.8) 
MS3 [595→301]: 271 (100), 255 (74.5), 193 (51.5), 179 (19.8), 
151 (50.0) 
Quercetin-O-(pentosyl)hexoside       [84] 
80 16.7 479 MS2 [479]: 318 (17.4), 317 (83.0), 316 (100) 
MS3 [479→317]: 288 (30.0), 287 (98.1), 273 (12.0), 272 (34.3), 
271 (100), 255 (100), 179 (84.8), 151 (36.2) 
MS4 [479→317→271]: 179 (100), 151 (44.5) 
Myricetin-O-hexoside       [142] 
81 17.2 739 MS2 [739]: 629 (16.6), 587 (100), 569 (44.0), 435 (37.1), 339 
(32.0) 
MS3 [739→587]: 569 (100), 417 (99.0), 339 (75.0), 325 (22.6), 
229 (23.6) 
MS4 [739→587→339]: 229 (32.8), 178 (17.3), 177 (100), 117 
(23.4) 
MS4 [739→587→417]: 376 (63.9), 308 (69.0), 281 (100), 255 
(10.9), 182 (10.5) 
Unknown        
82 17.9 367 MS2 [367]: 191 (17.0), 179 (100), 161 (17.5), 135 (62.7) 
MS3 [367→179]: 135 (100) 
Methyl-(5-caffeoyl)quinate       [228] 
83 18.2 535 MS2 [535]: 491 (18.5), 373 (60.7), 329 (90.6), 191 (66.6), 163 
(100) 
MS3 [535→329]: 311 (12.0), 285 (41.0), 163 (100), 145 (36.9), 
119 (38.8) 
MS4 [535→329→163]: 119 (100) 
Coumaroyl iridoid       [84] 
84 18.4 455 MS2 [455]: 325 (48.1), 265 (97.1), 235 (100), 163 (39.3) 
MS3 [455→235]: 163 (100), 119 (46.7) 
MS3 [455→265]: 205 (100), 163 (86.4), 119 (30.0) 
Coumaric acid derivative        
85 19.0 355 MS2 [355]:194 (11.5), 193 (100) 
MS3 [355→193]:162 (35.8), 134 (100) 
Ferulic acid-O-hexoside       [80] 
86 19.5 609 MS2 [609]: 301 (100), 300 (30.3) 
MS3 [609→301]: 273 (12.0), 272 (16.3), 271 (23.7), 255 (14.2), 
193 (10.6), 179 (83.1), 151 (100), 107 (16.3) 
Quercetin-O-rutinoside 
(Rutin) 
      [200] 
87 19.8 535 MS2 [535]: 491 (13.0), 373 (52.5), 372 (18.4), 371 (73.5), 330 
(15.9), 329 (95.0), 311 (28.6), 267 (11.4), 239 (15.9), 191 (100), 
166 (13.6), 165 (54.3), 164 (11.5), 163 (92.1) 
MS3 [535→329]: 267 (41.7), 165 (86.7), 164 (12.2), 163 (100), 
147 (18.2), 145 (13.2), 123 (19.0), 119 (26.1) 
Coumaroyl iridoid       [84] 
88 19.9 455 MS2 [455]: 385 (20.1), 325 (25.3), 265 (72.6), 235 (100), 163 
(38.1), 145 (11.0) 
MS3 [455→235]: 163 (100) 
MS3 [455→265]: 205 (100), 163 (33.3), 119 (15.8) 
Coumaric acid derivative        
89 19.9 449 MS2 [449]: 317 (51.4), 316 (100), 271 (16.2), 241 (11.6) 
MS3 [449→317]: 271 (100), 243 (22.0), 242 (21.4), 179 (62.8), 
151 (29.5) 
Myricetin-O-pentoside       [79] 
90 20.2 535 MS2 [535]: 491 (45.3), 371 (100), 329 (79.5), 191 (91.8), 163 
(92.8), 161 (11.7) 
MS3 [535→329]: 163 (83.8), 147 (17.5), 119 (100) 
Coumaroyl iridoid       [84] 
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MS3 [451→341]: 323 (13.3), 297 (10.5), 217 (100), 177 (15.0) 
MS4 [451→341→217]: 191 (100), 189 (90.7) 
92 20.9 689 MS2 [689]: 527 (100), 353 (59.7), 191 (10.5) 
MS3 [689→527]: 353 (99.6), 191 (100), 179 (22.8) 
MS4 [689→527→353]: 191 (100) 
Caffeoylquinic acid derivative        
93 21.5 463 MS2 [463]: 302 (11.4), 301 (100), 300 (30.1) 
MS3 [463→301]: 271 (27.4), 255 (37.0), 179 (96.0), 151 (100) 
Quercetin-O-hexoside       [84] 
94 21.6 463 MS2 [463]: 318 (12.2), 317 (100) 
MS3 [463→317]: 288 (23.9), 287 (44.6), 272 (98.2), 271 (100), 
269 (50.5), 232 (29.3), 179 (96.3), 151 (44.6) 
Myricetin-O-deoxyhexoside       Standard 
95 22.6 463 MS2 [463]: 302 (11.4), 301 (100), 300 (30.1) 
MS3 [463→301]: 271 (27.4), 255 (37.0), 179 (96.0), 151 (100) 
Quercetin-O-hexoside       [84] 
96 23.3 535 MS2 [535]: 517 (11.5), 473 (17.0), 371 (23.2), 355 (100), 329 
(70.2), 311 (36.1), 163 (16.3), 147 (22.6) 
MS3 [535→355]: 163 (96.3), 147 (18.7), 119 (22.1) 
Coumaric acid derivative        
97 23.8 493 MS2 [493]: 456 (10.3), 331 (100), 330 (36.2) 
MS3 [493→331]: 316 (100), 315 (16.2), 193 (11.4), 179 (46.3), 
151 (10.3) 
MS4 [493→331→316]: 299 (15.4), 273 (24.9), 271 (31.4), 270 
(72.4), 203 (94.6), 179 (80.2), 151 (100) 
Laricitrin-O-hexoside       [212] 
98 24.1 463 MS2 [463]: 302 (11.4), 301 (100), 300 (30.1) 
MS3 [463→301]: 271 (27.4), 255 (37.0), 179 (96.0), 151 (100) 
Quercetin-O-hexoside       [84] 
99 24.3 579 MS2 [579]: 417 (100) 
MS3 [579→417]: 403 (15.1), 372 (10.2), 181 (100), 166 (41.3), 
151 (15.6) 
MS4 [579→417→181]: 172 (12.3), 166 (100) 
Syringaresinol-O-hexoside        
100 24.5 575 
[2M-H]− 
MS2 [575]: 449 (100), 424 (21.8), 423 (46.9), 289 (1.,4), 285 
(17.4) 
MS3 [575→449]: 287 (100) 
Procyanidin dimer (A type)       [84] 
101 26.1 433 MS2 [433]: 301 (100), 300 (92.7) 
MS3 [433→301]: 273 (11.4), 272 (38.0), 271 (100), 256 (15.9), 
255 (62.7), 179 (78.7), 151 (95.5) 
MS4 [433→301→271]: 245 (32.8), 243 (23.1), 229 (100), 227 
(14.7), 211 (24.0), 199 (13.0), 185 (13.0), 163 (18.5), 158 (10.7) 
Quercetin-O-pentoside       [84] 
102 26.7 593 MS2 [593]: 285 (100) 
MS3 [593→285]: 267 (49.6), 257 (100), 241 (52.0), 229 (41.3), 
213 (70.2), 197 (57.2), 163 (68.9) 
Kaempferol-O-rutinoside       [224] 
103 27.0 469 MS2 [469]: 326 (10.1), 325 (83.8), 265 (80.8), 235 (100), 163 
(16.7) 
MS3 [469→235]: 163 (100) 
MS4 [469→235→163]: 119 (100) 
4-Benzoyl-9-p-coumaroyl- 2,7-
anhydro-3-DOA 
      [233] 
104 27.3 433 MS2 [433]: 301 (100) 
MS3 [433→301]: 271 (100), 255 (58.5), 179 (95.7), 151 (55.0) 
Quercetin-O-pentoside       [84] 
105 27.5 451 MS3 [451→341]: 323 (17.0), 231 (21.2), 218 (15.5), 217 (100), 
177 (20.1) 
MS4 [451→341→217]: 191 (39.8), 189 (12.5), 189 (100) 
Cinchonain-Ib       [84] 
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MS3 [629→421]: 211 (100), 196 (25.5), 181 (44.4), 153 (33.7) 
MS4 [629→421→211]: 197 (65.7), 196 (100) 
(formate adduct) 
107 28.4 505 MS2 [505]: 301 (100) 
MS3 [505→301]: 271 (74.7), 179 (54.1), 151 (100) 
Quercetin-O-(acetyl)hexoside       [224] 
108 28.7 447 MS2 [447]: 327 (15.5), 285 (100), 255 (31.1) 
MS3 [447→285]: 255 (100), 227 (41.6), 210 (28.7), 184 (53.7), 
163 (23.6) 
Kaempferol-O-hexoside       [200] 
109 28.9 437 MS2 [437]: 325 (45.5), 267 (13.0), 265 (76.2), 235 (100), 163 
(25.8) 
MS3 [437→235]: 163 (100), 119 (12.5) 
Coumaric acid derivative        
110 28.6 653 MS2 [653]: 593 (10.7), 491 (33.4), 345 (100), 330 (38.9), 315 
(17.7) 
MS3 [653→345]: 330 (100), 329 (17.6), 315 (42.4), 287 (31.8), 
285 (17.4), 271 (41.9) 
6,3-Dimethoxyquercetin-3-O--D-6-
(p-coumaroyl)glucopyranoside 
      [230] 
111 29.8 477 MS2 [477]: 437 (10.2), 331 (100), 315 (13.1), 287 (14.6), 271 
(10.1) 
MS3 [477→331]: 316 (100), 298 (12.4), 287 (10.8), 272 (11.6), 
151 (13.1) 
MS4 [477→331→316]: 287 (100), 179 (89.3) 
Laricitrin-O-rhamnoside        
112 29.8 507 MS2 [507]: 345 (100), 301 (13.7) 
MS3 [507→345]: 331 (12.5), 330 (100), 317 (12.9), 315 (58.2), 
301 (97.4), 274 (13.0), 273 (35.4), 259 (15.2), 241 (10.6) 
MS3 [507→345→301]: 286 (79.4), 273 (20.6), 270 (33.9), 269 
(100), 258 (23.7), 241 (78.8) 
6-Hydroxy-7,4-dimethoxyquercetin-
O-hexoside 
      [230] 
113 30.0 437 MS2 [437]: 325 (45.5), 267 (13.0), 265 (76.2), 235 (100), 163 
(25.8) 
MS3 [437→235]: 163 (100) 
MS3 [437→265]: 205 (100), 163 (72.5), 119 (78.5) 
Coumaric acid derivative        
114 30.1 473 MS2 [473]: 438 (20.3), 437 (100), 325 (58.2), 265 (19.2), 235 
(41.0) 
MS3 [473→437]: 325 (78.6), 265 (87.5), 236 (20.3), 235 (100), 
205 (14.2), 163 (23.2) 
MS4 [473→437→235]: 163 (100), 119 (13.5) 
Coumaric acid derivative        
115 30.4 505 MS2 [505]: 445 (67.4), 301 (100), 271 (17.0) 
MS3 [505→301]: 271 (74.7), 255 (81.4), 151 (100) 
Quercetin-O-(acetyl)hexoside       [224] 
116 31.8 417 MS2 [417]: 285 (100) 
MS3 [417→285]: 267 (18.9), 257 (53.1), 255 (100), 241 (21.6), 
229 (39.0) 
Kaempferol-O-pentoside       [107] 
117 31.9 489 MS2 [489]: 285 (100) 
MS3 [489→285]: 255 (68.4), 257 (100), 229 (40.1), 213 (23.2), 
197 (26.0) 
Kaempferol-O-(acetyl)hexoside       [87] 
118 32.4 533 MS2 [533]: 489 (100) 
MS3 [533→489]: 285 (100), 267 (18.9), 257 (53.1), 241 (21.6), 
229 (34.1), 213 (10.7), 167 (12.3) 
Kaempferol-O-(malonyl)hexoside        
119 32.5 563 MS2 [563]: 531 (100), 463 (79.7) 
MS3 [563→531]: 463 (100), 301 (18.9) 
MS4 [563→531→463]: 301 (99.3), 179 (100), 151 (18.2) 
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120 32.8 451 MS2 [451]: 341 (100) 
MS3 [451→341]: 231 (12.9), 217 (100), 189 (15.8), 177 (12.4) 
MS4 [451→341→217]: 191 (100), 190 (10.8), 189 (93.8) 
Cinchonain-Ib       [84] 
121 33.0 613 MS2 [613]: 503 (100), 461 (11.7), 393 (12.6), 341 (10.2) 
MS3 [613→503]: 393 (100), 379 (12.2), 351 (25.8), 341 (96.7), 
307 (16.7) 
MS4 [613→503→393]: 375 (15.6), 304 (25.8), 285 (47.1), 255 
(22.3), 241 (63.5), 239 (100), 229 (69.1), 225 (18.2), 197 (12.1) 
bis-Dihydroxylphenylpropanoid-
substituted catechin 
      [229] 
122 33.1 549 MS2 [549]: 345 (100), 330 (13.5) 
MS3 [549→345]: 330 (100), 315 (30.5), 302 (14.4) 
MS4 [549→345→330]: 315 (100), 287 (38.8), 271 (14.2) 
6-Hydroxy-7,4-dimethoxy-quercetin-
O-(acety)lhexoside 
       
123 33.4 489 MS2 [489]: 285 (100) 
MS3 [489→285]: 255 (68.4), 257 (100), 229 (40.1), 213 (23.2), 
197 (26.0) 
Kaempferol-O-(acetyl)hexoside       [87] 
124 33.9 471 MS2 [471]: 307 (100), 163 (23.8), 145 (18.7) 
MS3 [471→307]: 247 (24.2), 201 (30.7), 187 (28.5), 163 (59.9), 
159 (15.2), 145 (100), 119 (25.1) 
Coumaric acid derivative        
125 34.5 585 MS2 [585]: 555 (16.0), 537 (73.0), 371 (41.1), 359 (37.0), 357 
(79.5), 345 (100) 
MS3 [585→345]: 330 (100) 
MS4 [585→345→330]: 297 (100), 255 (63.7), 213 (43.6) 
6-Hydroxy-7,4-dimethoxyquercetin 
derivative 
       
126 34.8 613 MS2 [613]: 503 (100), 461 (11.7), 393 (12.6), 341 (10.2) 
MS3 [613→503]: 393 (100), 379 (12.2), 351 (25.8), 341 (96.7), 
307 (16.7) 
MS4 [613→503→393]: 375 (15.6), 304 (25.8), 285 (47.1), 255 
(22.3), 241 (63.5), 239 (100), 229 (69.1), 225 (18.2), 197 (12.1) 
bis-Dihydroxylphenylpropanoid-
substituted catechin 
      [229] 
127 35.3 585 MS2 [585]: 371 (41.2), 359 (45.4), 357 (71.0), 345 (100) 
MS3 [585→345]: 330 (100), 299 (14.2) 
MS4 [585→345→330]: 315 (35.6), 297 (100), 256 (37.4), 251 
(14.5), 213 (16.4) 
6-Hydroxy-7,4-dimethoxyquercetin 
derivative 
       
128 35.5 479 MS2 [479]: 307 (100), 289 (11.6), 235 (44.8), 163 (54.2), 145 
(10.4) 
MS3 [479→307]: 259 (17.1), 235 (31.4), 217 (19.7), 215 (15.6), 
163 (100), 119 (18.1) 
Coumaric acid derivative        
129 38.0 763 MS2 [763]: 343 (100), 328 (13.5) 
MS3 [763→343]: 328 (100), 183 (17.1), 164 (14.7) 
MS4 [763→343→328]: 236 (31.2), 224 (25.3), 212 (33.1), 183 
(61.1), 183 (86.0), 182 (100), 164 (67.3), 138 (32.7), 121 (16.0) 
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m/z (% base peak) 
Assigned identity Berries Young 
Leaves 
References 
2013 2014 2013 2014  
3 3.5 597 MS2 [597]: 303 (100) 
MS3 [597→303]: 257 (59.9), 229 (4100), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-
(pentosyl)hexoside 
    [214] 
5 3.6 465 MS2 [465]: 303 (100) 
MS3 [465→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-hexoside 
 
    [200] 
7 3.8 435 MS2 [435]: 303 (100) 
MS3 [435→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-pentoside     [188,214] 
9 4.1 479 MS2 [479]: 317 (100) 
MS3 [479→317]: 302 (100), 275 (12.6), 274 (50.0), 246 (15.4), 229 (11.7), 228 (10.3)  
Petunidin-O-hexoside 
 
    [200] 
10 4.3 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 




    Standard 
13 4.4 597 MS2 [597]: 303 (100) 
MS3 [597→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-
(pentosyl)hexoside 
    [214] 
16 4.6 465 MS2 [465]: 303 (100) 




    [200] 
18 4.7 435 MS2 [435]: 303 (100) 
MS3 [435→303]: 257 (100), 229 (42.2), 213 (54.2), 201 (26.8), 159 (46.6), 150 (25.7) 
Delphinidin-O-pentoside     [188,214] 
19 4.8 611 MS2 [611]: 317 (100) 
MS3 [611→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 
(27.1), 150 (27.2) 
Petunidin-O-
(pentosyl)hexoside 
    [214] 
20 4.8 479 MS2 [479]: 317 (100) 
MS3 [479→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 
(27.1), 150 (27.2) 
Petunidin-O-hexoside     [200] 
21 4.9 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 




     
23 5.1 419 MS2 [419]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [419→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 
(19.2) 
Cyanindin-O-pentoside     [188,214] 
25 5.2 479 MS2 [479]: 317 (100) 
MS3 [479→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 
(27.1), 150 (27.2) 
Petunidin-O-hexoside 
 
    [200] 
26 5.3 449 MS2 [449]: 317 (100), 303 (47.7) 
MS3 [449→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 
(27.1), 150 (27.2) 
Petunidin-O-pentoside 
 
    [214] 
28 5.4 449 MS2 [449]: 303 (100) 
MS3 [449→303]: 257 (100), 229 (42.2), 201 (26.8), 159 (46.6), 150 (25.7) 
MS4 [449→303→257]: 229 (100), 213 (54.2), 201 (19.9), 147 (21.1), 117 (10.1) 
Delphinidin-O-rhamnoside     [214] 
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MS3 [493→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 
(27.7) 
32 6.0 449 MS2 [449]: 317 (100), 303 (47.7) 
MS3 [449→317]: 303 (100), 274 (57.3), 257 (14.4), 245 (24.3), 229 (34.4), 218 (33.1), 203 
(27.1), 150 (27.2) 
Petunidin-O-pentoside 
 
    [214] 
34 6.2 463 MS2 [463]: 301 (100) 
MS3 [463→301]: 287 (100), 268 (0.3), 258 (50.0), 230 (50.4), 213 (36.7), 202 (26.4), 187 
(14.4), 177 (11.1), 147 (11.0) 
Peonidin-O-hexoside 
 
    [200] 
36 6.6 627 MS2 [627]: 465 (100), 303 (28.9) 
MS3 [627→465]: 303 (54.7), 257 (100), 229 (42.2), 213 (54.2), 201 (26.8), 159 (46.6), 150 
(25.7) 
Delphinidin-O-dihexoside     [206] 
39 6.7 449 MS2 [449]: 317 (17.4), 303 (61.9), 287 (100) 
MS3 [449→287]: 241 (82.2), 213 (100), 175 (57.6), 161 (87.3), 153 (78.9), 137 (24.6), 109 
(19.2) 
Cyanidin-O-hexoside       
42 6.9 493 MS2 [493]: 331 (100) 
MS3 [493→331]: 315 (53.1), 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-hexoside 
 
    [200] 
45 7.4 463 MS2 [463]: 331 (100) 
MS3 [463→331]: 315 (53.1), 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-pentoside     [188,214] 
46 7.5 493 MS2 [493]: 331 (100) 
MS3 [493→331]: 315 (53.1), 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-hexoside      [200] 
52 8.8 493 MS2 [493]: 331 (100) 
MS3 [493→331]: 315 (53.1), 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-hexoside      [200] 
55 9.0 477 MS2 [477]: 331 (100) 
MS3 [477→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 
(27.7) 
Malvidin-O-rhamnoside      
58 9.6 493 MS2 [493]: 331 (100) 
MS3 [493→331]: 299 (100), 287 (21.3), 271 (15.9), 242 (13.4), 179 (27.7) 
Malvidin-O-hexoside      [200] 
59 10.0 477 MS2 [477]: 331 (100) 
MS3 [477→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 
(27.7) 
Malvidin-O-rhamnoside       
61 10.2 463 MS2 [463]: 331 (100) 
MS3 [463→331]: 315 (100), 299 (66.5), 298 (28.1), 287 (50.3), 271 (15.9), 242 (13.4), 179 
(27.7) 
Malvidin-O-pentoside      [188,214] 
 
 
 
 
 
 
 
 
 
 
 
